Sentence,class,file
"Surgical Treatment for Brain Metastasis in NSCLC  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 111Black PM, et al.",Non-OADS,/arxiv_data1/oa_pdf/37/cb/ymj-56-103.PMC4276743.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 112The Effect of  Bortezomib on Expression of  Inflammatory  Cytokines and Survival in a Murine Sepsis Model Induced   by Cecal Ligation and Puncture Sang Hoon Han,1 Jin Seok Kim,1 Jun Hee Woo,2 Su Jin Jeong,1 Jeon-Soo Shin,3   Young Soo Ahn,4 and June Myung Kim1 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul; 2Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 3Department of Microbiology, Brain Korea 21 Project for Medical Science, Yonsei University College of Medicine, Seoul; 4Brain Korea 21 Project for Medical Science, Brain Research Institute and Department of Pharmacology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Although the proteasome inhibitor known as bortezomib can modulate the  inflammatory process through the nuclear factor-kappa B signaling pathway, the im - munomodulatory effect of pre-incubated bortezomib has not been fully evaluated for inflammation by infectious agents.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Key Words:    Bortezomib, proteasome inhibitor, lipopolysaccharide, inflammatory  cytokines, cecal ligation and puncture INTRODUCTION The proteasome inhibitors that halt the non-lysosomal degradation of cellular pro -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.112 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):112-123, 2015",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 113MATERIALS AND METHODS Cell culture The murine-macrophage-like cell line RAW 264.7, which is  most commonly used in LPS-treated sepsis in in vitro  experi - ments, was prepared.16 The RAW 264.7 cells were purchased  from the Korean Cell Line Bank, Seoul, Korea and main - tained at 37°C in liquid growth media composed of Dulbec - co’s Modified Eagle Medium (DMEM), 10% fetal bovine  serum (FBS), and penicillin (100 unit/mL) and streptomycin  (100 μg/mL) (WelGENE Inc., Daegu, Korea) for all the ex - periments.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 114ty) was measured at 450 nm.,OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 115administration of bortezomib on survival, the mice (n=8)  that had received bortezomib at a 0.01 mg/kg concentration  24 hr after CLP surgery were compared with the positive  control group.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 116LPS alone, without pre-incubation with bortezomib (the ar - rows in Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 11725 or 50 nM of bortezomib.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 118ezomib at the 0.01 mg/kg concentration 1 hr before CLP  surgery showed minimal infiltration of inflammatory cells  in the pulmonary parenchyma.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 119deleterious effects associated with multiple organ failure  and shock.28  The UPS is the major proteolytic mechanism for non-ly - sosomal degradation of cellular proteins.10 UPS plays a role  in turnover and quality control of proteins,29 cell cycle and  apoptosis,30,31 transcription and cell signaling,32-35 immune  response and antigen presentation,36 and inflammation and  development.37,38 Bortezomib, a peptide-boronic acid ana - log, has been shown to have potent inhibitory activity at the  chymotrypsin-like subunit in the 20S core of proteasomes.39  It is the first drug of its kind that has received accelerated  approval for the treatment of relapsed or refractory multiple  myeloma.39 A significant decrease in the level of NF-κB, re -fore CLP surgery (Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 120to host defense and their blockade is excessively immuno - suppressive.44 Measurements of circulating concentrations  of inflammatory mediators may prove to be useful in evalu - ating the stage of sepsis and in tailoring the administration  of anti-inflammatory agents.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 121ter the development of sepsis.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 122ed or damaged proteins.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
Bortezomib and Sepsis in a Murine CLP Model Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 123assay.,Non-OADS,/arxiv_data1/oa_pdf/e5/84/ymj-56-112.PMC4276744.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 124Risk Factors for Osteoarthritis and Contributing Factors to  Current Arthritic Pain in South Korean Older Adults Kyoung Min Lee,1 Chin Youb Chung,1 Ki Hyuk Sung,2 Seung Yeol Lee,3 Sung Hun Won,1   Tae Gyun Kim,4 Young Choi,5 Soon-Sun Kwon,6 Yeon Ho Kim,1 and Moon Seok Park1 Departments of 1Orthopaedic Surgery and 6Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam; 2Department of Orthopaedic Surgery, Myongji Hospital, Goyang; 3Department of Orthopaedic Surgery, Ewha Womans University Hospital, Seoul;  4Department of Orthopaedic Surgery, Gwang Hye Hospital, Busan; 5Department of Orthopaedic Surgery, Konyang University Hospital, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Although previous studies have focused on risk factors for osteoarthritis,  there is some debate on this issue.",Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"Key Words:    Osteoarthritis, joint related pain, risk factors, older adults INTRODUCTION Reflecting the impact of osteoarthritis on our lives, numerous studies have set out  to investigate the risk factors of the disease.1-11 However, studies have shown  somewhat inconsistent or often conflicting results in terms of body mass index Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.124 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):124-131, 2015",Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"Osteoarthritis and Arthralgia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 125form international physical activity questionnaire, 5) health  related quality of life (evaluated by using EuroQoL), and 6)  psychological aspects (subjective health status using a Lik - ert scale, suicidal ideation, stress, and depressive mood).",Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 126In binary logistic regression analysis, the variables that  were significantly different between the osteoarthritis and  non-osteoarthritis groups were included except for height  and waist circumference because these two were represent - ed by BMI.",OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
Osteoarthritis and Arthralgia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 127Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 128associated with osteoarthritis, while higher education level  (p=0.025) was a significant protective factor against osteo - arthritis.",Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
Osteoarthritis and Arthralgia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 129thritic pain at the same time.,Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 130REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
Osteoarthritis and Arthralgia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 131by high sensitivity C reactive protein.,Non-OADS,/arxiv_data1/oa_pdf/7f/d2/ymj-56-124.PMC4276745.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 132Characteristics and Trends of  Published Adult Hip   Research over the Last Decade  Hong Suk Kwak,1,2 Pil Whan Yoon,3 Moon Seok Park,4 Jeong Joon Yoo,1 and Hee Joong Kim1,5 1Department of Orthopaedic Surgery, Seoul National University College of Medicine, Seoul; 2Department of Orthopaedic Surgery, SMG-SNU Boramae Medical Center, Seoul; 3Department of Orthopedic Surgery, Asan Medical Center, Seoul; 4Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam; 5Medical Research Center, Seoul National University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: We designed this study to demonstrate recent trends in the proportion of  adult hip research in orthopedics, to identify countries leading the adult hip re - search, and to evaluate the relationship between the economic power of the coun - tries and their contributions.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Several studies have addressed the relationship between the economic power of countries with research Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.132 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):132-138, 2015",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Geographic Characteristics of Adult Hip Articles Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 133thopedic surgery, such as The Spine Journal or Arthrosco - py, were excluded.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 134RESULTS   A total of 7218 articles were published in 2000, 2005, 2009,  and 2011 in the seven journals.",OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Geographic Characteristics of Adult Hip Articles Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 135DISCUSSION The importance of clinical publications is growing, howev - er, the state of published adult hip research remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 136crepancy between our selections, some articles could have  been excluded although they were related to the adult hip.",Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
Geographic Characteristics of Adult Hip Articles Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 137reasons.,Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 138presented at the Annual Meeting of The American Academy of  Orthopaedic Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/1d/2f/ymj-56-132.PMC4276746.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 139Incidence of  Deep Vein Thrombosis after Major Lower Limb  Orthopedic Surgery: Analysis of  a Nationwide Claim Registry Seung Yeol Lee,1* Du Hyun Ro,2* Chin Youb Chung,2 Kyoung Min Lee,2   Soon-Sun Kwon,3 Ki Hyuk Sung,4 and Moon Seok Park2 1Department of Orthopaedic Surgery, Ewha Womans University Mokdong Hospital, Seoul; 2Department of Orthopaedic Surgery, 3Biomedical Research Institute, Seoul National University Bundang Hospital, Seongnam;   4Department of Orthopaedic Surgery, Myongji Hospital, Goyang, Korea.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: We aimed to evaluate the nationwide incidence and risk factors for symp - tomatic deep vein thrombosis (DVT) after major lower limb orthopedic surgeries.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"1 In the United States, DVT and PE result in Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.139 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):139-145, 2015",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 140is obliged to enroll in the government-operated National  Health Insurance (NHI) program, which is the only public  medical insurance system.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"DVT after Major Lower Limb Orthopedic Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 141there were differences in the population size for each year  with regard to age and gender, the age- and gender-adjusted  annual incidence of DVT was also calculated, after adjust - ing with the 2009 population.",OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 142from 2008 to 2011.,Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"DVT after Major Lower Limb Orthopedic Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 143Interestingly, we found that knee replacement arthroplasty  cases showed the highest incidence of postoperative DVT.",Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 1446.,Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
DVT after Major Lower Limb Orthopedic Surgery Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 145past and future population changes on the number of arthroplasties  performed.,Non-OADS,/arxiv_data1/oa_pdf/8b/6f/ymj-56-139.PMC4276747.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 146Finite Element Analysis for Comparison of  Spinous Process  Osteotomies Technique with Conventional Laminectomy   as Lumbar Decompression Procedure Ho-Joong Kim,1* Heoung-Jae Chun,2* Kyoung-Tak Kang,2 Hwan-Mo Lee,3   Bong-Soon Chang,4 Choon-Ki Lee,4 and Jin S. Yeom1 1Spine Center and Department of Orthopedic Surgery, Seoul National University College of Medicine,   Seoul National University Bundang Hospital, Seongnam; 2Department of Mechanical Engineering, Yonsei University, Seoul; 3Department of Orthopedic Surgery, Yonsei University College of Medicine, Seoul; 4Department of Orthopedic Surgery, Seoul National University College of Medicine, Seoul National University Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose of this study was to evaluate and compare the biomechani - cal behavior of the lumbar spine after posterior decompression with the spinous  process osteotomy (SPiO) technique or the conventional laminectomy (CL) tech - nique using a finite element (FE) model.",Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
"Key Words:    Lumbar spinal stenosis, spinous process osteotomies, conventional  laminectomy, finite element model INTRODUCTION Degenerative lumbar stenosis (DLS) is a common condition in degenerative Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.146 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):146-153, 2015",Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
"Biomechanical Analysis of Decompression Technique Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 147MATERIALS AND METHODS An FE model of the intact lumbar spine (L2 ‒5) We developed a three-dimensional (3D) nonlinear FE model  of the lumbar spine that consisted of four lumbar vertebrae,  three intervertebral discs, and the associated spinal ligaments.",OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 148moval of the ligamentum flavum of L3‒4 was then per - formed.,Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
Biomechanical Analysis of Decompression Technique Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 149model and a 13.8% increase in the SPiO model (Figs.,OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 150dex segment under both the flexion and torsion moments.,Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
"Biomechanical Analysis of Decompression Technique Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 151differ between decompression with and without fusion.27,28  Given that facet cysts are associated with degenerative  changes, the markedly increased facet contact force after de - compression surgery might be a cause of the development or  recurrence of facet cysts.",Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 15210.,Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
Biomechanical Analysis of Decompression Technique Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 15330.,Non-OADS,/arxiv_data1/oa_pdf/4e/95/ymj-56-146.PMC4276748.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 154Effect of  the Starting Point of  Half-Pin Insertion   on the Insertional Torque of  the Pin at the Tibia Sung-Jae Kim, Sung-Hwan Kim, Young-Hwan Kim, and Yong-Min Chun Department of Orthopaedic Surgery, Arthroscopy and Joint Research Institute,  Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The authors have observed a failure to achieve secure fixation in elderly  patients when inserting a half-pin at the anteromedial surface of the tibia.",Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
"1-5 Osteoporosis, a frequent comorbidity  in elderly patients, increases the likelihood of loosening.6 Although osteoporosis is  characterized by thinner cross-linking within trabecular bone and follows a de - crease in cancellous bone mineral density, cortical bone density also decreases.7 Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.154 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):154-158, 2015",Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
Insertion Torque of a Half-Pin Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 155determine where the half-pin should be inserted at the mid- shaft of the tibia to compare the insertion torque by inser - tion site.,Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 156drill bit, a pilot hole was created across the near and far cor - tices.",Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
Insertion Torque of a Half-Pin Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 157drill with a mallet.,Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 158figures and research.,Non-OADS,/arxiv_data1/oa_pdf/80/57/ymj-56-154.PMC4276749.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 159Feasibility of  Translaminar Screw Placement in Korean  Population: Morphometric Analysis of  Cervical Spine Gyu Yeul Ji,1,2 Chang Hyun Oh,2 Sang Hyuk Park,1 Ferry Kurniawan,3 Junho Lee,2   Jae Kyun Jeon,2 Dong Ah Shin,1 and Keung Nyun Kim1 1Department of Neurosurgery, Yonsei University College of Medicine, Seoul;  2Department of Neurosurgery, Guro Cham Teun Teun Hospital, Seoul, Korea; 3Department of Neurosurgery, Hasan Sadikin Hospital, Bandung, Indonesia.",Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To analyze the feasibility of unilateral and bilateral translaminar screw  placement in Koran population, and compare the acceptance rate using previously reported data in American population.",Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"Key Words:    Translaminar, cervical fusion, cervical spine, ethics, Korean, American  INTRODUCTION Posterior cervical screw fixation has been broadly used to correct cervical spine in - stability and spinal deformity, as it has been reported to induce high fusion rates Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.159 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):159-166, 2015",Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 160MATERIALS AND METHODS Morphometric analyses were performed on the subaxial  vertebral lamina of 50 randomly chosen Korean patients  (25 males and 25 females) who underwent cervical spine  computed tomography (CT) scan, utilizing the same meth - ods described by Alvin, et al.1 in a previous study.",OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"Cervical Translaminar Screw Fixation in Asians Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 161compared to 50 (25 men, 25 women) cervical spine radio - graphs of an American cohort assessed in a previous study  by Alvin, et al.1 For the American cohort, the mean age of  the male patients was 54.0±12.1 years (range: 31‒75 yr) and  the mean age of the female patients was 49.2±15.2 years  (range: 22‒80 yr).",Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 162the American males.,Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
Cervical Translaminar Screw Fixation in Asians Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 163Table 2.,Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 164and to analyze the feasibility of translaminar screw place - ment, one reported that unilateral translaminar screw place - ment is a potentially safe and effective technique for use at  all vertebral levels,1 while the other reported that translami - nar fixation should be attempted with caution.24 This dis - crepancy could have derived from differences in ethnicity.",Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
Cervical Translaminar Screw Fixation in Asians Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 1656.,Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 166Anat 2012;34:203-7.,Non-OADS,/arxiv_data1/oa_pdf/75/99/ymj-56-159.PMC4276750.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 16Anthocyanin Induces Apoptosis of  DU-145 Cells In Vitro  and  Inhibits Xenograft Growth of  Prostate Cancer U-Syn Ha,1 Woong Jin Bae,2 Su Jin Kim,1 Byung Il Yoon,1 Sung Hoo Hong,1 Ji Youl Lee,1   Tae-Kon Hwang,1 Sung Yeoun Hwang,3 Zhiping Wang,4 and Sae Woong Kim1 1Department of Urology, College of Medicine, The Catholic University of Korea, Seoul; 2Catholic Integrative Medicine Research Institute, College of Medicine, The Catholic University of Korea, Seoul; 3Korea Bio Medical Science Institute, Seoul, Korea;   4Department of Urology, Second Hospital of Lanzhou University, Lanzhou, China.",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  To investigate the effects of anthocyanins extracted from black soy - bean, which have antioxidant activity, on apoptosis in vitro  (in hormone refracto - ry prostate cancer cells) and on tumor growth in vivo (in athymic nude mouse xe - nograft model).",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"1 Recently, Asian countries, including Korea, have report - ed high PCa incidences and consequent mortality rates.2 Epidemiological studies  suggest that diets rich in natural ingredients (e.g., fruits and vegetables), such as those common in Asian countries, have the potential to protect against prostate Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.16 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):16-23, 2015",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
Anthocyanin Induces Apoptosis of Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 17cell line and inhibit tumor growth in an athymic nude mouse  xenograft model.,Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 18heated to 60°C for 30 min, and then samples were cooled  on ice.",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
Anthocyanin Induces Apoptosis of Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 19shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 20DISCUSSION Several reports8,13,14 suggest that oxidative stress is an early  event in carcinogenesis and contributory risk factor for de - veloping prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"Anthocyanin Induces Apoptosis of Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 212 is overexpressed, it heterodimerizes with Bax, and death  signals decrease.",Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 22tion.,Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
Anthocyanin Induces Apoptosis of Prostate Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 2328.,Non-OADS,/arxiv_data1/oa_pdf/8c/d9/ymj-56-16.PMC4276751.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 167Various Applications of  Deep Temporal Fascia in Rhinoplasty Sung Wan Park,1 Jae Hoon Kim,1 Chang Yong Choi,2 Kyu Hwa Jung,2 and Jin Woo Song1 1April31 Aesthetic Plastic Surgery Clinic, Seoul; 2Department of Plastic and Reconstructive Surgery, Soonchunhyang University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: In Asians, nasal dorsal and tip augmentation procedures are usually per - formed at the same time, and most dorsal augmentations use implants.",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"However, for the purpose of achieving a natural-looking out - come and minimizing the occurrence of secondary drawbacks such as inflamma - tion, foreign body reaction, contracture, skin change, redness, demarcation, and transparency, dorsal augmentation using autogenous tissues such as various carti - lages, including dermofat, and fat grafts have been performed in gradually increas -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.167 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):167-174, 2015",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 168addition, DTF is harvested within the same operative field;  thus, scars are hidden, making it applicable as a material for  various grafts used in rhinoplasty.",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"Deep Temporal Fascia in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 169bella area with bolster sutures, where it remained until re - moval 5‒7 days later.",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 170urally after healing (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
Deep Temporal Fascia in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 171 Fig.,Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 172DTF is a safe autogenous tissue material that has been con - sidered useful not only for nasal dorsal irregularity correc - tions but also for implants in patients with thin skin.,Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"Deep Temporal Fascia in Rhinoplasty Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 173fascia in the areas of contour irregularity, radix depression,  and supratip depression.",Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 174chondrocutaneous composite graft for nasal alar and columellar  reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/7b/69/ymj-56-167.PMC4276752.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 175Clinical Implications of  Microsatellite Instability   in T1 Colorectal Cancer Jeonghyun Kang, Hak Woo Lee, Im-kyung Kim, Nam Kyu Kim,   Seung-Kook Sohn, and Kang Young Lee Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  The estimation of regional lymph node metastasis (LNM) risk in T1  colorectal cancer is based on histologic examination and imaging of the primary  tumor.",Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
"When the cancer is confined to Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.175 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):175-181, 2015",Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 176regional LNM.,Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
MSI in T1 Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 177together and denoted as MSI-L/MSS.,Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 178er’s exact test).,Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
"MSI in T1 Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 179aging and histologic characteristics of the primary tumor  such as depth of tumor invasion, tumor differentiation and  lymphovascular invasion.8 In current practice, even after  complete removal of the primary tumor, an additional radi - cal resection is recommended for patients found to have  high LNM risk upon histologic examination.",Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 180colon cancer and not in stage II colon cancer, the associa - tion was not evident in stage III colorectal cancer in another  series.33 It was reported that this discrepancy might have  originated from different uses of panels in defining MSI-H,  different incidences of MSI-H phenotype, and limited num - bers of MSI-H cases.26,34 In our study, although the frequency  of MSI-H was relatively low (7.5%), a higher lymph node  harvest was observed in MSI-H tumors ( p=0.044), confirm - ing the positive correlation of MSI-H and retrieved lymph  node numbers.",Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
MSI in T1 Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 181of gastrointestinal cancer.,Non-OADS,/arxiv_data1/oa_pdf/08/fe/ymj-56-175.PMC4276753.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 182Overcoming the Limitations of  Fine Needle Aspiration Biopsy:  Detection of  Lateral Neck Node Metastasis   in Papillary Thyroid Carcinoma Hak Hoon Jun,1 Seok Mo Kim,2 Bup Woo Kim,2 Yong Sang Lee,2   Hang-Seok Chang,2 and Cheong Soo Park2  1Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam; 2Thyroid Cancer Center, Department of Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Ultrasound (US) and US-guided fine needle aspiration biopsies (FNAB)  are considered the modalities of choice for assessing lymph nodes suspected of containing metastases, but the sensitivity of FNAB varies and is specific to the op - erator.",Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
"Key Words:    Papillary thyroid carcinoma, metastasis INTRODUCTION Papillary thyroid carcinoma (PTC) accounts for about 80% of thyroid carcinomas  and usually has a good prognosis, with a mortality rate of less than 10%.1,2 In 30‒  80% of patients, however, PTC metastasizes to regional lymph nodes.3,4 Many  studies have shown prognostic significance of node metastasis in thyroid carcino -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.182 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):182-188, 2015",Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
"Detection of Lateral Neck Node Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 183using a 7- to 15-MHz linear array transducer (HDI 5000;  Philips Medical Systems, Bothell, WA, USA) or a 5- to 12- MHz linear array transducer (iU22; Philips Medical Sys - tems).",Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 184Cary, NC, USA).",Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
Detection of Lateral Neck Node Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 185wash-out Tg concentration >34.8 ng/mL was significantly  correlated with false negative results on FNAB ( p=0.002)  (Table 5).,Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 186specificity (Table 7).,Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
Detection of Lateral Neck Node Metastasis Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 187kits are used worldwide and also the techniques and volumes  used for syringe washout differ considerably.,Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 188thyroid cancer.,Non-OADS,/arxiv_data1/oa_pdf/f7/48/ymj-56-182.PMC4276754.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 189The First Experiences of  Robotic Single-Site Cholecystectomy   in Asia: A Potential Way to Expand Minimally-Invasive   Single-Site Surgery?,Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Herein, we firstly present the robotic single-site cholecystectomy (RSSC)  as performed in Asia and evaluate whether it could overcome the limitations of con - ventional laparoscopic single-site cholecystectomy.",Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"Key Words:    Robotic, single-site, single port, cholecystectomy INTRODUCTION Laparoscopic cholecystectomy (LC) is the gold standard approach for treating be - nign gallbladder diseases.1 With advancements in laparoscopic techniques and ex - periences, the indication of LC has expanded to acute severe cholecystitis, and  even early gallbladder cancer.2,3 In addition, reduced-port LC has been actively ap - plied for cosmetic purposes.4,5 Recently, single-port LC has been introduced with the Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.189 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):189-195, 2015",Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 190Robotic single-site surgical system The da Vinci Single-Site™ Instrumentation and the da Vin - ci® SiTM System (Intuitive Surgical®, Sunnyvale, CA, USA)  was adopted for RSSC.",Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"The First Experience of RSSC in Asia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 191Comparison between SFLC and RSSC To compare the improvement of proficiency and learning  period for early experiences of the new surgical technique,  the first 20 cases that received a single-fulcrum laparoscop - ic cholecystectomy (SFLC) were obtained in our prospec - tive data set.10,11 We compared factors including clinico - pathologic factors and operative outcomes between RSSC  and SFLC.",Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 192the day after the operation.,Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"The First Experience of RSSC in Asia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 193addition, intraoperative stable 3-D images, no tremor, and  real-time fluorescent cholangiography provided optimal  conditions for safe laparoscopic single-site cholecystectomy.",Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 194prolonged operation time in our series.,Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
The First Experience of RSSC in Asia Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 195angiography in single-site robotic cholecystectomy (SSRC): a sin - gle-institutional prospective study.,Non-OADS,/arxiv_data1/oa_pdf/8a/4c/ymj-56-189.PMC4276755.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 196Attenuation of  Peripheral Regulatory T-Cell Suppression   of  Skin-Homing CD8+T Cells in Atopic Dermatitis  Bao-Xiang Zhang,1 Jun-Cheng Lyu,2 Hai-Bo Liu,3 Dian-Qin Feng,1 Dian-Cai Zhang,1   Xing-Jie Bi,4 Zhi-Wu Duan,1 and Gang Ding5 1Department of Dermatology, Yidu Central Hospital, Weifang Medical University, Weifang; 2Department of Health Statistics, Public Health College of Weifang Medical University, Weifang; 3Department of Clinical Laboratory, Yidu Central Hospital, Weifang Medical University, Weifang; 4Department of Dermatology, Weifang Skin Disease Hospital, Weifang; 5Department of Stomatology, Yidu Central Hospital, Weifang Medical University, Weifang, P .R.",Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  Cutaneous lymphocyte-associated antigen (CLA)-expressing CD8+T  cells have been known to play an important role in the pathogenesis of atopic der - matitis (AD).",Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Key Words:    Cutaneous lymphocyte-associated antigen, CD8+T cell, regulatory, T  cells, atopic dermatitis INTRODUCTION Atopic dermatitis (AD) is a T-cell-mediated highly pruritic chronic inflammatory  skin disease.1 Recent findings have suggested that CD8+T cells are required for the  development of AD lesion.2,3 Cutaneous lymphocyte-associated antigen (CLA) is an  important skin-homing receptor displayed by memory/effector T cells which recog -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.196 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):196-203, 2015",Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Decreased Inhibition of Tregs on CD8+CLA+T Cells in AD Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 197CLA-FITC, anti-CD4-FITC, anti-CD25-PECY7, FOXP3- APC, purified anti-CD3 NA/LE and anti-CD28 NA/LE  (anti-CD3/CD28), and FACSCalibur Flow Cytometer, all of  which were obtained from BD Biosciences (Franklin Lakes,  NJ, USA).",Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 198namely, cells cultured in the absence (5×104 cells/well) and  presence (5×104 cells/well) of unlabeled autologous Tregs.",OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
Decreased Inhibition of Tregs on CD8+CLA+T Cells in AD Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 199centages of proliferating CD8+CLA+T cells were analyzed  and found to be significantly higher in the AD group than  the control group (Fig.,Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 200in the cocultures of Tregs and CD8+CLA+T cells, Tregs could  produce high levels of TGF-β1 and IL-10 in both groups.",Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Decreased Inhibition of Tregs on CD8+CLA+T Cells in AD Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 201Akdis, et al.5 demonstrated that CLA+CD8+T cells isolated  from the skin or peripheral blood of AD patients responded  to superantigenic stimulation to the same extent as CD4+T  cells: they spontaneously proliferated ex vivo , secreting high  levels of IL-5 and IL-13, and therefore, were capable of  preventing spontaneous eosinophil apoptosis and enhanc - ing IgE.",OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 202allergen exposure sites in atopy patch test reactions in human  atopic dermatitis.,Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
Decreased Inhibition of Tregs on CD8+CLA+T Cells in AD Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 203mune diseases.,Non-OADS,/arxiv_data1/oa_pdf/60/e3/ymj-56-196.PMC4276756.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 204NGF and HB-EGF: Potential Biomarkers that Reflect the Effects  of  Fesoterodine in Patients with Overactive Bladder Syndrome Soo Rim Kim,1 Yeo Jung Moon,2 Sei Kwang Kim,2 and Sang Wook Bai2 1Department of Obstetrics and Gynecology, International St. Mary ’s Hospital, Catholic Kwandong University College of Medicine, Incheon; 2Department of Obstetrics and Gynecology, Institute of Women ’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To determine whether levels of nerve growth factor (NGF) and hepa - rin-binding epidermal growth factor-like growth factor (HB-EGF) can be used to  objectively assess overactive bladder syndrome (OAB) treatment outcome and to evaluate the effects of fixed-dose fesoterodine on OAB symptoms.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"Key Words:    Heparin-binding EGF-like growth factor, nerve growth factor, over - active bladder, questionnaire, urinary biomarkers INTRODUCTION Overactive bladder syndrome (OAB) is highly prevalent and exhibits lower uri - nary tract symptoms (LUTS) of frequency, nocturia, and urgency, with or without  urgency urinary incontinence; urgency is the primary symptom defining OAB.1,2  Painful bladder syndrome/interstitial cystitis (PBS/IC) is another prevalent urolog -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.204 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):204-211, 2015",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
OAB Biomarkers after Fesoterodine Treatment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 205nence within a 3-day period without previous history of di - agnosis or treatment for OAB.,Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 206and 1 and 4 months.,Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"OAB Biomarkers after Fesoterodine Treatment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 207awaken in the morning?”, “How often do you have a sudden  desire to urinate, which is difficult to defer?”, and “How of - ten do you leak urine because you cannot defer your sud - den urge to urinate?” were lower than their corresponding  pretreatment scores ( p<0.001, for all comparisons) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 208HB-EGF, as an autocrine regulator of the growth of hu - man bladder epithelial cells, has been proven to antagonize  APF via activation of the mitogen-activated protein kinase  pathway.9 A defective glycosaminoglycan layer and a per - meable urothelium allow urinary potassium to depolarize  nerves in the urothelium, detrusor, and perivesical area,  leading to urinary urgency and frequency.10 We consider that  this mechanism might also be related to OAB symptoms  and have a keen interest in studying urinary HB-EGF levels  in OAB patients because of its potential use as a biomarker;  hence, this study evaluated HB-EGF levels adjusted to the  Cr level.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"OAB Biomarkers after Fesoterodine Treatment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 209race/ethnicity, diet, and the specific time of urine collection.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 210bladder, and other lower urinary tract symptoms in five countries:  results of the EPIC study.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"OAB Biomarkers after Fesoterodine Treatment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 211ters KM, Rovner ES, et al.",Non-OADS,/arxiv_data1/oa_pdf/7c/e5/ymj-56-204.PMC4276757.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 212Efficacy of  Veno-Venous Extracorporeal Membrane  Oxygenation in Severe Acute Respiratory Failure  Jae Jun Lee,1* Sung Mi Hwang,1* Jae Houn Ko,1 Hyoung Soo Kim,2   Kyung Soon Hong,3 Hyun Hee Choi,3 Myung Goo Lee,4 Chang Youl Lee,4   Won Ki Lee,5 Eun Jin Soun,6 Tae Hun Lee,6 and Jeong Yeol Seo6 Departments of 1Anesthesiology and 2Thoracic and Cardiovascular Surgery, 3Division of Cardiology, Department of Internal Medicine,   4Division of Pulmonology, Department of Internal Medicine, Departments of 5Urology and 6Emergency Medicine,   School of Medicine, Hallym University, Chuncheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The objective of this study was to evaluate our institutional experience  with veno-venous (VV) extracorporeal membrane oxygenation (ECMO) in pa - tients with severe acute respiratory failure (ARF).",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
"3  Extracorporeal membrane oxygenation (ECMO) has the unique potential to sup -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.212 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):212-219, 2015",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
Efficacy of ECMO in Severe ARF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 213controllable bleeding were excluded.,Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 214performing ECMO, the number of pre-ECMO mechanical  ventilation days, and the ECMO duration were shorter, with  a low-peak blood urea nitrogen (BUN) level ( p<0.05).",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
Efficacy of ECMO in Severe ARF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 215Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 216Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
"Efficacy of ECMO in Severe ARF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 217and multiple organ failure, although duration of pre-ECMO  mechanical ventilation was not a risk factor.",Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 218perienced ECMO team.,Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
Efficacy of ECMO in Severe ARF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 219et al.,Non-OADS,/arxiv_data1/oa_pdf/ab/6f/ymj-56-212.PMC4276758.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 220Epidemiology of  Trauma Patients and Analysis of    268 Mortality Cases: Trends of  a Single Center in Korea  Chun Sung Byun,1 Il Hwan Park,1 Joong Hwan Oh,1 Keum Seok Bae,2 Kang Hyun Lee,3 and Eunbi Lee4 Departments of 1Thoracic and Cardiovascular Surgery, 2Surgery, 3Emergency Medicine, and 4Anesthesiology and Pain Medicine,   Yonsei University Wonju College of Medicine, Wonju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose:  There is an increasing incidence of mortality among trauma patients;  therefore, it is important to analyze the trauma epidemiology in order to prevent  trauma death.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"3 Also, according to the Annual Report of Emergency  Medicine in Korea, the proportion of trauma patients have steadily grown, and the overall mortality of trauma patients in emergency centers have gradually increased Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.220 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):220-226, 2015",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"Epidemiology of Trauma Patients and Mortality Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 221craniocerebral, thoracic, abdominopelvic, and extremity.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 222Disposition of trauma patients at emergency center As shown in Table 1, 56.0% (n=9516) of a total of 17007 pa - tients were discharged from the emergency center after early  recovery, and 15.6% (n=2642) transferred to a regional hos - pital after primary treatment.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"Epidemiology of Trauma Patients and Mortality Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 223significant differences for age, RTS, ISS, major injury site,  multiple site injury, emergency operation, CPR at arrival,  and Ps from TRISS.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 224emergency center.,Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"Epidemiology of Trauma Patients and Mortality Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 225jor craniocerebral injury, CPR at arrival, and Ps <25% from  TRISS were independent risk factors for trauma mortality.",Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 22610.,Non-OADS,/arxiv_data1/oa_pdf/52/8a/ymj-56-220.PMC4276759.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 227A Polymorphism of  the Renin Gene rs6682082    Is Associated with Essential Hypertension Risk and Blood  Pressure Levels in Korean Women Jongkeun Park,1 Kijun Song,2 Yangsoo Jang,3 and Sungjoo Kim Yoon1 1Department of Medical Life Science, The Catholic University of Korea, Seoul;   2Department of Biostatistics, Yonsei University College of Medicine, Seoul; 3Cardiovascular Genome Center, Cardiovascular Yonsei University Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The aim of the present study was to investigate associations between the  renin gene ( REN) and the risk of essential hypertension and blood pressure (BP) lev - els in Koreans.",Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"3-5 Among the single-nucleotide polymorphisms (SNPs) shown to be as -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.227 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):227-234, 2015",OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 228scription of REN.19 Recently, a few SNPs in the 5’ upstream  region of the REN gene have been shown to be positively  associated with EH.",Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"A Polymorphism of the REN and EH Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 229by the manufacturer, with the following primers, 5’-TTA  GGC CAG CTA CCA AAA ACG CAA AGA AAA ACT  TTC TGT AG-3’ and 5’-CTA CAG AAA GTT TTT CTT  TGC GTT TTT GGT AGC TGG CCT AA-3’.",Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 230rs6682082  and EH, we used Fisher’s exact test and χ2 analy - sis; the results are shown in Table 2.",OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
A Polymorphism of the REN and EH Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 231pants with the AA/AG genotype and 100.39±1.14 mm Hg  for those with the GG genotype ( p=0.017) in postmeno - pausal EH patients.,Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 232Map-HCB), as there was no genotype data available for  rs5707  in Koreans.",OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"A Polymorphism of the REN and EH Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 233a new TF that regulates REN expression and affects BP lev - el, especially in females.",Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
We searched for transcrip - tion factors (TF) that might bind to the sequence containing  rs6682082  using publicly available transcription binding  factor prediction programs (TOMTOM; http://meme.nbcr.,OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 234cells.,Non-OADS,/arxiv_data1/oa_pdf/ba/b4/ymj-56-227.PMC4276760.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 235The Effects of  Different Noise Types on Heart Rate   Variability in Men  Chang Sun Sim,1 Joo Hyun Sung,1 Sang Hyeon Cheon,2 Jang Myung Lee,3 Jae Won Lee,4 and Jiho Lee1 Departments of 1Occupational and Environmental Medicine and 2Urology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan; 3Department of Mechanical Engineering, University of Ulsan College of Engineering, Ulsan; 4Indoor Environment & Noise Research Division, National Institute of Environmental Research, Incheon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To determine the impact of noise on heart rate variability (HRV) in men,  with a focus on the noise type rather than on noise intensity.",Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
"The effects of noise on the human body are extensive, ranging from hearing loss Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.235 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):235-243, 2015",Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 236pre-exposure and post-exposure HRV parameter results  with background, traffic, speech, and mixed noise (traffic  and speech).",OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
"The Effects of Noise Types on Heart Rate Variability Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 237Statistical analysis The Kruskal-Wallis test was used to compare age, anthro - pometric measurements, audiometry results, and systolic  and diastolic blood pressure measurements in the back - ground, traffic, speech, and mixed noise groups.",OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 238Psychosocial stress states and the ability to cope with  stress Susceptibility to noise was affected by the subjects’ social  and psychological states of stress and their ability to cope  with stress.,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
The Effects of Noise Types on Heart Rate Variability Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 239type and found no statistically significant differences.,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 240ratio as the noise level increased.,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
The Effects of Noise Types on Heart Rate Variability Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 241ber of subjects in each group was small (n=10).,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 24218.,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
The Effects of Noise Types on Heart Rate Variability Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 243Cardiol 1996;28:1539-46.,Non-OADS,/arxiv_data1/oa_pdf/a7/b9/ymj-56-235.PMC4276761.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 24Adjuvant Radiotherapy Outcome of  Stage I Testicular Seminoma:  A Single Institution Study Hayoon Lee,1* Jun Won Kim,1* Sung Joon Hong,2 Seung Choul Yang,2   Young Deuk Choi,2 Koon Ho Rha,2 and Jaeho Cho1 Departments of 1Radiation Oncology and 2Urology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To analyze treatment outcome and side effects of adjuvant radiotherapy  using radiotherapy fields and doses which have evolved over the last two decades in a single institution.",Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
"4 Postoperative adjuvant radiotherapy has long been considered as a standard Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.24 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):24-30, 2015",Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
Treatment Outcome of Stage I Seminoma Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 25cluded from this study.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 26ty occurred in 22 patients (54%); of these patients grade 1  and grade 2 leukopenia occurred in 14 patients (34%) and 8  patients (20%).,Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
Treatment Outcome of Stage I Seminoma Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 271.67 Gy per fraction showed the best toxicity profile for  both hematologic toxicity and GI disorders.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 28the alternative treatment regimens should be re-evaluated  based on the treatment outcomes and adverse events of  modern radiotherapy.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
"Treatment Outcome of Stage I Seminoma Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 29lignancy, resulting in a high salvage rate via orchiectomy,  systemic chemotherapy may not be a suitable option for the  prevention of contralateral testicular seminoma, which has  a recurrence rate of only 2%.",Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 30binational prospective population-based study from the Swedish  norwegian testicular cancer study group.,Non-OADS,/arxiv_data1/oa_pdf/56/17/ymj-56-24.PMC4276762.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 244Effects of  Diabetic Case Management on Knowledge,   Self-Management Abilities, Health Behaviors, and Health Service  Utilization for Diabetes in Korea  Soon Ae Shin,1 Hyeongsu Kim,2 Kunsei Lee,2 Vivian Lin,3 George Liu,4 and Eunyoung Shin5 1Bigdata Steering Department, National Health Insurance Service, Seoul, Korea;  2Department of Preventive Medicine, School of Medicine, Konkuk University, Seoul, Korea;  3Health Sector Development, Western Pacific Region, WHO, Manila, Philippines; 4Department of Public Health, School of Public Health & Human Biosciences, Faculty of Health Sciences, La Trobe University, Melbourne, Australia; 5Department of Public Health Administration, Hanyang Women ’s University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: This study aimed to evaluate the effects of a case management program for  diabetics, using a pre-post comparison design.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Diabetes has been ranked as Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.244 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):244-252, 2015",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Effects of Diabetic Case Management Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 245of contacts or to extend or shorten the length of the interven - tion by 1 week, depending on patient needs.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 2462005 to December 31, 2007, based on the dates during  which patients visited the clinics.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
Effects of Diabetic Case Management Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 247Changes in scores for knowledge and management of di - abetes are shown in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 248ter intervention (males: p<0.001; females: p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Effects of Diabetic Case Management Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 249program was working and to show its effects by estimating  changes in diabetics’ knowledge, self-management ability,  health behaviors, such as smoking, alcoholic drinking, or  exercise, BMI, and the utilization of healthcare services for  diabetes.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 250remained unchanged in the lay-led self-management pro - grams heavily promoted by the UK Department of Health  as part of a drive to reduce usage of acute healthcare servic - es.16-19 Foster, et al.20 and Griffiths, et al.21 argued that if lay- led self-management programs aim to reduce healthcare re - source usage, there is insufficient evidence to justify wide - spread lay-led self-management interventions.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
Effects of Diabetic Case Management Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 251and prospective trials in order to evaluate the appropriate - ness of healthcare usage and clinical outcome which will in  turn show the direct effectiveness of a case management  program by including a control group.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
Available at: http://www.index.go.kr/ potal/main/EachDtlPageDetail.do?idx_cd=1012.,OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 25221.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ymj-56-244.PMC4276763.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 253Quantitative Analysis of  the Effect of  Iterative   Reconstruction Using a Phantom:   Determining the Appropriate Blending Percentage Hyun Gi Kim, Yong Eun Chung, Young Han Lee, Jin-Young Choi, Mi-Suk Park,   Myeong-Jin Kim, and Ki Whang Kim Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To investigate the optimal blending percentage of adaptive statistical it - erative reconstruction (ASIR) in a reduced radiation dose while preserving a de - gree of image quality and texture that is similar to that of standard-dose computed  tomography (CT).",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"1  Unlike FBP, the iterative reconstruction technique can reduce image noise even in low-dose computed tomography (CT) images, because it can be operated in raw data space and can accurately characterize data acquisition according to each phys -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.253 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):253-261, 2015",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 254deep cavities, each with different sizes (3.2, 6.4, 9.5, 12.7,  19.1, and 25.4 mm) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
Appropriate Percentage with Iterative Reconstruction Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 255was the average CNR value obtained from the standard  protocol of 0% ASIR.,OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"Among them,  we adopted the grey-level co-occurrence matrices (GLCM)  method,5,6 and an open plug-in of GLCM texture analysis  for ImageJ (http://rsb.info.nih.gov/ij/plugins/) was used.",OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 256CTDI vol and DLP were obtained from the scanner console  for each protocol.,OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
Appropriate Percentage with Iterative Reconstruction Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 257mAs) with 20% ASIR also satisfied the required values of  analyzed image qualities and texture parameters.,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 258According to previous reports, image noise can be de - creased by increasing the blending percentage of ASIR,2,4   and a previous phantom study determined that noise de - creased about 75% and 50% from the original image with rent-time product of 150 mAs (40% dose reduction) result - ed in quantitatively acceptable image quality in terms of  noise, spatial, and low-contrast resolution and showed simi - lar image texture to that of standard-dose CT images.",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"Appropriate Percentage with Iterative Reconstruction Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 259In terms of low-contrast resolution, most previous studies  have reported unanimous results that an increase in the per - centage of ASIR resulted in increased low-contrast resolu - tion, which is consistent with our results.2,5,7,10 The CNR  was calculated from the HU difference between the cavity  and the background divided by the noise value.",Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 260our study should be confirmed with patient data in the fu - ture.,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
Appropriate Percentage with Iterative Reconstruction Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 26110.,Non-OADS,/arxiv_data1/oa_pdf/6c/f1/ymj-56-253.PMC4276764.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 262Characteristics of  Inpatient Care and Rehabilitation   for Acute First-Ever Stroke Patients  Won Hyuk Chang,1 Yong-Il Shin,2 Sam-Gyu Lee,3 Gyung-Jae Oh,4 Young Shil Lim,5 and Yun-Hee Kim1  1Department of Physical and Rehabilitation Medicine, Center for Prevention and Rehabilitation,   Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; 2Department of Rehabilitation Medicine, Pusan National University School of Medicine, Busan;  3Department of Physical and Rehabilitation Medicine, Chonnam National University Medical School, Gwangju; 4Department of Preventive Medicine, Wonkwang University School of Medicine, Iksan;  5Ministry of Health and Welfare, Sejong, Korea.",Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The purpose of this study was to analyze the status of inpatient care for  acute first-ever stroke at three general hospitals in Korea to provide basic data and useful information on the development of comprehensive and systematic rehabili - tation care for stroke patients.",Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
"Key Words:    Stroke, inpatients, acute management, rehabilitation, Korea INTRODUCTION       Stroke is a major cause of serious, long-term disability in Korea.1 In Korea, the an-Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.262 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):262-270, 2015",Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Inpatient Care and Rehabilitation for Acute Stroke Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 263stroke symptoms.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 264Demographic characteristics The demographic characteristics of the patients are shown in  Fig.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
"Inpatient Care and Rehabilitation for Acute Stroke Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 265versity Hospital, only 19 patients (2.0%) were transferred  to the rehabilitation department.",Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 266was directly related to stroke.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Inpatient Care and Rehabilitation for Acute Stroke Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 267stroke patients admitted to three general hospitals in Korea.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 268base on stroke patients in Korea.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Inpatient Care and Rehabilitation for Acute Stroke Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 269land Stroke Outcomes Study.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 270Stroke 1988;19:1083-92.,Non-OADS,/arxiv_data1/oa_pdf/1d/9a/ymj-56-262.PMC4276765.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 271Reliability and Validity of  the Upper Limb Physician’s Rating Scale  in Children with Cerebral Palsy Eun Sook Park, Ji-Woon Joo, Seon Ah Kim, Dong-Wook Rha, and Soo Jin Jung Department of Rehabilitation Medicine, Severance Hospital, Research Institute of Rehabilitation Medicine,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The Upper Limb Physician’s Rating Scale (ULPRS) is a tool that assesses  movement quality of the upper limbs.",Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"2 A reduction of muscle Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.271 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):271-276, 2015",Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 272ability of the ULPRS in children with spastic cerebral palsy  and 2) to examine the concurrent validity of the ULPRS by  investigating its relationship with the MUUL.,Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"Reliability, Validity of ULPRS in Children with CP Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 273interrater and intrarater reliability (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 274of administration are crucial for periodic assessments.,Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"Reliability, Validity of ULPRS in Children with CP Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 275cant positive correlation between total ULPRS and MUUL  scores in our study indicates that the two scales may be  comparable.",Non-OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 276Arner M, Ohrvall AM, et al.",OADS,/arxiv_data1/oa_pdf/00/12/ymj-56-271.PMC4276766.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 277Biologic Response of  Degenerative Living Human Nucleus  Pulposus Cells to Treatment with Cytokines Sang Hyun Kim,1 Sung Uk Kuh,2 Keung Nyun Kim,2 Jeong Yoon Park,2   Ki Hong Cho,1 Dong Kyu Chin,2 Keun Su Kim,2 and Yong Eun Cho2 1Department of Neurosurgery, Ajou University College of Medicine, Suwon; 2Department of Neurosurgery, The Spine and Spinal Cord Institute, Gangnam Severance Hospital,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To investigate the molecular responses of various genes and proteins re - lated to disc degeneration upon treatment with cytokines that affect disc-cell pro - liferation and phenotype in living human intervertebral discs (IVDs).",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"This causes Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.277 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):277-286, 2015",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 278of IVDs to treatment with cytokines.,Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Molecular Response in Human NP Cell with Cytokines Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 279USA), IL-1β 10 ng/mL (Invitrogen) and TNF-α 10 ng/mL  (Invitrogen) for 6 days.",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 280RESULTS   Degeneration of IVD Using the Pfirrmann grading system, the discs of 12 pa - tients were classified into two groups: group 1 (6 patients)  contained mildly degenerated discs (grade II; 3 patients and  grade III; 3 patients) and group 2 (6 patients) contained se - verely degenerated discs (grade IV; 2 patients and grade V; 4  patients).",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Molecular Response in Human NP Cell with Cytokines Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 281morphogens increased by 4.35-fold with rhBMP-2 and  3.87-fold with TGF-β in group 1, and increased by 1.84- fold with rhBMP-2 and 2.54-fold with TGF-β in group 2.",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 282respectively, in group 2.",Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Molecular Response in Human NP Cell with Cytokines Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 283spectively, in group 1, and 5.58×103, 1.37×104, and 1.10×104,  respectively, in group 2.",OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 284phogenic cytokines and inflammatory mediators in this  study.,Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
Molecular Response in Human NP Cell with Cytokines Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 285effectiveness analysis of extended conservative therapy versus  surgical intervention in the management of herniated lumbar inter - vertebral disc.,Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 28633.,Non-OADS,/arxiv_data1/oa_pdf/5d/80/ymj-56-277.PMC4276767.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 287Predictors of  Response to Corticosteroid Treatment in Patients  with Early Acute Respiratory Distress Syndrome:   Results of  a Pilot Study Kyeongman Jeon,1,2 Chi Ryang Chung,1 Jeong Hoon Yang,1,3 Chi-Min Park,1,4 and Gee Young Suh1,2  Departments of 1Critical Care Medicine and 4Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; Divisions of 2Pulmonary and Critical Care Medicine and 3Cardiology, Department of Medicine, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Prospective observational cohort study was performed to evaluate predictors for  responsiveness to corticosteroid treatment in patients with acute respiratory dis - tress syndrome (ARDS).",Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
"Brief Communicationhttp://dx.doi.org/10.3349/ymj.2015.56.1.287 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):287-291, 2015",Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 288breathing trial according to our protocol.,Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
Steroid Treatment for ARDS Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 289Clinical characteristics and outcomes of responders and  non-responders to prolonged corticosteroid treatment are  presented in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 290corticosteroid treatment may lead to negative effects that  counterbalance the positive effects of this agent.,Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
Steroid Treatment for ARDS Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 291et al.,Non-OADS,/arxiv_data1/oa_pdf/54/c2/ymj-56-287.PMC4276768.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 292Bacteroides faecis  and Bacteroides intestinalis  Recovered   from Clinical Specimens of  Human Intestinal Origin Yangsoon Lee,1 Hyun Soo Kim,2 Dongeun Yong,2 Seok Hoon Jeong,2   Kyungwon Lee,2 and Yunsop Chong2 1Department of Laboratory Medicine, Hanyang University College of Medicine, Hanyang University Seoul Hospital, Seoul;    2Department of Laboratory Medicine, Severance Hospital, Research Institute of Bacterial Resistance,   Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cc/31/ymj-56-292.PMC4276769.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.We report three cases of recently named Bacteroides  spp.",Non-OADS,/arxiv_data1/oa_pdf/cc/31/ymj-56-292.PMC4276769.pdf
"2) with a history of rectal Brief Communicationhttp://dx.doi.org/10.3349/ymj.2015.56.1.292 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):292-294, 2015",Non-OADS,/arxiv_data1/oa_pdf/cc/31/ymj-56-292.PMC4276769.pdf
"Bacteroides faecis  and Bacteroides intestinalis Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 293formed using the Clinical and Laboratory Standards Institute  agar dilution method as previously described.10,11 Piperacillin  and tazobactam (Yuhan, Seoul, Korea), cefoxitin (Merck  Sharp & Dohme, West Point, PA, USA), cefotetan (Daiichi  Pharmaceutical, Tokyo, Japan), clindamycin (Korea Upjohn,  Seoul, Korea), imipenem and metronidazole (Choong Wae,  Seoul, Korea), meropenem (Sumitomo, Tokyo, Japan),  chloramphenicol (Chong Kun Dang, Seoul, Korea), and  moxifloxacin (Bayer Korea, Seoul, Korea) were used.",Non-OADS,/arxiv_data1/oa_pdf/cc/31/ymj-56-292.PMC4276769.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 294rods.,Non-OADS,/arxiv_data1/oa_pdf/cc/31/ymj-56-292.PMC4276769.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 295Efficacy of  Team-Based Financial Incentives for Smoking  Cessation in the Workplace Chang Dong Yeo, Hea Yeon Lee, Jick Hwan Ha, Hyeon Hui Kang, Ji Young Kang,   Sung Kyoung Kim, Myung Sook Kim, Hwa Sik Moon, and Sang Haak Lee Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine,   College of Medicine, The Catholic University of Korea, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Worksite smoking cessation programs offer accessibility of the target population,  availability of occupational health support, and the potential for peer pressure and peer support.",Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
"2 Seventy percent of smokers report being interested in quitting,  and 40% attempt to quit each year.3 However, only 2 to 3% of smokers succeed  annually.4 Physician’s advice can increase quitting by a further 1 to 3%,5 while be - havioral support is likely to increase the chance of success by about 10 to 25%.6  Pharmacotherapy, including nicotine replacement therapy with varenicline and bu - propion, has been shown to be effective for long term (≥6 months) quit rates by Brief Communicationhttp://dx.doi.org/10.3349/ymj.2015.56.1.295 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):295-299, 2015",Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 296Each team consisted of smoking participants and non- smoking fellow workers from the same department.,OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
Team-Based Incentives for Smoking Cessation Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 297cluding nicotine patch or electronic cigarette.,Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 298treatments, highlighting the effectiveness of team-based fi - nancial incentives for smoking cessation.",Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
Team-Based Incentives for Smoking Cessation Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 29910.,Non-OADS,/arxiv_data1/oa_pdf/9a/01/ymj-56-295.PMC4276770.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 300The First Korean Case of  HDR Syndrome Confirmed   by Clinical and Molecular Investigation  Chong-Kun Cheon,1,2 Gu-Hwan Kim,3 and Han-Wook Yoo3  1Department of Pediatrics, Pusan National University Children ’s Hospital, Pusan National University School of Medicine, Yangsan;   2Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan;   3Medical Genetics Clinic and Laboratory, Asan Medical Center Children ’s Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome is a rare con - dition inherited as autosomal dominant trait and characterized by hypoparathyroid - ism, sensorineural deafness, and renal dysplasia.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"Key Words:    HDR syndrome, GATA3 gene, hypoparathyroidism INTRODUCTION Hypoparathyroidism, deafness and renal dysplasia (HDR, OMIM 131320) syn - drome is a rare condition inherited as autosomal dominant trait.1 Clinically, hypo - parathyroidism is characterized by symptomatic or asymptomatic hypocalcemia  with undetectable or normal serum concentrations of parathyroid hormone (PTH).2  The sensorineural hearing loss is bilateral and most pronounced at higher frequen - cies, and hearing loss is typically moderate to severe and present at birth.3 Renal  anomalies include developmental anomalies, such as, renal dysplasia, hypoplasia, Case Reporthttp://dx.doi.org/10.3349/ymj.2015.56.1.300 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):300-303, 2015",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"HDR Patient with GATA3  Mutation  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 301cium therapy was started, and the therapy successfully re - sulted in normal serum calcium and phosphate values.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 302 In summary, this is the first case with HDR syndrome in  Korea that was confirmed by genetic analysis, to involve a  novel de novo  GATA3  gene mutation.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"HDR Patient with GATA3  Mutation  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 303Gortner L, et al.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ymj-56-300.PMC4276771.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 304A Case of  Life-Threatening Acute Kidney Injury with Toxic  Encephalopathy Caused by Dioscorea quinqueloba Kyung-Sik Kang and Sang Taek Heo Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ec/7a/ymj-56-304.PMC4276772.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Some herbal medications induce acute kidney injury.",Non-OADS,/arxiv_data1/oa_pdf/ec/7a/ymj-56-304.PMC4276772.pdf
"This case is noteworthy because it was a more  critical than previously reported cases, and the patient needed more aggressive care than conservative care only.Case Reporthttp://dx.doi.org/10.3349/ymj.2015.56.1.304 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):304-306, 2015",Non-OADS,/arxiv_data1/oa_pdf/ec/7a/ymj-56-304.PMC4276772.pdf
"Toxic Encephalopathy due to Dioscorea quinqueloba Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 305DISCUSSION Herbs are widely used for health care in developed and de - veloping countries.8,9 Many of them are classified as dietary  supplements.",Non-OADS,/arxiv_data1/oa_pdf/ec/7a/ymj-56-304.PMC4276772.pdf
Kyung-Sik Kang and Sang Taek Heo Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 306REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ec/7a/ymj-56-304.PMC4276772.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 307Intralesional 3% Sodium Tetradecyl Sulfate for Treatment   of  Cutaneous Kaposi’s Sarcoma Jee Young Kim, Ji Seok Kim, Myung Hwa Kim, Byung Cheol Park, and Seung Phil Hong Department of Dermatology, College of Medicine, Dankook University, Cheonan, Korea.",Non-OADS,/arxiv_data1/oa_pdf/ff/13/ymj-56-307.PMC4276773.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Kaposi’s sarcoma is an angioproliferative disease thought to have originated from  endothelial cell lineage, and it is classically described as a multipigmented sarcoma appearing on the lower extremities of elderly men.",Non-OADS,/arxiv_data1/oa_pdf/ff/13/ymj-56-307.PMC4276773.pdf
"According to the literature, vincristine, a cytotoxic agent, showed better complete remission rate than sclerosing agents, but also showed higher rate of no reaction to mild re -Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2015.56.1.307 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):307-308, 2015",Non-OADS,/arxiv_data1/oa_pdf/ff/13/ymj-56-307.PMC4276773.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 308ma.,Non-OADS,/arxiv_data1/oa_pdf/ff/13/ymj-56-307.PMC4276773.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 309Does Liver Resection Provide Long-Term Survival Benefits for  Breast Cancer Patients with Liver Metastasis?,Non-OADS,/arxiv_data1/oa_pdf/ba/a6/ymj-56-309.PMC4276774.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.To the Editor: We read with great interest the study by Kim, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/a6/ymj-56-309.PMC4276774.pdf
"The authors com - pared the patients with solitary BCLM to a group with extrahepatic as well as iso - lated BCLM and demonstrated that there is a significant recurrence-free survival Letter to the Editorhttp://dx.doi.org/10.3349/ymj.2015.56.1.309 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):309-310, 2015",Non-OADS,/arxiv_data1/oa_pdf/ba/a6/ymj-56-309.PMC4276774.pdf
"Ser Yee Lee and Eran Sadot Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 310gical resection of non-colorectal non-neuroendocrine liver  metastases, specifically for oligometastatic breast cancer,  will argue that if a well-matched cohort of isolated BCLM  patients is appropriately treated with modern effective med - ical treatment such as trastuzumab (Herceptin, Roche, South  San Francisco, CA, USA), the benefits of surgery may not  seem so clear or may even disappear.",Non-OADS,/arxiv_data1/oa_pdf/ba/a6/ymj-56-309.PMC4276774.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 31Predictors of  Sick Sinus Syndrome in Patients after Successful  Radiofrequency Catheter Ablation of  Atrial Flutter Changho Song, Moo-Nyun Jin, Jung-Hee Lee, In-Soo Kim, Jae-Sun Uhm, Hui-Nam Pak,   Moon-Hyoung Lee, and Boyoung Joung Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The identification of sick sinus syndrome (SSS) in patients with atrial  flutter (AFL) is difficult before the termination of AFL.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
"The purpose of this study is to investigate the predictors of SSS before AFL ab - lation in patients with persistent AFL.Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.31 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):31-37, 2015",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 32tioned in the right atrium (RA), parallel to the TA so that  the distal pole was located in the medial region of the CTI.",Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
Sinus Node Dysfunction and Atrial Flutter Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 33or not.,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 34likely to have atypical flutter waves (SSS: 30%; no-SSS:  3%; p=0.006) and longer flutter CLs (SSS: 262±39 ms; no- SSS: 243±40 ms; p=0.02).,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
Sinus Node Dysfunction and Atrial Flutter Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 35use was more common in patients with reversible SSS.,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 36clinical practice.,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
Sinus Node Dysfunction and Atrial Flutter Ablation Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 3715.,Non-OADS,/arxiv_data1/oa_pdf/03/cb/ymj-56-31.PMC4276775.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 38Screening for Abdominal Aortic Aneurysm during   Transthoracic Echocardiography in Patients   with Significant Coronary Artery Disease Sung Ho Lee,1* Sung-A Chang,2* Shin Yi Jang,2 Sang-Chol Lee,2 Young Bin Song,2   Seung Woo Park,2 Seung-Hyuk Choi,2 Hyeon-Cheol Gwon,2 Jae K. Oh,2,3 and Duk-Kyung Kim2 1Division of Cardiology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul;   2Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul, Korea;   3Division of Cardiovascular Diseases, Mayo Clinic College of Medicine, Rochester, MN, USA.",Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Coronary artery disease (CAD) shares several risk factors with abdomi - nal aortic aneurysm (AAA).",Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
"AAA usually remains asymptomatic unless it ruptures, and in cases of rupture, operative mortal -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.38 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):38-44, 2015",Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
Screening for AAA during TTE in CAD Patients  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 39in 1300 consecutive patients who had been diagnosed with  significant CAD.,Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 40index value ≤0.9.17 Statistical analysis Continuous variables were described as mean±standard de - viation.,OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
"Screening for AAA during TTE in CAD Patients  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 41and the prevalence of hypertension and dyslipidemia were  higher in AAA, they were not statistically significant.",Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 42casians with CAD.,Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
"Screening for AAA during TTE in CAD Patients  Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 43abdominal aortic aneurysm and surveillance of small abdominal  aortic aneurysms, rationale and recommendations of the French  Society for Vascular Medicine.",Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 442006;43:95-100.,Non-OADS,/arxiv_data1/oa_pdf/01/03/ymj-56-38.PMC4276776.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 45Impact of  Statin Treatment on Strut Coverage   after Drug-Eluting Stent Implantation Yongsung Suh,1 Byeong-Keuk Kim,1 Dong-Ho Shin,1 Jung-Sun Kim,1 Young-Guk Ko,1   Donghoon Choi,1 Yangsoo Jang,1,2 and Myeong-Ki Hong1,2 1Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul;  2Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: To evaluate the effect of statin treatment on strut coverage after drug- eluting stent (DES) implantation.",Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
"5,6 Although several variables such  as the implantation of sirolimus-eluting stents (SESs)7,8 and acute coronary syn - drome9,10 were reported as risk factors for delayed strut coverage in previous OCT Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.45 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):45-52, 2015",Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 46also randomly allocated.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
"Statin Treatment vs. Strut Coverage Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 47dent’s t-test, or the Mann-Whitney U test.",Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
"Intrastent thrombi were defined as irregular masses protrud - ing into the lumen by more than 250 μm at the thickest  point.19  Statistical analysis Statistical analysis was performed using Statistical Analysis  System software (v. 9.1.3., SAS Institute, Cary, NC, USA)  and R version 2.15.1 (R Development Core Team, Vienna,  Austria, http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 48Table 1.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Statin Treatment vs. Strut Coverage Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 49with the degree of LDL cholesterol reduction (r=-0.456;  p=0.015) in SES-implanted patients but not in BES-implant - ed patients.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 50for this finding is that the vascular healing response to  statins or lower LDL cholesterol levels could be different ac - cording to the type of DES.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Statin Treatment vs. Strut Coverage Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 51cle and endothelial cell proliferation and reduces neointima on a  drug-eluting stent platform.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 5233.,Non-OADS,/arxiv_data1/oa_pdf/58/24/ymj-56-45.PMC4276777.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 53Mitochondrial DNA 4977bp Deletion Mutation   in Peripheral Blood Reflects Atrial Remodeling in Patients   with Non-Valvular Atrial Fibrillation Jihei Sara Lee,1 Young-Guk Ko,1 Kyoung-Jin Shin,2 Sook-Kyoung Kim,1   Jae Hyung Park,1 Ki-Cheol Hwang,1 and Hui-Nam Pak1 Departments of 1Internal Medicine and 2Forensic Medicine, Yonsei Univerisity College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Recently, mitochondrial DNA 4977bp deletion (mtDNA 4977-mut), a so - matic mutation related to oxidative stress, has been shown to be associated with  atrial fibrillation (AF).",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"1 Many studies have investi-Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.53 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):53-61, 2015",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 54GE Vingmed Ultrasound, Horten, Norway) to evaluate pa - tients for additional structural heart disease, LA remodel - ing, and ventricular function.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Mitochondrial DNA 4977bp Deletion Mutation in AF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 55plasma levels of the following protein markers were mea - sured using enzyme-linked immunosorbent assay kits: tissue  inhibitor of metalloproteinases-1 (TIMP-1; R&D Systems,  Minneapolis, MN, USA), transforming growth factor-β  (R&D Systems, Minneapolis, MN, USA), and pro-atrial  natriuretic peptide (pro-ANP; Biomedica, Antony, France).",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Two primer sets were designed using  Primer3 (http://frodo.wi.mit.edu/primer3/), and each forward  primer was labeled with the fluorescent dye 6-FAM (Macro - gen Inc., Seoul, Korea) for PCR amplification of mtD - NA4977-mut (Fig.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 56when they were further broken down according to age (Fig.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Mitochondrial DNA 4977bp Deletion Mutation in AF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 571.225, p=0.029] was found to be independently associated  with mtDNA 4977-mut (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 58tween peripheral blood mtDNA 4977-mut, AF, and remodel - ing, suggesting the potential applicability of the mtDNA  mutation as a biomarker of cardiac arrhythmia.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
Mitochondrial DNA 4977bp Deletion Mutation in AF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 59tation in AF.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 6012.,Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Mitochondrial DNA 4977bp Deletion Mutation in AF Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 61KR, et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/35/ymj-56-53.PMC4276778.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 62Clinical Characteristics and Impact of  Diabetes Mellitus on  Outcomes in Patients with Nonvalvular Atrial Fibrillation Bi Huang, Yanmin Yang, Jun Zhu, Yan Liang, Han Zhang, Li Tian, Xinghui Shao, and Juan Wang State Key Laboratory of Cardiovascular Disease, Emergency and Critical Care Center, National Center for Cardiovascular Diseases, Fuwai Hospital,  Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People ’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Studies have shown that diabetes mellitus (DM) is a risk factor for car - diovascular disease, including atrial fibrillation (AF); however, the clinical charac - teristics and prognostic impact of DM in patients with nonvalvular AF have not  been well understood in China.",Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"AF is associated with substantial complications, including increased risk of stroke, heart failure, and Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.62 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):62-71, 2015",Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"Outcomes in AF Patients with DM Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 63and rhythm strip) AF at the time of ED visits, regardless of  the reason.",Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 64RESULTS   Of 2016 AF patients, 331 patients with valvular AF and 41  nonvalvular AF patients with incomplete data were exclud - ed; consequently, 1644 patients were analyzed, of which  277 patients (16.8%) had concomitant DM.",OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
Outcomes in AF Patients with DM Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 65between the two groups were comparable (DM: 10.1%;  non-DM: 7.4%; p=0.141).,Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 66(p=0.002), cardiovascular mortality ( p=0.019), and cumula - tive CEE rates ( p=0.004).",Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
Outcomes in AF Patients with DM Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 67Table 4.,Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 68Table 4 displays the predictors of 1-year outcomes by  univariate Cox analysis.,OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
Outcomes in AF Patients with DM Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 69current guidelines by means of propaganda and education  for both clinicians and patients.,Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 70ing data and all the study coordinators, as well as the pa - tients who participated in the multicenter study.",OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
Outcomes in AF Patients with DM Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 7126.,Non-OADS,/arxiv_data1/oa_pdf/83/ee/ymj-56-62.PMC4276779.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 72Efficacy and Safety of  Endoscopic Resection Therapies   for Rectal Carcinoid Tumors: A Meta-Analysis Lei He, Tao Deng, and Hesheng Luo Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, China.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Several endoscopic resection therapies have been applied for the treatment  of rectal carcinoid tumors.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"The number of incidence of carcinoid tumors of the gas - trointestinal tract has increased over the past five decades, due in part to rapid ad - vances in screening endoscopy.3,4 Approximately 80% of rectal carcinoid tumors  are smaller than 1 cm in diameter, without invasion or metastasis at the time of di -Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.72 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):72-81, 2015",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Endoscopic Resection Therapy for Rectal Carcinoid Tumor Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 73tal carcinoid tumors, and 3) presenting detailed outcomes of  two groups or including such data for calculation in the arti - cle text.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 74plete resection rate and pooled data suggested a significantly  higher rate of complete resection among patients treated with  ESD or m-EMR than among those treated with EMR (OR=  0.42, 95% CI: 0.25‒0.71; OR=0.10, 95% CI: 0.03‒0.33, re - spectively), while there was no significant difference be - tween the m-EMR group and ESD group (OR=1.19, 95%  CI: 0.49‒2.86) (Table 2, Fig.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
Endoscopic Resection Therapy for Rectal Carcinoid Tumor Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 75Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 76and m-EMR group (MD=0.80, 95% CI: 0.09‒1.51).",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
Endoscopic Resection Therapy for Rectal Carcinoid Tumor Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 77Sensitivity analysis and publication bias  The sensitivity analysis performed using sequential exclud - ing of one study at a time did not alter the results.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 78submucosal layer because both the horizontal margin and  the submucosal layer beneath the tumors can be visualized  directly during the procedure.,Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Endoscopic Resection Therapy for Rectal Carcinoid Tumor Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 79EMR ESDWeight  (%)Odds ratio Odds ratio Study or subgroup Events Total Events Total M-H, fixed, 95% CI M-H, fixed, 95% CI Baek 2010 0 9 0 3 Not estimable Choi 2013 0 29 1 31 19.1 0.34 [0.01, 8.80] Dou 2013 4 26 0 20 6.3 8.20 [0.42, 161.83] Kim 2013 0 71 0 44 Not estimable Lee 2010 1 28 2 46 19.6 0.81 [0.07, 9.42] Lee 2013 1 44 2 26 32.9 0.28 [0.02, 3.24] Niimi 2012 1 11 0 13 5.4 3.86 [0.14, 104.65] Onozato 2010 0 26 0 9 Not estimable Park 2010 4 62 1 31 16.7 2.07 [0.22, 19.34] Zhao 2012 0 20 0 10 Not estimable Zhou 2010 0 23 0 20 Not estimable Total (95% CI) 349 253 100.0 1.39 [0.54, 3.57] Total events 11 6 Heterogeneity: Chi2=4.39; df=5 ( p=0.49); I2=0% Test for overall effect: Z=0.68 ( p=0.50) Favours [EMR] Favours [ESD] EMR ESDWeight (%)Odds ratio Odds ratio Study or subgroup Events Total Events Total M-H, fixed, 95% CI M-H, fixed, 95% CI Baek 2010 0 9 0 3 Not estimable Choi 2013 0 29 0 31 Not estimable Dou 2013 0 26 1 20 26.4 0.25 [0.01, 6.35] Kim 2013 1 71 0 44 9.6 1.89 [0.08, 47.51] Lee 2010 0 28 1 46 18.0 0.53 [0.02, 13.52] Lee 2013 0 44 0 26 Not estimable Niimi 2012 0 11 0 13 Not estimable Onozato 2010 0 26 0 9 Not estimable Park 2010 1 62 1 31 20.9 0.49 [0.03, 8.14] Zhao 2012 0 20 0 10 Not estimable Zhou 2010 0 23 1 20 25.0 0.28 [0.01, 7.18] Total (95% CI) 349 253 100.0 0.51 [0.14, 1.92] Total events 2 4 Heterogeneity: Chi2=0.97; df=4 ( p=0.91); I2=0% Test for overall effect: Z=0.99 ( p=0.32) Favours [EMR] Favours [ESD] EMR ESDWeight (%)Odds ratio Odds ratio Study or subgroup Events Total Events Total M-H, fixed, 95% CI M-H, fixed, 95% CI Baek 2010 0 9 0 3 Not estimable Dou 2013 0 26 0 20 Not estimable Kim 2008 0 6 0 2 Not estimable Kim 2013 0 71 0 44 Not estimable Lee 2010 1 28 0 46   29.6 5.07 [0.20, 128.90] Lee 2013 0 44 0 26 Not estimable Niimi 2012 1 11 0 13   33.1 3.86 [0.14, 104.65] Onozato 2010 0 26 0 9 Not estimable Park 2010 0 62 0 31 Not estimable Zhao 2012 0 20 0 10 Not estimable Zhou 2010 3 23 0 20   37.3 7.00 [0.34, 144.27] Total (95% CI) 326 224 100.0 5.39 [0.86, 33.61] Total events 5 0 Heterogeneity: Chi2=0.07; df=2 ( p=0.97); I2=0% Test for overall effect: Z=1.80 ( p=0.07) Favours [EMR] Favours [ESD]A B C Fig.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 80cluded due to differences in procedure time, which may in - fluence the results.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Endoscopic Resection Therapy for Rectal Carcinoid Tumor Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 81analysis detected by a simple, graphical test.",Non-OADS,/arxiv_data1/oa_pdf/b7/45/ymj-56-72.PMC4276780.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 82Immunohistochemical Detection of  p53 Expression in Patients  with Preoperative Chemoradiation for Rectal Cancer:   Association with Prognosis Jung Wook Huh,1 Woo Yong Lee,1 Seok Hyung Kim,2 Yoon Ah Park,1 Yong Beom Cho,1   Seong Hyeon Yun,1 Hee Cheol Kim,1 Hee Chul Park,3 Doo Ho Choi,3 Joon Oh Park,4   Young Suk Park,4 and Ho-Kyung Chun5 Departments of 1Surgery, 2Pathology, 3Radiation Oncology, and 4Hematology-Oncology, Samsung Medical Center,   Sungkyunkwan University School of Medicine, Seoul; 5Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: The expression of p53 in patients with rectal cancer who underwent pre - operative chemoradiationand and its potential prognostic significance were evaluat - ed.",Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
"Key Words:    p53, rectal cancer, immunohistochemistry INTRODUCTION Total mesorectal excision after preoperative chemoradiation remains the corner - stone of treatment for patients with potentially resectable, locally advanced rectal  cancer, as it allows for increased control of local disease, greater sphincter preser - vation rates, and improved disease-free survival.1-3 Pathologic variables related to Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.82 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):82-88, 2015",Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
p53 in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 83patients underwent radical surgery 6 to 8 weeks after preop - erative chemoradiation.,Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 84The relationships between tumor p53 expression and the  clinicopathological features of colorectal adenocarcinoma  are summarized in Table 1.,OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
p53 in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 85(Table 2).,Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 86by arresting the cell cycle in G1.7 The clinical significance  of p53 in the progression and metastasis of colorectal cancer  is controversial.8,13,19-23 A number of studies have reported  worse clinical outcomes in patients with p53 overexpression  or mutations; however, this association has not been found  to be universally true, as several investigations, including a  large series of 541 patients with colorectal cancers with a  long follow-up period by Soong, et al.,23 have suggested  that the presence of p53 accumulation is associated with  improved survival, independently of tumor stage or grade,  in distal colorectal cancers.",Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
"p53 in Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 87negatives and all other samples.29 Occasionally, a cut-off is  chosen on the basis of earlier studies.",Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 8818.,Non-OADS,/arxiv_data1/oa_pdf/af/6d/ymj-56-82.PMC4276781.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 89Insulin Resistance Is an Important Risk Factor for Cognitive  Impairment in Elderly Patients with Primary Hypertension Lina Ma, Ming Feng, Yuying Qian, Wei Yang, Jia Liu, Rui Han, Hong Zhu, and Yun Li Department of Geriatrics, Xuan Wu Hospital, Capital Medical University, Beijing, China.",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: Insulin resistance plays a role in the development of dementia and hy - pertension.",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"AD Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.89 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):89-94, 2015",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 90ria included secondary hypertension, diabetes, cancer, recent  acute infection, severe cardiac, liver or kidney dysfunction,  cerebrovascular disease, severe Parkinson’s disease, depres - sion or anxiety, hypothyroidism, intracranial space-occupy - ing, alcohol dependence, cognitive dysfunction after trau - matic brain injury, alcohol and drug abuse.",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"Insulin Resistance and Cognitive Impairment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 91DISCUSSION To our knowledge, this is the first clinical study that sys - tematically investigated the effects of IR on cognitive im - pairment in elderly Chinese patients with hypertension.",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 92leukin (IL)-1a, IL-6, and tumor necrosis factor (TNF)-a in  cerebrospinal fluid (CSF) and plasma.33,34 AD has been con - firmed to involve inflammation in the brain;33,34 and 4) Hy - percortisolism.",Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
Insulin Resistance and Cognitive Impairment Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 93hypertension: an integrated view in humans.,Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 94tion in senile dementia patients.,Non-OADS,/arxiv_data1/oa_pdf/4f/3a/ymj-56-89.PMC4276782.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 95Reference Values of  Body Composition Indices: The Korean  National Health and Nutrition Examination Surveys   Hye Won Park,1,2 Ha Yeong Yoo,1 Chul-Hyun Kim,3 Hyeoijin Kim,4  Byung Ok Kwak,1 Kyo Sun Kim,1,2 and Sochung Chung1,2 1Department of Pediatrics, Konkuk University Medical Center, Seoul; 2Konkuk University School of Medicine, Seoul;   3Department of Sports Medicine, Soonchunhyang University, Asan;   4Department of Physical Education, Korea National University of Education, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
"© Copyright: Yonsei University College of Medicine 2015 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Purpose: An increase in the prevalence of obesity has been observed in children  and adolescents.",Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
"Original Articlehttp://dx.doi.org/10.3349/ymj.2015.56.1.95 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 56(1):95-102, 2015",Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 96fat mass index (FMI), and fat-free mass index (FFMI) were  calculated as body weight (kg), fat mass (kg), and fat-free  mass (kg), respectively, divided by the square of the height  in meters (kg/m2).",OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
Reference Values of Body Composition Indices Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 97Table 2-1.,Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 98Table 2-3.,Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
Reference Values of Body Composition Indices Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 99 Fig.,Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
"Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 100The mean BMI value and the 85th and 90th percentile val - ues on the LMS curve in this study were higher than the BMI  values in the 2007 Korean National Growth Chart, which  used data of a 2005 national survey.14 The values of BMI be - low the 85th percentile showed a tendency to be lower in the  present study than those in the 2007 Korean National  Growth Chart.14 The difference between the 3rd percentile  and 97th percentiles for BMI were 13.14‒14.23 kg/m2 in this  study and 11.28‒13.08 kg/m2 in 2007 for males and 10.46‒  12.78 kg/m2 in this study and 9.53‒11.24 kg/m2 in 2007 for  females.",Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
Reference Values of Body Composition Indices Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 101adolescents.,OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
Yonsei Med J   http://www.eymj.org   Volume 56   Number 1   January 2015 102process and an outlook.,Non-OADS,/arxiv_data1/oa_pdf/77/3f/ymj-56-95.PMC4276783.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.102 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:102-111  102Original Article www.cmj.ac.k r OCT-1 , ABCB1 , and ABCG2  Expression in Imatinib-Resistant  Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib Yeo-Kyeoung Kim1,*, Seung-Shin Lee1, Sung-Hoon Jeong1, Jae-Sook Ahn1, Deok-Hwan Yang1,  Je-Jung Lee1, Myung-Geun Shin2 and Hyeoung-Joon Kim1,3 1Department of Hematology-Oncology, Hematology Clinics, Chonnam National University Hwasun Hospital,  2Department of Laboratory  Medicine, Chonnam National University Medical School, Gwangju, 3Genome Research Center for Hematopoietic Diseases, Chonnam  National University Hwasun Hospital, Hwasun, Korea This study explored drug transporter expressi on levels and their impact on clinical re- sponse to imatinib and seco nd-generation tyrosine kinase  inhibitors (TKIs) in im- atinib-resistant chronic myeloid leukemia (CML).",OADS,/arxiv_data1/oa_pdf/8e/ec/cmj-50-102.PMC4276791.pdf
"Key Words:  ABCB1 protein; ABCG2 protein; Myeloid leukemia; Imatinib This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 16 October, 2014 revised 23 November, 2014 accepted 24 November, 2014 Corresponding Author: Yeo-Kyeoung Kim Department of Hematology-Oncology,  Hematology Clinics, Chonnam  National University Hwasun Hospital, 322, Seoyang-ro, Hwasun-eup,  Hwasun 519-809, Korea TEL: +82-61-379-7626FAX: +82-61-379-7628  E-mail: yeokim@jnu.ac.kr INTRODUCTION Imatinib mesylate (imatinib), a potent BCR-ABL tyro- sine kinase inhibitor (TKI), ha s been widely used for newly  developed chronic myel oid leukemia (CML).1 However, the  failure rate in achieving op timal response to imatinib  reaches up to 20% to 30%.2 For these patients, second-gen- eration TKIs (dasatinib or nilotinib) may be used as al-ternatives.",Non-OADS,/arxiv_data1/oa_pdf/8e/ec/cmj-50-102.PMC4276791.pdf
Available at: http://www.nccn.org/professionals/ physician_gls/PDF/cml.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8e/ec/cmj-50-102.PMC4276791.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.112 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:112-114  112Case Report www.cmj.ac.k r Thrombotic Occlusion during Intravascular  Ultrasonography-Guided Percutaneous Coronary Intervention of Stumpless Chronic Total Occlusion Un Joo Lee, Hyun Soo Kim, Cheolhyun Lee, Kwang-yeol Kim and Weon Kim * Division of Cardiology, Department of In ternal Medicine, Kyung Hee University Hosp ital, Kyung Hee University, Seoul, Korea Percutaneous coronary intervention (PCI) of  stumpless chronic total occlusion (CTO)  lesions with a side branch st emming from the occlusion have a significantly lower treat- ment success rate because phys icians cannot identify an accu rate entry point with only  conventional angiographic images.",Non-OADS,/arxiv_data1/oa_pdf/97/c0/cmj-50-112.PMC4276792.pdf
"Key Words:  Thrombosis; Percutaneous coronary intervention; Ul trasonography,  Interventional This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 July, 2014 revised 28 July, 2014 accepted 9 August, 2014 Corresponding Author: Weon Kim Division of Cardiolog, Department of Internal Medicine, Kyung Hee  University Hospital, Kyung Hee  University, 1.",Non-OADS,/arxiv_data1/oa_pdf/97/c0/cmj-50-112.PMC4276792.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.115 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:115-118  115Case Report www.cmj.ac.k r Recurrent Pneumothorax after Etanercept Therapy in a  Rheumatoid Arthritis Patient: A Case Report Sang Hoon Kim, Sung Jae Choi1,*, Young Ho Seo1, Ji Hyoung Kim, Il Woo Jeong and  Sung Birm Sohn  Department of Internal Medicine, Korea University Medical Center, Seoul, 1Department of Rheumatology, Ko rea University Ansan Hospital,  Asan, Korea The use of anti-tumor necrosi s factor (anti-TNF) agents fo r rheumatoid arthritis (RA)  patients who are refractory to disease-mo difying anti-rheumatic drugs is gradually  increasing.",Non-OADS,/arxiv_data1/oa_pdf/cb/30/cmj-50-115.PMC4276793.pdf
"Key Words:  Lung diseases, interstitial; Pneu mothorax; Arthritis, rheumatoid This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 26 May, 2014 revised 2 July, 2014 accepted 4 July, 2014 Corresponding Author: Sung Jae Choi Department of Rheumatology,  Korea University Ansan Hospital, Jeokkeum-ro 123, Danwon-gu,  Ansan 425-707, Korea TEL: +82-31-412-4267FAX: +82-31-412-5984  E-mail: spring0107@naver.com INTRODUCTION Respiratory manifestations of rheumatoid arthritis  (RA) include pleural effusion , pleural thickening, pulmo- nary fibrosis, bronchiolitis ob literans, bronchiectasis, in- terstitial pneumonitis, pulmonary hypertension, and nec-robiotic nodules.",Non-OADS,/arxiv_data1/oa_pdf/cb/30/cmj-50-115.PMC4276793.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.75 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:75-81  75Review Article www.cmj.ac.k r HDL-Associated Paraoxonase 1 as a Bridge between  Postmenopausal Osteoporosis and Cardiovascular Disease Esin Eren *, Hamit Yasar Ellidag1, Ozgur Aydin2 and Necat Y ılmaz1 Biochemistry Laboratory, Antalya Public Health  Center of Ministry of Health, Antalya, 1Central Laboratories of Antalya Education and  Research Hospital of Ministry of Health, Antalya, 2Biochemistry Laboratory, Maternity a nd Children’s Hospital, Batman, Turkey The association of postmenopausal osteoporos is (PMOP) with both atherosclerosis and  vascular/valvular calcification is well known.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cmj-50-75.PMC4276794.pdf
"Key Words:  Osteoporosis; Menopause; Oxidative stress; Atherosclerosis; HDL This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 May, 2014 revised 11 June, 2014 accepted 12 June, 2014 Corresponding Author: Esin ErenBiochemistry Laboratory, Antalya  Public Health Center of Ministry of  Health, Anafartalar Cad.",Non-OADS,/arxiv_data1/oa_pdf/05/df/cmj-50-75.PMC4276794.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.82 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:82-85  82Review Article www.cmj.ac.k r Use of Umbilical Cord Serum in Ophthalmology Kyung Chul Yoon * Department of Ophthalmology and Research Inst itute of Medical Sciences, Chonnam National  University Medical School and Hospital ,  Gwangju, Korea Among blood preparations, serum has been topically used in the management of vari- ous ocular diseases in ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/25/1f/cmj-50-82.PMC4276795.pdf
"Key Words:  Ophthalmology; Umbilica l cord; Serum; Dry eye This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 11 November, 2014 revised 19 November, 2014 accepted 20 November, 2014 Corresponding Author: Kyung Chul YoonDepartment of Ophthalmology,  Chonnam National University Medical  School and Hospital, 42, Jebong-ro, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6741 FAX: +82-62-227-1642E-mail: kcyoon@jnu.ac.kr  INTRODUCTION Blood preparations includin g autologous serum (AS),  plasma rich in growth factors,  platelets, and umbilical cord  serum (UCS) have been introduced to treat many ocular diseases because they contain a high concentration of bio- logically active components and growth factors.",Non-OADS,/arxiv_data1/oa_pdf/25/1f/cmj-50-82.PMC4276795.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.86 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:86-90  86Original Article www.cmj.ac.k r Effect of Propofol on microRNA Expression Profile in  Adipocyte-Derived Adult Stem Cells Jung-Ho Kim, Bo-Kyeom Kim1, Dong-Wook Kim1, Hye-Young Shin1, Soo-Bong Yu1,  Doo-Sik Kim1, Sie-Jeong Ryu1, Kyung-Han Kim1, Hee-Kyung Jang2 and Ju-Deok Kim1,* Department of Anesthesiology and Pain Medicine, CHA Ahngang Hospital, Seoul, Departments of  1Anesthesiology and Pain Medicine and  2Pathology, Kosin University College of Medicine, Busan, Korea MicroRNA (miRNA) pathways have been implicat ed in stem cell regulation.",OADS,/arxiv_data1/oa_pdf/30/dc/cmj-50-86.PMC4276796.pdf
"Key Words:  microRNA; Propofol; Stem cell This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 20 June, 2014 revised 4 July, 2014 accepted 7 July, 2014 Corresponding Author: Ju-Deok KimDepartment of Anesthesiology and  Pain Medicine, Kosin University  College of Medicine, 34, Amnam-dong, Seo-gu, Busan  602-030, Korea  TEL: +82-51-990-6283FAX: +82-51-254-2504 E-mail: uamyfriends@hanmail.net INTRODUCTION 　MicroRNA (miRNA) is an intr insic RNA molecule that  is made up of 20 to 25 nucleotides.1 miRNA regulates cell  growth, differentiation, and apoptosis by negatively con-trolling post-transcriptional gene expression.",Non-OADS,/arxiv_data1/oa_pdf/30/dc/cmj-50-86.PMC4276796.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.91 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:91-95  91Original Article www.cmj.ac.k r Intraoperative Observation of the Degree and Pattern of Urine  Leakage before Adjustment of the Mesh during a Transobturator Tape Procedure Jae-Joon Park, Hyung Ho Lee1 and Young Sig Kim1,* Department of Urology, Severance Hospital, Seoul and 1NHIS Ilsan Hospital, Goyang, Korea Most intraoperative provocative tests previo usly reported were performed after mesh  adjustment to confirm the absence of urine leakage.",Non-OADS,/arxiv_data1/oa_pdf/2d/85/cmj-50-91.PMC4276797.pdf
"Key Words:  Mesh; Surgical tape; Urinary incontinence  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 July, 2014 revised 9 October, 2014 accepted 10 October, 2014 Corresponding Author: Young Sig Kim Department of Urology, NHIS Ilsan Hospital, 100 Ilsan-ro, Ilsandong-gu,  Goyang 410-719, Korea TEL: +82-31-900-0249FAX: +82-31-900-0279 E-mail: urokim@nhimc.or.kr",Non-OADS,/arxiv_data1/oa_pdf/2d/85/cmj-50-91.PMC4276797.pdf
"http://dx.doi.org/10.4068/cmj.2014.50.3.96 ⒸChonnam Medical Journal, 2014 Chonnam Med J 2014;50:96-101  96Original Article www.cmj.ac.k r Risk Factors for Distant Metastasis as a Primary Site of Treatment  Failure in Early-Stage Breast Cancer Hyeli Park, Sei Kyung Chang1, Ja Young Kim1, Bo Mi Lee1 and Hyun Soo Shin1,* Department of Radiation Oncology, Pr esbyterian Medical Center, Jeonju, 1Department of Radiation Oncology, CHA Bundang Medical  Center, CHA University, Seongnam, Korea The aim of this study was to evaluate the ri sk factors for distant metastasis (DM) as  a primary site of failure in early-stage brea st cancer.",OADS,/arxiv_data1/oa_pdf/0a/63/cmj-50-96.PMC4276798.pdf
"Key Words:  Breast neoplasm; Neoplasm metastasis; Risk factors This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 3 September, 2014 revised 4 November, 2014 accepted 5 November, 2014 Corresponding Author: Hyun Soo Shin Department of Radiation Oncology,  CHA Bundang Medical Center, CHA University, 351, Yatap-dong,  Seongnam 463-712, Korea TEL: +82-31-780-5426FAX: +82-31-780-5420 E-mail: shin029@chamc.co.kr INTRODUCTION Breast cancer is known to have a relatively favorable sur- vival rate in comparison with other cancers.1 In Korea,  5-year relative survival rates were reported as 89.9% dur-ing 2004-2008 for breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/0a/63/cmj-50-96.PMC4276798.pdf
"However, in Hypothesis: Somatic Mosaicism   and Parkinson Disease Han-Joon Kim and Beom S. Jeon * Department of Neurology and Movement Disorder Center, Parkinson Study Group,   and Neuroscience Research Institute, College of Medicine, Seoul National University, Seoul, Koreahttp://dx.doi.org/10.5607/en.2014.23.4.271 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
"Key words:  somatic mutation, somatic mosaicism, genetics, Parkinson disease Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
272 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.271Han-Joon Kim and Beom S. Jeon Fig.,OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
"273 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.271Somatic Mosaicism and PD some patients with genetic disorders, a mutation is not detected in  the parents.",Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
274 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.271Han-Joon Kim and Beom S. Jeon of SNpc dopaminergic neurons before the final mitosis takes  place will result in an individual with somatic mosaicism in  the SNpc.,Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
275 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.271Somatic Mosaicism and PD when analyzing the tissues.,Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
276 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.271Han-Joon Kim and Beom S. Jeon deletions of the PARK2 gene in patients with early-onset  Parkinson disease.,OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK1208/.,Non-OADS,/arxiv_data1/oa_pdf/89/9f/en-23-271.PMC4276799.pdf
"Edith Sturm and Nadia Stefanova * Division of Neurobiology, Department of Neurology, Innsbruck Medical University, Innsbruck A-6020, Austriahttp://dx.doi.org/10.5607/en.2014.23.4.277 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
"Key words:  Multiple system atrophy, α-synuclein, neurodegeneration, genetics, epigenetics Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
278 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova α-synuclein in MSA oligodendrocytes [25].,OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
279 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
"280 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova early-onset PD [103-105], genetic variants of MAPT encoding for  the microtubule-associated protein tau [106-108], PD risk factors  LRRK2  and GBA  genes [26, 65, 109-114] and other mutations  in genes coding for apolipoprotein E, dopamine β-hydroxylase,  ubiquitin C-terminal hydrolase-1 (UCH-1), fragile x mental  retardation 1, leucine-rich kinase 2 (LRRK2), progranulin (PRGN)  [115-118], dopamine-β-hydroxylase (DBH) [119], CYP2D6 [120- 122], BDNF , CNTF , IGF1, HLA and hiGIRK [94], PITX3 [123]  and rs1572931 polymorphisms in the RAB7L1  gene [124].",Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
281 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
282 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova families are known in mammalians.,OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
283 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
284 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova 24.,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
285 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
286 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova 1920.,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
287 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
"288 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova Uitti RJ, Wszolek ZK, Farrer MJ, Ross OA (2010) Association  of the MAPT locus with Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
289 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
290 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277Edith Sturm and Nadia Stefanova 158.,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
291 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.277MSA: Genetic or Epigenetic?,Non-OADS,/arxiv_data1/oa_pdf/9f/a4/en-23-277.PMC4276800.pdf
"Similar repeat sequences are found in the  exchangeable apolipoproteins, and as for many apolipoproteins,  the N-terminal lipid-binding domain of alpha synuclein adopts an  amphipathic helical structure upon binding to detergent micelles Alpha-Synuclein Function and Dysfunction on  Cellular Membranes David Snead and David Eliezer * Department of Biochemistry, Weill Cornell Medical College, New York, NY 10065, USAhttp://dx.doi.org/10.5607/en.2014.23.4.292 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"Key words:  alpha-synuclein, Parkinson, amyloid, aggregation, neurotransmission, synucleinopathy Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
293 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes or phospholipid vesicles.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"294 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer serine/threonine and tyrosine phosphorylation [75-79], tyrosine  nitration [80], ubiquitination [75,81,82], sumoylation [83],   transglutamination [84-86], and methionine oxidation [87].",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
295 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes [107].,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"296 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer First, synuclein reportedly binds to and inhibits tyrosine  hydroxylase, the rate-limiting enzyme in dopamine biosynthesis  [140].",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"297 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes and M5) become oxidized upon binding to vesicles containing  peroxidized lipids, and these methionine residues have been  established as substrates for methionine sulfoxide reductase when  synuclein is in its free, soluble form.",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"298 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer as well as phospholipid bilayers [180,181].",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
299 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes though results are conflicting as to whether membrane-bound  synuclein is more or less prone to aggregation; membrane  composition and relative concentration of protein vs. lipid are  likely key factors determining the contribution of the membrane  to synuclein aggregation [195-199].,OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
300 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer of Lewy Body formation.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"301 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes has become an attractive model for how neurodegeneration  may spread through the synucleinopathy-diseased brain [5,225- 227].",OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"302 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer synuclein assembly-state specific: aggregated fibrils or oligomers  display receptor mediated endocytosis, while monomeric  synuclein passively diffuses across the plasma membrane [241].",OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"303 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes the etiology of Parkinson's disease, and we posit that advances in  our understanding of synuclein-membrane interactions will help  bring us closer to improved treatments.",Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
304 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer in primary hippocampal neurons.,OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
305 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes aggregation.,OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"306 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer synuclein with membranes affects bilayer structure, stability,  and fibril formation.",OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"307 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes Masliah E, Halliday G, Hantschel O, Lashuel HA (2014) c-Abl  phosphorylates α-synuclein and regulates its degradation:  implication for α-synuclein clearance and contribution to  the pathogenesis of Parkinson's disease.",OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
308 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer Nussbaum RL (2002) Synaptic vesicle depletion correlates  with attenuated synaptic responses to prolonged repetitive  stimulation in mice lacking α-synuclein.,OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
309 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes 134.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
310 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer 158.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"311 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes molecular weight complexes, binds fatty acids, and shows  homology to the fatty acid-binding proteins.",OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
312 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292David Snead and David Eliezer Divergent effects of the H50Q and G51D SNCA mutations  on the aggregation of α-synuclein.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
313 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.292Alpha-Synuclein on Cellular Membranes Parkinson's disease and normal subjects.,Non-OADS,/arxiv_data1/oa_pdf/39/7d/en-23-292.PMC4276801.pdf
"ALPHA-SYNUCLEIN Asyn is, by far, the most extensively studied protein in the ATP13A2 and Alpha-synuclein:   a Metal Taste in Autophagy Tomás Lopes da Fonseca1,2 and Tiago Fleming Outeiro1,2* 1Department of Neurodegeneration and Restorative Research, Center for Nanoscale Microscopy and   Molecular Physiology of the Brain, University Medical Center Göttingen, 37073 Göttingen, Germany,   2Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugalhttp://dx.doi.org/10.5607/en.2014.23.4.314 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
"Key words:  ATP13A2,  alpha-synuclein,  Parkinson ’ s  Disease,  autophagy,  metal homeostasis Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
315 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314The Interplay between ATP13A2 and Alpha-synuclein context of PD.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
316 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314Tomás Lopes da Fonseca and Tiago Fleming Outeiro has arisen from studies focusing on the interaction between this  protein and asyn.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
317 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314The Interplay between ATP13A2 and Alpha-synuclein Fig.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
318 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314Tomás Lopes da Fonseca and Tiago Fleming Outeiro asyn accumulation.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
"319 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314The Interplay between ATP13A2 and Alpha-synuclein role in both metal homeostasis and autophagy in order to better  understand the biological function of ATP13A2 and, consequently,  how it causes disease.",Non-OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
"320 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314Tomás Lopes da Fonseca and Tiago Fleming Outeiro Krüger R, Federoff M, Klein C, Goate A, Perlmutter J, Bonin M,  Nalls MA, Illig T , Gieger C, Houlden H, Steffens M, Okun MS,  Racette BA, Cookson MR, Foote KD, Fernandez HH, T raynor  BJ, Schreiber S, Arepalli S, Zonozi R, Gwinn K, van der Brug M,  Lopez G, Chanock SJ, Schatzkin A, Park Y , Hollenbeck A, Gao  J, Huang X, W ood NW , Lorenz D, Deuschl G, Chen H, Riess  O, Hardy JA, Singleton AB, Gasser T (2009) Genome-wide  association study reveals genetic risk underlying Parkinson's  disease.",OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
321 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314The Interplay between ATP13A2 and Alpha-synuclein lysosomal type 5 P-type ATPase.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
322 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314Tomás Lopes da Fonseca and Tiago Fleming Outeiro 55.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
323 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.314The Interplay between ATP13A2 and Alpha-synuclein 1037.,OADS,/arxiv_data1/oa_pdf/01/2c/en-23-314.PMC4276802.pdf
"In this review, we explore  the recent findings from cell-based assays and animal models  of α-syn prion-like propagation and discuss how and where  the pathological α-syn species could be initiated and the key  mechanisms related to its intercellular transmission.Protein Transmission, Seeding and Degradation:  Key Steps for α-Synuclein Prion-Like Propagation Abid Oueslati1#*, Methodios Ximerakis2# and Kostas Vekrellis2 1Centre de Recherche du Centre Hospitalier de Québec, Axe Neuroscience et Département de Médecine Moléculaire   de l'Université Laval, Québec G1V4G2, Canada, 2Center for Neurosciences, Biomedical Research Foundation,   Academy of Athens, Athens 11526, Greecehttp://dx.doi.org/10.5607/en.2014.23.4.324 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"Key words:  secretion, seeding, turnover, extracellular proteins, disease propagation Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
325 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading α-SYNUCLEIN TRANSMISSION Extracellular α-synuclein A crucial tilting point in the PD field was the discovery of  α-syn secretion.,OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"326 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
327 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading ordered protein aggregates defined by their insolubility and  β-sheet structure.,Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"328 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"329 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading significantly delayed the appearance of the pathology in the  brain, thus suggesting the implication of long-distance retrograde  transport from the periphery to the central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"330 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
331 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading α-syn prion-like spreading.,Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"However, “Parkinson ’ s disease is not  a disorder in which somebody injects synuclein into your brain, ”  (Prof. T ed Dawson, http://www.nature.com/news/misfolded- protein-transmits-parkinson-s-from-cell-to-cell-1.11838) and  an important question remains to be elucidated concerning the  origin and the identity of the endogenous seed(s).",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"332 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
333 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading Lee VM (2012) Intracerebral inoculation of pathological  α-synuclein initiates a rapidly progressive neurodegenerative  α-synucleinopathy in mice.,Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"334 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
335 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Key Steps for Pathogenic α-Syn Spreading of the ubiquitin-proteasome system causes dopaminergic cell  death and inclusion body formation in ventral mesencephalic  cultures.,Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"336 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.324Abid Oueslati, et al.",Non-OADS,/arxiv_data1/oa_pdf/d8/d9/en-23-324.PMC4276803.pdf
"The aetiology Exploring Myelin Dysfunction   in Multiple System Atrophy Joanna H. Wong1,2, Glenda M. Halliday1,2 and Woojin Scott Kim1,2* 1Neuroscience Research Australia, Sydney, NSW 2031,   2School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australiahttp://dx.doi.org/10.5607/en.2014.23.4.337 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"Key words:  Multiple system atrophy, oligodendrocyte, α-synuclein, myelin, lipid dyshomeostasis Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"338 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Joanna H. Wong, et al.",OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
339 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Myelin Dysfunction in MSA α-synuclein becomes aberrantly translocated to the cytoplasm  of oligodendrocytes.,Non-OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"340 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Joanna H. Wong, et al.",OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"341 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Myelin Dysfunction in MSA tissues to the lipid acceptor apolipoprotein A1 for subsequent liver  metabolism [70], whereas ABCA3 transports phospholipids to  lamellar bodies in lungs for the synthesis of pulmonary surfactants  [71,72].",Non-OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"342 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Joanna H. Wong, et al.",OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"343 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Myelin Dysfunction in MSA PC, Jäkälä P , Beyreuther K, Masters CL, Li QX (2001) The  solubility of alpha-synuclein in multiple system atrophy  differs from that of dementia with Lewy bodies and  Parkinson's disease.",Non-OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"344 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.337Joanna H. Wong, et al.",OADS,/arxiv_data1/oa_pdf/71/30/en-23-337.PMC4276804.pdf
"of Brain and Cognitive Sciences, Brain Disease Research Institute,   2Graduate School of Pharmaceutical Sciences, College of Pharmacy, Ewha Womans University, Seoul 120-750, Koreahttp://dx.doi.org/10.5607/en.2014.23.4.345 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"Key words:  PD genes, PINK1, Parkin, DJ-1, Mitophagy, Biogenesis  Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Received October 1, 2014, Revised November 25, 2014, Accepted November 25, 2014  *T o whom correspondence should be addressed.",Non-OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"346 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Ji-Y oung Han, et al.",OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
347 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Mitochondrial Dysfuction in Familial PD interaction is disrupted by CCCP treatment [21].,Non-OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"348 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Ji-Y oung Han, et al.",OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"349 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Mitochondrial Dysfuction in Familial PD When analyzing the phosphoproteome of complex I in the livers  and brains of PINK1-null mice, the specific loss of phosphorylation  of serine-250 in the complex I subunit NdufA10 occurs [43].",Non-OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"350 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Ji-Y oung Han, et al.",OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"351 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.345Mitochondrial Dysfuction in Familial PD Campbell DG, Gourlay R, Burchell L, W alden H, Macartney  TJ, Deak M, Knebel A, Alessi DR, Muqit MM (2012)  PINK1 is activated by mitochondrial membrane potential  depolarization and stimulates Parkin E3 ligase activity by  phosphorylating Serine 65.",Non-OADS,/arxiv_data1/oa_pdf/47/95/en-23-345.PMC4276805.pdf
"Dana Kim1,2, Jin Hui Paik3, Dong-Woon Shin4,   Hak-Su Kim1,2, Chang-Shin Park1,2 and Ju-Hee Kang1,2,5* 1Department of Pharmacology, 2Hypoxia-related Disease Research Center, Inha University School of Medicine,   3Department of Emergency Medicine, Inha University Hospital, Incheon 400-712,   4Department of Emergency Medicine, Inje University Ilsan Paik Hospital, Ilsan 411-706, Korea,   5Department of Pathology and Laboratory Medicine, Perelman School of Medicine,   University of Pennsylvania, Philadelphia, PA, 19104, USAhttp://dx.doi.org/10.5607/en.2014.23.4.352 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"Key words:  Parkinson ’ s disease, Biomarker, Cerebrospinal fluid, alpha-synuclein, Progression markers Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.Review Article A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"353 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker itself is not a direct cause of death, the broad spectrum of motor  and non-motor symptoms causes a decrease in the quality of life  and the life span of afflicted persons [1].",Non-OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"354 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"355 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker α-syn-encoding SNCA  gene is known to cause familial PD [5, 6].",Non-OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"356 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
357 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker DJ-1 in PD was lower than healthy controls with a high sens.,OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"358 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
359 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker measured level (pre-analytical bias) of CSF α-syn [45].,OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"360 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"361 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker REFERENCES 1. de Lau LM, Breteler MM (2006) Epidemiology of Parkinson's  disease.",Non-OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"362 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
363 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Clinical Significance of PD CSF Biomarker pathway.,OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"364 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.352Dana Kim, et al.",OADS,/arxiv_data1/oa_pdf/e6/43/en-23-352.PMC4276806.pdf
"Progress in PD research has been driven by human genetic ATP13A2/PARK9 Deficiency Neither Cause  Lysosomal Impairment Nor Alter α-Synuclein  Metabolism in SH-SY5Y Cells Eun-Jin Bae1,2, Cheolsoon Lee2,3, He-Jin Lee2,3, Seokjoong Kim4 and Seung-Jae Lee1,2,5,* 1Department of Biomedical Science and Technology, 2Institute of Biomedical Science and Technology,   3Department of Anatomy, School of Medicine, Konkuk University, Seoul 143-701,   4ToolGen, Inc., Biotechnology Incubating Center, Seoul National University, Seoul 305-390,   5College of Veterinary Medicine, Konkuk University, Seoul 143-701, Koreahttp://dx.doi.org/10.5607/en.2014.23.4.365 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
"Key words:  ATP13A2, PARK9, Lysosome, Parkinson ’ s disease, alpha-synuclein, SH-SY5Y cell Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.A featured article of the special issue on Parkinsonian Syndrome",Non-OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
"366 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Eun-Jin Bae, et al.",OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
367 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Deficiency of ATP13A2 in SH-SY5Y Cells growth medium for 30 min and fixed with a 4% PFA solution.,OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
"368 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Eun-Jin Bae, et al.",OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
369 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Deficiency of ATP13A2 in SH-SY5Y Cells is not critical for lysosomal functions at least in SH-SY5Y  neuroblastoma cells.,Non-OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
"370 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Eun-Jin Bae, et al.",OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
371 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.365Deficiency of ATP13A2 in SH-SY5Y Cells and manganese toxicity.,Non-OADS,/arxiv_data1/oa_pdf/58/a6/en-23-365.PMC4276807.pdf
"Inflammation is the first biological response to toxic stimuli and Involvement of Endoplasmic Reticulum Stress  Response in Orofacial Inflammatory Pain Eun Sun Y ang1, Jin Y oung Bae1, Tae Heon Kim1,   Yun Sook Kim1, Kyoungho Suk2 and Y ong Chul Bae1* 1Department of Anatomy and Neurobiology, School of Dentistry, Kyungpook National University, Daegu 700-412,  2Department of Pharmacology, Brain Science & Engineering Institute, BK21 Plus KNU Biomedical Convergence Program,  Kyungpook National University School of Medicine, Daegu 700-422, Koreahttp://dx.doi.org/10.5607/en.2014.23.4.372 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"Key words:  ER stress, trigeminal ganglion, inflammatory pain, orofacial pain Copyright © Experimental Neurobiology 2014. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"373 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372ER Stress in Orofacial Inflammatory Pain tissue injury [6,7].",Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"374 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372Eun Sun Y ang, et al.",OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
375 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372ER Stress in Orofacial Inflammatory Pain treated and naïve rats.,Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"376 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372Eun Sun Y ang, et al.",OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
377 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372ER Stress in Orofacial Inflammatory Pain terminals in trigeminal caudal nuclei (V c) of the brainstems.,Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"378 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372Eun Sun Y ang, et al.",OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
379 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372ER Stress in Orofacial Inflammatory Pain inflammatory basis of metabolic disease.,Non-OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"380 www.enjournal.org http://dx.doi.org/10.5607/en.2014.23.4.372Eun Sun Y ang, et al.",OADS,/arxiv_data1/oa_pdf/6d/44/en-23-372.PMC4276808.pdf
"Original Article This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.217pISSN 2093-3665   eISSN 2093-3673 Microarray analysis after umbilical cord blood derived mesenchymal stem cells injection in monocrotaline-induced pulmonary artery hypertension rats Jae Chul Lee1,2, Kwan Chang Kim3, Yoon Sun Yang4, Wonil Oh4, Soo Jin Choi4, Soo Young Choe2,  Y oung Mi Hong1 1Department of Pediatrics, Ewha Womans University School of Medicine, Seoul, 2Department of Biology, School of Life Sciences, Chungbuk National  University, Cheongju, 3Department of Thoracic and Cardiovascular Surgery, Ewha Womans University School of Medicine, 4Biomedical Research Institute,  MEDIPOST, Co., Seoul, Korea Abstract:  Pulmonary arterial hypertension (PAH) is associated with structural alterations of lung vasculature.",Non-OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anat Cell Biol 2014;47:217-226 Jae Chul Lee, et al 218 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.217cardiomyocytes, or even cells of nonmesodermal derivation,  including hepatocytes and neurons [7-11].",OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
Microarray analysis after hUMSCs in PAH  http://dx.doi.org/10.5115/acb.2014.47.4.217Anat Cell Biol 2014;47:217-226 219 www.acbjournal.orgRelative signal intensities for each gene were generated  using the Robust Multi-Array Average algorithm.,OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anat Cell Biol 2014;47:217-226 Jae Chul Lee, et al 220 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.217Apolipoprotein L 9a [ Apo19a ], and Receptor [chemosensory]  transporter protein 4 [ Rtp4 ]) were related to transport, five  were related to immune response (RT1 class Ib, locus S3  [RT1-S3 ], Apolipoprotein C-III [ Apoc3 ], 2'-5'-oligoadenylate  synthetase-like [ Oasl ], RT1 class Ia, locus A1 [ RT1-A1 ], and  MHC class I RT1.Aa alpha-chain [ Rt1.aa ]), six were related to signal transduction (Olfactory receptor 1250 [ Olr1250 ],  Olfactory receptor 1315 [ Olr1315 ], 24-dehydrocholesterol  reductase [ Dhcr24 ], Olfactory receptor 675 [ Olr1250 ],  Olfactory receptor 53 [ Olr53 ], and Mitogen-activated protein  kinase 8 interacting protein 2 [ Mapk8ip2 ]), and three were  related to cell proliferation (Protein phosphatase 2 [formerly  T able 4.",OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Microarray analysis after hUMSCs in PAH  http://dx.doi.org/10.5115/acb.2014.47.4.217Anat Cell Biol 2014;47:217-226 221 www.acbjournal.org2A], regulatory subunit B [PR 52], beta isoform [ Ppp2r2b ],  Interleukin 25 [ Il25], and Met proto-oncogene [ Met]).",OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anat Cell Biol 2014;47:217-226 Jae Chul Lee, et al 222 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.217[Epc1 ], and Transcription factor Dp-2 [ Tfdp2 ]), and two were  related to immune response (Killer cell lectin-like receptor,  subfamily A, member 5 [ Klra5 ], and ATP-binding cassette,  sub-family A [ABC1], member 1 [ Abca1 ]).",OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Microarray analysis after hUMSCs in PAH  http://dx.doi.org/10.5115/acb.2014.47.4.217Anat Cell Biol 2014;47:217-226 223 www.acbjournal.orgHuman UCB-MSCs were able to be identified at passage  5 with CD73+, CD105+.",OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anat Cell Biol 2014;47:217-226 Jae Chul Lee, et al 224 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.217Previous reports suggested that naive or gene-modified  endothelial progenitors from peripheral blood or bone  marrow can ameliorate some of the symptoms of MCT-induced pulmonary hypertension [40, 41].",Non-OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
Microarray analysis after hUMSCs in PAH  http://dx.doi.org/10.5115/acb.2014.47.4.217Anat Cell Biol 2014;47:217-226 225 www.acbjournal.org11.,OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Anat Cell Biol 2014;47:217-226 Jae Chul Lee, et al 226 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.217perimental treatment of pulmonary interstitial fibrosis with  human umbilical cord blood mesenchymal stem cells.",Non-OADS,/arxiv_data1/oa_pdf/ae/03/acb-47-217.PMC4276895.pdf
"Original Article Corresponding author:  Ji Hyun KimDepartment of Anatomy, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712, KoreaTel: +82-63-250-2234, Fax: +82-63-271-6197, E-mail: 407kk@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.227pISSN 2093-3665   eISSN 2093-3673 Mesoesophagus and other fascial structures of the abdominal and lower thoracic esophagus: a histological study using human embryos and fetuses Si Eun Hwang1, Ji Hyun Kim2, Sang In Bae3, José Francisco Rodríguez-Vázquez4, Gen Murakami5,  Baik Hwan Cho3 1Department of Surgery, Daejeon Sun Hospital, Daejeon, 2Department of Anatomy, Chonbuk National University Medical School, 3Department of Surgery  and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, Korea, 4Institute of Embryology, Universitad Complutense, Madrid,  Spain, 5Division of Internal Medicine, Iwamizawa Asuka Hospital, Iwamizawa, Japan Abstract:  A term “mesoesophagus” has been often used by surgeons, but the morphology was not described well.",Non-OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Anat Cell Biol 2014;47:227-235 Si Eun Hwang, et al 228 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.227structure that connects to the aorta at the 5th -6th week [2].",OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Mesoesophagus and other fascial structures http://dx.doi.org/10.5115/acb.2014.47.4.227Anat Cell Biol 2014;47:227-235 229 www.acbjournal.org7, and 10 week specimens were serial, while those from the 18  week specimens were prepared at 50 mm intervals.",OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Anat Cell Biol 2014;47:227-235 Si Eun Hwang, et al 230 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.227university ethics committee (No.",Non-OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Mesoesophagus and other fascial structures http://dx.doi.org/10.5115/acb.2014.47.4.227Anat Cell Biol 2014;47:227-235 231 www.acbjournal.orga mesentery-like structure, which we have named the  “mesoesophagus, ” became evident between the aorta and esophagus.",Non-OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Anat Cell Biol 2014;47:227-235 Si Eun Hwang, et al 232 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.227mesoesophagus could still be clearly identified (Fig.",OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
Mesoesophagus and other fascial structures http://dx.doi.org/10.5115/acb.2014.47.4.227Anat Cell Biol 2014;47:227-235 233 www.acbjournal.orgmesentery.,OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Anat Cell Biol 2014;47:227-235 Si Eun Hwang, et al 234 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.227We observed that the abdominal esophagus became  attached to or fused with the left adrenal at the 7th week but  this connection became detached by the peritoneal recess at the 10th -18th week.",OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
Mesoesophagus and other fascial structures http://dx.doi.org/10.5115/acb.2014.47.4.227Anat Cell Biol 2014;47:227-235 235 www.acbjournal.orgadrenal gland and liver caudate lobe as well as the developing  lymphatic tissues: a histological study using human fetuses.,Non-OADS,/arxiv_data1/oa_pdf/0f/9d/acb-47-227.PMC4276896.pdf
"Original Article Corresponding author:  Ji Hyun KimDepartment of Anatomy, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin-gu, Jeonju 561-712, KoreaTel: +82-63-250-2234, Fax: +82-63-271-6197, E-mail: 407kk@hanmail.net This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.236pISSN 2093-3665   eISSN 2093-3673 Upper terminal of the inferior vena cava and development of the heart atriums: a study using human embryos   Ji Hyun Kim1, Si Eun Hwang2, José Francisco Rodríguez-Vázquez3, Gen Murakami4, Baik Hwan Cho5   1Department of Anatomy, Chonbuk National University Medical School, Jeonju, 2Department of Surgery, Daejeon Sun Hospital, Daejeon, Korea, 3Institute  of Embryology, Universidad Complutense, Madrid, Spain, 4Division of Internal Medicine, Iwamizawa Asuka Hospital, Iwamizawa, Japan, 5Department of  Surgery and Biomedical Research Institute, Chonbuk National University Hospital, Jeonju, Korea Abstract:  In the embryonic heart, the primitive atrium is considered to receive the bilateral sinus horns including the upper  terminal of the inferior vena cava (IVC).",Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Upper terminal of the IVC and heart atriums development http://dx.doi.org/10.5115/acb.2014.47.4.236Anat Cell Biol 2014;47:236-243 237 www.acbjournal.org7, 8].",Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Anat Cell Biol 2014;47:236-243 Ji Hyun Kim, et al 238 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.236appeared to be the interatrial septum, but we discriminated  the valve from the septum according to observations of the serial sections.",OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Upper terminal of the IVC and heart atriums development http://dx.doi.org/10.5115/acb.2014.47.4.236Anat Cell Biol 2014;47:236-243 239 www.acbjournal.orgvein, with the distance between the caval vein terminals  ranging from 0.3 -0.7 mm.",Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Anat Cell Biol 2014;47:236-243 Ji Hyun Kim, et al 240 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.236lumen at 6 -7 weeks.",OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
Upper terminal of the IVC and heart atriums development http://dx.doi.org/10.5115/acb.2014.47.4.236Anat Cell Biol 2014;47:236-243 241 www.acbjournal.orgpathogenesis of the scimitar anomaly [12].,Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Anat Cell Biol 2014;47:236-243 Ji Hyun Kim, et al 242 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.236attaches to the left atrium at the right posterior margin.",OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
Upper terminal of the IVC and heart atriums development http://dx.doi.org/10.5115/acb.2014.47.4.236Anat Cell Biol 2014;47:236-243 243 www.acbjournal.orgReferences 1.,Non-OADS,/arxiv_data1/oa_pdf/41/fb/acb-47-236.PMC4276897.pdf
"Original Article Corresponding author:  Dong Hoon ShinBioanthropology and Paleopathology Laboratory, Department of Anatomy, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, KoreaTel: +82-2-740-8203, Fax: +82-2-745-9528, E-mail: cuteminjae@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.244pISSN 2093-3665   eISSN 2093-3673 Stable isotope analysis of Joseon people skeletons from the cemeteries of Old Seoul City, the capital of Joseon Dynasty Jeong-A Yu1, Chang Seok Oh1, Jong Ha Hong1, So Ri Min2, Seugn Whan Oh3, Yi-Suk Kim2, Jun Bum  Park4, Dong Hoon Shin1 1Department of Anatomy, Seoul National University College of Medicine, 2Department of Anatomy, Ehwa Womans University School of Medicine,  3Hangang Institute of Cultural Heritage, 4Sangmyung University, Seoul, Korea Abstract:  Stable carbon and nitrogen isotope analysis reveals the diets of different human populations in history.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
Stable isotope analysis of Joseon people http://dx.doi.org/10.5115/acb.2014.47.4.244Anat Cell Biol 2014;47:244-252 245 www.acbjournal.orgis not at all insignificant.,Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Anat Cell Biol 2014;47:244-252 Jeong-A Yu, et al 246 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.244this study, we tried to find out the outliers by general boxplot  methods [30, 31].",OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
Stable isotope analysis of Joseon people http://dx.doi.org/10.5115/acb.2014.47.4.244Anat Cell Biol 2014;47:244-252 247 www.acbjournal.org0.05 level are reported as significant.,OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Anat Cell Biol 2014;47:244-252 Jeong-A Yu, et al 248 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.244difference in δ13C values between age groups (young, middle  and old; F=0.274, P=0.762).",OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
Stable isotope analysis of Joseon people http://dx.doi.org/10.5115/acb.2014.47.4.244Anat Cell Biol 2014;47:244-252 249 www.acbjournal.org The isotope ratios in each cemetery were analyzed further  by sexes.,Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Anat Cell Biol 2014;47:244-252 Jeong-A Yu, et al 250 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.244conclude that the Joseon people (especially those living in  Old Seoul City, the Joseon capital) represented by our samples consumed protein mainly of terrestrial origin.",Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
Stable isotope analysis of Joseon people http://dx.doi.org/10.5115/acb.2014.47.4.244Anat Cell Biol 2014;47:244-252 251 www.acbjournal.org4.,Non-OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Anat Cell Biol 2014;47:244-252 Jeong-A Yu, et al 252 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.24436.",OADS,/arxiv_data1/oa_pdf/ee/70/acb-47-244.PMC4276898.pdf
"Original Article Corresponding author:  Satheesha B. NayakDepartment of Anatomy, Melaka Manipal Medical College (Manipal Campus), International Centre for Health Sciences, Madhav Nagar, Manipal, Udupi District, Karnataka State 576 104, IndiaTel: +91-820-292-2519, Fax: +91-820-257-1905, E-mail: nayaksathish@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.253pISSN 2093-3665   eISSN 2093-3673 arrangement of lung tissue into lobes by fissures facilitates  the movements of the lobes in relation to one another thus helping in uniform expansion of the whole lung in inspiration [2].,Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
"Anat Cell Biol 2014;47:253-258 Bincy M. George, et al 254 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.253tial foundation of the surgical knowledge.",Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
"Morphological variations of the lungs http://dx.doi.org/10.5115/acb.2014.47.4.253Anat Cell Biol 2014;47:253-258 255 www.acbjournal.orglungs, and 73 were left lungs.",Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
"Anat Cell Biol 2014;47:253-258 Bincy M. George, et al 256 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.253of the lungs had 2 veins in the hilum and 14 (19.17%) had  three veins in the hilum.",Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
Morphological variations of the lungs http://dx.doi.org/10.5115/acb.2014.47.4.253Anat Cell Biol 2014;47:253-258 257 www.acbjournal.orgsegments and pulmonary veins is also useful clinically [19].,Non-OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
"Anat Cell Biol 2014;47:253-258 Bincy M. George, et al 258 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.25321.",OADS,/arxiv_data1/oa_pdf/51/a3/acb-47-253.PMC4276899.pdf
"Original Article Corresponding author:  Sang Pil YoonDepartment of Anatomy, Jeju National University School of Medicine, 102 Jejudaehang-ro, Jeju 690-756, KoreaTel: +82-64-7543823, Fax: +82-64-7252593, E-mail: spyoon@jejunu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.259pISSN 2093-3665   eISSN 2093-3673 Outcome-based self-assessment on a  team-teaching subject in the medical school Sang Pil Y oon, Sa Sun Cho Department of Anatomy, Jeju National University School of Medicine, Jeju, Korea Abstract:  We attempted to investigate the reason why the students got a worse grade in gross anatomy and the way how  we can improve upon the teaching method since there were gaps between teaching and learning under recently changed  integration curriculum.",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
Anat Cell Biol 2014;47:259-266 Sang Pil Y oon and Sa Sun Cho 260 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.259time productively by lessening course hours [2].,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
Outcome-based self-assessment http://dx.doi.org/10.5115/acb.2014.47.4.259Anat Cell Biol 2014;47:259-266 261 www.acbjournal.orgyear at Jeju National University School of Medicine: 41 in  2012 and 42 in 2011 (Table 2).,OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"Anat Cell Biol 2014;47:259-266 Sang Pil Y oon and Sa Sun Cho 262 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.259questions as types A, K and R 63.51%, 14.87%, and 21.62% in  2011, and types A and K 68.75% and 31.25% in 2012.",OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"Outcome-based self-assessment http://dx.doi.org/10.5115/acb.2014.47.4.259Anat Cell Biol 2014;47:259-266 263 www.acbjournal.orgItems were further classified by corrected item difficulty  (0.75) and item discrimination (0.2) as described above:  excellent, good, suspended, considered, and eliminable.",OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
Anat Cell Biol 2014;47:259-266 Sang Pil Y oon and Sa Sun Cho 264 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.259the professor’s teaching is the best?,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"Outcome-based self-assessment http://dx.doi.org/10.5115/acb.2014.47.4.259Anat Cell Biol 2014;47:259-266 265 www.acbjournal.orga continued impetus for collaboration, yet practitioners and  researchers have not made, or cannot make, empirically based claims that their cooperative efforts have been effective in terms of student outcomes [17].",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"Anat Cell Biol 2014;47:259-266 Sang Pil Y oon and Sa Sun Cho 266 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.259In conclusion, this study revealed that students were  affected by the item difficulty irrelevant to the quantity in  order to obtain academic achievement.",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/acb-47-259.PMC4276900.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/3d/b8/acb-47-267.PMC4276901.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.267pISSN 2093-3665   eISSN 2093-3673 Unilateral ureteric stone associated with gross hydronephrosis and kidney shrinkage: a cadaveric report Omid Iravani, Ern-Wei Tay, Boon-Huat Bay, Y ee-Kong Ng Department of Anatomy, Y ong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore Abstract:  Ureteric stones are a common cause of obstruction of the urinary tract, usually presenting with characteristic signs  and symptoms, such as acute ureteric colic and hematuria.",Non-OADS,/arxiv_data1/oa_pdf/3d/b8/acb-47-267.PMC4276901.pdf
"Anat Cell Biol 2014;47:267-270 Omid Iravani, et al 268 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.267the proximal part of the ureter could not pass through the  obstruction into the urinary bladder.",Non-OADS,/arxiv_data1/oa_pdf/3d/b8/acb-47-267.PMC4276901.pdf
"Unilateral ureteric stone http://dx.doi.org/10.5115/acb.2014.47.4.267Anat Cell Biol 2014;47:267-270 269 www.acbjournal.orgurine extravasation, which may damage the renal tissue and  consequently resulting in interstitial fibrosis, leading to kidney atrophy [8, 9].",Non-OADS,/arxiv_data1/oa_pdf/3d/b8/acb-47-267.PMC4276901.pdf
"Anat Cell Biol 2014;47:267-270 Omid Iravani, et al 270 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.2677.",OADS,/arxiv_data1/oa_pdf/3d/b8/acb-47-267.PMC4276901.pdf
"Case Report Corresponding author:  Srinivasa Rao SirasanagandlaDepartment of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal University, Madav Nagar, Manipal, Karnataka 567104, IndiaTel: +91-820-2922644, Fax: +91-820-2571905, E-mail: seenaih.anat@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/9c/75/acb-47-271.PMC4276902.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.271pISSN 2093-3665   eISSN 2093-3673 Unusual morphology of the superior belly of omohyoid muscle  Rajesh Thangarajan, Prakashchandra Shetty, Srinivasa Rao Sirasanagnadla, Melanie Rose D’souza Department of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal University, Manipal, Karnataka, India Abstract:  Though anomalies of the superior belly of the omohyoid have been described in medical literature, absence of  superior belly of omohyoid is rarely reported.",Non-OADS,/arxiv_data1/oa_pdf/9c/75/acb-47-271.PMC4276902.pdf
"Anat Cell Biol 2014;47:271-273 Rajesh Thangarajan, et al 272 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.271superior root of the ansa cervicalis (Figs.",OADS,/arxiv_data1/oa_pdf/9c/75/acb-47-271.PMC4276902.pdf
Variant superior belly of omohyoid muscle http://dx.doi.org/10.5115/acb.2014.47.4.271Anat Cell Biol 2014;47:271-273 273 www.acbjournal.orgto head and neck surgeons during the surgical procedures  involving the anterior cervical region.,Non-OADS,/arxiv_data1/oa_pdf/9c/75/acb-47-271.PMC4276902.pdf
"Case Report Corresponding author:  Shahriar AhmadpourDepartment of Anatomy and Pathobiology, School of Medicine, North Khorasan University of Medical Sciences, Bojnurd, IranTel: +98-584-2220133, Fax: +98-584-2247124, E-mail: Shahahmadpour@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.274pISSN 2093-3665   eISSN 2093-3673 branches of main arteries accompanied with other develop - mental abnormalities is an extremely rare variation.,Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
Multiple absences of the branches of abdominal aorta http://dx.doi.org/10.5115/acb.2014.47.4.274Anat Cell Biol 2014;47:274-278 275 www.acbjournal.orgendocrine abnormalities have not been reported.,Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
Anat Cell Biol 2014;47:274-278 Shahriar Ahmadpour and Khadijeh Foghi 276 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.274veins drained left kidney as follow; anterior renal vein run  horizontally to right side in front of aorta and other behind AA and drained to inferior vena cava (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
Multiple absences of the branches of abdominal aorta http://dx.doi.org/10.5115/acb.2014.47.4.274Anat Cell Biol 2014;47:274-278 277 www.acbjournal.orga fetus.,Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
Anat Cell Biol 2014;47:274-278 Shahriar Ahmadpour and Khadijeh Foghi 278 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.27410.,Non-OADS,/arxiv_data1/oa_pdf/ba/b1/acb-47-274.PMC4276903.pdf
"Case Report Corresponding author:  Satheesha B. NayakDepartment of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal University, Manipal, Karnataka State 576104, IndiaTel: +91-984-4009059, Fax: +91-820-2571905, E-mail: nayaksathish@gmail.com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Copyright © 2014.",Non-OADS,/arxiv_data1/oa_pdf/d0/c9/acb-47-279.PMC4276904.pdf
Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2014.47.4.279pISSN 2093-3665   eISSN 2093-3673 of developing a volvulus at any stage of life.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/acb-47-279.PMC4276904.pdf
Anat Cell Biol 2014;47:279-281 Prakashchandra Shetty and Satheesha B. Nayak 280 www.acbjournal.org http://dx.doi.org/10.5115/acb.2014.47.4.279free border containing the left colic artery.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/acb-47-279.PMC4276904.pdf
Displaced small and large intestines http://dx.doi.org/10.5115/acb.2014.47.4.279Anat Cell Biol 2014;47:279-281 281 www.acbjournal.orgabdomen.,Non-OADS,/arxiv_data1/oa_pdf/d0/c9/acb-47-279.PMC4276904.pdf
"6: 581-593, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.581 ▣MINI-REVIEW •Received 3 April 2014, revised 21 August 2014, accepted 22 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/b6/d2/kjp-52-581.PMC4277020.pdf
"*Corresponding author (sherenelim@um.edu.my) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Recent Advances in Toxoplasma gondii   Immunotherapeutics Sherene Swee-Yin Lim1,*, Rofina Yasmin Othman1,2 1Genetics and Molecular Biology Department, Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603, Kuala Lumpur,  Malaysia; 2Centre for Research in Biotechnology for Agriculture, University of Malaya, 50603 Kuala Lumpur, Malaysia Abstract:  Toxoplasmosis is an opportunistic infection caused by the protozoan parasite Toxoplasma gondii .",Non-OADS,/arxiv_data1/oa_pdf/b6/d2/kjp-52-581.PMC4277020.pdf
"6: 595-603, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.595 ▣ORIGINAL ARTICLE •Received 8 April 2014, revised 4 September 2014, accepted 29 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/1a/33/kjp-52-595.PMC4277021.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Trichomonas vaginalis  Metalloproteinase Induces mTOR  Cleavage of SiHa Cells Juan-Hua Quan1,†, In-Wook Choi2,†, Jung-Bo Yang3,†, Wei Zhou2, Guang-Ho Cha2, Yu Zhou1, Jae-Sook Ryu4,  Young-Ha Lee2,* 1Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College, Zhanjiang 524-001, Guangdong, China; 2Department of  Infection Biology, Chungnam National University School of Medicine, Daejeon 301-131, Korea; 3Department of Obstetrics and Gynecology,  Chungnam National University Hospital, Daejeon 301-131, Korea; 4Department of Environmental Biology and Medical Parasitology, Hanyang  University College of Medicine, Seoul 133-791, Korea Abstract:  Trichomonas vaginalis  secretes a number of proteases which are suspected to be the cause of pathogenesis;  however, little is understood how they manipulate host cells.",Non-OADS,/arxiv_data1/oa_pdf/1a/33/kjp-52-595.PMC4277021.pdf
"6: 605-612, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.605 ▣ORIGINAL ARTICLE •Received 18 September 2014, revised 12 October 2014, accepted 13 October 2014.",Non-OADS,/arxiv_data1/oa_pdf/11/0e/kjp-52-605.PMC4277022.pdf
"*Corresponding author (ehshin@snu.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prominent IL-12 Production and Tumor Reduction in  Athymic Nude Mice after Toxoplasma gondii  Lysate  Antigen Treatment Kyoung-Ho Pyo1, Bong-Kwang Jung1, Chun-Feng Xin1, You-Won Lee1, Jong-Yil Chai1, Eun-Hee Shin1,2,* 1Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine, and Institute of Endemic Diseases, Seoul National  University Medical Research Center, Seoul 110-799, Korea; 2Seoul National University Bundang Hospital, Seongnam 463-707, Korea Abstract:  Toxoplasma gondii  is an intracellular protozoan parasite that causes a Th1 cellular immunity.",Non-OADS,/arxiv_data1/oa_pdf/11/0e/kjp-52-605.PMC4277022.pdf
"6: 613-619, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.613 ▣ORIGINAL ARTICLE •Received 9 April 2014, revised 5 September 2014, accepted 6 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/3d/be/kjp-52-613.PMC4277023.pdf
"*Corresponding author (costasl2011@gmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Flavonoids Modulate the Proliferation of Neospora  caninum  in Glial Cell Primary Cultures Rosan Barbosa de Matos1, Suzana Braga-de-Souza1, Bruno Pena Seara Pitanga1,  Victor Diógenes Amaral da Silva1, Erica Etelvina Viana de Jesus1, Alexandre Morales Pinheiro2,  Maria de Fátima Dias Costa1, Ramon dos Santos El-Bacha1, Cátia Suse de Oliveira Ribeiro1, Silvia Lima Costa1,* 1Laboratório de Neuroquímica e Biologia Celular, Instituto de Ciências da Saúde, Universidade Federal da Bahia – UFBA, Av.",Non-OADS,/arxiv_data1/oa_pdf/3d/be/kjp-52-613.PMC4277023.pdf
"6: 621-629, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.621 ▣ORIGINAL ARTICLE •Received 15 April 2014, revised 4 August 2014, accepted 29 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/fd/26/kjp-52-621.PMC4277024.pdf
"*Corresponding author (wajihullahkhan@yahoo.co.in; wajihullahkhankau@gmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence and Clinical Manifestations of Malaria in  Aligarh, India Umm-e Asma, Farha Taufiq, Wajihullah Khan * Department of Zoology, Aligarh Muslim University, Aligarh 202002, India Abstract:  Malaria is one of the most widespread infectious diseases of tropical countries with an estimated 207 million  cases globally.",Non-OADS,/arxiv_data1/oa_pdf/fd/26/kjp-52-621.PMC4277024.pdf
2013 (http://who.int/malaria/pub - lications/world_malaria_report_2013/en).,Non-OADS,/arxiv_data1/oa_pdf/fd/26/kjp-52-621.PMC4277024.pdf
"Int J Nephrol  2013; Article ID 841518, 6 pages (http://dx.doi.org/10.1 1559/   2013/841518).",OADS,/arxiv_data1/oa_pdf/fd/26/kjp-52-621.PMC4277024.pdf
"6: 631-637, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.631 ▣ORIGINAL ARTICLE •Received 3 March 2014, revised 9 September 2014, accepted 28 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/bf/f3/kjp-52-631.PMC4277025.pdf
"*Corresponding author (k.congpuong@gmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Plasmodium falciparum  Genotype Diversity in Artemisinin  Derivatives Treatment Failure Patients along the   Thai-Myanmar Border Kanungnit Congpuong1,*, Thirasak Hoonchaiyapoom2, Kornnarin Inorn1 1Bansomdejchaopraya Rajabhat University, Bangkok 10600, Thailand; 2Bureau of Vector Borne Disease, Department of Disease Control, Ministry of  Public Health, Nonthaburi, Thailand Abstract:  Genetic characteristics of Plasmodium falciparum  may play a role in the treatment outcome of malaria infection.",Non-OADS,/arxiv_data1/oa_pdf/bf/f3/kjp-52-631.PMC4277025.pdf
Available from http://www.who.int/ material/publication/atzo/rgptext_ sti.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bf/f3/kjp-52-631.PMC4277025.pdf
"6: 639-644, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.639 ▣ORIGINAL ARTICLE •Received 28 April 2014, revised 8 July 2014, accepted 18 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/2e/b7/kjp-52-639.PMC4277026.pdf
"*Corresponding author (nejpom@gmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Congenital Malaria in Newborns Selected for Low   Birth-Weight, Anemia, and Other Possible Symptoms in  Maumere, Indonesia Loeki Enggar Fitri1, Natalia Erica Jahja2,*, Irene Ratridewi Huwae2, Mario B. Nara3, Nicole Berens-Riha4 1Department of Parasitology, Faculty of Medicine, University of Brawijaya, Jalan Veteran Malang, East Java 65145, Indonesia; 2Department of  Pediatrics, dr. Saiful Anwar Hospital/Faculty of Medicine, University of Brawijaya, Jalan J.",Non-OADS,/arxiv_data1/oa_pdf/2e/b7/kjp-52-639.PMC4277026.pdf
"6: 645-652, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.645 ▣ORIGINAL ARTICLE •Received 9 September 2014, revised 20 November 2014, accepted 21 November  2014.",Non-OADS,/arxiv_data1/oa_pdf/0c/8b/kjp-52-645.PMC4277027.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Fasciola hepatica  in Snails Collected from Water-Dropwort  Fields using PCR Hwang-Yong Kim1,†, In-Wook Choi2,†, Yeon-Rok Kim1, Juan-Hua Quan3, Hassan Ahmed Hassan Ahmed Ismail2,  Guang-Ho Cha2, Sung-Jong Hong4, Young-Ha Lee2,* 1Rural Development Administration, Suwon 441-707, Korea; 2Department of Infection Biology, Chungnam National University School of Medicine,  Daejeon 301-131, Korea; 3Department of Gastroenterology, The Affiliated Hospital of Guangdong Medical College, Zhanjiang 524-001, Guangdong,  China; 4Department of Medical Environmental Biology, College of Medicine, Chung-Ang University, Seoul 156-756, Korea Abstract:  Fasciola hepatica  is a trematode that causes zoonosis mainly in cattle and sheep and occasionally in humans.",Non-OADS,/arxiv_data1/oa_pdf/0c/8b/kjp-52-645.PMC4277027.pdf
"6: 653-659, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.653 ▣ORIGINAL ARTICLE •Received 11 July 2014, revised 9 August 2014, accepted 26 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/67/11/kjp-52-653.PMC4277028.pdf
"*Corresponding author (majid.fasihi@gmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Scolicidal Effects of Black Cumin Seed ( Nigella sativa )  Essential Oil on Hydatid Cysts   Hossein Mahmoudvand1,2, Ebrahim Saedi Dezaki2, Farnaz Kheirandish3, Behrouz Ezatpour4, Sareh Jahanbakhsh1,2,  Majid Fasihi Harandi5,* 1Research Center for Tropical and Infectious Diseases, 2Department of Medical Parasitology and Mycology, Kerman University of Medical Sciences,   Kerman, Iran; 3Department of Medical Parasitology and Mycology and 4Razi Herbal Medicines Research Center, Lorestan University of Medical  Sciences, Khorramabad, Iran; 5Research Center for Hydatid Disease in Iran, Kerman University of Medical Sciences, Kerman, Iran Abstract:  Surgery remains the preferred treatment for hydatid cyst (cystic echinococcosis, CE).",Non-OADS,/arxiv_data1/oa_pdf/67/11/kjp-52-653.PMC4277028.pdf
"6: 661-666, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.661 ▣ORIGINAL ARTICLE •Received 20 July 2014, revised 9 October 2014, accepted 9 October 2014.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/kjp-52-661.PMC4277029.pdf
"*Corresponding author (cjy@snu.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence of Intestinal Helminths among Inhabitants of  Cambodia (2006-2011) Tai-Soon Yong1, Jong-Yil Chai2,*, Woon-Mok Sohn3, Keeseon S. Eom4, Hoo-Gn Jeoung5, Eui-Hyug Hoang5,  Cheong-Ha Yoon5, Bong-Kwang Jung2, Soon-Hyung Lee2, Muth Sinuon6, Duong Socheat6 1Department of Environmental Medical Biology and Arthropods of Medical Importance Bank, Institute of Tropical Medicine, Yonsei University College  of Medicine, Seoul 120-752, Korea; 2Department of Parasitology and Tropical Medicine, Seoul National University College of Medicine,   Seoul 110-799, Korea; 3Department of Parasitology and Tropical Medicine, and Institute of Health Sciences, Gyeongsang National University School  of Medicine, Jinju 660-751, Korea; 4Department of Parasitology and Medical Research Institute, Chungbuk National University School of Medicine,  Cheongju 361-763, Korea; 5Korea Association of Health Promotion, Seoul 157-916, Korea; 6Center for Parasitology, Entomology, and Malaria  Control, Phnom Penh, Cambodia Abstract:  In order to investigate the status of intestinal helminthic infections in Cambodia, epidemiological surveys were  carried out on a national scale, including 19 provinces.",Non-OADS,/arxiv_data1/oa_pdf/5b/d9/kjp-52-661.PMC4277029.pdf
"6: 667-672, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.667 ▣CASE REPORT •Received 20 August 2014, revised 1 October 2014, accepted 1 October 2014.",Non-OADS,/arxiv_data1/oa_pdf/e3/93/kjp-52-667.PMC4277030.pdf
"*Corresponding author (macropha@korea.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.An Imported Case of Severe Falciparum Malaria with  Prolonged Hemolytic Anemia Clinically Mimicking   a Coinfection with Babesiosis  Young Ju Na1, Jong-Yil Chai2, Bong-Kwang Jung2, Hyun Jung Lee1, Ji Young Song1, Ji Hye Je1, Ji Hye Seo1,  Sung Hun Park1, Ji Seon Choi3, Min Ja Kim1,* 1Department of Internal Medicine, 3Department of Laboratory Medicine, Korea University Anam Hospital, Seoul 136-705, Korea; 2Department of  Parasitology and Tropical Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea Abstract:  While imported falciparum malaria has been increasingly reported in recent years in Korea, clinicians have diffi - culties in making a clinical diagnosis as well as in having accessibility to effective anti-malarial agents.",Non-OADS,/arxiv_data1/oa_pdf/e3/93/kjp-52-667.PMC4277030.pdf
"Epidemiologic characteristics of imported malaria in Korea,  2003-2012. http://www.cdc.go.kr/CDC/contents/CdcKrContent - Link.jsp?fid=31&cid=22134&ctype=6.",Non-OADS,/arxiv_data1/oa_pdf/e3/93/kjp-52-667.PMC4277030.pdf
"6: 673-676, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.673 ▣CASE REPORT •Received 27 July 2014, revised 15 September 2014, accepted 2 October 2014.",Non-OADS,/arxiv_data1/oa_pdf/a0/fd/kjp-52-673.PMC4277031.pdf
"*Corresponding author (bbbenji@naver.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Three Cases of Diphyllobothrium nihonkaiense  Infection in  Korea Hong-Ja Kim1, Keeseon S. Eom2, Min Seo3,* 1Department of Internal Medicine, College of Medicine, Dankook University, Cheonan 330-714, Korea; 2Department of Parasitology and Medical  Research Institute, Parasite Resource Bank of Korea, Chungbuk National University School of Medicine, Cheongju 361-763, Korea; 3Department of  Parasitology and Research Center for Mummy, College of Medicine, Dankook University, Cheonan 330-714, Korea Abstract:  Until 2012, a total of 48 cases of diphyllobothriasis had been reported in Korea, all of which were morphologically  identified as Diphyllobothrium latum .",Non-OADS,/arxiv_data1/oa_pdf/a0/fd/kjp-52-673.PMC4277031.pdf
"6: 677-680, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.677 ▣CASE REPORT •Received 18 July 2014, revised 4 September 2014, accepted 10 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/84/fb/kjp-52-677.PMC4277032.pdf
"*Corresponding author (kyjoo@hanyang.ac.kr) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Extracorporeal Worm Extraction of Diphyllobothrium  nihonkaiense  with Amidotrizoic Acid in a Child Hye Kyung Shin1, Joo-Hyung Roh1, Jae-Won Oh1, Jae-Sook Ryu2, Youn-Kyoung Goo3, Dong-Il Chung3,  Yong Joo Kim1,* 1Department of Pediatrics, 2Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 133-792,  Korea; 3Department of Parasitology and Tropical Medicine, Kyungpook National University School of Medicine, Daegu 700-422, Korea Abstract:  Infection cases of diphyllobothriid tapeworms are not much in the below teen-age group.",Non-OADS,/arxiv_data1/oa_pdf/84/fb/kjp-52-677.PMC4277032.pdf
"6: 681-684, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.681 ▣CASE REPORT •Received 6 March 2014, revised 20 August 2014, accepted 31 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/10/d1/kjp-52-681.PMC4277033.pdf
"*Corresponding author (tsyong212@yuhs.ac) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Human Sting of Cephalonomia gallicola  (Hymenoptera:  Bethylidae) in Korea In-Yong Lee1, Chang-Seob Shin2, Seobo Sim3, Jung-Won Park4, Tai-Soon Yong1,* 1Department of Environmental Medical Biology and Institute of Tropical Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea;  2Gangnam Clean Pest Control, Seoul 135-862, Korea; 3Department of Environmental and Tropical Medicine, School of Medicine, Konkuk University,  Chungju 380-701, Korea; 4Department of Internal Medicine, Yonsei University College of Medicine, Seoul 120-752, Korea Abstract:  Hymenoptera stings can cause serious injury to humans.",Non-OADS,/arxiv_data1/oa_pdf/10/d1/kjp-52-681.PMC4277033.pdf
"6: 685-690, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.685 ▣CASE REPORT •Received 28 November 2013, revised 12 July 2014, accepted 15 July 2014.",Non-OADS,/arxiv_data1/oa_pdf/9f/05/kjp-52-685.PMC4277034.pdf
"*Corresponding author (jinkim16@hanmail.net) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Perianal Tick-Bite Lesion Caused by a Fully Engorged  Female Amblyomma testudinarium Jin Kim1,*, Haeng An Kang2, Sung Sun Kim3, Hyun Soo Joo1, Won Seog Chong4 1Department of Parasitology, College of Medicine, Seonam University, Namwon 590-711, Korea; 2Department of Colorectal Surgery, Kangmoon  Surgical Clinic, Gwangju 502-835, Korea; 3Department of Pathology, Chonnam National University Medical School, Gwangju 501-746, Korea;  4Department of Pharmacology, College of medicine, Seonam University, Namwon 590-711, Korea Abstract:  A perianal tick and the surrounding skin were surgically excised from a 73-year-old man residing in a south - western costal area of the Korean Peninsula.",Non-OADS,/arxiv_data1/oa_pdf/9f/05/kjp-52-685.PMC4277034.pdf
"6: 691-694, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.691 ▣BRIEF COMMUNICATION •Received 3 December 2013, revised 7 August 2014, accepted 26 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/11/f2/kjp-52-691.PMC4277035.pdf
"© 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Prevalence of Dirofilaria immitis  Infection in Stray Cats by  Nested PCR in Korea Hyung-Jin Park1,†, Sang-Eun Lee2,†, Won-Ja Lee2, Jung-Hyun Oh3, Easwaran Maheswaran4, Kyoung-Won Seo1,  Kun-Ho Song1,* 1Laboratory of Veterinary Internal Medicine, College of Veterinary Medicine, Chungnam National University, Daejeon 305-764, Korea; 2Division of  Malaria & Parasitic Diseases, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Osong-eup, Cheongwon-gun,  Chungbuk 363-951, Korea; 3Department of Statistics, Chung-Ang University, Seoul 156-756, Korea; 4Laboratory of Veterinary Infectious Disease,  College of Veterinary Medicine, Chungnam National University, Daejeon 305-764, Korea Abstract:  The purpose of this study was to conduct a survey of Dirofilaria immitis  infection among stray cats in Korea us - ing nested PCR.",Non-OADS,/arxiv_data1/oa_pdf/11/f2/kjp-52-691.PMC4277035.pdf
"6: 695-699, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.695 ▣BRIEF COMMUNICATION •Received 7 May 2014, revised 2 September 2014, accepted 7 September 2014.",Non-OADS,/arxiv_data1/oa_pdf/81/38/kjp-52-695.PMC4277036.pdf
"*Corresponding author (moses_bility@med.unc.edu) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Chronic Opisthorchis viverrini  Infection and Associated  Hepatobiliary Disease Is Associated with Iron Loaded M2- like Macrophages Moses T. Bility1,*, Banchob Sripa2 1Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USA; 2Department of Pathology, Khon Kaen  University, Khon Kaen, Thailand Abstract:  Chronic Opisthorchis viverrini -induced hepatobiliary disease is associated with significant leukocyte infiltration,  including activated macrophages; however, the polarization of infiltrating macrophages remains to be fully characterized.",Non-OADS,/arxiv_data1/oa_pdf/81/38/kjp-52-695.PMC4277036.pdf
"6: 701-705, December 2014   http://dx.doi.org/ 10.3347/kjp.2014.52.6.701 ▣BRIEF COMMUNICATION •Received 3 May 2014, revised 22 July 2014, accepted 26 August 2014.",Non-OADS,/arxiv_data1/oa_pdf/41/9a/kjp-52-701.PMC4277037.pdf
"*Corresponding author (anshu8282@rediffmail.com) © 2014, Korean Society for Parasitology and Tropical Medicine This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Molecular Characterization of Gastrothylax crumenifer   (Platyhelminthes: Gastrothylacidae) from Goats in the  Western Part of India by LSU of Nuclear Ribosomal DNA Ashwani Kumar1, Anshu Chaudhary1,2,*, Chandni Verma1, Hridaya Shanker Singh1 1Molecular Taxonomy Laboratory, Department of Zoology, Chaudhary Charan Singh University, Meerut (U.P .)",Non-OADS,/arxiv_data1/oa_pdf/41/9a/kjp-52-701.PMC4277037.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/a8/dddt-9-013.PMC4277119.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 13–19Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  13Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7368 6T emsirolimus for patients with metastatic renal  cell carcinoma: outcomes in patients receiving  temsirolimus within a compassionate use program  in a tertiary referral center Mehran afshar1,* Jennifer Pascoe1,2,* sue Whitmarsh1 nicholas James1,3 emilio Porfiri1,2 1Queen elizabeth hospital  Birmingham nhs Foundation Trust,   2cancer research UK clinical Trials  Unit, school of cancer sciences,   University of Birmingham, Birmingham,   UK; 3cancer research Unit, clinical  Trials Unit, University of Warwick,   coventry, UK *These authors have contributed  equally to this workAim:  Temsirolimus has shown efficacy as first-line treatment of patients with metastatic renal  cell carcinoma and poor prognostic features.",Non-OADS,/arxiv_data1/oa_pdf/84/a8/dddt-9-013.PMC4277119.pdf
"Keywords:  survival, renal cancer, toxicity, retrospective, tumor Introduction The management of metastatic renal cell carcinoma (RCC) has been revolutionized by  the advent of a new generation of drugs that target the molecular pathways often impli - cated in the development of this malignancy.1 Drugs targeting the aberrant activation of  the vascular endothelial growth factor (VEGF) pathway, such as sunitinib, pazopanib,  and bevacizumab, have shown significant efficacy and have replaced interferon-based Correspondence: Emilio Porfiri cancer research UK clinical Trials Unit,  school of cancer sciences, University  of Birmingham, Vincent Drive, edgbaston,  Birmingham B15 2TT, UK Tel +44 7768 838 762 email emilio.porfiri@uhb.nhs.u k Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Afshar et al Running head recto: Temsirolimus in metastatic renal cell carcinoma DOI: http://dx.doi.org/10.2147/DDDT.S73686",Non-OADS,/arxiv_data1/oa_pdf/84/a8/dddt-9-013.PMC4277119.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/84/a8/dddt-9-013.PMC4277119.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/a8/dddt-9-013.PMC4277119.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/e1/dddt-9-163.PMC4277120.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 163–174Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  163Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7494 0clinical effect of a positive surgical margin  after hepatectomy on survival of patients  with intrahepatic cholangiocarcinoma chun-n an Yeh1 Feng-Jen hsieh1 Kun-chun chiang1 Jen-shi chen2 Ta-sen Yeh1 Yi-Yin Jan1 Miin-Fu chen1 1Department of general surgery,   2Department of Medical Oncology,   chang gung Memorial hospital,   chang gung University, Taoyuan,   TaiwanBackground:  Several unfavorable prognostic factors have been proposed for peripheral  cholangiocarcinoma (PCC) in patients undergoing hepatectomy, including gross type of tumor,  vascular invasion, lymph node metastasis, a high carbohydrate antigen 19-9 level, and a positive  resection margin.",Non-OADS,/arxiv_data1/oa_pdf/16/e1/dddt-9-163.PMC4277120.pdf
"Keywords:  surgical margin, hepatectomy, cholangiocarcinoma Introduction Peripheral cholangiocarcinoma (PCC) is a malignant tumor of the liver, arising from  the second or more distal branches of the intrahepatic bile ducts.1 The incidence of  PCC varies widely in different regions, but generally accounts for 5%–30% of primary  liver cancers.1 In a report from the Japan Liver Cancer Society, histologically proven  PCC represented 3.58% of all primary liver cancers.1 Because of causative factors like liver flukes and hepatolithiasis, the incidence  of PCC is ten times higher in Oriental countries.2–4 Due to its intrahepatic location,  early symptoms are rare and most patients present with advanced tumors and have  dismal survival.5,6 Hepatic resection provides the only chance of cure for PCC; how - ever, most of the tumors are detected at an advanced stage, making curative resection  challenging.6 In addition, there are no definitive guidelines for adjuvant chemotherapy  or radiotherapy, leaving PCC patients with few treatment options.7–9 Although liver correspondence: Yi-Yin Jan Department of general surgery, chang  gung Memorial hospital, chang gung  University, 5 Fu-hsing street, Kwei-shan,  Taoyuan 333, Taiwan Tel +886 3 328 1200 extension 3219 Fax +886 3 328 5818 email janyy@adm.cgmh.org.tw Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y eh et al Running head recto: Surgical margins and cholangiocarcinoma in patients undergoing hepatectomy DOI: http://dx.doi.org/10.2147/DDDT.S74940",Non-OADS,/arxiv_data1/oa_pdf/16/e1/dddt-9-163.PMC4277120.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/16/e1/dddt-9-163.PMC4277120.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/e1/dddt-9-163.PMC4277120.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 103–125Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  103Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5147 6Pharmacological approaches to improving  cognitive function in Down syndrome: current  status and considerations Katheleen J Gardiner Linda Crnic institute for Down  Syndrome, Department of Pediatrics,   Department of Biochemistry and  Molecular Genetics, Human Medical  Genetics and Genomics Program,   Neuroscience Program, University  of Colorado School of Medicine,   Aurora, CO, USA Correspondence: Katheleen J Gardiner Linda Crnic institute for Down  Syndrome, Department of Pediatrics,  Department of Biochemistry and  Molecular Genetics, Human Medical  Genetics and Genomics Program,  Neuroscience Program, University  of Colorado School of Medicine,  Mail Stop 8608, 12700 e 19th Avenue,  Aurora, CO 80045, USA email katheleen.gardiner@ucdenver.ed uJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Gardiner Running head recto: Cognitive function in Down syndrome DOI: http://dx.doi.org/10.2147/DDDT.S51476 Abstract:  Down syndrome (DS), also known as trisomy 21, is the most common genetic  cause of intellectual disability (ID).",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"EGCG has been shown to be a powerful  antioxidant and antitumor agent, and it is possible that most of  its targets and effectors are unknown.89,90 EGCG is currently  in clinical trials for obesity, several types of malignancy,  Huntington’s disease, Fragile X, and AD, as well as for DS  (http://clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"The Hsa21 connection to the  thyroid hormone may involve NRIP1, which is also not tri - somic in the Ts65Dn mice.133 A larger trial with folate plus  thyroxine is in progress (see http://clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"Clinical trials currently recruiting participants include a  Phase II trial with another GABAA α5 antagonist, RG1662  (Hoffman-La Roche Ltd., Basel, Switzerland), that started  in May 2014 ( http://clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"Rapamycin is US FDA approved  and is being investigated in clinical trials for other IDs,  including Fragile X, tuberous sclerosis, and Rett syndrome  (http://clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/5a/dddt-9-103.PMC4277121.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 155–161Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  155Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7615 8Profile of netupitant/palonosetron (NEPA)  fixed dose combination and its potential  in the treatment of chemotherapy-induced  nausea and vomiting (CINV) Rudolph M Navari Cancer Care Program, Eastern  europe, world Health Organization,   Mishawaka, IN, USA; Indiana  University School of Medicine,   South  Bend, IN, USA; South Bend  Medical Services Corporation,   IN, USAAbstract:  Chemotherapy-induced nausea and vomiting (CINV) is associated with a significant  deterioration in quality of life.",Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
"If CINV cannot be controlled in an outpatient facility, patients may  subsequently be treated in an emergency department or require hospitalization.1,3  Patients who have an electrolyte imbalance or those who have recently undergone  surgery or radiation therapy, are at greater risk of experiencing serious complications  from CINV.1–3Correspondence: Rudolph M Navari 202 Lincolnway East, Suite #105,  Mishawaka, IN 46544, USA Tel +1 574 252 7225 email rmnavari@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Navari Running head recto: NEPA and its potential in the treatment of CINV DOI: http://dx.doi.org/10.2147/DDDT.S76158",Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
"Available from URL: http://www.nccn.org/professionals/physician_gls/ PDF/antiemesis.pd f. Accessed July 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements.,Non-OADS,/arxiv_data1/oa_pdf/29/c5/dddt-9-155.PMC4277122.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/25/dddt-9-093.PMC4277123.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 93–102Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  93Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7546 4analysis of malignancies in patients after heart  transplantation with subsequent immunosuppressive  therapy rasmus rivinius1 Matthias helmschrott1 arjang ruhparwar2 Bastian schmack2 Berthold Klein2 christian erbel1 christian a gleissner1 Mohammadreza  akhavanpoor1 lutz Frankenstein1 Fabrice F Darche1 Dierk Thomas1 Philipp ehlermann1 T om Bruckner3 hugo a Katus1 andreas O Doesch1 1Department of cardiology, angiology  and Pneumology, 2Department  of cardiac surgery, 3institute  for Medical Biometry and informatics,   University of heidelberg, heidelberg,   germanyObjective: The aim of this study was to analyze the distribution of malignancies in patients  after heart transplantation (HTX) and to evaluate the risk factors including immunosuppressive  therapy with regard to the development of malignancies and survival.",Non-OADS,/arxiv_data1/oa_pdf/92/25/dddt-9-093.PMC4277123.pdf
"Keywords:  immunosuppression, risk factors, cyclosporine A, tacrolimus, azathioprine, myco - phenolate mofetil, mTOR inhibitor, steroids Introduction As survival of patients after heart transplantation (HTX) has been improving in the last  decades, malignancy secondary to immunosuppressive therapy has become a major correspondence: andreas O Doesch Medizinische Klinik, Universitätsklinikum  heidelberg, innere Medizin iii – abteilung  für Kardiologie, angiologie und  Pneumologie, im neuenheimer Feld 410,  69120 heidelberg, germany   Tel +49 6221 56 39936   Fax +49 6221 56 4105   email andreas.doesch@med.uni- heidelberg.de  Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Rivinius et al Running head recto: Malignancies in patients after HTX with immunosuppressive therapy DOI: http://dx.doi.org/10.2147/DDDT.S75464",Non-OADS,/arxiv_data1/oa_pdf/92/25/dddt-9-093.PMC4277123.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/92/25/dddt-9-093.PMC4277123.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/25/dddt-9-093.PMC4277123.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d2/91/dddt-9-127.PMC4277124.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 127–146Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  127Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6850 1Schisandra chinensis  regulates drug metabolizing  enzymes and drug transporters via activation  of nrf2-mediated signaling pathway Jin-lian he1 Zhi-Wei Zhou2,3 Juan-Juan Yin2 chang-Qiang he1 shu-Feng Zhou2,3 Yang Yu1 1college of chinese Medicine,   guangzhou University of chinese  Medicine, guangzhou, guangdong,   People’s republic of china;   2Department of Pharmaceutical  sciences, college of Pharmacy,   University of south Florida, Tampa,   Fl, Usa; 3guizhou Provincial Key  laboratory for regenerative  Medicine, stem cell and Tissue  engineering research center and  sino-U s Joint laboratory for Medical  sciences, guiyang Medical University,   guiyang, guizhou, People’s republic  of chinaAbstract:  Drug metabolizing enzymes (DMEs) and drug transporters are regulated via epigenetic,  transcriptional, posttranscriptional, and translational and posttranslational modifications.",Non-OADS,/arxiv_data1/oa_pdf/d2/91/dddt-9-127.PMC4277124.pdf
"The 2002 National Health correspondence:  Yang Yu college of chinese Medicine, guangzhou  University of chinese Medicine, no.12  Jichang road, guangzhou, guangdong,  510405, People’s republic of china Tel +86 20 3935 8094 Fax +86 20 3935 8090 email yuyang@gzucm.edu.c n shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Blvd,  MDc 30, Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed uJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: He et al Running head recto: SCE regulates DMEs and transporters through Nrf2 activation DOI: http://dx.doi.org/10.2147/DDDT.S68501",Non-OADS,/arxiv_data1/oa_pdf/d2/91/dddt-9-127.PMC4277124.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d2/91/dddt-9-127.PMC4277124.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/91/dddt-9-127.PMC4277124.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/17/2c/dddt-9-147.PMC4277125.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 147–154Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  147Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S5034 8Designing biologic selectivity for inflammatory  bowel disease – role of vedolizumab Niklas Krupka Daniel C Baumgart Division of Gastroenterology  and Hepatology, Department  of Medicine, Charité Medical School,   Humboldt-University of Berlin, Berlin,   GermanyAbstract:  Crohn’s disease and ulcerative colitis are two chronic inflammatory bowel conditions.",Non-OADS,/arxiv_data1/oa_pdf/17/2c/dddt-9-147.PMC4277125.pdf
"From the current understanding, the pathophysiological events in  IBD involve a disturbance of the commensal microbiota, an impairment of mucosal  defense mechanisms, an increased permeability of the gut’s epithelial layer, and a  dysregulation of the innate and adaptive immune system, all of which eventually  promote an aberrant immune response against nonpathogenic gut bacteria and subse - quent tissue damage.1–4 Genome-wide association studies have shown a wide range of  susceptibility loci for CD and UC, with a significant overlap between both diseases;  however, the precise interplay of genetic and environmental factors that underlies  disease is still unknown.5–7 One of the histopathological hallmarks of CD, UC, and most chronic inflamma - tory processes in general is a markedly increased number of leukocytes, specifically  memory T cells, in affected tissues, which results from increased cell extravasation  and/or retention.8,9 Importantly, the transendothelial migration of leukocytes is a  highly regulated process that involves numerous leukocyte and endothelial surface  molecules.10,11 Specifically, binding of the leukocyte α4β7 integrin to its principal  ligand, the mucosal addressin cellular adhesion molecule 1 (MAdCAM-1), which  is expressed in high endothelial venules of the gut lamina propria, gut-associated  lymphoid tissue, and mesenteric lymph nodes, has been shown to be pivotal in  leukocyte homing to the gastrointestinal tract.12–17 In CD and UC, the expression of  MAdCAM-1 is highly upregulated in high endothelial venules of inflammatory sites  and promotes an increased capacity to bind leukocytes.18,19 This strongly supports  relevance of the MAdCAM-1– α4β7 integrin interaction in disease and makes it a  promising therapeutic target.Correspondence: Daniel C Baumgart Division of Gastroenterology and  Hepatology, Department of Medicine,  Charité Medical Center – virchow  Hospital, Medical School of the  Humboldt-University, D-13344 Berlin,  Germany Tel +49 30 450 553315 Fax +49 30 450 553983 email daniel.baumgart@charite.d e Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Krupka and Baumgart Running head recto: Vedolizumab: biologic selectivity for inflammatory bowel disease DOI: http://dx.doi.org/10.2147/DDDT.S50348",Non-OADS,/arxiv_data1/oa_pdf/17/2c/dddt-9-147.PMC4277125.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/17/2c/dddt-9-147.PMC4277125.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/17/2c/dddt-9-147.PMC4277125.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/80/dddt-9-033.PMC4277126.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 33–78Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  33Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7289 2An evidence-based update on the pharmacological  activities and possible molecular targets of Lycium  barbarum  polysaccharides Jiang Cheng1,2 Zhi-w ei Zhou2 Hui-Ping Sheng3 Lan-Jie He4 Xue-w en Fan1 Zhi-Xu He5 Tao Sun6 Xueji Zhang7 Ruan Jin Zhao8 Ling Gu9 Chuanhai Cao2 Shu-Feng Zhou2,5 1Department of Neurology, General  Hospital of Ningxia Medical University,  Yinchuan, Ningxia, People’s Republic of  China; 2Department of Pharmaceutical  Science, College of Pharmacy, University of  South Florida, Tampa, FL, USA; 3Department  of infectious Diseases, 4Department of  endocrinology, General Hospital of Ningxia  Medical University, Yinchuan, Ningxia,  5Guizhou Provincial Key Laboratory for  Regenerative Medicine, Stem Cell and Tissue  engineering Research Center and Sino-US  Joint Laboratory for Medical Sciences,  Guiyang Medical University, Guiyang,  Guizhou, 6Key Laboratory of Craniocerebral  Diseases of Ningxia Hui Autonomous  Region, Ningxia Medical University,  Yinchuan, Ningxia, 7Research Center for  Bioengineering and Sensing T echnology,  University of Science and T echnology Beijing,  Beijing, People’s Republic of China; 8Center  for Traditional Chinese Medicine, Sarasota,  FL, USA; 9School of Biology and Chemistry,  University of Pu’er, Pu’er, Yunnan, People’s  Republic of ChinaAbstract:  Lycium barbarum  berries, also named wolfberry, Fructus lycii , and Goji berries,  have been used in the People’s Republic of China and other Asian countries for more than  2,000 years as a traditional medicinal herb and food supplement.",Non-OADS,/arxiv_data1/oa_pdf/a1/80/dddt-9-033.PMC4277126.pdf
"Correspondence: Shu-Feng Zhou  Department of Pharmaceutical Sciences,  College of Pharmacy, University of South  Florida, 12901 Bruce B. Downs Boulevard,  MDC 30, Tampa, FL 33612, USA Tel +1 813 974 6276   Fax +1 813 905 9885 email szhou@health.usf.ed u Tao Sun  Key Laboratory of Craniocerebral Diseases  of Ningxia Hui Autonomous Region, Ningxia  Medical University, Yinchuan, Ningxia, People’s  Republic of China   Tel +86 951 698 0002   Fax +86 951 698 0018 email suntao6699@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Cheng et al Running head recto: Pharmacology of LBPs DOI: http://dx.doi.org/10.2147/DDDT.S72892",Non-OADS,/arxiv_data1/oa_pdf/a1/80/dddt-9-033.PMC4277126.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a1/80/dddt-9-033.PMC4277126.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/80/dddt-9-033.PMC4277126.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 175–185Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  175Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7556 5a thorough QT study in the context of an  uptitration regimen with selexipag, a selective  oral prostacyclin receptor agonist Matthias hoch1 Borje Darpo2,3 Tatiana remenova4 randall stoltz5 Meijian Zhou2 Priska Kaufmann1 shirin Bruderer1 Jasper Dingemanse1 1Department of clinical Pharmacology,  actelion Pharmaceuticals ltd, allschwil,  switzerland; 2icardiac T echnologies  inc, rochester, n ew Y ork, n Y, Usa;  3Karolinska institute, Department of  clinical sciences, Danderyd’s hospital,  Division of cardiovascular Medicine,  stockholm, sweden; 4Drug safety  Department, actelion Pharmaceuticals  ltd, allschwil, switzerland; 5covance  clinical research Unit, evansville,  in, UsaAbstract:  The effects of selexipag and its active metabolite ACT-333679 on cardiac  repolarization were assessed in a thorough QT study as per International Conference on   Harmonisation E14 guidance.",Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
"In the same study, following a 1,800 µg dose of selexipag, correspondence: Matthias hoch Department of clinical Pharmacology,  actelion Pharmaceuticals ltd,  gewerbestrasse 16, ch-4123 allschwil,  switzerland Tel +416 1565 6643 Fax +416 1565 6200 email matthias.hoch@actelion.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hoch et al Running head recto: Thorough QT study with selexipag DOI: http://dx.doi.org/10.2147/DDDT.S75565",Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
Available from: http://www.ich.org/products/guidelines/efficacy/ article/efficacy-guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
Available  from: http://www.ich.org/products/guidelines/efficacy/article/efficacy- guidelines.html.,Non-OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
Available from: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/2a/02/dddt-9-175.PMC4277127.pdf
"Factsheet N°282 updated august 2014. available  from: http://www.who.int/mediacentre/factsheets/fs282/en /,  accessed on October 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/21/72/IJMR-140-472.PMC4277129.pdf
"available from: http://www.tbcindia.nic.i n, accessed on  February 18, 2014.",Non-OADS,/arxiv_data1/oa_pdf/bc/8f/IJMR-140-475.PMC4277130.pdf
"available from: http://www.who.int/ tb/publications/global_report/en/ , accessed on October 20,  2014.",Non-OADS,/arxiv_data1/oa_pdf/63/a3/IJMR-140-477.PMC4277131.pdf
"available from:  http://dx.doi.org/10.5402/2013/898125 , accessed March 28,  2014.",Non-OADS,/arxiv_data1/oa_pdf/4b/03/IJMR-140-483.PMC4277133.pdf
available from: http://www.avertsociety.,Non-OADS,/arxiv_data1/oa_pdf/71/06/IJMR-140-491.PMC4277134.pdf
Annual report 2013-14. available from: http://www.naco.gov.,OADS,/arxiv_data1/oa_pdf/71/06/IJMR-140-491.PMC4277134.pdf
available from: http://www.naco.gov.in/ upload/IEC%20Division/NACO%20monographs%20for% 20 CHaKRa VaRTY  et al: DETERMINaNTS OF SURVIV aL IN aDULT  HIV Pa TIENTS ON aNTIRETROVIRaL  THERaPY  499,OADS,/arxiv_data1/oa_pdf/71/06/IJMR-140-491.PMC4277134.pdf
"available from: 9. http://labmed.ucsf.edu/ labmanual/db/resource/proc-25OHVitDTotal.pdf , accessed on  October 9, 2012.",OADS,/arxiv_data1/oa_pdf/c7/53/IJMR-140-531.PMC4277140.pdf
The aligned sequences  were analyzed with the Bioedit sequence program and  similarity searches for the nucleotide sequences were  performed with the BLaST program ( http://www.ncbi.,OADS,/arxiv_data1/oa_pdf/a5/25/IJMR-140-546.PMC4277142.pdf
"Discrepancies in detection and specificity  This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/01/ef/idmm-25-294.PMC4277155.pdf
"Over the past decade, caspofungin, an echinocandin, original article This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/b1/ba/idmm-25-299.PMC4277157.pdf
"Those toxins include clinicAl vignette This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/92/6b/idmm-25-321.PMC4277160.pdf
"reView This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/01/c2/idmm-25-327.PMC4277162.pdf
"While polymerase chain reaction (PCR) was negative  for the latter two organisms, real-time PCR was performed using prim-ers that target the chaperonin-containing t-complex eta (CCTƞ) (1)  and subsequently confirmed using a second real-time PCR assay target - ing the 18S ribosomal RNA gene (in-house/Applied Biosystems, Case reporT This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is  properly cited and the reuse is restricted to noncommercial purposes.",Non-OADS,/arxiv_data1/oa_pdf/da/8a/idmm-25-e87.PMC4277163.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2e/5e/opth-9-017.PMC4277237.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 17–20Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  17SHORT REPORTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S7319 3Evaluation of the iPad as a low vision aid  for improving reading ability Shamim A Haji  Kumar Sambhav Sandeep Grover Kakarla V Chalam Department of Ophthalmology,   University of Florida College  of  Medicine, Jacksonville, FL, USAPurpose:  To evaluate the effect of the iPad as a low vision aid in improving the reading ability  of low vision patients (LVPs).",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/opth-9-017.PMC4277237.pdf
"Correspondence: KV Chalam Department of Ophthalmology, University  of Florida College of Medicine, 580  W 8th  Street, Tower 2, 3rd Floor, Jacksonville,  FL, USA Tel +1 904 244 9361 Fax +1 904 244 9391 Email kchalam@jax.ufl.ed u Journal name: Clinical Ophthalmology Article Designation: SHORT REPORT Y ear: 2015 Volume: 9 Running head verso: Haji et al Running head recto: iPad for improving reading ability DOI: http://dx.doi.org/10.2147/OPTH.S73193",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/opth-9-017.PMC4277237.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/2e/5e/opth-9-017.PMC4277237.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2e/5e/opth-9-017.PMC4277237.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/b7/mder-8-021.PMC4277238.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 21–29Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  21ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S7052 0The perceptions of cognitively impaired patients  and their caregivers of a home telecare system shima Mehrabian1 Jocelyne Extra2 Ya-huei Wu2 Maribel Pino2 latchezar Traykov1 anne-sophie Rigaud2 1Department of n eurology, University  hospital (Uh) “ alexandrovska”,   sofia, Bulgaria;  2Department of  gerontology, hôpital Broca, assitance  Publique-hôpitaux de Paris, Ea 4468,   Faculte de Médecine, Université Paris  Descartes, Paris, France correspondence: anne-sophie Rigaud   Department of gerontology, hôpital  Broca, assistance Publique–hôpitaux   de Paris,  Ea4468, Faculte de Médecine,  Université Paris Descartes, 5 4/56 rue  Pascal, 75013 Paris, France   Tel +33 1 44 08 35 03  Fax +33 1 44 08 35 10  Email anne-sophie.rigaud@brc.aphp.f rAbstract:  Assistive and telecare technologies have been developed to support older adults  with cognitive impairments, as well as their caregivers, from their homes.",Non-OADS,/arxiv_data1/oa_pdf/0f/b7/mder-8-021.PMC4277238.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 29Perception of a home telecare system  27.,Non-OADS,/arxiv_data1/oa_pdf/0f/b7/mder-8-021.PMC4277238.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/47/ccid-8-009.PMC4277239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 9–17Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  9OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S7543 9an antiaging skin care system containing alpha  hydroxy acids and vitamins improves the  biomechanical parameters of facial skin Diana Tran Joshua P T ownley Tanya M Barnes Kerryn a greive ego Pharmaceuticals, Braeside,   Victoria, australia Correspondence: Kerryn a greive   ego Pharmaceuticals Pty ltd,   21-31 Malcolm road, Braeside,   VIC 3195, australia   Tel +61 3 9586 8874  Fax +61 3 9580 7647  email kerryng@egopharm.co mBackground:  The demand for antiaging products has dramatically increased in recent years,  driven by an aging population seeking to maintain the appearance of youth.",Non-OADS,/arxiv_data1/oa_pdf/85/47/ccid-8-009.PMC4277239.pdf
Available from: http://www.freedoniagroup.,Non-OADS,/arxiv_data1/oa_pdf/85/47/ccid-8-009.PMC4277239.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/85/47/ccid-8-009.PMC4277239.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/85/47/ccid-8-009.PMC4277239.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f8/0a/ndt-11-021.PMC4277240.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 21–24Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  21Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7543 2Cerebellar cryptococcosis characterized by a  space-occupying lesion in an immunocompetent  non-HIV patient Bi-Xia Liu1,* Xi-Jian Dai2,3,* Heng Liu4,* Hong-Han Gong3 Yi-Xiang J Wang2 Lun-Li Zhang1 1Department of Infectious Diseases,   The First affiliated Hospital  of Nanchang University, Nanchang,   Jiangxi, people’s republic of China;   2Department of Imaging and  Interventional radiology, prince  of Wales Hospital, The Chinese  University of Hong Kong, shatin,   New T erritories, Hong Kong;   3Department of radiology, The First  affiliated Hospital of Nanchang  University, Nanchang, Jiangxi, people’s  republic of China; 4Department  of radiology, affiliated Hospital  of Zunyi Medical University, Guizhou,   people’s republic of China *These authors contributed equally  to this workAbstract:  Central nervous system (CNS) cryptococcosis is an opportunistic fungal infection that  typically occurs in patients with reduced immunological function, such as patients with AIDS,  patients receiving organ transplants, or patients receiving corticosteroid and immunosuppressive  therapy.",Non-OADS,/arxiv_data1/oa_pdf/f8/0a/ndt-11-021.PMC4277240.pdf
"There was no midline shift, and the compression of Correspondence: Lun-Li Zhang Department of Infectious Diseases, The  First Affiliated Hospital of Nanchang  University, No 17, Yongwai Zheng street,  Donghu District, Nanchang City 330006,  Jiangxi, people’s republic of China Tel +86 791 8869 2570 email lunliz@126.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Liu et al Running head recto: Cerebellar cryptococcosis in an immunocompetent non-HIV patient DOI: http://dx.doi.org/10.2147/NDT.S75432",Non-OADS,/arxiv_data1/oa_pdf/f8/0a/ndt-11-021.PMC4277240.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f8/0a/ndt-11-021.PMC4277240.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f8/0a/ndt-11-021.PMC4277240.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/a8/hyu167.PMC4277255.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/bd/cvu218.PMC4277256.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/7a/cvu224.PMC4277257.pdf
NELF also shares extensively transcriptional target genes with peroxisome  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/54/26/nihms649550.PMC4277258.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, four figures, and four tables and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.02.028 .",OADS,/arxiv_data1/oa_pdf/54/26/nihms649550.PMC4277258.pdf
"Available from: http://globocan.iarc.fr, accessed on 4 January 2014.",Non-OADS,/arxiv_data1/oa_pdf/80/a4/ijc0136-1117.PMC4277320.pdf
"Ideally studies should encom- pass both approaches, and also measure patient intervals ofpatients with relevant symptoms who do not necessarily have cancer, as in the DISCOVERY programme’s SYMPTOMstudy, due to report 2014 (http://discovery-programme.org/ symptom_study.php).",Non-OADS,/arxiv_data1/oa_pdf/f7/21/ijc0135-1220.PMC4277322.pdf
2011. http://www.dh.gov.uk/ en/Publicationsandstatistics/Publications/ PublicationsPolicyAndGuidance/DH_123371 (lastaccessed December 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/21/ijc0135-1220.PMC4277322.pdf
2011. http://www.cancerplan.cancerinstitute.org.au/ (last accessed December2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/21/ijc0135-1220.PMC4277322.pdf
Available from:http://www.cancerresearchuk.org/cancer-info/spotcancerearly/naedi/beclearoncancer/ background (last accessed January 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/21/ijc0135-1220.PMC4277322.pdf
2011. https://www.dur.,Non-OADS,/arxiv_data1/oa_pdf/f7/21/ijc0135-1220.PMC4277322.pdf
Image J software version 1.43u (http://rsbweb.nih.gov/ij/) was used to processall images for quantiﬁcation purposes.,OADS,/arxiv_data1/oa_pdf/87/f4/ijc0136-E230.PMC4277326.pdf
"The col- lapsed sequence reads were aligned to UCSC human genome (hg19) using Bowtie (v2.0.0) and then processed by PARaly-zer v1.1 (http://www.genome.duke.edu/labs/ohler/research/ PARalyzer) using the default settings that allow a minimum sequence length of 13 nucleotides, at most two conversions(T to C) per read, a sequence read count must occur at least ﬁve times, extension of overlapped region by ﬁve nucleotides on each side and reads without T to C conversions were Cancer Cell BiologyXieet al .",OADS,/arxiv_data1/oa_pdf/87/f4/ijc0136-E230.PMC4277326.pdf
The candidate targets were compared with the targets predicted by TargetScan 6.2 (http://www.targetscan.org/).,OADS,/arxiv_data1/oa_pdf/87/f4/ijc0136-E230.PMC4277326.pdf
Available at: http://www.aihw.gov.au/acim-books/ (Accessed 8 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ijc0136-0603.PMC4277328.pdf
Avail- able at: http://www.ancr.nu (Accessed 8 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ijc0136-0603.PMC4277328.pdf
Available at: http://seer.cancer.gov/csr/1975_2010/browse_csr.php?sectionSEL 532&page SEL5sect_32_table.20.html (Accessed 8 April 2014).,Non-OADS,/arxiv_data1/oa_pdf/41/ab/ijc0136-0603.PMC4277328.pdf
"Conﬂict of Interest: All authors have completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that their respective institutions received clinical trial funding from the GlaxoSmithKline group of companies, through the Jiangsu Province CDC, the CICAMS (Beijing, China) and the National Institutes for Food and Drug Control (NIFDC) (Beijing, China).",Non-OADS,/arxiv_data1/oa_pdf/f4/b3/ijc0135-2612.PMC4277330.pdf
Available at http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/ijc0135-2612.PMC4277330.pdf
Available at: http://esa.un.org/wpp/Excel-Data/ population.htm.,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/ijc0135-2612.PMC4277330.pdf
Available athttp://www.who.int/biologicals/publications/trs/ areas/vaccines/human_papillomavirus/ HPVg%20Final%20BS%202050%20.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/ijc0135-2612.PMC4277330.pdf
Available at http://www.hpv2011.,Non-OADS,/arxiv_data1/oa_pdf/f4/b3/ijc0135-2612.PMC4277330.pdf
"Material and Methods From a previously described series of 233 breast cancer patients from whom both primary tumor tissue as well as metachronous nonbone distant metastatic tumor tissue was collected,6we selected patients based on adjuvant treatment data, which were obtained from The Netherlands cancer registry (IKNL, The Netherlands (http://www.ikcnet.nl/)).",OADS,/arxiv_data1/oa_pdf/e8/42/ijc0135-1257.PMC4277331.pdf
"Available at: http://www.mhlw.go.jp/ﬁle/05-Shingikai-12601000-Seisakutoukatsukan-Sanjikanshitsu_Shakaihoshoutantou/0000031544.pdf (in Japanese, accessed 24 June 2014).",Non-OADS,/arxiv_data1/oa_pdf/96/20/inr0061-0487.PMC4277332.pdf
"Avail- able at: http://www.ipss.go.jp/pp-shicyoson/j/shicyoson13/t-page.asp (inJapanese, accessed 14 March 2014).",Non-OADS,/arxiv_data1/oa_pdf/96/20/inr0061-0487.PMC4277332.pdf
"Conﬂict of Interest: All authors have completed the Uniﬁed Competing Interest form at http://www.icmje.org/coi_disclosure.pdf and declare that their respective institutions received clinical trial funding from the GlaxoSmithKline group of companies, through the Jiangsu ProvinceCDC, the CICAMS (Beijing, China) and the National Institute for Food and Drug Control (NIFDC) (Beijing, China).",Non-OADS,/arxiv_data1/oa_pdf/fd/83/ijc0135-2604.PMC4277334.pdf
Available at http://globocan.iarc.fr.Retrieved 7 August 2013.,Non-OADS,/arxiv_data1/oa_pdf/fd/83/ijc0135-2604.PMC4277334.pdf
The gastric cancer samples were collected and made available to research after the approval of the ethicscommittee of H. S. Joao in compliance with the Helsinki Declaration (http://www.wma.net/e/policy/b3.htm).,Non-OADS,/arxiv_data1/oa_pdf/e4/04/ijc0136-0844.PMC4277335.pdf
"20,21,35–37However, large-scale analyses of molecular aberrations across thousands of tumors, including several gas-trointestinal carcinomas, are currently being generated by TCGA (http://cancergenome.nih.gov/).",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ijc0136-0844.PMC4277335.pdf
"However, highthroughput array-based DNA methylation data from TCGA (http://cancergenome.nih.gov/) validated that all genes ana- lyzed here display signiﬁcantly higher methylation levels intumor samples compared to matching controls (stomach: n525, pancreas: n59, Supporting Information Table S6).",Non-OADS,/arxiv_data1/oa_pdf/e4/04/ijc0136-0844.PMC4277335.pdf
"Salmonid complementary(c) DNAmicroarrays(cGRASP16KsalmonidcDNAarrays;batch numberGG003,slides011–014)werepurchasedfromB.F.Koop(cGRASP,UniversityofVic- toria,BC,Canada;http://web.uvic.ca/grasp/microarray/array.html/).Microarrayfabricationandqualitycontrolhavebeenpreviouslydescribed(vonSchalburg et al.,2005).Toassistingridding, 16K cGRASP microarrays contain five 280bp green fluorescent protein (GFP) cDNA spots printedineachofthe48sub-grids.AGFPspikewasusedinthisstudyduetouncertaintyofthenumberoftranscriptsfrominnereartissuethatwouldhybridizetothearrays.AGFP100expres- sionclonewasprovidedbyB.Koop(cGRASP,UniversityofVictoria,BC,Canada)anda280bp GFP product was prepared and purified from this clone (Hall et al., 2011).",OADS,/arxiv_data1/oa_pdf/fa/cb/jfb0084-1793.PMC4277336.pdf
"Available at http://www.dot.ca.gov/hq/env/bio/files/Effects_of_Sound_ on_Fish23Aug05.pdf/ McCauley,R.D.,Fewtrell,J.,Duncan,A.J.,Jenner,C.,Jenner,M-N.,Penrose,J.D.,Prince,R.",Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jfb0084-1793.PMC4277336.pdf
The Australian Petroleum Production and Exploration Association (APPEA) Journal 692-708.Available athttp://www.appea.com.au/ © 2014 HerMajestythe QueeninRight ofCanada.,Non-OADS,/arxiv_data1/oa_pdf/fa/cb/jfb0084-1793.PMC4277336.pdf
Available at: http://www.blood-safety.macopharma.com/category/documents-lit-eratures/thera ﬂex-mb-plasma/toxicity/.,Non-OADS,/arxiv_data1/oa_pdf/d8/60/php0090-0957.PMC4277684.pdf
"2013) as well as ‘biostats’ (K. McGarigal, http://www.umass.edu/landeco/teach ing/multivariate/labs/multivariate_labs.html).",Non-OADS,/arxiv_data1/oa_pdf/bd/40/JPE-51-1554.PMC4277685.pdf
R pack- age version 2.0-5. http://CRAN.R-project.org/package=vegan.,Non-OADS,/arxiv_data1/oa_pdf/bd/40/JPE-51-1554.PMC4277685.pdf
"ISBN 3-900051-07-0, URL http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/bd/40/JPE-51-1554.PMC4277685.pdf
R package version 2.66.53. http://CRAN.R-project.org/ package=PBSmapping.,Non-OADS,/arxiv_data1/oa_pdf/bd/40/JPE-51-1554.PMC4277685.pdf
(http://plotdigitizer.sourceforge.net/).,Non-OADS,/arxiv_data1/oa_pdf/c3/71/jpe0051-1669.PMC4277688.pdf
"Speciﬁcally for mammal species from North America, we further used infor- mation on habitat classiﬁcation from the Smithsonian NationalMuseum of Natural History (http://www.nmh.si.edu; accessed 18June 2013).",Non-OADS,/arxiv_data1/oa_pdf/c3/71/jpe0051-1669.PMC4277688.pdf
http://www.jstatsoft.,Non-OADS,/arxiv_data1/oa_pdf/c3/71/jpe0051-1669.PMC4277688.pdf
"Available at:http://cdiac.ornl.gov/oceans/co2rprt.html (accessed 1 March 1997) Quinn GP, Keough MJ (2002) Experimental Design and Data Analysis for Biologists.",OADS,/arxiv_data1/oa_pdf/83/99/ppl0151-0468.PMC4277689.pdf
"Once confirmed as likely sufferers, owners were invited to com-plete an invitation-only online survey (this survey can be viewed at: http://www.surveymonkey.com/s/DVSCECS2012).",Non-OADS,/arxiv_data1/oa_pdf/a4/a4/jsap0055-0102.PMC4277704.pdf
Available from: http://www.unicef.org/evaluation/ﬁles/Final_report_of_BPP-June_Jordan.pdf[last accessed 13 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/69/75/jcpp0055-1187.PMC4277854.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/69/75/jcpp0055-1187.PMC4277854.pdf
Available from: http://www.fatherhoodinstitute.org/wp- content/uploads/2010/12/FI-FiFI-Report-2010_FINAL.pdf [last accessed 22 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/69/75/jcpp0055-1187.PMC4277854.pdf
Available from: http://www.fatherhoodinstitute.org/2013/case-study-fathers-family-nurse-partnership-fnp-programme/ [lastaccessed 9 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/69/75/jcpp0055-1187.PMC4277854.pdf
Available from: http://www.fatherhoodinstitute.org/2013/fatherhood- institute-research-summary-fathers-and-their-childrens- education/ [last accessed 22 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/69/75/jcpp0055-1187.PMC4277854.pdf
R package version 0.9-2 available at http://CRAN.R-project.org/package=mcmc.,Non-OADS,/arxiv_data1/oa_pdf/d7/12/jec0102-1451.PMC4277856.pdf
The authors would like to acknowledge the use of the Oxford Supercomputing Centre (OSC) and the HPC services of Imperial College London (http://www.imperial.ac.uk/ict/services/teachingandresearchservices/highperformancecomputing) in carrying out this work.,Non-OADS,/arxiv_data1/oa_pdf/8b/48/JPE-50-1216.PMC4277857.pdf
"Images were imported into ImageJ (U. S. National Institutes of Health, Bethesda, http://imagej.nih.gov/ij/) and representative line profiles as well as Fast Fourier Transform (FFT) of 1024 ×1024 pixel subsets were extracted (Fig.",OADS,/arxiv_data1/oa_pdf/95/8a/jmi0257-0008.PMC4277858.pdf
"209 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 49 ㆍNumber 4 ㆍDecember 2014 http://dx.doi.org/10.5045/br.2014.49.4.209 Editorial Here comes the cord Satoshi Takahashi, M.D., Ph.D.",Non-OADS,/arxiv_data1/oa_pdf/ba/a6/br-49-209.PMC4277998.pdf
"Ther e are approximately 621,000  CB units in the database of Bone Marrow Donors Worldwide (BMDW: http://www.bmdw.org /).",Non-OADS,/arxiv_data1/oa_pdf/ba/a6/br-49-209.PMC4277998.pdf
"211 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is prop erly cited.BLOOD RESEARCH Volume 49 ㆍNumber 4 ㆍDecember 2014 http://dx.doi.org/10.5045/br.2014.49.4.211 Perspective The puzzle of myeloproliferative  neoplasms: novel disease-specific mutations and new proposals for diagnostic criteria Hee-Jin Kim1#, Chul Won Choi2#, Jong-Ho Won3 1Department of Laboratory Me dicine & Genetics, Samsung  Medical Center, Sungkyunkwa n University School of  Medicine, 2Department of Internal Medicine, Korea University  Guro Hospital, Korea University College of Medicine,  3Department of Internal Medici ne, Soonchunhyang University  Seoul Hospital, Soonchunhyan g University College of  Medicine, Seoul, Korea #Hee-Jin Kim and Chul Won Choi contributed equally to this  work.",Non-OADS,/arxiv_data1/oa_pdf/12/e2/br-49-211.PMC4277999.pdf
"214 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 49 ㆍNumber 4 ㆍDecember 2014 http://dx.doi.org/10.5045/br.2014.49.4.214 Spontaneous intramural hemorrhage in a patient with severe  hemophilia A Ken-Hsyuan Shan1, Li-Mien Chen2, Cheng-Ming Peng3, Jiaan-Der Wang4,5 1Division of Pediatrics, 2Division of Hematology/Oncology, Department of Internal Medicine, Taichung Armed Forces General  Hospital, 3Division of Ge neral Surgery, 4Center of Hemophilia and Rare Disease,  Taichung Veterans General Hospital, 5School of  Medicine, China Medical University, Taichung, Taiwan, China Correspondence to Jiaan-Der Wang, M.D., Ph.D., Center of Rare Disease and Hemophilia, 1650 Taiwan Boulevard Sect.",Non-OADS,/arxiv_data1/oa_pdf/77/c3/br-49-214.PMC4278000.pdf
"215 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial us e, distribution, and reproduction in any medium, provided the original work is prop erly cited.Blood Research Educational Material BLOOD RESEARCH Volume 49 ㆍNumber 4 ㆍDecember 2014 http://dx.doi.org/10.5045/br.2014.49.4.215 Visceral leishmaniasis in an Afghan woman with systemic lupus  erythematosus Sadia Sultan, Syed Mohammad Irfan Hematology Department, Liaquat National Hospital, Pakistan Correspondence to Sadia Sultan, MBBS, FCPS, Hematology Department, Liaquat National Hospital, National Stadium Road, Karachi 74800, Pakistan,  E-mail: sadia.sultan@lnh.edu.pk A 35-year-old Afghan woman with systemic lupus erythe matosus for 3 years had been  on immunosuppressive and  low-dose steroid therapy for 1 year.",Non-OADS,/arxiv_data1/oa_pdf/6d/36/br-49-215.PMC4278001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014REVIEW  ARTICLE Pathogenesis of myelodysplastic syndromes: an overview of  molecular and non-molecular aspects of the disease Valeria Visconte1, Ramon V. Tiu1,2, Heesun J. Rogers3 1Department of Translational Hema tology and Oncology Research, 2Department of Hematologic On cology and Blood Disorders,  3Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.216Blood Res 2014;49:216-27.",Non-OADS,/arxiv_data1/oa_pdf/5b/b4/br-49-216.PMC4278002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Transplant physiciansÊ perceptions of cord blood transplantation in  Korea: a questionnaire survey Byeong Seon Choi1, Yeung-Chul Mun2, Ji Yoon Kim3, Young-Ho Lee1, On behalf of Cord Blood  Committee in Korean Society of Blood and Marrow Transplantation  1Department of Pediatrics, Hany ang University Medical Center, 2Department of Internal Medici ne, Ewha Woman’s University  School of Medicine, Seoul, 3Department of Pediatrics, Keimyung Univer sity Dongsan Medical Center, Daegu, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.228Blood Res 2014;49:228-33.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(A ccessed June 5, 2014, at  http://www.kmdp.or.kr) 4.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(Accessed  June 5, 2014, at http://www.jmdp.or.jp/documents/file/07_about_ us/press/press_12_08_29.pdf) 5.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(A ccessed June 5, 2014, at  https://bethematchclinical.org/Transplant-Therapy-and-Donor- Matching/Donor-or-Cord-Blood-Search-Process/Likelihood-of- Finding-a-Match/) 6.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(Accessed June 5, 2014,  at https://bethematchclinical.org/Transplant-Therapy-and-Donor- Matching/Cell-Sources/) 7.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(Accessed June 5, 2014,  at http://www.esh.org/wp-content/uploads/2013/11/Session-V- State-of-the-art.pptx-Lecture-seule.pdf) 8.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(Accessed June 5, 2014, at  http://www.mw.go.kr/front_new/index.jsp) 12.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"(Accessed June 5, 2014, at http://is.cdc.go.kr/)  13.",Non-OADS,/arxiv_data1/oa_pdf/a3/0c/br-49-228.PMC4278003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Monosomal and complex karyotypes as prognostic parameters in  patients with International Prognostic Scoring System higher risk myelodysplastic syndrome treated with azacitidine Kyung-Lim Hwang1, Moo-Kon Song1, Ho-Jin Shin1, Hae-Jung Na1, Dong-Hun Shin1, Joong-Keun Kim1,  Joon-Ho Moon2, Jae-Sook Ahn3, Ik-Chan, Song4, Junshik Hong5, Gyeong-won Lee6, Joo-Seop Chung1 1Department of Hematology-O ncology, Pusan National Un iversity Hospital, Busan, 2Department of Hema tology, Kyungpook  National University Hospital, Daegu, 3Department of Hematology, Chonnam National University Hwasun Hospital, Hwasun,  4Department of Hematology, Chungnam Na stional Ujnversity Hospital, Daejeon, 5Department of Hematology, Gachon University Gil  Medical Center, Incheon, 6Department of Hematology, Gyeong-S ang National University Hospital, School of Medici ne, Gyeongsang  Natioinal University, Jinju, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.234Blood Res 2014;49:234-40.",Non-OADS,/arxiv_data1/oa_pdf/f6/64/br-49-234.PMC4278004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Aberrant myeloid antigen co-expression is correlated with high  percentages of CD34-positive cells among blasts of acute lymphoblastic leukemia patients: an Indian tertiary care center perspective Rahul Kumar Sharma, Abhishek Purohit, Venkatesan  Somasundaram, Pravas Ch andra Mishra, Mrinalini  Kotru, Ravi Ranjan, Sunil Kumar,  Sudha Sazawal, Hara Prasad Pati, Seema Tyagi, Renu Saxena Department of Hematology, All India Instit ute of Medical Scienc es, New Delhi, India p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.241Blood Res 2014;49:241-5.",Non-OADS,/arxiv_data1/oa_pdf/80/37/br-49-241.PMC4278005.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Clinical characteristics and treatment outcomes of children with  anaplastic large cell lymphoma: a single center experience Jee Yeon Han, Jin Kyung Suh, Seong Wook Lee,  Kyung-Nam Koh, Ho Joon Im, Jong Jin Seo Division of Pediatric Hema tology/Oncology, Department of Pedi atrics, Asan Medical Center Childr en’s Hospital, University of Uls an  College of Medicine, Seoul, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.246Blood Res 2014;49:246-52.",Non-OADS,/arxiv_data1/oa_pdf/15/c0/br-49-246.PMC4278006.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Clinical features and outcomes in patients with human  immunodeficiency virus-negative, multicentric CastlemanÊs disease: a single medical center experience Seyoung Seo1, Changhoon Yoo2, Dok Hyun Yoon2, Shin Kim2, Jung Sun Park2, Chan-Sik Park3, Jooryung  Huh3, Cheolwon Suh2 Departments of  1Internal Medicine, 2Oncology, and 3Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.253Blood Res 2014;49:253-8.",Non-OADS,/arxiv_data1/oa_pdf/78/95/br-49-253.PMC4278007.pdf
"Kazuhisa Hachisuga, Nobuhiro Hidaka, Yasuyu ki Fujita, Kotaro Fukushima, Kiyoko Kato Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.259Blood Res 2014;49:259-64.",Non-OADS,/arxiv_data1/oa_pdf/39/72/br-49-259.PMC4278008.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014ORIGINAL  ARTICLE Progress of in vitro  factor VIII coagulant activity from 0 to 8 hours  after reconstitution Ye Jee Shim1, Kun Soo Lee2, Uk Hyun Kim3, Jin Kyung Suh4, Sae Yun Baik5, Shin Young Hyun6 Department of Pediatrics, 1Keimyung University Dongsan Medical Center, Keimyung University School of Medicine, 2Kyungpook  National University Hospital, Kyungpook National University School of Medicine, Daegu, 3Incheon Medical Center Beakryung  Hospital, Incheon, 4Division of Pediat ric Hematology/Oncology, Asan Medical Center Children’s Hospital, Department of Pediatrics,  University of Ulsan College of Medicine, Seoul, 5Green Cross Laboratories, Yongin, 6Department of Intern al Medicine, Yonsei  University Wonju College of  Medicine, Wonju, Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.265Blood Res 2014;49:265-9.",Non-OADS,/arxiv_data1/oa_pdf/98/2e/br-49-265.PMC4278009.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://c reativecommons.org/licenses/by-nc/3.0 ) which permits unrestricted non-commercial use, distribution, and re production in any medium, provided the original work is prop erly cited.BLOOD RESEARCHVOLUME 49 ㆍNUMBER 4 December 2014CASE  REPORT Case series of precursor B-cell lymphoblastic lymphoma Jin Yong Kim1, Sang Yong Om1, Su-Jin Shin2, Jeong Eun Kim3, Dok Hyun Yoon3, Cheolwon Suh3 Departments of  1Internal Medicine, 2Pathology, 3Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul,  Korea p-ISSN 2287-979X / e-ISSN 2288-0011 http://dx.doi.org/10.5045/br.2014.49.4.270Blood Res 2014;49:270-4.",Non-OADS,/arxiv_data1/oa_pdf/12/ca/br-49-270.PMC4278010.pdf
"Yosep Chong, Chang Suk Kang, Woo Jin Oh,  Tae-Jung Kim, Eun Jung Lee Department of Hospital Pathology, College of Medicine,  The Catholic University of Korea, Seoul, Korea Correspondence to:  Yosep Chong and Chang Suk Kang Department of Hospital Pathology,  Yeouido St. Mary’s Hospital, 10, 63-ro,  Yongdeungpo-gu, Seoul 150-713, Korea  E-mail: ychong@catholic.ac.k r; cskang@catholic.ac.kr   Received on May 9, 2014; Revised on May 16, 2014; Accepted on Nov. 6, 2014 http://dx.doi.org/10.5045/br.2014.49.4.275 ACKNOWLEDGEMENTS We would like to thank Mr. Corey Tobin for proofreading the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/72/fb/br-49-275.PMC4278011.pdf
"27, 2014; Revised on Nov. 14, 2014; Accepted on Nov. 19, 2014 http://dx.doi.org/10.5045/br.2014.49.4.279 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/a8/b4/br-49-279.PMC4278012.pdf
"27, 2014; Revised on Nov. 14, 2014; Accepted on Nov. 19, 2014 http://dx.doi.org/10.5045/br.2014.49.4.279 AuthorsÊ Disclosures of Pote ntial Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/e9/69/br-49-280.PMC4278013.pdf
"Mohammad Jaseem Hassan1, Sabina Khan1, Mukta Pujani1,  Sujata Jetley1, Prabhat Kumar Raina2, Rayees Ahmad2 Departments of 1Pathology, 2General Surgery, Hamdard  Institute of Medical Sciences and Research (HIMSR), India Correspondence to:  Sujata Jetley Department of Pathology, HIMSR, Jamia Hamdard,  New Delhi 110062, India E-mail: sujatajetley@gmail.com   Received on May  8, 2014; Revised on Nov. 7, 2014; Accepted on Nov. 10, 2014 http://dx.doi.org/10.5045/br.2014.49.4.280 ACKNOWLEDGEMENTS The authors would like to ac knowledge the contribution  of our histopathology laboratory technicians.",Non-OADS,/arxiv_data1/oa_pdf/e9/69/br-49-280.PMC4278013.pdf
"Mohammad Jaseem Hassan1, Sabina Khan1, Mukta Pujani1,  Sujata Jetley1, Prabhat Kumar Raina2, Rayees Ahmad2 Departments of 1Pathology, 2General Surgery, Hamdard  Institute of Medical Sciences and Research (HIMSR), India Correspondence to:  Sujata Jetley Department of Pathology, HIMSR, Jamia Hamdard,  New Delhi 110062, India E-mail: sujatajetley@gmail.com   Received on May  8, 2014; Revised on Nov. 7, 2014; Accepted on Nov. 10, 2014 http://dx.doi.org/10.5045/br.2014.49.4.280 ACKNOWLEDGEMENTS The authors would like to ac knowledge the contribution  of our histopathology laboratory technicians.",Non-OADS,/arxiv_data1/oa_pdf/a8/1a/br-49-283.PMC4278014.pdf
"9, 2014; Revised on Sep. 1, 2014; Accepted on Nov. 19, 2014 http://dx.doi.org/10.5045/br.2014.49.4.283 AuthorsÊ Disclosures of Potential Conflicts of Interest No potential conflicts of intere st relevant to this article  were reported.",Non-OADS,/arxiv_data1/oa_pdf/a8/1a/br-49-283.PMC4278014.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Educational Inequality in Female Cancer Mortality in Korea  We evaluated the influence of socioeconomic factors on female cancer mortality using  death data from the Cause of Death Statistics and the Korean Population and Housing  Census databases collected in 2001, 2006, and 2011.",Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
"Keywords:  Educational Status; Mortality; Neoplasms; Socioeconomic Factors; WomenMi-Hyun Kim,1 Kyunghee Jung-Choi,2  Hyoeun Kim,1 and Yun-Mi Song1 1Department of Family Medicine, Samsung Medical  Center, Sungkyunkwan University School of  Medicine, Seoul; 2Department of Preventive  Medicine, Ewha Womans University School of  Medicine, Seoul, Korea Received: 31 May 2014 Accepted: 27 August 2014 Address for Correspondence: Yun-Mi Song, MD Department of Family Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine, 81 Irwon-ro,  Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-2442, Fax: +82.2-3410-0388  E-mail: yunmisong@skku.edu Funding:  This research work was supported by Basic Science  Research Program through the National Research Foundation of  Korea (NRF) funded by the Ministry of Science, ICT and future  Planning (2011-0013545 and 2014R1A2A2A01002705).http://dx.doi.org/10.3346/jkms.2015.30.1.1  • J Korean Med Sci 2015; 30: 1-6 INTRODUCTION Korea has undergone rapid economic growth over the last sev - eral decades.",Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
"• Educational Inequality in Female Cancer Mortality 2  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.110 codes: C500-C509 (breast cancer); C530-539 (cervical can - cer); C56 (ovarian cancer); and C540-C549, C55, and C570-574  (uterine cancer).",Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
• Educational Inequality in Female Cancer Mortality http://jkms.org   3 http://dx.doi.org/10.3346/jkms.2015.30.1.1ity from ovarian cancer.,Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
"• Educational Inequality in Female Cancer Mortality 4  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.1ty was more evident in younger women than in older women  for mortality due to cancers of the cervix, breast, and ovary.",Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
"• Educational Inequality in Female Cancer Mortality http://jkms.org   5 http://dx.doi.org/10.3346/jkms.2015.30.1.1of preventing death from ovarian cancer, are needed.",Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
ORCID Mi-Hyun Kim http://orcid.org/0000-0003-1828-0955 Kyunghee Jung-Choi http://orcid.org/0000-0002-9800-0994 Hyoeun Kim http://orcid.org/0000-0001-7078-7599  Yun-Mi Song http://orcid.org/0000-0001-9232-5563 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
Avail - able at http://gini-research.org/system/uploads/439/original/Korea.,Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
• Educational Inequality in Female Cancer Mortality 6  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.115.,Non-OADS,/arxiv_data1/oa_pdf/30/21/jkms-30-1.PMC4278015.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Scene Time Interval and Basic Life Support Termination of  Resuscitation Rule in Adult Out-of-Hospital Cardiac Arrest  We validated the basic life support termination of resuscitation (BLS TOR) rule  retrospectively using Out-of-Hospital Cardiac Arrest (OHCA) data of metropolitan  emergency medical service (EMS) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
"Keywords:  Out-of-Hospital Cardiac Arrest; Cardiopulmonary Resuscitation; Decision  Support TechniqueTae Han Kim,1 Sang Do Shin,2   Yu Jin Kim,2 Chu Hyun Kim,3   and Jeong Eun Kim1  1Laboratory of Emergency Medical Services, Seoul  National University Hospital Biomedical Research  Institute, Seoul; 2Department of Emergency  Medicine, Seoul National University College of  Medicine, Seoul; 3Department of Emergency  Medicine, Inje University College of Medicine, Seoul,  Korea Received: 21 June 2014 Accepted: 16 September 2014 Address for Correspondence: Sang Do Shin, MD  Department of Emergency Medicine, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744  Korea Tel: +82.2-2072-0854, Fax: +82.2-741-7855  E-mail: shinsangdo@medimail.co.kr Funding:  The study was financially supported by the Korea  Centers for Disease Control and Prevention (2012E3301000).http://dx.doi.org/10.3346/jkms.2015.30.1.104  • J Korean Med Sci 2015; 30: 104-109 INTRODUCTION Despite many improvements in the emergency medical service  (EMS) system and in the technique of cardiopulmonary resus - citation (CPR), survival rate of adult patients with out-of hospi - tal cardiac arrests (OHCA) is still low.",Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
• Scene Time Interval and Termination of Resuscitation http://jkms.org   105 http://dx.doi.org/10.3346/jkms.2015.30.1.104arrests without compromising the care of potentially viable pa - tients (12).,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
• Scene Time Interval and Termination of Resuscitation 106  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.104formed consent was waived by the board because of the obser - vational nature of the study.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
• Scene Time Interval and Termination of Resuscitation http://jkms.org   107 http://dx.doi.org/10.3346/jkms.2015.30.1.104Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
"• Scene Time Interval and Termination of Resuscitation 108  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.104in clinical rule validation studies, 1% or less survival rate was  suggested as reflective of medical futility (16).",Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
ORCID  Tae Han Kim http://orcid.org/0000-0003-3855-081X Sang Do Shin http://orcid.org/0000-0003-4953-2916 Yu Jin Kim http://orcid.org/0000-0003-2562-615X Chu Hyun Kim http://orcid.org/0000-0002-9466-104X Jeong Eun Kim http://orcid.org/0000-0002-5457-745X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
• Scene Time Interval and Termination of Resuscitation http://jkms.org   109 http://dx.doi.org/10.3346/jkms.2015.30.1.104ogy for trauma and respiratory distress patients.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
• Scene Time Interval and Termination of Resuscitation http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.104Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/35/jkms-30-104.PMC4278016.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Megalocytic Interstitial Nephritis Following Acute Pyelonephritis  with Escherichia coli  Bacteremia: A Case Report Megalocytic interstitial nephritis is a rare form of kidney disease caused by chronic  inflammation.",Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
"Keywords:  Acute Kidney Injury; Megalocytic Interstitial Nephritis; Interstitial NephritisHee Jin Kwon,1 Kwai Han Yoo,1   In Young Kim,1 Seulkee Lee,1   Hye Ryoun Jang,2 and Ghee Young Kwon3  1Department of Medicine, 2Division of Nephrology,  Department of Medicine, and 3Department of  Pathology, Samsung Medical Center, Sungkyunkwan  University School of Medicine, Seoul, Korea  Received: 24 April 2014 Accepted: 27 August 2014 Address for Correspondence: Hye Ryoun Jang, MD Division of Nephrology, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea  Tel: +82.2-3410-0782, Fax: +82.2-3410-3849 E-mail: shinehr@gmail.comhttp://dx.doi.org/10.3346/jkms.2015.30.1.110  • J Korean Med Sci 2015; 30: 110-114 INTRODUCTION Megalocytic interstitial nephritis is a rare form of chronic renal  inflammatory disease associated with defect in intracellular  destruction of invading foreign organisms by macrophages (1).",Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
"• Megalocytic Interstitial Nephritis with Bacteremia http://jkms.org   111 http://dx.doi.org/10.3346/jkms.2015.30.1.110as fever, CRP , and procalcitonin, there were persistent severe  leukocytosis with atypical lymphocytes and high level of lactate  dehydrogenase over 1,000 IU/L.",Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
• Megalocytic Interstitial Nephritis with Bacteremia 112  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.110DISCUSSION Megalocytic interstitial nephritis is an uncommon form of in - terstitial nephritis affecting mainly the renal cortex in an other - wise normal kidney.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
"• Megalocytic Interstitial Nephritis with Bacteremia http://jkms.org   113 http://dx.doi.org/10.3346/jkms.2015.30.1.110Perls’ stain (for iron), Prussian blue (for iron), and alizarin red  (for calcium) (11).",Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
ORCID Kwon Hee Jin http://orcid.org/0000-0002-8953-3254 Kwai Han Yoo http://orcid.org/0000-0002-3049-9055 In Young Kim http://orcid.org/0000-0001-8846-4448 Seulkee Lee http://orcid.org/0000-0002-5551-4178 Hye Ryoun Jang http://orcid.org/0000-0001-9856-6341 Ghee Young Kwon http://orcid.org/0000-0002-3304-577X  REFERENCES  1.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
• Megalocytic Interstitial Nephritis with Bacteremia 114  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.11015.,Non-OADS,/arxiv_data1/oa_pdf/d8/28/jkms-30-110.PMC4278017.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.1.115  • J Korean Med Sci 2015; 30: 115-116 Rebuttal to Authors’ Reply, Re: Cancer  Risk in Adult Residents Near Nuclear  Power Plants in Korea – A Cohort  Study of 1992–2010 Jeong-Min Kim,1 Myoung-Hee Kim,2 Young-Su Ju,3   Seung-sik Hwang,4 Mina Ha,5 and Domyung Paek6 1Department of Occupational and Environmental Medicine, Cheongju Medical  Center, Cheongju; 2People’s Health Institute, Seoul; 3Department of Occupational  & Environmental Medicine, Hallym University Sacred Heart Hospital, Hallym  University College of Medicine, Anyang; 4Department of Social and Preventive  Medicine, Inha University School of Medicine, Incheon; 5Department of Preventive  Medicine, Dankook University College of Medicine, Cheonan; 6Department of  Occupational and Environmental Medicine, School of Public Health, Seoul  National University, Seoul, Korea To the Editor: The followings are point-by-point rebuttal to the explanation by  authors of the original paper (1).",Non-OADS,/arxiv_data1/oa_pdf/fd/db/jkms-30-115.PMC4278018.pdf
"• Rebuttal to Authors’ Reply, Re: Adult Cancer Risks Near NPP 116  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.115Domyung Paek, MD Department of Occupational and Environmental Medicine, School of Public Health,  Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 151-742, Korea Tel: +82.2-880-2733, Fax: +82.2-743-8240, E-mail: paekdm@snu.ac.kr Funding:  This work was funded by a project grant (1301029-0113-SB110) from the  Korea Radiation Safety Foundation.",Non-OADS,/arxiv_data1/oa_pdf/fd/db/jkms-30-115.PMC4278018.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.1.117  • J Korean Med Sci 2015; 30: 117 Erratum: Correction of Prevalence of Falls by Sex in Article ‘Risk Factors for Falls  in Older Korean Adults: The 2011 Community Health Survey’ Eun jin Choi, Sun A Kim, Nu Ri Kim, Jung-Ae Rhee, Yong-Woon Yun, and Min-Ho Shin To the Editor: We made a mistake in our recently published article: Eun jin Choi, Sun A Kim, Nu Ri Kim, Jung-Ae Rhee, Yong-Woon Yun, and Min-Ho Shin.",Non-OADS,/arxiv_data1/oa_pdf/e7/ed/jkms-30-117.PMC4278019.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.1.118  • J Korean Med Sci 2015; 30: 118 Erratum: Correction of 1.3 Investigators in Supplementary Materials           Ji Hoon Park, for the LOCAT Group To the Editor: We made a mistake in our recently published article: Park JH, LOCAT Group.",Non-OADS,/arxiv_data1/oa_pdf/6b/89/jkms-30-118.PMC4278020.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357http://dx.doi.org/10.3346/jkms.2015.30.1.119  • J Korean Med Sci 2015; 30: 119 Erratum: Efficacy and Tolerability of Anticholinergics in Korean Children with  Overactive Bladder: A Multicenter Retrospective Study Se Jin Park, Ki Soo Pai, Jun Mo Kim, Kwanjin Park, Kun Suk Kim, Sang Hoon Song, Sungchan Park, Sun-Ouck Kim, Dong Soo Ryu,  Minki Baek, Sang Don Lee, Jung Won Lee, Young Jae Im, Sang Won Han, Jae Min Chung, Min Hyun Cho, Tae-Sun Ha, Won Yeol Cho,  Hong Jin Suh, and The Korean Children’s Continence and Enuresis Society To the Editor: We made a mistake in our recently published article: In this article (J Korean Med Sci 2014;29:1550-4.",Non-OADS,/arxiv_data1/oa_pdf/1b/47/jkms-30-119.PMC4278021.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Peer Review in 2014: More Supports than Neglects Sung-Tae Hong Editor-in-Chief, Journal of Korean Medical Science (http://orcid.org/0000-0002-0300-1944)http://dx.doi.org/10.3346/jkms.2015.30.1.120  • J Korean Med Sci 2015; 30: 120-125 At the time of editing the first issue of 2015, Volume 30 Number  1 of the Journal of Korean Medical Science (JKMS), the editors  and editorial staffs heartfully thank all authors and reviewers  for their contribution to publication.",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"Hong S-T • Peer Review in 2014: More Supports than Neglects http://jkms.org   121 http://dx.doi.org/10.3346/jkms.2015.30.1.120Choi, Inyoung   The Cathoic University of Korea Choi, Jae Young*   Yonsei University Choi, Jin-Ho*   Sungkyunkwan University Choi, Kee-Joon   University of Ulsan Choi, Kyu Bok   Ewha Womans University Choi, Min-Ho*   Seoul National University Choi, Seong Hye   Inha University Choi, Seonghoon   Hallym University Choi, Seung Ho*   Seoul National University Choi, Seung Hong   Seoul National University Choi, Seung Suk   Hanyang University Choi, So-Yeon   Ajou University Choi, Sung jae   Korea Univeristy Choi, Won-Il   Keimyung University Choi, Yeong-Jin   The Catholic University of Korea Choi, Yong Soo   Yonsei University Choi, Yong-Jun   Hallym University Choi, Young Deuk   Yonsei University Choi, Young Hwa   Ajou University Choi, Young Sik   Yonsei University Choi, Young Youn*   Chungnam National University  Choi, Youngwoong   Inje University Choo, Eun Ju   Soon Chun Hyang University  Choung, Jitae   Korea Univeristy Chu, Min Kyung   Hallym University Chun, Eun Mi*   Ewha Womans University Chung, Byung Ha*   The Cathoic University of Korea Chung, Doo Hyun   Seoul National University Chung, Ho Yeon   Kyung Hee University Chung, Ho Yun   Kyungpook National University Chung, Jae-il   Inje UniversityChung, Jong Woo*   University of Ulsan Chung, Nak Gyun   The Cathoic University of Korea Chung, Woo-Young   Seoul National University  Chung, Young-yool   Kwangju Christian Hospital Dhong, Eun Sang   Korea Univeristy Do, Jun-Young   Yeungnam University Duarte, Rui   Birmingham City University, UK Eun, Baik-Lin   Korea Univeristy Fazeli, Bahare   Inflammation and Inflammatory Diseases  Research Center, Iran Fuh, Jong-Ling   Taipei Veterans General Hospital, Taipei Furuya, Takefumi   Tokyo Women’ s Medical University,  Japan Gasparyan, Armen Yuri*   University of Birmingham, UK Goh, Choong-Won   Inje University Goo, Jin Mo   Seoul National University Gwak, Ho-Shin*   National Cancer Center Ha, Tae-Sun   Chungbuk National University Hahn, Joo-Yong   Sungkyunkwan University Ham, Byung joo   Korea University Han, Changsu   Korea Univeristy Han, Dong Soo   Hanyang University Han, Eun-Taek   Kangwon National University Han, Hyuk-Soo   Seoul National University Han, Jin   Inje University Han, Kye Young   Kangwon National University Han, Sang Youb   Inje University Han, Seol-Heui   Konkuk University Han, Seung Hwan*   Gachon Univeristy Han, Seung-Kyu*   Korea Univeristy Heo, Dae Seog   Seoul National University Heo, Sang Taek   Jeju National UniversityHeo, Sung Hyuk*   Kyung Hee University Hong, Jong Won   Yonsei University Hong, Jong-Myeon   Chungbuk National University Hong, Joon Pio   University of Ulsan Hong, Sang Hyun   The Catholic University of Korea Hong, Sang-Bum   University of Ulsan Hong, Semie*   Konkuk University Hong, Soon Cheol   Korea Univeristy Hong, Soon Jun   Korea Univeristy Hong, Sung Pil   Yonsei University Huh, Chang-Hun   Seoul National University Huh, Jung-Sik   Jeju National University Hur, Sooyoung   The Catholic University of Korea Hwang, Eu Chang*   Chonnam National University  Hwang, Eung-Soo*   Seoul National University Hwang, Eun-Gu   Inje University Hwang, Gyo-Seung*   Ajou University Hwang, Jin Soon   Ajou University Hwang, Jun-Won   Kangwon National University  Hwang, Sung Ho   Mokpo National Hospital Hwang, Sung Oh   Yonsei University Hwang, Yoo-Cheol   Kyung Hee University Hwang, Young-Hwan*   Eulji University Hwang, Young-Il   Seoul National University Hyun, Jae Seog   Gyeongsang National University Hyun, Seung-Jae   Seoul National University Im, Gi Jung   Korea Univeristy Im, Jong Pil*   Seoul National University Im, Sanghyuk   Wonjin Institute for Occupational &  Environmental Health Jang, Byoung Kuk   Keimyung UniversityJang, Chul-Ho   Chonnam National University  Jang, Eun Chul   Soon Chun Hyang University  Jang, Eun Jin   Andong National University Jang, Hak Chul   Seoul National University Jang, Hyun Joo   Hallym University Jang, Tae-Won   Hallym University Jang, Won-Jong   Konkuk University Janssens, Hein*   Radboud University Nijmegen,  Netherlands Javier, Gisbert   La Princesa University Hospital, Spain Jeon, EunSeok   Sungkyunkwan University Jeon, Hong Jin*   Sungkyunkwan University Jeon, Jae Yong   University of Ulsan Jeon, Sang Ryong   University of Ulsan Jeon, Seong Woo   Kyungpook National University Jeong, Byung-Hoon   Chonbuk National University Jeong, Eui Cheol   Seoul National University Jeong, Jinwoo*   Dong-A University Jeong, Jong-Hyun   The Catholic University of Korea Jeong, Kyungah   Ewha Womans University Jeong, Myung Ho*   Chonnam National University  Jeong, Soung Won*   Soon Chun Hyang University  Jeong, Young-Hoon   Gyeongsang National University Jeyaruban, Andrew   James Cook University, Australia Jin, Young-Woo   Korea Institute of Radiological and  Medical Sciences Jo, Heui Seung*   CHA University Jo, Heui Sug   Kangwon National University Jo, Sang-Kyung   Korea Univeristy Jo, Young Suk   Yonsei University Joh, JoonSung   National Medical Center Joo, Eun Yeon   Sungkyunkwan University",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"Hong S-T • Peer Review in 2014: More Supports than Neglects 122  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.120Joo, Jong Kil   Pusan National University Joo, Kwan Joong*   Sungkyunkwan University  Joung, Boyoung   Yonsei University Jun, Young-Joon   The Cathoic University of Korea Jung, Chan Kwon   The Catholic University of Korea Jung, Eui Dal*   The Catholic University of Daegu Jung, Hye Seung*   Seoul National University Jung, Hyun Chae   Seoul National University Jung, Jae-Seung*   Korea Univeristy Jung, Ji Yong*   Gachon Univeristy Jung, Sung-Chul   Ewha Womans University Kang Seok Hoon   Seoul National University  Kang, Cheol-In   Sungkyunkwan University Kang, Dae Hwan   Pusan National University Kang, Gilwon   Chungbuk National University Kang, Hee Gyung   Seoul National University Kang, Jung Hun*   Gyeongsang National University Kang, Ki Mun   Gyeongsnag National University Kang, Min-Kyung   Hallym University Kang, Myoung Sheen   Gangneung-Wonju National University Kang, Nakheon   Chungnam National University  Kang, Seok Min   Yonsei University Kang, Young Ae   Yonsei University Ki, Chang-Seok   Sungkyunkwan University Ki, Sae Hwi   Inha University Kim, Baek-Nam*   Inje University Kim, Beom Seok   Yonsei University Kim, Bumjoon   Seoul National University Kim, Byeong Chae   Chonnam National University  Kim, Byung Jin*   Sungkyunkwan University  Kim, Byung Wook   The Cathoic University of KoreaKim, Changsoo   Yonsei University Kim, Chul Sik   Hallym University Kim, Chun-Bae   Yonsei University Kim, Dae Hwan   Inje University Kim, Dae Jung   Ajou University Kim, Dong-Gyu   Hallym University Kim, Eun Key   University of Ulsan Kim, Eun Young   Chosun University Kim, Eun-A*   Korea Occupational Safety and Health  Agency Kim, Gaabsoo   Sungkyunkwan University Kim, Geun-Tae   Kosin University Kim, Gheun-Ho   Hanyang University Kim, Gi Beom   Seoul National University Kim, Heon*   Chungbuk National University Kim, Hojoong   Sungkyunkwan University Kim, Hong Bin   Seoul National University Kim, Hwi Gon   Pusan National University Kim, Hyo-Soo   Seoul National University Kim, Hyoung Ryoul   The Cathoic University of Korea Kim, Hyun   Hallym University Kim, Hyun Soo   Chonnam National University  Kim, Hyung Hun   The Cathoic University of Korea Kim, Hyung Jin*   Chonbuk National University  Kim, In Kyeom   Kyungpook National University Kim, Jae Weon   Seoul National University Kim, Jae Yeol   Chung-Ang University Kim, Jang-Young   Yonsei University Kim, Jeong Tae*   Hanyang University Kim, Jhingook   Sungkyunkwan University Kim, Ji Won   Seoul National UniversityKim, Jin   The Cathoic University of Korea Kim, Jin Seok*   Yonsei University Kim, Jin Won   Korea Univeristy Kim, Jinsoo   Gwangmyeong Sungae General Hospital Kim, Joong-Seok   The Cathoic University of Korea Kim, Jung Young   Korea Institute of Radiological &  Medical Sciences Kim, Jung-Sun   Yonsei University Kim, Jungwon   Kosin University Kim, Kiwon   National Cancer Center Kim, Koon Soon   Chungnam National University  Kim, Kwang Seog   Chonnam National University  Kim, Kwang-il*   Seoul National University Kim, Kye-Hyung   Seoul National University Kim, Kyoo Sang   Korea Occupational Safety and Health  Agency Kim, Kyung Soo   Chung-Ang University Kim, Kyuseok*   Seoul National University Kim, Mi Kyung   Hanyang University Kim, Min Gi   Dongguk University Kim, Min-Wook   The Cathoic University of Korea Kim, Moon Young*   Yonsei University Kim, Nam Joong*   Seoul National University Kim, Namkyu   Yonsei University Kim, Sang Gyune   Soon Chun Hyang University  Kim, Sang Hyun*   Seoul National University Kim, Sang Wook   Chung-Ang University Kim, Sang-Wan   Seoul National University Kim, Sangyun*   Seoul National University Kim, Sejoong*   Seoul National University Kim, Seok Jin   Sungkyunkwan University Kim, Seok-ki   National Cancer CenterKim, Seong Cheol*   Inje University Kim, Seung Hyun*   Hanyang University Kim, Seung Up   Yonsei University Kim, Shin-Yoon*   Kyungpook National University Kim, Si-Young   Kyung Hee University Kim, Soo Wan*   Chonnam National University  Kim, Soo-Geun   Sungkyunkwan University Kim, Soo-Joong   Kyung Hee University Kim, Soon Bae*   University of Ulsan Kim, Soon Ki   Inha University Kim, Sung Eun   Hallym University Kim, Sung Hoon   University of Ulsan Kim, Sung Soo   University of Ulsan Kim, Sung-Hoon   Kwandong University Kim, Sung-Hwan   The Catholic University of Korea Kim, Sungjoo   Sungkyunkwan University Kim, Tae Ho   The Catholic University of Korea Kim, Tae Hyeon   Wonkwang University Kim, Tae Il   Yonsei University Kim, Tae Wan*   Seoul National University  Kim, Tae Yong   University of Ulsan Kim, Tae-Bum   University of Ulsan Kim, Tae Hyeon   Wonkwang University Kim, Tae-im   Yonsei University Kim, Tae-Yoon   The Catholic University of Korea Kim, Tae-Young   Hallym University Kim, Un-Kyung   Kyungpook National University Kim, Weon*   Kyung Hee University Kim, Won   Seoul National University Kim, Won Tae*   Chungbuk National University Kim, Woo Kyung   Inje University",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"Hong S-T • Peer Review in 2014: More Supports than Neglects http://jkms.org   123 http://dx.doi.org/10.3346/jkms.2015.30.1.120Kim, Woo Seob*   Chung-Ang University Kim, Woo Sun   Seoul National University Kim, Yae-Jean   Sungkyunkwan University Kim, Yangho   University of Ulsan Kim, Yang-Ki*   Soon Chun Hyang University  Kim, Yeul Hong   Korea Univeristy Kim, Yong Beom   Seoul National University Kim, Yong Sun   Hallym University Kim, YongChul   Armed Forces Capital Hospital Kim, Yong-June   Chungbuk National University Kim, Yoon   Seoul National University Kim, Yoon Jun   Seoul National University Kim, You Sun*   Inje University Kim, Young Don*   Jeju National University Kim, Young Hoon   The Catholic University of Korea Kim, Young Hoon   The Catholic University of Korea Kim, Young Whan   Seoul National University Kim, Young-Hak   University of Ulsan Kim, Younghan   Yonsei University Kim, Young-Ho   Sungkyunkwan University Kim, Youngki   Pusan National University Kim, Yu Ri   Yonsei University Kim, Yu-Mi   Dong-A University Kim, Yun Hwan   Ewha Womans University Kim, Yun Joong   Hallym University Ko, Hyun Sun   The Catholic University of Korea Ko, Jaekon*   University of Ulsan Ko, Young-Guk   Yonsei University Koh, Donghee   Korea Occupational Safety and Health  Agency Koh, In Jun*   The Catholic University of KoreaKoh, Jung-Min*   University of Ulsan Koh, Won-Jung   Sungkyunkwan University Koh, Younsuck*   University of Ulsan Kong, Yoon   Sungkyunkwan University Koo, Ho Suk*   Inje University Koo, Kyung-Hoi*   Seoul National University Kook, Hoon   Chonnam National University  Ku, Ja-Lok*   Seoul National University  Kwak, Cheol   Seoul National University Kwak, Young Ho   Seoul National University Kwon, Bo Sang   Seoul National University Kwon, Kun-Young*   Keimyung University Kwon, Ohyun   Eulji University Kwon, Sung Tack   Seoul National University Kwon, Yong Soo*   Chonnam National University  Lee, Bae Young   The Catholic University of Korea Lee, Beom Hee   University of Ulsan Lee, Bong Hwa   Hallym University Lee, Byung Seok   Chungnam National University  Lee, Chang Keun   University of Ulsan Lee, Chang-Hoon   Wonkwang University Lee, Cheolsoon   Gyeongsang National University Lee, Dong Ho*   Seoul National University Lee, Dong Won   Pusan National University Lee, Dong Won   Yonsei University Lee, Duk-Hee   Kyungpook National University Lee, Eun   Yonsei University Lee, Eun Bong*   Seoul National University Lee, Hae-Young   Seoul National University Lee, Hajeong*   Seoul National University Lee, Hee Joong   The Cathoic University of KoreaLee, Hoan Jong*   Seoul National University Lee, Hwa Mu   University of California, USA Lee, Hwa-Young   Soon Chun Hyang University  Lee, Hye Seung*   Seoul National University Lee, Hye-Eun   The Catholic University of Korea Lee, Hyuk-Joon   Seoul National University Lee, Hyung-Lae   Kyung Hee University Lee, Jae Hyup*   Seoul National University Lee, Jaeho   Seoul National University Lee, Jae-Ho*   The Catholic University of Korea Lee, JaeHo*   University of Ulsan Lee, Jae-Hong   University of Ulsan Lee, Jae-hwan   Chungnam National University Lee, Jee Young   Seoul National University Lee, Je-Jung   Chonnam National University  Lee, Jeong Hun   Dongguk University Lee, Jeonghwan*   Hallym University Lee, Jeongmin   Korea National Institute of Health Lee, Jiho   University of Ulsan Lee, Jin Hee   Seoul National University Lee, Jin Yong   Seoul National University Lee, Jin-Seok   Seoul National University  Lee, Jinwoong*   Chungnam National University  Lee, Jong-Min   Kyung Hee University Lee, Joo Hoon   University of Ulsan Lee, Joon Seong   Soon Chun Hyang University  Lee, Joon-Ho   Soon Chun Hyang University  Lee, Jung Goo   Inje University Lee, Jung Nam   Gachon Univeristy Lee, Jung Pyo   Seoul National University Lee, Jung Ryeol*   Seoul National UniversityLee, Jung-Il   Sungkyunkwan University Lee, Kang Young   Yonsei University Lee, Ki Hyeong   Chungbuk National University Lee, Ki-Young   Yonsei University Lee, Kook Hyun*   Seoul National University Lee, Kunsei   Konkuk University Lee, Kwang Young   Presbyterian Medical Center Lee, Kyeong-Seok   Soon Chun Hyang University  Lee, Moo-Song   University of Ulsan Lee, Ryung-Ah   Ewha Womans University Lee, Sang Ah   Jeju National University Lee, Sang Haak*   The Catholic University of Korea Lee, Sang Hyub*   Seoul National University Lee, Sang Lak   Keimyung University Lee, Sang-Hak   Yonsei University Lee, Sangho   Kyung Hee University Lee, Sang-il   Gyeongsang National University Lee, Sang-Il   University of Ulsan Lee, Seung Heon   Korea Univeristy Lee, Seung Hun   Yonsei University Lee, Shin-Seok*   Chonnam National University  Lee, Soonil   Dankook University Lee, So-Yeon   Hallym University Lee, Suk-Hwan   Kyung Hee University Lee, Sun Ju*   Kyung Hee University Lee, Sung Koo*   University of Ulsan Lee, Sung Woo   Korea Univeristy Lee, Sunhee   Pusan National University Lee, Sun-Young*   Konkuk University Lee, Taek Sang   Seoul National University Lee, U-Young   Tha Catholic University of Korea",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"Hong S-T • Peer Review in 2014: More Supports than Neglects 124  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.120Lee, Won Jai   Yonsei University Lee, Won Jin*   Korea Univeristy Lee, Won Young*   Sungkyunkwan University Lee, Won-Woo   Seoul National University Lee, Young Kyung   Hallym University Lee, Young-Ha   Chungnam National University  Lee, Young-Kyun   Seoul National University Lee, Yun-Sang   Seoul National University Lim, Cheong   Seoul National University Lim, Hong Seok   Ajou University Lim, Hyun-Sul   Dongguk University Lim, Jae-Young   Seoul National University Lim, YongTaik   The Catholic University of Korea Lyu, Chuhl Joo   Yonsei University Min, Young Joo   University of Ulsan Minami, Yasunori   Kinki University Faculty of Medicine,  Japan Miura, Tomofumi   National Cancer Center Moon, Kyoung Ho   Inha University Moon, Seong-Hwan   Yonsei University Mun, Goo-Hyun   Sungkyunkwan University Myong, Jun-Pyo*   The Cathoic University of Korea Myung, Sun Jung   Seoul National University Na, Baeg-ju   Konyang University Na, Sungwon   Yonsei University Nam, Chang-Wook   Keimyung Univeristy Nam, Gi-Byoung   University of Ulsan Nam, Hae Sung   Chungnam National University  Nam, Moonsuk   Inha University Nam, Soonyuhl   University of Ulsan Novikov, Alexander   FSBI, Russian FederationNovikova, Diana   Nasonova Research Institute of  Rheumatology, Russian Federation Oh, Chang-Kwon   Ajou University Oh, Doyeun   CHA University Oh, Il-Young*   Seoul National University Oh, Jaeryung   Korea University Oh, Jieun*   Hallym University Oh, Joo Han   Seoul National University Oh, Jung-Tak   Yonsei University Oh, Jun-Hyok   Pusan National University Oh, Min-Kyun   Gyeongsang National University Oh, Sang-Ha   Chungnam National University Oh, Yeon*   Wonkwang University Oh, Yeon-Mok   University of Ulsan Oh, Yong-Seog   The Catholic University of Korea On, Young Keun*   Sungkyunkwan University Ong, Eng Hock Marcus*   Singapore General Hospital, Singapore Osuga, Yutaka   The University of Tokyo, Japan Ozgur, Kasapcopur   Cerrahpasa Medical Faculty Istanbul  University, Turkey Ozlem, Balbaloglu   Bozok University, Turkey Pae, Chi-Un   The Catholic University of Korea Paek, Sun Ha   Seoul National University  Paeng, Jin Chul*   Seoul National University Pak, Hui-Nam   Yonsei University Park, Cheol Whee   The Cathoic University of Korea Park, Do Joong   Seoul National University Park, Eunsoo   Soon Chun Hyang University  Park, Hong Ju   University of Ulsan Park, Hue Jung   The Catholic University of Korea Park, Hyeong Kyu   Soon Chun Hyang University  Park, Hyun Jun   Pusan National UniversityPark, In Won   Chung-Ang University Park, Jae Myung   The Cathoic University of Korea Park, Jae Young   Korea Univeristy Park, Jae-Hyeong   Chungnam National University  Park, Jeonghyun*   Inje University Park, Jeong-Yeol   University of Ulsan Park, Ji Sook   Gyeongsang National University Park, Jin-Sun   Ajou University Park, Jong Tae   Korea Univeristy Park, Jong Yeon   University of Ulsan Park, Jong-Ik   Kangwon National University Park, Jong-Wan   Seoul National University Park, Jung-Duck   Chung-Ang University Park, Jung-Hwan*   Konkuk University Park, Jung-Won   Yonsei University Park, Kay-Hyun   Seoul National University Park, Kyoung-Ha   Hallym University Park, Kyung Sik   Keimyung University Park, Kyung-Su   The Cathoic University of Korea Park, Min Soo   Yonsei University Park, Moon-Sung   Ajou University Park, Rae Woong   Ajou University Park, Seon-Cheol   Yong-In Mental Hospital Park, Seungmin   Hallym University Park, Sungha   Yonsei University Park, Sung-Hye   Seoul National University Park, Sung-Ji   Sungkyunkwan University Park, Wan Beom   Seoul National University Park, Won Hee   Inha University Park, Yong Chon*   Hanyang University Park, Yong Mean   Konkuk UniversityPark, Yoonseon   NHIS Ilsan Hospital Park, Young Ho   Seoul National University Park, Young Joo   Seoul National University Park, Young Seok*   CHA University Park, Younhee   Kwandong University Pyun, Bok Yang   Soon Chun Hyang University  Rasoul, Baharlou   Jahrom University of Medical Science,  Iran Rha, Seung-Woon*   Korea University Rhee, Moo-Yong   Dongguk University Rhie, Jong Won   The Catholic University of Korea Ro, Han*   Gachon Univeristy Roh, Cheong-Rae   Sungkyunkwan University Roh, Jong-Lyel   University of Ulsan Roh, Tai Suk   Yonsei University Ryu, Jae-Sook   Hanyang University Ryu, Ji Kon   Seoul National University Ryu, Seung   Chungnam National University  Sakong, Joon   Yeungnam University Sekib, Sokolovic   University Clinical Center, Bosnia and  Herzegovina Seo, Hye-Sun   Soon Chun Hyang University  Seo, Hyo Jung   Seoul National University Seo, Jae Bin   Seoul National University  Seo, Jeong Seok   Konkuk University Seo, Jeong Wan   Ewha Womans University Seo, Jeong-Wook   Seoul National University Seo, Min*   Dankook University Seo, Yeon Seok*   Korea University  Seok, Jeong-Ho   Yonsei University Shim, Chi Young   Yonsei University Shim, Jae-Yong   Yonsei University",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"Hong S-T • Peer Review in 2014: More Supports than Neglects http://jkms.org   125 http://dx.doi.org/10.3346/jkms.2015.30.1.120Shim, Jong Sup   Sungkyunkwan University Shim, Ki-Nam*   Ewha Womans University Shim, Tae Sun*   University of Ulsan Shim, Wan Joo*   Korea University Shin, Aesun   Seoul National University Shin, Dong Ho   Yonsei University Shin, Dong Il*   The Catholic University of Korea Shin, Dong Wook   Seoul National University Shin, Donghyeok   Konkuk University Shin, Hae-Won   Chung-Ang University Shin, Hee Young*   Seoul National University Shin, Hojin   Pusan National University Shin, Jaepil   Kyungpook National University Shin, Min-Ho   Chonnam National University  Shin, Sang Do   Seoul National University Shin, See-Ok   Chungbuk National University Shin, Seon Hee   Hallym University Shin, Sujin   Soon Chun Hyang University  Sohn, Chul-Ho   Seoul National University Sohn, Il Suk   Kyung Hee University Sohn, Joo Hyun   Hanyang UniversitySon, Ho Sung   Korea Univeristy Son, Ji Woong   Konyang University Son, Weon-Young   MUHC Reproductive Center, Canada Song, Hong Ji   Hallym University Song, Jae-Kwan   University of Ulsan Song, Jinyoung   Sungkyunkwan University Song, Sang Hoon   Seoul National University Song, Si Youn   Yeungnam University Song, Woo-Jung   Seoul National University Song, YoonJu   The Catholic University of Korea Song, Young Bin   Sungkyunkwan University Suh, DongIn   Seoul National University Suh, Gee Young   Sungkyunkwan University Suh, Jon*   Soon Chun Hyang University  Suh, Jung-Won   Seoul National University Suk, Ki Tae   Hallym University Sung, Jung-Joon   Seoul National University Sung, Ki Woong*   Sungkyunkwan University Sung, Sunwoo   University of Ulsan Um, Soo-jung   Dong-A University Wang, Kyu-Chang*   Seoul National UniversityWon, Hye-Sung   University of Ulsan Won, Jong Uk   Yonsei University Won, Kyu Chang   Yeungnam University Won, Young-Joo   National Cancer Center Woo, Se Joon   Seoul National University Woo, Seung Hoon   Kyungsang University Yang, Hyeon Jong   Soon Chun Hyang University  Yang, Jung Dug   Kyungpook National University Yang, Sei Won   Seoul National University Ye, Byong Duk   University of Ulsan Yeom, Joon Sup   Sungkyunkwan University Yi, Cheolho   Changwon Teo Occupational Medical  Center Yi, Hyeong-Joong*   Hanyang University Yim, Dong-Seok   The Catholic University of Korea Yim, Hyeon Woo*   The Catholic University of Korea Yim, Jae-Joon   Seoul National University Yong, Dongeun   Yonsei University Yoo, ByungSu   Yonsei University Yoo, Cheol-In   University of Ulsan Yoo, Chul-Gyu*   Seoul National UniversityYoo, Dae-Hyun   Hanyang University Yoo, Gyeol   The Cathoic University of Korea Yoo, Heon   National Cancer Center Yoo, Jin-Hong   The Cathoic University of Korea Yoo, Tae-Hyun   Yonsei University Yoo, Weonseob   Chungnam National University  Yoon, Chang-Hwan   Seoul National University Yoon, Hyun Koo*   Kwandong University Yoon, Hyun-Sun   Seoul National University Yoon, Jin Hwan   Hannam University Yoon, Jin-Ha   Occupational Lung Disease Institute Yoon, Jisung   Yeungnam University Yoon, Kyung Chul   Chonnam National University  Yoon, Young-Ran   Kyungpook National University Youn, Hee-Shang   Gyeongsang National University Yu, Jinho   University of Ulsan Yu, Seung Young   Kyung Hee University Yun, Kyeong Ho   Wonkwang University Yun, Seok Joong   Chungbuk National University",Non-OADS,/arxiv_data1/oa_pdf/f7/00/jkms-30-120.PMC4278022.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinicopathologic Impacts of Poorly Differentiated Cluster-Based  Grading System in Colorectal Carcinoma  Differentiation-based histologic grading of colorectal carcinoma (CRC) is widely used, but  its clinical impact is limited by insufficient prognostic value, interobserver disagreement,  and the difficulty of its application to CRC with specific histologic types such as mucinous  and medullary carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
"Keywords:  Colorectal Neoplasms; Carcinoma; Prognosis; Neoplasm Grading; Microsatellite  InstabilityJeong Won Kim,1 Mi Kyung Shin,1   and Byung Chun Kim2 1Department of Pathology and 2Department of  Surgery, Hallym University College of Medicine,  Kangnam Sacred Heart Hospital, Seoul, Korea Received: 18 July 2014 Accepted: 20 October 2014 Address for Correspondence: Jeong Won Kim, MD Department of Pathology, Hallym University College of  Medicine, Kangnam Sacred Heart Hospital, 1 Shingil-ro,  Yeongdeungpo-gu, Seoul 150-950, Korea Tel: +82.2-829-5267, Fax: +82.2-829-5268 E-mail: jwkim@hallym.or.krhttp://dx.doi.org/10.3346/jkms.2015.30.1.16  • J Korean Med Sci 2015; 30: 16-23 INTRODUCTION Traditionally, colorectal carcinoma (CRC) has been graded as  well-differentiated (WD), moderately differentiated (MD), poor - ly differentiated (PD), and undifferentiated on the basis of the  percentage of gland formation (1).",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma http://jkms.org   17 http://dx.doi.org/10.3346/jkms.2015.30.1.16ated with specific and variable histological features.,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma 18  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.16 A CB D Fig.,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
"• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma http://jkms.org   19 http://dx.doi.org/10.3346/jkms.2015.30.1.160.006, and 0.001, respectively) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
"• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma 20  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.16histologic grading frequently showed MSI-H, and these were all  classified as G3.",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma http://jkms.org   21 http://dx.doi.org/10.3346/jkms.2015.30.1.16 A B Fig.,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
"• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma 22  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.16studies of Chinese and Koreans (17, 20-22).",Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
ORCID Jeong Won Kim http://orcid.org/0000-0002-6552-9875 Mi Kyung Shin http://orcid.org/0000-0002-5908-2050 Byung Chun Kim http://orcid.org/0000-0002-0748-7136 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
• Poorly Differentiated Cluster-Based Grading of Colorectal Carcinoma http://jkms.org   23 http://dx.doi.org/10.3346/jkms.2015.30.1.16budding is a reproducible index for risk stratification of patients with  stage II colon cancer.,Non-OADS,/arxiv_data1/oa_pdf/cd/cd/jkms-30-16.PMC4278023.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cardiac Resynchronization Therapy and QRS Duration:  Systematic Review, Meta-analysis, and Meta-regression Cardiac resynchronization therapy (CRT) has been shown to reduce the risk of death and  hospitalization in patients with advanced heart failure with left ventricular dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"Received: 30 May 2014 Accepted: 4 September 2014 Address for Correspondence: Seil Oh, MD Department of Internal Medicine, Seoul National University  College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744,  Korea Tel: +82.2-2072-2088, Fax: +82.2-762-9662 E-mail: seil@snu.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.1.24  • J Korean Med Sci 2015; 30: 24-33 INTRODUCTION Heart failure is a leading cause of death in developed countries  (1).",Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"• Cardiac Resynchronization Therapy and QRS Duration http://jkms.org   25 http://dx.doi.org/10.3346/jkms.2015.30.1.24control arm, 3) compared different types of programming (such  as simultaneous versus sequential biventricular pacing), and 4)  compared different methods of procedure (such as transve - nous versus epicardial LV lead placement or triple site versus  double site pacing).",Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"• Cardiac Resynchronization Therapy and QRS Duration 26  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.24Statistical analysis Statistical analysis was performed using the “metafor” and “me - ta-commands” packages in R programming, version 3.0.2 (The  R Foundation for Statistical Computing, Vienna, Austria).",OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
• Cardiac Resynchronization Therapy and QRS Duration http://jkms.org   27 http://dx.doi.org/10.3346/jkms.2015.30.1.24Systematic review and study characteristics Table 1 briefly describes the key features of the included trials.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
• Cardiac Resynchronization Therapy and QRS Duration 28  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.24ed a similar relationship and slope with wider credible ranges  than did the REML estimate model.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"• Cardiac Resynchronization Therapy and QRS Duration http://jkms.org   29 http://dx.doi.org/10.3346/jkms.2015.30.1.24left to the discretion of the treating physician, and patients were  randomized to CRT-ON or CRT-OFF groups while keeping a  double dummy (4).",Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"• Cardiac Resynchronization Therapy and QRS Duration 30  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.24pivotal trials, showed that QRS duration at baseline had no val - ue in predicting unfavorable outcomes (12).",OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
• Cardiac Resynchronization Therapy and QRS Duration http://jkms.org   31 http://dx.doi.org/10.3346/jkms.2015.30.1.24a study-level meta-regression and lacked individual patient- level data which would have permitted a more thorough inves - tigation.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
ORCID Si-Hyuck Kang http://orcid.org/0000-0003-4755-6367 Il-Young Oh http://orcid.org/0000-0002-5584-605X Do-Yoon Kang http://orcid.org/0000-0002-6307-0562 Myung-Jin Cha http://orcid.org/0000-0001-6180-0157 Youngjin Cho http://orcid.org/0000-0002-9263-9957 Eue-Keun Choi http://orcid.org/0000-0002-0411-6372 Seokyung Hahn http://orcid.org/0000-0002-4684-4917 Seil Oh http://orcid.org/0000-0002-3836-6038 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
• Cardiac Resynchronization Therapy and QRS Duration 32  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.2472.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
Available at  http://www.cochrane-handbook.org/ [accessed on 06 December 2013].,OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
Available at http://www.nicedsu.org.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"Jonas DE, Wilkins TM, Bangdiwala S, Bann CM, Morgan LC, Thaler KJ,  Amick HR, Gartlehner G. Findings of Bayesian mixed treatment com - parison meta-analyses: comparison and exploration using real-world  trial data and simulation Available at http://www.ncbi.nlm.nih.gov/ books/NBK126104/ [accessed on 06 December 2013].",OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
Summary of Safety and Effectiveness Data: St. Jude Epic and Atlas+HF  CRT-D Systems Available at http://www.fda.gov/ohrms/dockets/dockets/  05m0492/05m-0492-aav0001-03-SSED-vol1.pdf [accessed on 02 Novem - ber 2013].,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
Available at http://www.fda.gov/ohrms/dock - ets/dockets/05m0289/05m-0289-aav0001-03-SSED-vol1.pdf [accessed  on 02 November 2013].,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
• Cardiac Resynchronization Therapy and QRS Duration http://jkms.org   33 http://dx.doi.org/10.3346/jkms.2015.30.1.2442.,Non-OADS,/arxiv_data1/oa_pdf/9a/79/jkms-30-24.PMC4278024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Cardioprotective Effect of Fimasartan, a New Angiotensin  Receptor Blocker, in a Porcine Model of Acute Myocardial  Infarction Cardioprotective effect of fimasartan, a new angiotensin receptor blocker (ARB), was  evaluated in a porcine model of acute myocardial infarction (MI).",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
"Keywords:  Angiotensin-Converting Enzyme Inhibitors; Angiotensin Receptor Blockers;  Myocardial InfarctionDoo Sun Sim,1 Myung Ho Jeong,1   Ho Chun Song,2 Jahae Kim,2 Ari Chong,2  Hee Seung Bom,2 In Seok Jeong,3   Sang Gi Oh,3 Jong Min Kim,1   Dae Sung Park,1 Jung Ha Kim,1   Kyung Seob Lim,1 Min Suk Kim,1   Shi Hyun Ryu,1 Hyun Kuk Kim,1   Sung Soo Kim,1 Su Young Jang,1   Jae Yeong Cho,1 Hae Chang Jeong,1   Ki Hong Lee,1 Keun Ho Park,1   Nam Sik Yoon,1 Hyun Ju Yoon,1   Kye Hun Kim,1 Young Joon Hong,1   Hyung Wook Park,1 Ju Han Kim,1  Youngkeun Ahn,1 Jeong Gwan Cho,1   Jong Chun Park,1 and Jung Chaee Kang1 1The Heart Research Center of Chonnam National  University Hospital Designated by Korea Ministry of  Health, Welfare and Family Affairs, Gwangju;  2Department of Nuclear Medicine, and 3Department  of Cardiothoracic Surgery, Chonnam National  University Hospital, Gwangju, Korea Received: 11 June 2014 Accepted: 29 August 2014 Address for Correspondence: Myung Ho Jeong, MD Director of The Heart Research Center of Chonnam National  University Hospital Designated by Korea Ministry of Health,  Welfare and Family Affairs, 671 Jaebong-ro, Dong-gu,   Gwangju 501-757, Korea Tel: +82.62-220-6243, Fax: +82.62-228-7174 E-mail: myungho@chollian.net Funding:  This study was supported by grants of the Korean  Health Technology R &D Project, Ministry of Health & Welfare  (HI13C1527) and Boryung Pharmaceutical Co., Ltd, Seoul,  Republic of Korea.http://dx.doi.org/10.3346/jkms.2015.30.1.34  • J Korean Med Sci 2015; 30: 34-43 INTRODUCTION The role of angiotensin receptor blockers (ARBs) in attenuating ischemia-reperfusion  injury is not fully elucidated.",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction http://jkms.org   35 http://dx.doi.org/10.3346/jkms.2015.30.1.34periment.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
"• Fimasartan in Acute Myocardial Infarction 36  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.34ed with an additional administration of zolazepam (1.25 mg/ kg, intravenous injection), tiletamine (1.25 mg/kg, intravenous  injection), xylazine (1.5 mg/kg, intravenous injection), and aza - perone (6 mg/kg, intramuscular injection).",Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction http://jkms.org   37 http://dx.doi.org/10.3346/jkms.2015.30.1.34of dextrose intravenously with simultaneous intravenous and  subcutaneous insulin to adjust blood glucose to 5 mM/L) (15).,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction 38  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.34ROIs.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction http://jkms.org   39 http://dx.doi.org/10.3346/jkms.2015.30.1.34logic myocardial infarct size.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction 40  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.34Fig.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction http://jkms.org   41 http://dx.doi.org/10.3346/jkms.2015.30.1.34macrophage accumulation in the rabbit aortic plaques.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
ORCID Doo Sun Sim http://orcid.org/0000-0003-4162-7902 Myung Ho Jeong http://orcid.org/0000-0003-4173-1494 Ho Chun Song http://orcid.org/0000-0002-6407-8160 Jahae Kim http://orcid.org/0000-0003-4077-7722 Ari Chong http://orcid.org/0000-0001-9327-9810 In Seok Jeong http://orcid.org/0000-0002-2249-0667 Sang Gi Oh http://orcid.org/0000-0001-9394-4980 Dae Sung Park http://orcid.org/0000-0002-9948-7546 Jung Ha Kim http://orcid.org/0000-0003-3334-3432 Kyung Seob Lim http://orcid.org/0000-0002-9117-887X Shi Hyun Ryu http://orcid.org/0000-0001-8376-5946 Hyun Kuk Kim http://orcid.org/0000-0002-4554-041X Sung Soo Kim http://orcid.org/0000-0002-5190-227X,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction 42  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.34Su Young Jang http://orcid.org/0000-0001-5843-0802 Jae Yeong Cho http://orcid.org/0000-0002-9393-2821 Hae Chang Jeong http://orcid.org/0000-0002-1273-3864 Ki Hong Lee http://orcid.org/0000-0002-9938-3464 Nam Sik Yoon http://orcid.org/0000-0001-9112-150X Young Joon Hong http://orcid.org/0000-0003-0192-8161 Hyung Wook Park http://orcid.org/0000-0002-9630-0467 Jong Chun Park http://orcid.org/0000-0002-3168-2054 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
Available  at http://www.asnc.org/content_1884.cfm [accessed on 13 November  2007].,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
• Fimasartan in Acute Myocardial Infarction http://jkms.org   43 http://dx.doi.org/10.3346/jkms.2015.30.1.34emia.,Non-OADS,/arxiv_data1/oa_pdf/b2/4f/jkms-30-34.PMC4278025.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Predictive Value of Echocardiographic Parameters for Clinical  Events in Patients Starting Hemodialysis Echocardiographic parameters can predict cardiovascular events in several clinical settings.",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
"Keywords:  Heart Failure, Diastolic; Echocardiography; Kidney Failure, Chronic; Renal  Dialysis; Morbidity; MortalitySeung Seok Han,1 Goo-Yeong Cho,1,2  Youn Su Park,2 Seon Ha Baek,2   Shin Young Ahn,2 Sejoong Kim,1,2   Ho Jun Chin,1,2 Dong-Wan Chae,1,2   and Ki Young Na1,2 1Department of Internal Medicine, Seoul National  University College of Medicine, Seoul; 2Department  of Internal Medicine, Seoul National University  Bundang Hospital, Seongnam, Korea Received: 26 May 2014 Accepted: 4 September 2014 Address for Correspondence: Ki Young Na, MD Department of Internal Medicine, Seoul National University  Bundang Hospital, 82 Gumi-ro, 173beon-gil, Bundang-gu,  Seongnam 463-707, Korea Tel: +82.31-787-7014, Fax: +82.31-787-4051 E-mail: kyna@snubh.orghttp://dx.doi.org/10.3346/jkms.2015.30.1.44  • J Korean Med Sci 2015; 30: 44-53 INTRODUCTION End-stage renal disease (ESRD) significantly increases overall  morbidity and mortality (1), and thus, its social and economic  burden is globally large (2).",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients http://jkms.org   45 http://dx.doi.org/10.3346/jkms.2015.30.1.44tality cases (15).,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients 46  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.44are presented as means ± standard deviation (SD) for continu - ous variables and as proportions for categorical variables.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
"• Predictability of Echocardiography in Hemodialysis Patients http://jkms.org   47 http://dx.doi.org/10.3346/jkms.2015.30.1.44verting enzyme inhibitor/angiotensin II receptor blocker, he - moglobin, calcium, creatinine, and cholesterol had a P value  < 0.10 in the univariate analysis for several clinical events (Table  4).",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
"• Predictability of Echocardiography in Hemodialysis Patients 48  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.44of LVEDV , E/e’ was not associated ( P= 0.908) with the risk of  non-cardiovascular events; HR, 1.00 (0.959-1.049).",Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients http://jkms.org   49 http://dx.doi.org/10.3346/jkms.2015.30.1.44Table 4.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients 50  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.44Table 6.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients http://jkms.org   51 http://dx.doi.org/10.3346/jkms.2015.30.1.44Fig.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients 52  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.44despite the details of the outcome data.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
ORCID Seung Seok Han http://orcid.org/0000-0003-0137-5261 Sejoong Kim http://orcid.org/0000-0002-7238-9962 Ho Jun Chin http://orcid.org/0000-0003-1185-2631 Ki Young Na http://orcid.org/0000-0002-8872-8236 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
• Predictability of Echocardiography in Hemodialysis Patients http://jkms.org   53 http://dx.doi.org/10.3346/jkms.2015.30.1.4416.,Non-OADS,/arxiv_data1/oa_pdf/1f/c6/jkms-30-44.PMC4278026.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Three-month Treatment Response and Exacerbation in Chronic  Obstructive Pulmonary Disease The aim of this study was to investigate relationships between acute exacerbation and  Forced Expiratory Volume 1 second (FEV 1) improvement after treatment with combined  long-acting beta-agonist (LABA) and inhaled corticosteroid (ICS) in patients with chronic  obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
"Keywords:  Pulmonary Disease, Chronic Obstructive; Forced Expiratory Volume; Disease  ProgressionJung Su Lee,1 Chin Kook Rhee,2   Kwang Ha Yoo,3 Ji-Hyun Lee,4   Ho Il Yoon,5 Tae-Hyung Kim,6   Woo Jin Kim,7 JinHwa Lee,8   Seong Yong Lim,9 Tai Sun Park,1   Jae Seung Lee,1 Sei Won Lee,1   Sang-Do Lee,1 and Yeon-Mok Oh1 1Department of Pulmonary and Critical Care  Medicine, and Clinical Research Center for Chronic  Obstructive Airway Diseases, Asan Medical Center,  University of Ulsan College of Medicine, Seoul;  2Department of Internal Medicine, Seoul St. Mary’s  Hospital, The Catholic University of Korea, Seoul;  3Department of Internal Medicine, Konkuk  University School of Medicine, Seoul; 4Department  of Internal Medicine, CHA Bundang Medical Center,  CHA University, Seongnam; 5Department of Internal  Medicine, Seoul National University Bundang  Hospital, Seoul National University College of  Medicine, Seongnam; 6Division of Pulmonology,  Department of Internal Medicine, Hanyang  University Guri Hospital, Hanyang University College  of Medicine, Guri; 7Department of Internal Medicine  and Environmental Health Center, Kangwon  National University Hospital, School of Medicine,  Kangwon National University, Chuncheon;  8Department of Internal Medicine, Ewha Womans  University Mokdong Hospital, College of Medicine,  Ewha Womans University, Seoul; 9Division of  Pulmonary and Critical Care Medicine, Department  of Medicine, Kangbuk Samsung Hospital,  Sungkyunkwan University School of Medicine,  Seoul, Korea Received: 29 May 2014 Accepted: 29 August 2014 Address for Correspondence: Yeon-Mok Oh, MD Department of Pulmonary and Critical Care Medicine, and  Clinical Research Center for Chronic Obstructive Airway  Diseases, Asan Medical Center, University of Ulsan College of  Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736,  Korea Tel: +82.2-3010-3136, Fax: +82.2-3010-6968 E-mail: ymoh55@amc.seoul.kr Funding:  This study was supported by a grant from the Korean  Health 21 R &D Project, Ministry of Health and Welfare, Republic  of Korea (HI10C2020 and A102065).http://dx.doi.org/10.3346/jkms.2015.30.1.54  • J Korean Med Sci 2015; 30: 54-59 INTRODUCTION Chronic obstructive pulmonary disease (COPD) is believed to be complex and hetero - geneous, not a simple and homogeneous disorder.",Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
• Treatment Response and Exacerbation in COPD http://jkms.org   55 http://dx.doi.org/10.3346/jkms.2015.30.1.54uated over a 1 yr period.,Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
• Treatment Response and Exacerbation in COPD 56  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.54Table 1.,Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
• Treatment Response and Exacerbation in COPD http://jkms.org   57 http://dx.doi.org/10.3346/jkms.2015.30.1.54clinical outcome.,Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
• Treatment Response and Exacerbation in COPD 58  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.54tients showed significant reversibility of airflow limitation in re - sponse to short-acting bronchodilator or combined LABA/ICS  treatment compared with emphysema-dominant patients.,Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
"• Treatment Response and Exacerbation in COPD http://jkms.org   59 http://dx.doi.org/10.3346/jkms.2015.30.1.54Su, Rhee CK, Yoo KH, Lee Ji-Hyun, Yoon HI, Kim TH, Kim WJ,  Lee JinHwa, Lim SY, Park TS, Lee Jae Seung, Lee SW, Lee SD,  Oh YM.",Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
ORCID Jung Su Lee http://orcid.org/0000-0001-5644-0150 Yeon-Mok Oh http://orcid.org/0000-0003-0116-4683 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/01/91/jkms-30-54.PMC4278027.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Association between Asthma and Invasive Pneumococcal  Disease: A Nationwide Study in Korea The purpose of this study was to investigate the association between asthma and invasive  pneumococcal disease (IPD) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
"Keywords:  Asthma; Invasive Pneumococcal Disease; Diabetes MellitusByung Ok Kwak,1 Ji Tae Choung,2   and Yong Mean Park1 1Department of Pediatrics, Konkuk University School  of Medicine, 2Department of Pediatrics, Korea  University College of Medicine, Seoul, Korea Received: 23 June 2014 Accepted: 4 September 2014 Address for Correspondence: Yong Mean Park, MD Department of Pediatrics, Konkuk University Medical Center,  120-1 Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82.2-2030-7555, Fax: +82.2-2030-7748 E-mail: pymcko@marathoner.kr  Funding:  This study was supported by Pfizer Pharmaceuticals  Korea Ltd (2013, KUH1090025).http://dx.doi.org/10.3346/jkms.2015.30.1.60  • J Korean Med Sci 2015; 30: 60-65 INTRODUCTION Streptococcus pneumoniae  (pneumococcus) is a Gram-positive  diplococcus that causes a variety of diseases in both children  and adults.",Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
• Asthma and Invasive Pneumococcal Disease http://jkms.org   61 http://dx.doi.org/10.3346/jkms.2015.30.1.60MATERIALS AND METHODS Study population The databases of the Korean HIRA from January 2010 to Decem - ber 2011 were analyzed.,OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
"• Asthma and Invasive Pneumococcal Disease 62  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.60of 2010 (aOR, 1.12; 95% CI, 0.16-7.99; P= 0.914) and 2011 (aOR,  2.33; 95% CI, 0.58-9.44, P= 0.236).",Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
• Asthma and Invasive Pneumococcal Disease http://jkms.org   63 http://dx.doi.org/10.3346/jkms.2015.30.1.60the airways could be associated with an increased risk for IPD.,Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
"• Asthma and Invasive Pneumococcal Disease 64  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.60lyzed the data: Kwak BO, Choung JT, Park YM.",OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
ORCID Byung Ok Kwak http://orcid.org/0000­0001­5527­0794 Yong Mean Park http://orcid.org/0000­0002­2586­584X   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
"• Asthma and Invasive Pneumococcal Disease http://jkms.org   65 http://dx.doi.org/10.3346/jkms.2015.30.1.60Reingold A, Thomas A, Schaffner W, Craig AS, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/1b/jkms-30-60.PMC4278028.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A Clinical Analysis of Brain Metastasis in Gynecologic Cancer:   A Retrospective Multi-institute Analysis  This study analyzes the clinical characteristics of the brain metastasis (BM) of gynecologic  cancer based on the type of cancer.",Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
"Keywords:  Brain Metastasis; Ovarian Neoplasm; Uterine Cervical Neoplasm; Uterine  Neoplasm, OutcomeYoung Zoon Kim,1 Jae Hyun Kwon,2   and Soyi Lim3 1Division of Neurooncology, Department of  Neurosurgery, Samsung Changwon Hospital,  Sungkyunkwan University School of Medicine,  Changwon; 2Department of Neurosurgery, Dong-A  University Medical Center, Dong-A University  College of Medicine, Busan; 3Department of  Obstetrics and Gynecology, Gil Medical Center,  Gachon University College of Medicine, Incheon,  Korea Received: 29 May 2014 Accepted: 21 August 2014 Address for Correspondence: Soyi Lim, MD Department of Obstetrics and Gynecology, Gil Medical Center,  Gachon University College of Medicine, 786 Namdong-daero,  Namdong-gu, Incheon 405-835, Korea Tel: +82.32-460-3254, Fax: +82.32-461-3290  E-mail: vclover@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.1.66  • J Korean Med Sci 2015; 30: 66-73 INTRODUCTION The American Cancer Society estimated about 1,284,900 new  cases of cancer and more than 550,000 cancer-related deaths as  of 2002 (1).",Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
"• Brain Metastasis from Gynecological Cancer http://jkms.org   67 http://dx.doi.org/10.3346/jkms.2015.30.1.66MATERIALS AND METHODS From January 2000 to December 2012, new BM cases were clin - ically and radiologically diagnosed in 61 patients with gyneco - logic cancer at Samsung Changwon Hospital, Gil Medical Cen - ter, and Dong-A Medical Center.",Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
• Brain Metastasis from Gynecological Cancer 68  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.66Overall survival Follow-up (months) 0 10 20 30 40 501.0 0.8 0.6 0.4 0.2 0.0Mean survival: 16.7 months ( ± 1.50) Median survival: 12.0 months ( ± 2.43) Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
• Brain Metastasis from Gynecological Cancer http://jkms.org   69 http://dx.doi.org/10.3346/jkms.2015.30.1.66tasis (FIGO stage IV) was found in 18 patients (56.3%) with ovar - ian cancer; 8 (42.1%) with uterine cancer; and 6 (60.0%) with  cervical cancer.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
"• Brain Metastasis from Gynecological Cancer 70  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.66ine cancer, KPS ≥ 70, a lack of extracranial metastasis, the lower  RPA class, synchronous BMs, single BMs, and multiple treatment  modalities increased the overall survival time (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
• Brain Metastasis from Gynecological Cancer http://jkms.org   71 http://dx.doi.org/10.3346/jkms.2015.30.1.66ter than that reported in previous studies.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
• Brain Metastasis from Gynecological Cancer 72  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.66but have some limitations.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
ORCID Young Zoon Kim http://orcid.org/0000-0001-9724-3081 Jae Hyun Kwon http://orcid.org/0000-0002-1507-0082 Soyi Lim http://orcid.org/0000-0001-8886-3107 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
• Brain Metastasis from Gynecological Cancer http://jkms.org   73 http://dx.doi.org/10.3346/jkms.2015.30.1.6617.,Non-OADS,/arxiv_data1/oa_pdf/bd/e4/jkms-30-66.PMC4278029.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357A De-identification Method for Bilingual Clinical Texts of Various  Note Types De-identification of personal health information is essential in order not to require written  patient informed consent.",Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"Received: 26 February 2014 Accepted: 29 August 2014 Address for Correspondence: Jae Ho Lee, MD Department of Biomedical Informatics, Asan Medical Center,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82.2-3010-5875, Fax: +82.2-3010-8126 E-mail: rufiji@gmail.com  Funding:  This study was supported by a grant (2013-7205)  from the Asan Institute for Life Sciences, Seoul, Korea.http://dx.doi.org/10.3346/jkms.2015.30.1.7  • J Korean Med Sci 2015; 30: 7-15 INTRODUCTION Electronic Health Record (EHR) systems have been widely ad - opted in the United States (1) and in Korea (2-4).",Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
• De-identification Methods for Bilingual Clinical Texts 8  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.7ods.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
• De-identification Methods for Bilingual Clinical Texts http://jkms.org   9 http://dx.doi.org/10.3346/jkms.2015.30.1.7Institutional definition of personal health identiﬁers Defined personal health identiﬁers are required to de-identify  narrative clinical text.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"• De-identification Methods for Bilingual Clinical Texts 10  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.7date, in the list of identiﬁers.",Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"• De-identification Methods for Bilingual Clinical Texts http://jkms.org   11 http://dx.doi.org/10.3346/jkms.2015.30.1.7ber (266, 34.4%).",Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"• De-identification Methods for Bilingual Clinical Texts 12  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.7phone numbers, birth-dates, and addresses, however, some  patient names were missed (25/108 cases).",Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
• De-identification Methods for Bilingual Clinical Texts http://jkms.org   13 http://dx.doi.org/10.3346/jkms.2015.30.1.7due to missed patient names.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"• De-identification Methods for Bilingual Clinical Texts 14  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.7based method, it was applied to the clinical research data ware - house system which can search, review, and extracts the neces - sary clinical data in our hospital.",OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
ORCID Soo-Yong Shin http://orcid.org/0000-0002-2410-6120 Yu Rang Park http://orcid.org/0000-0002-4210-2094 Yongdon Shin http://orcid.org/0000-0002-1144-9458 Hyo Joung Choi http://orcid.org/0000-0003-4715-2901 Jihyun Park http://orcid.org/0000-0002-1872-8708 Yongman Lyu http://orcid.org/0000-0002-9363-252X Moo-Song Lee http://orcid.org/0000-0003-1085-9073 Chang-Min Choi http://orcid.org/0000-0002-2881-4669 Woo-Sung Kim http://orcid.org/0000-0002-1254-1264 Jae Ho Lee http://orcid.org/0000-0003-2619-1231  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
Available  at http://www.healthit.gov/sites/default/files/rtc_adoption_of_healthit_  and_relatede ﬀorts.pdf [accessed on 19 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
Guidance regarding methods for de-identiﬁ- cation of protected health information in accordance with the health in - surance portability and accountability act (HIPAA) privacy rule Avail - able at http://www.hhs.gov/ocr/privacy/hipaa/understanding/covere- dentities/De-identification/hhs_deid_guidance.pdf [accessed on 7 Feb - ruary 2014].,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
• De-identification Methods for Bilingual Clinical Texts http://jkms.org   15 http://dx.doi.org/10.3346/jkms.2015.30.1.7view of recent research.,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
Available at http://www.iso.org/iso/ca- talogue_detail?csnumber=42807 [accessed on 7 February 2014].,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
Available  at http://privacyruleandresearch.nih.gov/pr_08.asp [accessed on 7 Feb - ruary 2014].,Non-OADS,/arxiv_data1/oa_pdf/44/f4/jkms-30-7.PMC4278030.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Hazardous Drinking-Related Characteristics of Depressive  Disorders in Korea: The CRESCEND Study This study aimed to identify clinical correlates of hazardous drinking in a large cohort of  Korean patients with depression.",Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
http://dx.doi.org/10.3346/jkms.2015.30.1.74  • J Korean Med Sci 2015; 30: 74-81 INTRODUCTION Depressive disorders have been of growing concern to mental  health specialists globally (1-3).,Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
• Hazardous Drinking and Depression http://jkms.org   75 http://dx.doi.org/10.3346/jkms.2015.30.1.74risk of harmful consequences; it defines harmful levels of alco - hol consumption as > 40 g/day for men and > 20 g/day for wo- men (10).,Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
"• Hazardous Drinking and Depression 76  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.74S, and SSI-Beck scales correspond to more severe symptoms,  while lower scores on the SOFAS and WHOQOL-BREF indicate  poorer overall function.",Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
"• Hazardous Drinking and Depression http://jkms.org   77 http://dx.doi.org/10.3346/jkms.2015.30.1.74ing behavior were more likely than non-hazardous drinkers to  be current smokers (adjusted odds ratio [aOR], 3.043; P< 0.001)  and have a history of suicidal attempts than non-hazardous drin- kers (aOR, 1.968; P= 0.005).",Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
• Hazardous Drinking and Depression 78  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.74model was performed to avoid issues related with multicollinea - rity.,Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
"• Hazardous Drinking and Depression http://jkms.org   79 http://dx.doi.org/10.3346/jkms.2015.30.1.74depression linked to hazardous drinking included higher levels  of psychomotor retardation and weight loss, as well as lower  levels of hypochondriasis.",Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
"• Hazardous Drinking and Depression 80  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.74ria for authorship read and met: SC Park, SK Lee, HS Oh, TY Jun,  MS Lee, JM Kim, JB Kim, HW Yim, YC Park.",Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
ORCID Seon-Cheol Park http://orcid.org/0000-0003-3691-4624 Sang Kyu Lee http://orcid.org/0000-0001-6714-850X Hong Seok Oh http://orcid.org/0000-0002-3071-3760 Tae-Youn Jun http://orcid.org/0000-0001-9516-0768 Min-Soo Lee http://orcid.org/0000-0002-3483-4375 Jae-Min Kim http://orcid.org/0000-0001-7409-6306 Jung-Bum Kim http://orcid.org/0000-0001-9444-1437 Hyeon-Woo Yim http://orcid.org/0000-0002-3646-8161 Yong Chon Park http://orcid.org/0000-0002-3019-5748 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
• Hazardous Drinking and Depression http://jkms.org   81 http://dx.doi.org/10.3346/jkms.2015.30.1.742014; 22: 866-74.,Non-OADS,/arxiv_data1/oa_pdf/44/ad/jkms-30-74.PMC4278031.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Long-term Outcome of Cochlear Implant in Patients with  Chronic Otitis Media: One-stage Surgery Is Equivalent to   Two-stage Surgery This study compared long-term speech performance after cochlear implantation (CI)  between surgical strategies in patients with chronic otitis media (COM).",Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
"Keywords:  Cochlear Implantation; Otitis Media; Tympanomastoidectomy; Speech  PerformanceJeong Hun Jang,1 Min-Hyun Park,2   Jae-Jin Song,3 Jun Ho Lee,4,5   Seung Ha Oh,4,5 Chong-Sun Kim,3   and Sun O Chang6 1Department of Otorhinolaryngology, Kyungpook  National University College of Medicine, Daegu;  2Department of Otorhinolaryngology, Seoul  Metropolitan Government-Seoul National University  Boramae Medical Center, Seoul; 3Department of  Otorhinolaryngology, Seoul National University  Bundang Hospital, Seongnam; 4Department of  Otorhinolaryngology, Seoul National University  College of Medicine; 5Sensory Organ Research  Institute, Seoul National University Medical  Research Center, Seoul; 6Department of  Otolaryngology-Head and Neck Surgery, Kangbuk  Samsung Hospital, Sungkyunkwan University School  of Medicine, Seoul, Korea Received: 26 June 2014 Accepted: 29 August 2014 Address for Correspondence: Sun O Chang, MD Department of Otolaryngology-Head and Neck Surgery,  Kangbuk Samsung Hospital, Sungkyunkwan University School  of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, Korea Tel: +82.2-2001-2263, Fax: +82.2-2001-2273 E-mail: suno@knu.ac.kr Funding:  This work was supported by Biomedical Research  Institute grant, Kyungpook National University Hospital (2013).http://dx.doi.org/10.3346/jkms.2015.30.1.82  • J Korean Med Sci 2015; 30: 82-87 INTRODUCTION  Profound sensorineural hearing loss (SNHL) can occur in pa - tients with chronic otitis media (COM) as a secondary effect of  labyrinthitis, a labyrinthine fistula, or iatrogenic injury during  surgery.",Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
• Long-term Results of Cochlear Implant in Chronic Otitis Media http://jkms.org   83 http://dx.doi.org/10.3346/jkms.2015.30.1.82analyzed the postoperative complication and post-CI long-term  speech performance of patients with COM treated via one- or  two-stage surgery.,Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
• Long-term Results of Cochlear Implant in Chronic Otitis Media 84  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.82Table 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
• Long-term Results of Cochlear Implant in Chronic Otitis Media http://jkms.org   85 http://dx.doi.org/10.3346/jkms.2015.30.1.82One-stage group (N = 17) STP-CI (N = 4) CC-CI (N = 6) OC-CI (N = 2) CI via canal app.,Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
"• Long-term Results of Cochlear Implant in Chronic Otitis Media 86  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.82vious studies have examined candidate selection, surgical me- thods and strategies, and postoperative complications.",Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
ORCID Jeong Hun Jang http://orcid.org/0000-0003-1707-5714 Min-Hyun Park http://orcid.org/0000-0003-4156-7639 Jae-Jin Song http://orcid.org/0000-0002-6631-3232 Jun Ho Lee http://orcid.org/0000-0002-5519-3263 Seung Ha Oh http://orcid.org/0000-0003-1284-5070 Chong-Sun Kim http://orcid.org/0000-0002-4273-5908 Sun O Chang http://orcid.org/0000-0003-2944-2753 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
• Long-term Results of Cochlear Implant in Chronic Otitis Media http://jkms.org   87 http://dx.doi.org/10.3346/jkms.2015.30.1.82tation in patients with a history of chronic otitis media.,Non-OADS,/arxiv_data1/oa_pdf/2c/f5/jkms-30-82.PMC4278032.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Bone Cement Augmentation Procedures for Spinal Pathologic  Fractures by Multiple Myeloma Efficacy and safety of bone cement augmentations for spinal pathologic fractures related  to multiple myeloma, and usefulness of radionuclide studies for surgical decision were  retrospectively evaluated.",Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
"Keywords:  Multiple Myeloma; Spine; Fractures, Spontaneous; Bone CementsKee-Yong Ha,1 Chang-Ki Min,2   Jun-Yeong Seo,3 Young-Hoon Kim,1   Joo-Hyun Ahn,1 Nak-Min Hyun,1   and Yoon-Chung Kim1 Departments of 1Orthopedic Surgery and 2Hematology,  Seoul St. Mary’s Hospital, College of Medicine, The  Catholic University of Korea, Seoul; 3Department of  Orthopedic Surgery, Jeju National University  Hospital, Jeju, Korea Received: 15 May 2014 Accepted: 25 July 2014 Address for Correspondence: Young-Hoon Kim, MD Department of Orthopedic Surgery, Seoul St. Mary’s Hospital,  College of Medicine, The Catholic University of Korea,   222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82.2-2258-6118, Fax: +82.2-505-9834 E-mail: boscoa@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.1.88  • J Korean Med Sci 2015; 30: 88-94 INTRODUCTION Multiple myeloma, one of hematologic malignancies, is known  to have a high chance of skeletal related events (SREs) from its  pathologic characteristics (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
"• Bone Cement Augmentation for Myeloma Spinal Fractures http://jkms.org   89 http://dx.doi.org/10.3346/jkms.2015.30.1.88and radiological results were compared with 29 patients who  had not undergone surgery, and treated conservatively as the  non-surgery group (group II).",Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
• Bone Cement Augmentation for Myeloma Spinal Fractures 90  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.88thopedic residents who were blinded to the purpose of this study  and clinical results.,Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
• Bone Cement Augmentation for Myeloma Spinal Fractures http://jkms.org   91 http://dx.doi.org/10.3346/jkms.2015.30.1.88ly.,Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
"• Bone Cement Augmentation for Myeloma Spinal Fractures 92  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.88DISCUSSION Multiple myeloma, one of hematologic malignancies is known  to have high incidence of skeletal related events such as patho - logic fracture or spinal cord compression by epidural myeloma  (2, 13, 14).",Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
• Bone Cement Augmentation for Myeloma Spinal Fractures http://jkms.org   93 http://dx.doi.org/10.3346/jkms.2015.30.1.88of this study is to investigate the efficiency of treatment for spi - nal pathologic fractures.,Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
ORCID Young Hoon Kim http://orcid.org/0000-0003-1237-4600 Kee-Yong Ha http://orcid.org/0000-0002-4059-7943 Jun-Yeong Seo http://orcid.org/0000-0001-8881-7952REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
"• Bone Cement Augmentation for Myeloma Spinal Fractures 94  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.88ple myeloma or breast carcinoma: a randomized, double-blind, multi - center, comparative trial.",Non-OADS,/arxiv_data1/oa_pdf/40/19/jkms-30-88.PMC4278033.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Epidemiology and Outcomes in Out-of-hospital Cardiac Arrest:   A Report from the NEDIS-Based Cardiac Arrest Registry in Korea  Sudden cardiac death (SCD) is a significant issue affecting national health policies.",Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"Keywords:  Death, Sudden, Cardiac; Resuscitation; Outcome; Cardiac Rhythms;  Emergency Department Hyuk Jun Yang,1,2 Gi Woon Kim,1,3   Hyun Kim,1,4 Jin Seong Cho,2   Tai Ho Rho,1,5 Han Deok Yoon,6   and Mi Jin Lee;1,7 The NEDIS-CA  Consortium  1The ACLS Committee of the Korean Association of  Cardiopulmonary Resuscitation, Seoul; 2Department  of Emergency Medicine, Gachon University Gill  Hospital, Incheon; 3Department of Emergency  Medicine, School of Medicine, Ajou University,  Suwon; 4Department of Emergency Medicine,  Wonju College of Medicine, Yonsei University,  Wonju; 5Division of Cardiology, Department of  Medicine, College of Medicine, The Catholic  University of Korea, Seoul; 6National Emergency  Medical Center, Seoul; 7Department of Emergency  Medicine, School of Medicine, Kyungpook National  University, Daegu, Korea  Received: 4 May 2014 Accepted: 18 September 2014 Address for Correspondence: Mi Jin Lee, MD Department of Emergency Medicine, School of Medicine,  Kyungpook National University, 680 Gukchaebosang-ro,   Jung-gu, Daegu 700-842, Korea  Tel: +82.53-420-6400, Fax: +82.53-428-2820 E-mail: emmam@knu.ac.kr http://dx.doi.org/10.3346/jkms.2015.30.1.95  • J Korean Med Sci 2015; 30: 95-103 INTRODUCTION Sudden cardiac death (SCD) is often fatal and remains a major  public health issue worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  96  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.95MATERIALS AND METHODS NEDIS database Data were obtained from the NEDIS database, which is updat - ed in real-time by the National Emergency Medical Center across  Korea.",OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  http://jkms.org   97 http://dx.doi.org/10.3346/jkms.2015.30.1.95ED outcomes (admitted, died, or transferred), hospital outcomes  (discharged alive, died, or transferred), neurological outcomes  at discharge, and whether post-CA treatment (i.e., therapeutic  hypothermia or percutaneous coronary intervention) was pro - vided.",OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  98  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.95Ethics statement The study was reviewed and approved by the institutional re - view board of Kyungpook National University Hospital (14-061).,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  http://jkms.org   99 http://dx.doi.org/10.3346/jkms.2015.30.1.95in the ED in 2,123 patients (51.1%).",Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  100  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.95Table 3.,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  http://jkms.org   101 http://dx.doi.org/10.3346/jkms.2015.30.1.95sessed data in Korea (the CAVAS project, which reported rates  of 10.1%, 3.5%, and 1.0%, respectively) (7).",OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  102  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.1.95those with CA that occurred more than 24 hr after symptom  onset were excluded.,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
ORCID Mi Jin Lee http://orcid.org/0000-0002-3773-8047  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
Available  at http://edis.nemc.go.kr [accessed on 30 October 2012].,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
Available at http://www.nemc.or.kr/ [accessed on 30 Octo - ber 2012].,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
• The Outcome Report of NEDIS-Based Cardiac Arrest Registry  http://jkms.org   103 http://dx.doi.org/10.3346/jkms.2015.30.1.9517.,Non-OADS,/arxiv_data1/oa_pdf/af/68/jkms-30-95.PMC4278034.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common invasive cancer in wom - en worldwide and it is also the leading cause of death from  cancer among women.",Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
"In addition, the  St. Gallen Expert Consensus Report found that an age cutoff of Unique Features of Young Age Breast Cancer and Its Management Han-Byoel Lee1, Wonshik Han1,2 1Department of Surgery, Seoul National University College of Medicine, Seoul; 2Cancer Research Institute, Seoul National University, Seoul, KoreaREVIEW ARTICLEJ Breast Cancer 2014 December; 17(4): 301-307  http://dx.doi.org/10.4048/jbc.2014.17.4.301 Young age breast cancer (YABC) has unique clinical and biologi - cal features that are not seen in older patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.301< 35 years was an indication for adjuvant chemotherapy [8].,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
Management of Young Age Breast Cancer303 http://dx.doi.org/10.4048/jbc.2014.17.4.301  http://ejbc.krhigher stage at diagnosis.,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
Online (http://www.adjuvan - tonline.com; Adjuvant!,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.301ADJUVANT CHEMOTHERAPY Although few clinical trials have assessed the effects of adju - vant chemotherapy in younger women alone, large scale trials  have shown similar efficacy of chemotherapeutic agents in all  age groups.",Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
Management of Young Age Breast Cancer305 http://dx.doi.org/10.4048/jbc.2014.17.4.301  http://ejbc.krtreatment [70].,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.301Oncol 2008;26:3324-30.,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
"Management of Young Age Breast Cancer307 http://dx.doi.org/10.4048/jbc.2014.17.4.301  http://ejbc.krchert-T oft M, et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
http://www.nccn.org/professionals/physician_gls/pdf/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/d6/c9/jbc-17-301.PMC4278047.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer has already become one of the principal fe - male-specific cancers in South Korea, and its incidence has  increased on annually [1].",Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
"Detailed decision rec - ommended for the treatment and diagnosis, according to the  consensus conference, is recorded in Supplementary Table 2.Meeting Highlights: The First Korean Breast Cancer Treatment Consensus  Conference Airi Han*, Kyoung Eun Lee1,*, Hae Kyung Lee2, Y eon Hee Park3, Jeryoung Kim4, Sung-Won Kim5, Kyung Hae Jung6,  Byung-Ho Son7, Korean Breast Cancer Treatment Consensus Conference Panelists8,† Department of Surgery, Y onsei University Wonju College of Medicine, Wonju; 1Department of Hematology-Oncology, Ehwa Womans University Hospital,  Seoul; 2Department of Surgery, Kwandong University College of Medicine, Goyang; 3Division of Hematology-Oncology, Department of Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine, Seoul; 4Department of Surgery, Chungnam National University Hospital, Daejeon;  5Department of Surgery, Seoul National University Bundang Hospital, Seongnam; Departments of 6Oncology and 7Surgery, University of Ulsan College of  Medicine, Seoul; 8The Korean Breast Cancer Society, Seoul, KoreaSPECIAL ARTICLEJ Breast Cancer 2014 December; 17(4): 308-313  http://dx.doi.org/10.4048/jbc.2014.17.4.308 The first Korean Breast Cancer Treatment Consensus Confer - ence Expert Panel reviewed and endorsed new evidence on as - pects of local and regional therapies and diagnostic procedures  that support the conservative application of results from recent  clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
"The First Korean Breast Cancer Treatment Consensus Conference309 http://dx.doi.org/10.4048/jbc.2014.17.4.308  http://ejbc.krTHE FIRST KOREAN BREAST CANCER  TREATMENT CONSENSUS CONFERENCE: NEWS  AND NEXT STEP FORWARD The Korean Breast Cancer Treatment Consensus Confer - ence was first held January 4, 2014, and was composed of  three sections: local treatment, systemic treatment, and diag - nostic evaluation of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.308cer” (the EMILIA trial) [14], capecitabine with or without lapa - tinib for women with refractory advanced or metastatic breast  cancer (EGF100151) [15], and trastuzumab in combination  with vinorelbine or taxane-based chemotherapy in patients  with metastatic breast cancer (the TRAVIOTA trial) [16] for  HER2-positive metastatic breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
The First Korean Breast Cancer Treatment Consensus Conference311 http://dx.doi.org/10.4048/jbc.2014.17.4.308  http://ejbc.krbegan in 2013.,Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.308in which active discussions were used to decide cases for  which chemotherapy could be added to hormone therapy, the  first Korean Breast Cancer Treatment Consensus Conference  aimed to identify cases where anticancer chemotherapy could  be left out and to determine a different therapeutic base, with  50% willing to use anticancer treatment even when all the  conditions were favorable.",Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
The First Korean Breast Cancer Treatment Consensus Conference313 http://dx.doi.org/10.4048/jbc.2014.17.4.308  http://ejbc.krREFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
http://www.nccn.org/professionals/physi - cian_gls/pdf/breast.pdf.,Non-OADS,/arxiv_data1/oa_pdf/bb/36/jbc-17-308.PMC4278048.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Despite recent advances in the diagnosis and treatment of  breast cancer, the disease remains to be a significant health  problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
"has antitumor ef -Anticancer Activity of Cobra Venom Polypeptide, Cytotoxin-II, against  Human Breast Adenocarcinoma Cell Line (MCF-7) via the Induction of  Apoptosis Karim Ebrahim, Farshad H. Shirazi1, Hosein Vatanpour, Abas zare2, Farzad Kobarfard3, Hadi Rabiei2 Department of Toxicology, Shahid Beheshti University of Medical Sciences School of Pharmacy, Tehran; 1Pharmaceutical Sciences Research Center, Shahid  Beheshti University of Medical Sciences, Tehran; 2Razi Vaccine and Serum Research Institute, Karaj; 3Department of Pharmaceutical Chemistry, Shahid  Beheshti University of Medical Sciences School of Pharmacy, Tehran, IranORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 314-322  http://dx.doi.org/10.4048/jbc.2014.17.4.314 Purpose:  Breast cancer is a significant health problem world - wide, accounting for a quarter of all cancer diagnoses in women.",Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
Use of Animal Toxins in Breast Cancer Treatment315 http://dx.doi.org/10.4048/jbc.2014.17.4.314  http://ejbc.krfects on adenocarcinoma cells.,Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.314bation, cells were harvested by trypsin and centrifuged at  700 × g. Then, 20 µL of acridine orange (20 µg/mL) and 20 µL  of ethidium bromide (20 µg/mL) were added to the cell  plaque and cells were viewed under a fluorescence micro - scope (Moticam Pro 2828) with 40 ×  magnification [15].",OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
Use of Animal Toxins in Breast Cancer Treatment317 http://dx.doi.org/10.4048/jbc.2014.17.4.314  http://ejbc.krRESULTS Morphological analysis Monitoring of cytotoxin-II treated cells under normal in - verted light microscopy showed significant morphological  changes compared to control cells.,Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.314ue of cytotoxin-II was 4.18 ± 1.23 µg/mL while the value for  cisplatin was approximately 28.02 ± 1.87 µg/mL.,OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
Use of Animal Toxins in Breast Cancer Treatment319 http://dx.doi.org/10.4048/jbc.2014.17.4.314  http://ejbc.kr7 cells.,Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.314Figure 7.,Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
Use of Animal Toxins in Breast Cancer Treatment321 http://dx.doi.org/10.4048/jbc.2014.17.4.314  http://ejbc.krcell proliferation and the rate of programmed cell death (apop - tosis).,Non-OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.314hibition of heat shock proteins.,OADS,/arxiv_data1/oa_pdf/58/b5/jbc-17-314.PMC4278049.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The role of epigenetic alterations, including the acetylation  status of histones and DNA methylation, has been an impor ­ tant focus in studies on the development of human cancers,  and such changes are often an early event in tumorigenesis  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"A total of 18 human HDAC isoenzymes have been de ­ scribed to date, and they are categorized into four classes: class  I HDACs (HDAC1, HDAC2, HDAC3, and HDAC8) are relat ­ ed to the yeast RPD3 deacetylase; class II HDACs are catego ­Expression of Histone Deacetylases HDAC1, HDAC2, HDAC3, and HDAC6 in  Invasive Ductal Carcinomas of the Breast Jinwon Seo, Soo Kee Min, Hye-Rim Park, Dong Hoon Kim, Mi Jung Kwon, Lee Su Kim1, Y oung-Su Ju2 Department of Pathology, 1Division of Breast and Endocrine Surgery, and 2Department of Occupation and Environmental Medicine, Hallym University  Sacred Heart Hospital, Hallym University College of Medicine, Anyang, KoreaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 323-331  http://dx.doi.org/10.4048/jbc.2014.17.4.323 Purpose:  DNA deacetylation by histone deacetylase (HDAC) is  an important mechanism involved in the oncogenic tumorigene ­ sis of breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.323rized into class IIa (HDAC4, HDAC5, HDAC7, and HDAC9)  and class IIb (HDAC6 and HDAC10) and are homologous to  the yeast Hda1 deacetylase; and class III HDACs include seven  HDACs (SIRT1 to SIRT7), which show homology with the  yeast Sir2 family [7].",OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"Expression of HDAC1, HDAC2, HDAC3, and HDAC6 in Breast Cancers325 http://dx.doi.org/10.4048/jbc.2014.17.4.323  http://ejbc.kranalysis.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.323(HDAC1, p= 0.386; HDAC2, p= 0.381; HDAC3, p= 0.361;  HDAC6, p= 0.091) or DFS (HDAC1, p= 0.747; HDAC2, p=  0.596; HDAC3, p= 0.383; HDAC6, p= 0.194) on univariate  analysis.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"Expression of HDAC1, HDAC2, HDAC3, and HDAC6 in Breast Cancers327 http://dx.doi.org/10.4048/jbc.2014.17.4.323  http://ejbc.krTable 3.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.323Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"Expression of HDAC1, HDAC2, HDAC3, and HDAC6 in Breast Cancers329 http://dx.doi.org/10.4048/jbc.2014.17.4.323  http://ejbc.krTable 5.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.323mors [23].,OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"Expression of HDAC1, HDAC2, HDAC3, and HDAC6 in Breast Cancers331 http://dx.doi.org/10.4048/jbc.2014.17.4.323  http://ejbc.kr500.",Non-OADS,/arxiv_data1/oa_pdf/de/b1/jbc-17-323.PMC4278050.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Transient receptor vanilloid 1 (TRPV1) is a member of the  transient receptor potential (TRP) family that is expressed in  several neural and nonneuronal tissues of different animal  species [1].",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"Based on this information, calcium is considered an impor -Transient Receptor Potential Vanilloid 1 Expression and Functionality in   MCF-7 Cells: A Preliminary Investigation Cristina Vercelli, Raffaella Barbero, Barbara Cuniberti, Silvia Racca1, Giuliana Abbadessa1, Francesca Piccione1,  Giovanni Re Department of Veterinary Sciences, Section of Pharmacology and Toxicology, University of Turin, Grugliasco, 1Department of Clinical and Biological  Sciences, Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano, ItalyORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 332-338  http://dx.doi.org/10.4048/jbc.2014.17.4.332 Purpose:  Transient receptor potential vanilloid 1 (TRPV1) is a non - selective cation channel belonging to the transient receptor po - tential family, and it is expressed in different neoplastic tissues.",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"TRPV1 Receptor Expression and Functionality in MCF-7 Cells 333 http://dx.doi.org/10.4048/jbc.2014.17.4.332  http://ejbc.krtant intracellular messenger that regulates physiological func - tions, including cellular differentiation, proliferation, and  apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.332with ice-cold PBS (140 mM NaCl, 27 mM KCl, 15 mM KH 2  PO 4, 90mM Na 2HPO 4, pH = 7.4; Sigma Aldrich).",OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"TRPV1 Receptor Expression and Functionality in MCF-7 Cells 335 http://dx.doi.org/10.4048/jbc.2014.17.4.332  http://ejbc.krnary bladder lysate, which was used as a positive control.",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.332DISCUSSION Although the importance of TRP channels in different solid  tumors has been recently outlined, their role in breast cancer  has been insufficiently investigated.",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"TRPV1 Receptor Expression and Functionality in MCF-7 Cells 337 http://dx.doi.org/10.4048/jbc.2014.17.4.332  http://ejbc.krbeen studied, and it was suggested that TRPV1 could repre - sent a promising therapeutic target for antineoplastic strate - gies [21].",Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.3322.,Non-OADS,/arxiv_data1/oa_pdf/cb/d4/jbc-17-332.PMC4278051.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the second most common cancer after thy - roid cancer in Korean women [1].",Non-OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
"In  this study, we assessed the clinical efficacy of weekly low-dose  GP in heavily pretreated patients with MBC.Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin  Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast  Cancer Patients Jung Sun Kim, In Hae Park, Keun Seok Lee, Jungsil Ro Center for Breast Cancer, National Cancer Center, Goyang, KoreaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 339-343  http://dx.doi.org/10.4048/jbc.2014.17.4.339 Purpose:  The combination of gemcitabine and cisplatin (GP) has  been shown to be safe and efficacious for patients with meta - static breast cancer (MBC), pretreated with anthracyclines and  taxanes.",Non-OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.339METHODS Patients and treatment We reviewed the medical records of patients diagnosed  with MBC who received palliative GP chemotherapy at the  National Cancer Center, Korea between January 1, 2001 and  November 19, 2012.",OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
Weekly Low-Dose Gemcitabine-Cisplatin for MBC341 http://dx.doi.org/10.4048/jbc.2014.17.4.339  http://ejbc.krfourth line.,Non-OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.339variate analysis.,OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
Weekly Low-Dose Gemcitabine-Cisplatin for MBC343 http://dx.doi.org/10.4048/jbc.2014.17.4.339  http://ejbc.krthat we found were associated with a less aggressive form of  the disease and better response to previous treatment.,Non-OADS,/arxiv_data1/oa_pdf/98/ab/jbc-17-339.PMC4278052.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Neoadjuvant chemotherapy (NC) is a standard treatment  for locally advanced breast cancer (LABC) and large operable  breast tumors, due to its safety and effectiveness as shown in  previous studies [1-3].",Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
"When administered  concomitantly, interactions between doxorubicin and pacli -A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and  Epirubicin for Locally Advanced Breast Cancer Jinsun Lee, Jeryong Kim, Eilsung Chang, Woonjung Choi1, Kwangman Lee1, Hyunjo Yoon2, Sunghoo Jung2, Minho Park3,  Junghan Y oon3, Sungyong Kim4 Department of Surgery, Chungnam National University, Daejoen; 1Department of Surgery, Wonkwang University School of Medicine, Iksan; 2Department  of Surgery, Chonbuk National University Medical School, Jeonju;  3Department of Surgery, Chonnam National University Hwasun Hospital, Hwasun;  4Department of Surgery, Soonchunhyang University Cheonan Hospital, Cheonan, KoreaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 344-349  http://dx.doi.org/10.4048/jbc.2014.17.4.344 Purpose:  Neoadjuvant chemotherapy (NC) is yet to be estab - lished as the definitive treatment regimen for locally advanced  breast cancer (LABC).",Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
"Neoadjuvant Genexol® (Paclitaxel) and Epirubicin345 http://dx.doi.org/10.4048/jbc.2014.17.4.344  http://ejbc.krtaxel are apparently responsible for the high cardiotoxicity,  arising from the pharmacokinetic modifications of doxorubi - cin and its cardiotoxic metabolites [8].",Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.344age.,Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
"Neoadjuvant Genexol® (Paclitaxel) and Epirubicin347 http://dx.doi.org/10.4048/jbc.2014.17.4.344  http://ejbc.kr5-year OS was 90.0% for the patients who had CR/PR, and  55.6% for those who had SD/PD ( p= 0.001) (Figure 2).",Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.344CJ, Seoul, Korea) plus epirubicin for the treatment of LABC.",Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
Neoadjuvant Genexol® (Paclitaxel) and Epirubicin349 http://dx.doi.org/10.4048/jbc.2014.17.4.344  http://ejbc.krin advanced breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/07/6b/jbc-17-344.PMC4278053.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Zoledronic acid (ZA), a potent nitrogen-containing bisphos - phonate, has been used in daily practice for the prevention of  skeletal-related events that are caused by bone metastasis from  diverse tumors [1-3].",Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
"In the  present study, we aimed to assess the survival benefit of com - bined ZA and upfront aromatase inhibitor therapy in post - menopausal Korean women with breast cancer.Survival Benefit of Zoledronic Acid in Postmenopausal Breast Cancer  Patients Receiving Aromatase Inhibitors Sung Gwe Ahn*, Sung Hyun Kim*, Hak Min Lee, Seung Ah Lee1, Joon Jeong Department of Surgery, Y onsei University College of Medicine, Seoul; 1Department of Surgery, Eulji University College of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 350-355  http://dx.doi.org/10.4048/jbc.2014.17.4.350 Purpose:  A growing body of evidence indicates that zoledronic  acid (ZA) can improve the clinical outcome in patients with  breast cancer and low estrogen levels.",Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
Survival Benefit of Zoledronic Acid351 http://dx.doi.org/10.4048/jbc.2014.17.4.350  http://ejbc.krMETHODS Patient selection We identified 252 hormone receptor-positive women who  received upfront adjuvant aromatase inhibitors after surgery  between January 2004 and December 2010 at a single institute.,Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
"The SPSS version 18 (SPSS Inc., Chi - cago, USA) and R softwares (http://www.r-projet.org) were  used to perform these analyses.",OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.350Survival outcome The median follow-up time was 62 months, when 14 wom - en had tumor recurrences.",OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
Survival Benefit of Zoledronic Acid353 http://dx.doi.org/10.4048/jbc.2014.17.4.350  http://ejbc.krcantly better for ZA-treated women than for ZA-untreated  women ( p= 0.029) (Figure 1B).,Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.350to chemotherapy enhances the clinical response.,Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
Survival Benefit of Zoledronic Acid355 http://dx.doi.org/10.4048/jbc.2014.17.4.350  http://ejbc.krNeoadjuvant chemotherapy with or without zoledronic acid in early  breast cancer: a randomized biomarker pilot study.,Non-OADS,/arxiv_data1/oa_pdf/a5/f7/jbc-17-350.PMC4278054.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The human epidermal growth factor receptor 2 ( HER2 )  gene encodes a growth factor receptor that is amplified in ap - proximately 20% to 25% of breast cancers [1].",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
"Cardiac toxicity is an overlapping side effect of both trastu -Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab  Compared to Standard Trastuzumab-Based Chemotherapy Regimens for  Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast  Cancer Potjana Jitawatanarat, Tracey L. O’Connor, Ellen B. Kossoff, Ellis G. Levine, Kaweesak Chittawatanarat1,  Nuttapong Ngamphaiboon2 Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY , USA; 1Department of Surgery, Chiang Mai University, Chiang Mai; 2Department of  Internal Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, ThailandORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 356-362  http://dx.doi.org/10.4048/jbc.2014.17.4.356 Purpose:  We evaluated the tolerability and cardiac safety of  docetaxel, cyclophosphamide, and trastuzumab (TCyH) for the  treatment of early-stage human epidermal growth factor receptor  2 (HER2)-positive breast cancer and compared to the standard  trastuzumab-based chemotherapy regimens doxorubicin with  cyclophosphamide followed by paclitaxel and trastuzumab (AC- TH) and docetaxel, carboplatin, and trastuzumab (TCaH).",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
"Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab for Early Stage HER2+ Breast Cancer357 http://dx.doi.org/10.4048/jbc.2014.17.4.356  http://ejbc.krzumab and anthracyclines.",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.356for Adverse Events (V .4) [20].,Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
"Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab for Early Stage HER2+ Breast Cancer359 http://dx.doi.org/10.4048/jbc.2014.17.4.356  http://ejbc.krabsolute LVEF decline was also similar between the AC-TH,  TCaH, and TCyH groups (5% vs. 4% vs. 4%, respectively, p= 0.24).",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.356line LVEF with no prior cardiac history.,Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
"Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab for Early Stage HER2+ Breast Cancer361 http://dx.doi.org/10.4048/jbc.2014.17.4.356  http://ejbc.krcancer is recognized [15].",Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
http://evs.nci.,Non-OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.356nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_   5x7.pdf.,OADS,/arxiv_data1/oa_pdf/60/a2/jbc-17-356.PMC4278055.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The use of human epidermal growth factor receptor 2  (HER2) monoclonal antibody, trastuzumab, to treat HER2- overexpressing breast cancer has significantly reduced risk of  relapse and improved survival in women with early stage and  metastatic diseases [1,2].",Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
"The aims of this prospective observational study were to as - sess the incidence of trastuzumab-related cardiotoxicity in  EBC patients in clinical practice and to identify potential risk  factors.Risk of Trastuzumab-Related Cardiotoxicity in Early Breast Cancer Patients: A  Prospective Observational Study Jian Xue*, Zefei Jiang1,*, Fan Qi1, Shuanghong Lv, Shaohua Zhang1, Tao Wang1, Xiaozhong Zhang Departments of Cardiology and 1Breast Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing, ChinaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 363-369  http://dx.doi.org/10.4048/jbc.2014.17.4.363 Purpose:  In the present study, we investigated the incidence of  cardiotoxicity within 5 years of trastuzumab treatment and evalu - ated potential risk factors in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.363METHODS Between January 1, 2008 and December 31, 2012, consecu - tive women aged 18 years or older diagnosed with invasive  breast cancer (stage I–III) were enrolled in this study.",Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
Risk of Trastuzumab-Related Cardiotoxicity365 http://dx.doi.org/10.4048/jbc.2014.17.4.363  http://ejbc.krTable 1.,Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.363Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
Risk of Trastuzumab-Related Cardiotoxicity367 http://dx.doi.org/10.4048/jbc.2014.17.4.363  http://ejbc.krTable 3.,Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.363concurrent treatment with adjuvant RT and trastuzumab.,Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
Risk of Trastuzumab-Related Cardiotoxicity369 http://dx.doi.org/10.4048/jbc.2014.17.4.363  http://ejbc.kret al.,Non-OADS,/arxiv_data1/oa_pdf/b2/8b/jbc-17-363.PMC4278056.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Sentinel lymph node biopsy (SLNB) has been validated in  early breast cancer patients and is the accepted standard of  care for axillary staging in patients with clinically node-nega - tive axilla [1-3].",Non-OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
"Additionally, it has been demonstrated that  there is a close relationship between subtype and risk of me -Subtype Is a Predictive Factor of Nonsentinel Lymph Node Involvement in  Sentinel Node-Positive Breast Cancer Patients Kaptan Gülben, Uğur Berberoğlu, Ogün Aydoğan, Volkan Kınaş1 Department of Surgery, Ankara Oncology Training and Research Hospital, Ankara;  1Department of Surgery, Samsun Training and Research Hospital,  Samsun, TurkeyORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 370-375  http://dx.doi.org/10.4048/jbc.2014.17.4.370 Purpose:  This study aimed to identify the effect of breast cancer  subtype on nonsentinel lymph node (NSLN) metastasis in pa - tients with a positive sentinel lymph node (SLN).",Non-OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
"Breast Cancer Subtypes and Nonsentinel Lymph Node371 http://dx.doi.org/10.4048/jbc.2014.17.4.370  http://ejbc.krtastasis to one or more axillary SLNs [22,23].",Non-OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.370minal/HER2+ and HER2 overexpression subtypes was 73%.,OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
Breast Cancer Subtypes and Nonsentinel Lymph Node373 http://dx.doi.org/10.4048/jbc.2014.17.4.370  http://ejbc.krmodel.,Non-OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.370addition, the HER2 overexpression subtype was significantly  associated with NSLN metastasis, in contrast to the study find - ings of Zhou et al.",OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
"Breast Cancer Subtypes and Nonsentinel Lymph Node375 http://dx.doi.org/10.4048/jbc.2014.17.4.370  http://ejbc.krDC, Burstein HJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/c3/38/jbc-17-370.PMC4278057.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer is the most common cancer and the leading  cause of cancer-related mortality in women, both worldwide  and in Thailand.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"Neoadjuvant chemotherapy is advanta - geous because it shrinks tumors, thereby rendering inoperable  tumors resectable; increases rates of BCS; enables early treat - ment of micrometastasis; and facilitates in vivo  assessment of Association between Pathological Complete Response and Outcome  Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer  Patients Sutima Luangdilok, Norasate Samarnthai1, Krittiya Korphaisarn Division of Medical Oncology, Department of Medicine and 1Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok,  ThailandORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 376-385  http://dx.doi.org/10.4048/jbc.2014.17.4.376 Purpose:  We aimed to determine the rate of pathological com - plete response (pCR), clinicopathological factors associated with  pCR, and clinical outcomes following neoadjuvant chemotherapy  in locally advanced breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
pCR and Outcome in LABC377 http://dx.doi.org/10.4048/jbc.2014.17.4.376  http://ejbc.krchemotherapy-sensitivity [4].,Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.376HER2-like tumors, defined as ER- and PR-negative, HER2- positive, all grades; and ( 4) triple-negative tumors: ER-, PR-,  and HER2-negative, all grades.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"pCR and Outcome in LABC379 http://dx.doi.org/10.4048/jbc.2014.17.4.376  http://ejbc.krAssociation between baseline clinicopathological factors and  pCR using the NSABP criteria According to univariate analysis, pCR was significantly as - sociated with HR status and intrinsic breast cancer subtype  (Table 3).",OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.376tered to 113 (63%) and 30 patients (17%), respectively.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"pCR and Outcome in LABC381 http://dx.doi.org/10.4048/jbc.2014.17.4.376  http://ejbc.krjusted hazard ratio [HR], 2.74; p= 0.012) and nonsignificantly  with a shorter OS (unadjusted HR, 2.04; p= 0.104), whereas  HER2 and triple-negative tumors were significantly associated  with shorter DFS and OS (HER2 tumors: unadjusted HR for  DFS, 3.05, p= 0.012; unadjusted HR for OS, 2.86, p= 0.025;  triple-negative: unadjusted HR for DFS, 3.42, p= 0.006; unad - justed HR for OS, 2.96, p= 0.026) (Figure 2, which shows Ka - plan-Meier survival curves).",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.3761.0 0.8 0.6 0.4 0.2 0 0 20 40 60 80 100 DFS (mo)Cumulative survival Intrinsic subtype Intrinsic subtype Luminal A-like (n= 45; 8 events) Luminal A-like (n= 45; 7 events) Luminal B-like (n= 62; 27 events) Luminal B-like (n= 62; 20 events) HER2 (n= 33; 14 events) HER2 (n= 33; 13 events) Tripic negative (n= 26; 13 events) Tripic negative (n= 26; 11 events) p= 0.005 p= 0.005 A1.0 0.8 0.6 0.4 0.2 0 0 20 40 60 80 100 OS (mo)Cumulative survival B Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"pCR and Outcome in LABC383 http://dx.doi.org/10.4048/jbc.2014.17.4.376  http://ejbc.krDISCUSSION Neoadjuvant chemotherapy is the standard treatment for  locally advanced and inflammatory breast cancer, and is also  offered to patients with early breast cancer who are consider - ing BCS.",Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.376of these patients (75%) did not received anti-HER2 therapy.,Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
pCR and Outcome in LABC385 http://dx.doi.org/10.4048/jbc.2014.17.4.376  http://ejbc.krof gemcitabine plus carboplatin as the neoadjuvant treatment in locally  advanced breast cancer.,Non-OADS,/arxiv_data1/oa_pdf/17/18/jbc-17-376.PMC4278058.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Surgery for breast cancer has changed from the radical ap - proach of removing the skin, nipple, and underlying glandular  tissue of the breast to a more conservative approach.",Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
"Thus far, there is no definite method of identi -Magnetic Resonance Imaging and Clinicopathological Factors for the  Detection of Occult Nipple Involvement in Breast Cancer Patients Wooseok Byon, Eunyoung Kim, Junseong Kwon, Y ong Lai Park, Chanheun Park Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, KoreaORIGINAL ARTICLEJ Breast Cancer 2014 December; 17(4): 386-392  http://dx.doi.org/10.4048/jbc.2014.17.4.386 Purpose:  Nipple sparing mastectomy provides good cosmetic  results and low local recurrence rates for breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
MRI and Clinicopathological Factors in Detection of Occult Nipple Involvement387 http://dx.doi.org/10.4048/jbc.2014.17.4.386  http://ejbc.krfying tumor invasion arising from clinically unremarkable  nipples except by direct tissue biopsy and sequential patholog - ical evaluation.,Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.386measured.,Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
MRI and Clinicopathological Factors in Detection of Occult Nipple Involvement389 http://dx.doi.org/10.4048/jbc.2014.17.4.386  http://ejbc.krRESULTS Four hundred sixty-six mastectomy specimens were evalu - ated in this study.,OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.386sults (OR, 1.23; 95% CI, 0.3–5.032; p= 0.776; and OR, 2.03;  95% CI, 0.6–6.93; p= 0.257, respectively), the OR showed a  sequential increase in the likelihood of nipple involvement  from group 1 to group 4, which was statistically significant  (p< 0.001) (Figure 4).",OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
MRI and Clinicopathological Factors in Detection of Occult Nipple Involvement391 http://dx.doi.org/10.4048/jbc.2014.17.4.386  http://ejbc.krnot accessible before surgery.,Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.3862.,Non-OADS,/arxiv_data1/oa_pdf/b4/29/jbc-17-386.PMC4278059.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Incomplete regression of the mammary ridges may result in  aberrant breast tissue, which can be classified based on its  components [1].",Non-OADS,/arxiv_data1/oa_pdf/56/3f/jbc-17-393.PMC4278060.pdf
"Lim’s Breast Clinic,  Daegu, KoreaCASE REPORTJ Breast Cancer 2014 December; 17(4): 393-396  http://dx.doi.org/10.4048/jbc.2014.17.4.393 Ectopic breast tissue can occur anywhere along the incom ­ pletely regressed mammary ridge.",Non-OADS,/arxiv_data1/oa_pdf/56/3f/jbc-17-393.PMC4278060.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.393a solid epithelial proliferation.,Non-OADS,/arxiv_data1/oa_pdf/56/3f/jbc-17-393.PMC4278060.pdf
Ectopic Breast Cancer with Microcalcification 395 http://dx.doi.org/10.4048/jbc.2014.17.4.393  http://ejbc.krthe cavity; histologic findings were similar to those for the   excision biopsy.,Non-OADS,/arxiv_data1/oa_pdf/56/3f/jbc-17-393.PMC4278060.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.393of postoperative complications (e.g., severe scarring, infection  in the remaining sweat glands, pain, or discomfort) is reported  to be as high as 4% to 10% [14,15].",Non-OADS,/arxiv_data1/oa_pdf/56/3f/jbc-17-393.PMC4278060.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Multiple symmetric lipomatosis (MSL) is a very rare lipid  metabolism disorder characterized by the accumulation of  multiple, symmetric, nonencapsulated lipomatous masses on  the face, neck, shoulders, and upper arms [1].",Non-OADS,/arxiv_data1/oa_pdf/0f/db/jbc-17-397.PMC4278061.pdf
"A mammography was per -Multiple Symmetric Lipomatosis (Madelung’s Disease) Presenting as Bilateral  Huge Gynecomastia Jae Hoon Jang, Anbok Lee, Sang-Ah Han1, Jung-Kyu Ryu2, Jeong-Y oon Song1 Department of Medicine, Graduate School, Kyung Hee University, Seoul; Departments of 1Surgery and 2Radiology, Kyung Hee University Hospital at  Gangdong, Kyung Hee University School of Medicine, Seoul, KoreaCASE REPORTJ Breast Cancer 2014 December; 17(4): 397-400  http://dx.doi.org/10.4048/jbc.2014.17.4.397 Multiple symmetric lipomatosis (MSL), or Madelung’s disease, is  a rare disease of unknown etiology.",Non-OADS,/arxiv_data1/oa_pdf/0f/db/jbc-17-397.PMC4278061.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.397formed which revealed that the patient’s breasts were com - prised almost entirely of fat.,Non-OADS,/arxiv_data1/oa_pdf/0f/db/jbc-17-397.PMC4278061.pdf
"Multiple Symmetric Lipomatosis399 http://dx.doi.org/10.4048/jbc.2014.17.4.397  http://ejbc.krDISCUSSION MSL is a rare disease with an incidence of approximately in  1/25,000 men.",Non-OADS,/arxiv_data1/oa_pdf/0f/db/jbc-17-397.PMC4278061.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2014.17.4.397forming a physical examination.,Non-OADS,/arxiv_data1/oa_pdf/0f/db/jbc-17-397.PMC4278061.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.327 Clinical and Molecular Hepatology 2014;20:327-337 Review Corresponding author :  Changik Jo Department of Economics, Hallym University College of Business,   1 Hallymdaehak-gil, Chuncheon 200-702, Korea Tel: +82-33-248-1811, Fax: +82-33-256-3424 E-mail: cjo@hallym.ac.krAbbreviations:   BOD, burden of disease; CA, conjoint analysis; CBA, cost-benefit analysis; CEA,  cost-effectiveness analysis; CL, conditional logit; COI, cost of illness; CUA, cost- utility analysis; CVM, contingent valuation method; DALY, disability-adjusted  life year; DCE, discrete choice experiment; EQ-5D, EuroQol five dimension  questionnaire; FCM, friction cost method; HCM, human capital method; HUI,  health utilities index; IID, independent and identically distributed; LY, life year;  MRS, marginal rate of substitution; MWTP, marginal willingness-to-pay PAF,  population-attributable fraction; NHE, national health expenditures; PV, present  value; QALY, quality-adjusted life year; QoL, quality of life; WTP , willingness to  pay; YLD, years lost to disability; YLL, years of life lost.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"(Clin Mol Hepatol 2014;20:327-337) Keywords:  Cost-of-illness study; Burden of disease; Health policies Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"328 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327Clin Mol Hepatol Volume _20  Number _4  December 2014important to understand how the costs are defined, classified and  measured in the COI study.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"Cost of illness studies: concepts, scopes and methods http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.3271) Human capital method From the economic perspective, the term capital refers to one of  the factors of production employed to produce valuable and us - able goods or services.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"330 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327Clin Mol Hepatol Volume _20  Number _4  December 20142) Friction cost method As an alternative to HCM, the friction cost method (FCM) esti - mates the value of human capital when another person from the  unemployment pool replaces the present value of a worker’s fu - ture earnings until the sick or impaired worker returns or is even - tually replaced.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"Cost of illness studies: concepts, scopes and methods http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327than others, which may cause a statistical bias that leads to spuri - ous estimation results.11,16,17 The WTP approach, usually with high - er estimates of the value of life than the HCM attempts to amelio - rate these problems.12 However, this approach is often difficult to  implement in COI studies.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"332 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327Clin Mol Hepatol Volume _20  Number _4  December 2014such as prevention, research and law enforcement costs).",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"Cost of illness studies: concepts, scopes and methods http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327do not affect the association between the two diseases holds.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"334 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327Clin Mol Hepatol Volume _20  Number _4  December 2014though there are many other possible variants for each of the re - gression analysis depending upon the types of the dataset and the  research purposes.35-38 Because the econometric approach mea - sures the incremental difference between persons who have the  disease and those who do not, it often only requires one dataset,  which is understood as a strength in adopting this approach.33,37  While the top-down approach usually requires cost data as well as  on the relative risks which are needed to calculate the PAFs, the  bottom-up approach often requires data from multiple sources for  the unit cost and utilization rate of the different types of health  care.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"Cost of illness studies: concepts, scopes and methods http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327PRESENT VALUE WITH DISCOUNTING AND  SENSITIVITY ANALYSIS Discounting is an economic method that captures an individual’s  preference for income or payment today rather than that in the fu - ture.",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
336 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327Clin Mol Hepatol Volume _20  Number _4  December 2014Conflicts of Interest The author has no conflicts to disclose.,Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"Cost of illness studies: concepts, scopes and methods http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.327attributable to overweight and obesity: how much, and who’s pay - ing?",Non-OADS,/arxiv_data1/oa_pdf/b6/29/cmh-20-327.PMC4278062.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.338 Clinical and Molecular Hepatology 2014;20:338-344 Review Corresponding author :  Jin-Wook Kim Department of Internal Medicine, Seoul National University Bundang  Hospital, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707,  Korea  Tel.",Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
"(Clin Mol Hepatol 2014;20:338-344) Keywords:  Liver transplantation; Viral hepatitis; Recurrence; Management; Antiviral therapy  Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
"Viral hepatitis in liver transplant recipient http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338past 10 to 15 years, there have been marked improvements in  graft and patient survival, and it reflects the advances in manage - ment to prevent and control HBV infections after LT. High-dose  Hepatitis B immunoglobulin (HBIG) and nucleos(t)ide analogues  (NAs), either as monotherapy or in combination, have been most  commonly used in Korea.6 However, currently, the combination of  long-term antiviral and low-dose HBIG can effectively prevent  HBV recurrence in more than 90% of transplant recipients.7-10 This  effective prevention depends on the complimentary mechanisms  of HBIG and NAs.",Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
340 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338Clin Mol Hepatol Volume _20  Number _4  December 2014thirds of graft failures.22 All patients who undergo LT with detect - able serum HCV RNA experience recurrent HCV infection.,Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
"Viral hepatitis in liver transplant recipient http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338of anemia are increased by 20% with first-generation DAAs in  non-transplant patients.37 Triple therapy leads to the nearly con - stant use of erythropoietin (EPO), a dose reduction in RBV in al - most 75% of patients and the use of blood transfusions.38 These  suggest that anemia should be carefully monitored and managed.",Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
342 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338Clin Mol Hepatol Volume _20  Number _4  December 2014nisms by which RBV achieves HEV clearance are unknown.,Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
Viral hepatitis in liver transplant recipient http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338liver transplantation.,Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
344 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.338Clin Mol Hepatol Volume _20  Number _4  December 201447.,Non-OADS,/arxiv_data1/oa_pdf/6c/f0/cmh-20-338.PMC4278063.pdf
pISSN 2287-2728        eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.345 Clinical and Molecular Hepatology 2014;20:345-346 Editorial Portal hypertension is one of the most important cause of mor - bidity and mortality in cirrhotic patients.,Non-OADS,/arxiv_data1/oa_pdf/b8/f2/cmh-20-345.PMC4278064.pdf
"Received :  Dec. 1, 2014 /  Revised :  Dec. 3, 2014  Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/f2/cmh-20-345.PMC4278064.pdf
"346 Clin Mol Hepatol Volume _20  Number _4  December 2014 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.345cirrhotic patients with portal hypertension.8 As a result, portal  pressure declined significantly in both groups (candesartan 8mg +  propranolol vs. propranolol monotherapy).",Non-OADS,/arxiv_data1/oa_pdf/b8/f2/cmh-20-345.PMC4278064.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.347 Clinical and Molecular Hepatology 2014;20:347-354 Original Article Corresponding author :  Jae Youn Cheong Department of Gastroenterology, Ajou University School of Medicine,   164 World cup-ro, Yeongtong-gu, Suwon 443-380,  Korea Fax: +82-31-219-5999, Tel: +82-31-219-5119 E-mail: jaeyoun620@gmail.comAbbreviations:   AAT, alpha-1 antitrypsin; ALP , alkaline phosphatase; ALT, alanine  aminotransferase; AST, aspartate aminotransferase; AUC, area under the  curve; CHB, chronic hepatitis B; GGT, gamma glutamyl transpeptidase;  HBeAg, hepatitis B e antigen; PT, prothrombin time; ROC, receiver  operating characteristics; Std, standard.",Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
"(Clin Mol Hepatol 2014;20:347-354) Keywords:  Chronic hepatitis B; Liver cirrhosis; Transferrin; Alpha-1 antitrypsin Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
"348 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347Clin Mol Hepatol Volume _20  Number _4  December 2014macroglobulin, apolipoprotein A1, haptoglobin, gamma glutamyl  transpeptidase (GGT) and bilirubin.7-11 Most serum-based panels  have been generated from studies of patients with chronic hepati - tis C.7,12-15 On the contrary, in the case of CHB, similar models  based on serum biochemical markers achieve a moderate correla - tion with liver fibrosis.16,17 Therefore, there would be a need for  finding accurate and specialized markers in CHB patients for pre - dicting the degree of liver fibrosis.",Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
"Serum transferrin as liver fibrosis marker http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.3471-way analysis of variancetest, as appropriate; differences be - tween means were considered statistically significant for P-value  of < 0.05.Logistic regression analysis was performed for multivari - ate analysis.",OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
350 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347Clin Mol Hepatol Volume _20  Number _4  December 2014transferrin levels among the fibrosis stages.,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
Serum transferrin as liver fibrosis marker http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347brosis.,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
"352 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347Clin Mol Hepatol Volume _20  Number _4  December 2014cirrhosis patients.36 These reports suggested that transferrin syn - thesis appeared to be raised during the early stage of liver disease,  and thereafter it was decreased in advanced liver fibrosis, proba - bly reflecting diminished synthetic capacity by the liver because of  severe liver cell injury.",Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
Serum transferrin as liver fibrosis marker http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347  5.,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
354 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.347Clin Mol Hepatol Volume _20  Number _4  December 2014C: Mechanisms and relevance to hepatocarcinogenesis.,Non-OADS,/arxiv_data1/oa_pdf/c6/ee/cmh-20-347.PMC4278065.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.355 Clinical and Molecular Hepatology 2014;20:355-360 Original Article Corresponding author :  Byung-Cheol Song Department of Internal Medicine, Jeju National University School of  Medicine, 15 Aran 13-gil, Jeju 690-716, Korea Tel: + 82-64-754-8177,  Fax: + 82-64-717-1131 E-mail: drsong@jejunu.ac.krAbbreviations:   ALT, alanine aminotransferase; CHB, chronic hepatitis B; HBV, hepatitis B  virus; ULN, upper limit of normal Received :  Nov. 20, 2014 /  Revised :  Nov. 27, 2014 /  Accepted :  Nov. 28, 2014Is it necessary to delay antiviral therapy for  3–6 months   to anticipate HBeAg seroconversion in patients with  HBeAg-positive chronic hepatitis B in endemic areas of  HBV genotype C?",Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
"(Clin Mol Hepatol 2014;20:355-360) Keywords:  Hepatitis B virus, chronic hepatitis B; acute exacerbation of hepatitis B, HBV genotype Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  Hepatitis B virus (HBV) is the most common cause of chronic liv - er disease including liver cirrhosis and hepatocellular carcinoma.1 Recently, potent oral nucleos(t)ide analogues, including entecavir  and tenofovir, have been widely used in the treatment of chronic  hepatitis B (CHB).2-5 The potent antiviral treatment in patients with  CHB can suppress the viral replication and prevent progression to",Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
"356 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.355Clin Mol Hepatol Volume _20  Number _4  December 2014cirrhosis, hepatic failure and HCC.6-12 During the natural course of CHB infection, spontaneous HBeAg  seroconversion, defined as loss of HBeAg and detection of anti- HBe in a person who was HBeAg positive and anti-HBe negative,4  occurred frequently in the immune reactive phase in patients with  HBeAg-positive CHB ranging from 2-17% per year depending on  serum alanime aminotranferase (ALT) levels.13-21 Spontaneous  HBeAg seroconversion is usually followed by normalization of se - rum aminotransferase levels and sustained suppression of HBV  DNA (<2,000 IU/ml) and is associated with favorable long-term  outcomes in patients with CHB.13,22,23 Therefore, in HBeAg-positive  CHB patients with elevated serum ALT, most guidelines recom - mend observation for 3-6 months before antiviral therapy to an - ticipate spontaneous HBeAg seroconversion.2-5 However, spontaneous HBeAg seroconversion occurred infre - quently in patients with genotype C compared to those with other  genotypes.15,16,24 Therefore, the strategy for initiation of antiviral  therapy would be different according to the distribution of HBV  genotype.",Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
"http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.355high ALT, high bilirubin and high HBV DNA levels in univariate  analysis (Table 1).",OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
358 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.355Clin Mol Hepatol Volume _20  Number _4  December 2014DISCUSSION The current study showed two important findings.,Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
"http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.355Acute exacerbation of hepatitis B may lead to hepatic decom - pensation and death from liver failure.20,33-36 In this study, acute  exacerbation of hepatitis B or aggravation of jaundice developed  in 17 patients (18.9%) and one patient received liver transplanta - tion even after introducing antiviral because of acute-on-chronic  liver failure following acute excerbation of hepatitis B. Jeng et al.",Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
360 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.355Clin Mol Hepatol Volume _20  Number _4  December 2014with earlier HBeAg seroconversion compared with hepatitis B virus  genotype C. Gastroenterology 2002;122:1756-1762.,Non-OADS,/arxiv_data1/oa_pdf/51/aa/cmh-20-355.PMC4278066.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.361 Clinical and Molecular Hepatology 2014;20:361-367 Original Article Corresponding author :  Sook-Hyang Jeong Department of Internal Medicine, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707,  Korea  Tel: +82-31-787-7034, Fax: +82-31-787-4052 E-mail: jsh@snubh.orgAbbreviations:   HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C  virus; LC, liver cirrhosis Received :  Nov. 15, 2014 /  Revised :  Nov. 21, 2014 /  Accepted :  Nov. 26, 2014INTRODUCTION  Hepatitis C virus (HCV) is a major cause of chronic liver disease  worldwide, and HCV-infected persons are at risk of developing liv -er cirrhosis and hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
"(Clin Mol Hepatol 2014;20:361-367) Keywords:  Hepatitis C; Korea; Epidemiology; Geographic variation Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
362 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361Clin Mol Hepatol Volume _20  Number _4  December 2014less than 0.5% up to near 30%.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
Completed questionnaires and clinical data were entered into  the electronic case report form at the Korean HCV cohort study  group homepage (http://www.hcvcohort.or.kr).,Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
Regional difference of HCV infection epidemiology http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361were performed.,Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
364 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361Clin Mol Hepatol Volume _20  Number _4  December 2014cosmetic procedures and having multiple sex partners compared  with those in capital area (Table 4).,Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
"Regional difference of HCV infection epidemiology http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361factors for HCV infection including invasive medical procedure,  acupuncture, cosmetic procedures, and multiple sex partners than  those in capital area.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
"366 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361Clin Mol Hepatol Volume _20  Number _4  December 2014ture is a risk factor for HCV transmission,6,12 but in this study, fre - quency as well as experience of acupuncture was higher in a re - gion with high prevalence of HCV infection.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
"Regional difference of HCV infection epidemiology http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.361tients did not want to answer private questions such as those per - taining to sexual relationships, which resulted in missing data.",Non-OADS,/arxiv_data1/oa_pdf/65/b4/cmh-20-361.PMC4278067.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.368 Clinical and Molecular Hepatology 2014;20:368-375 Original Article Corresponding author :  Byung-Cheol Song Department of Internal Medicine, Jeju National University School of  Medicine, 15 Aran 13-gil, Jeju 690-767, Korea Tel: + 82-64-754-8177,  Fax: + 82-64-717- 1121 E-mail: drsong@jejunu.ac.krAbbreviations:   AHC, acute hepatitis C; ALT, alanine aminotransferase, AST, aspartate  aminotransferase, CHC, chronic hepatitis C; HCV, hepatitis C virus; SVC,  spontaneous viral clearance; SVR, sustained viral response; ULN, upper  limit normal Received :  Oct. 31, 2014 /  Revised :  Nov. 26, 2014 /  Accepted :  Dec. 1, 2014INTRODUCTION  World Health Organization estimates that 130 to 170 million  people are chronically infected with hepatitis C virus (HCV) and at  risk of developing liver cirrhosis, liver cancer, or both.1 More than  350,000 people die from HCV-related liver diseases every year.",Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
"(Clin Mol Hepatol 2014;20:368-375) Keywords:  Acute hepatitis C; Spontaneous viral clearance; Interferon; HCV RNA Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
"Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368tients progressed to chronic hepatitis and remaining 20-50% of  AHC patients showed spontaneous viral clearance (SVC) without  treatment.6-11 Interferon-based antiviral therapy of AHC showed  high rates of sustained virological response (SVR), defined by un - detectable HCV RNA for 6 months after cessation of antiviral ther - apy,12 ranging 75-94% independent of HCV genotypes.13-16 It is important to predict the individuals who will spontaneously  clear the HCV infection in order to avoid unnecessary antiviral  treatment, while promptly initiating antiviral therapy to achieve  high SVR for those who have a high risk for chronic hepatitis C  (CHC).17  The benefit of SVR after interferon-based antiviral therapy in  CHC is well-documented.18-20 However, little data are available if  spontaneous or treatment-induced viral clearance is sustained in  patients with AHC.",Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
370 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368Clin Mol Hepatol Volume _20  Number _4  December 2014without antiviral treatment are summarized in Figure 1 and Table  2.,Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368(P=0.054).,Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
372 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368Clin Mol Hepatol Volume _20  Number _4  December 2014 Table 2.,Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
"Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.36812 weeks after diagnosis of AHC, respectively.",Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
374 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368Clin Mol Hepatol Volume _20  Number _4  December 2014feron or peginterferon alone showed nonresponse or a relapse of  hepatitis C after cessation of therapy.,Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
Predictors of spontaneous viral clearance and outcomes of acute hepatitis C infection  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.368who have sustained response to interferon therapy.,Non-OADS,/arxiv_data1/oa_pdf/7f/9f/cmh-20-368.PMC4278068.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.376 Clinical and Molecular Hepatology 2014;20:376-383 Original Article Corresponding author :  Moon Young Kim Department of Internal Medicine, Yonsei University Wonju College of  Medicine, Wonju Severance Christian Hospital, 20 Ilsanro, Wonju 220-701,  Korea Tel: +82-33-741-1229, Fax: +82-33-745-1228 E-mail: drkimmy@yonsei.ac.kr *Jae Hyun Kim and Jung Min Kim contributed equally to this study.Abbreviations:   ARB, angiotensin receptor blocker; AT1-R, angiotensin II type 1 receptor;  HVPG, hepatic venous pressure gradient; HSC, hepatic stellated cells;  IHR, intrahepatic résistance; NSBB, non-selective beta blocker; PH,  portal hypertension; RAA, renin-angiotensin-aldosterone Received :  Nov. 13, 2014 /  Revised :  Dec. 8, 2014 /  Accepted :  Dec. 9, 2014Effects of candesartan and propranolol combination  therapy versus propranolol monotherapy in reducing  portal hypertension Jae Hyun Kim1*, Jung Min Kim1*, Youn Zoo Cho1, Ji Hoon Na1, Hyun Sik Kim1, Hyoun A Kim1, Hye Won Kang1,   Soon Koo Baik1,2, Sang Ok Kwon1, Seung Hwan Cha3, Young Ju Kim3, and Moon Young Kim1,2 1Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju; 2Department of Cell Therapy and Tissue  Engineering, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju; 3Department of Radiology,  Yonsei University Wonju College of Medicine, Wonju, Korea Background/Aims:  Angiotensin receptor blockers (ARBs) inhibit activated hepatic stellate cell contraction and are  thought to reduce the dynamic portion of intrahepatic resistance.",Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
"(Clin Mol Hepatol 2014;20:376-383) Keywords:  Portal hypertension; Angiotensin receptor blocker; Non-selective beta blocker; Cirrhosis; Hepatic venous  pressure gradient Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
"Angiotensin receptor blocker in portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376INTRODUCTION  Portal hypertension (PH) is a critical prognostic factor for pa - tients with cirrhosis.1-3 The risk of PH related complications increas - es when hepatic venous pressure gradient (HVPG) elevates to  more than 10 mmHg.4,5 Variceal bleeding is one of the most com - mon and severe complications in patients with cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
378 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376Clin Mol Hepatol Volume _20  Number _4  December 2014tension more than 12 mmHg in HVPG.,OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
Angiotensin receptor blocker in portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376analysis.,Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
"380 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376Clin Mol Hepatol Volume _20  Number _4  December 2014Treatment response between two groups  Response rates were 61.5 % (16 out of 26) in combined therapy  group, and 55.6 %(15 out of 27) in propranolol monotherapy  group ( P=0.435).",Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
Angiotensin receptor blocker in portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376develop a new medical therapy for portal hypertension.,Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
"382 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.376Clin Mol Hepatol Volume _20  Number _4  December 2014ever, the result between anti-fibrotic effect and anti-portal hyper - tensive effect was different and there is a possibility that the dose  of ARB was not enough to reduce the HSC contractility and intra - hepatic resistance.",Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
Angiotensin receptor blocker in portal hypertension http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.3761999;29:334-339.,Non-OADS,/arxiv_data1/oa_pdf/37/64/cmh-20-376.PMC4278069.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.384 Clinical and Molecular Hepatology 2014;20:384-391 Original Article Corresponding author :  Jin-Wook Kim Department of Internal Medicine, Seoul National University Bundang  Hospital, 82 Gumi-ro 173 beon-gil, Bundang-gu, Seongnam 463-707,  Korea Tel: +82-31-787-7009, Fax: +82-31-787-4051 E-mail: kimjw@snubh.orgAbbreviations:   ALT, alanine transaminase; AST, aspartate transaminase; APRI, AST- to-platelet ratio index; CT, computed tomography; INR, international  normalized ratio; PT, prothrombin time; PVT, portal vein thrombosis Received :  Aug 22, 2014 /  Revised :  Nov. 28, 2014 /  Accepted :  Dec. 1, 2014INTRODUCTION  Liver cirrhosis is the end stage of liver disease, and presents vari - ous clinical manifestations, including thrombocytopenia, pro -longed prothrombin time (PT), ascites, encephalopathy, and vari - ceal bleeding.",Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
"(Clin Mol Hepatol 2014;20:384-391) Keywords:  Portal vein; Venous thrombosis; Liver cirrhosis; Warfarin; Propensity score Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
Anticoagulation in LC with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384rhosis.,Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
"386 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384Clin Mol Hepatol Volume _20  Number _4  December 2014was defined as disappearance of all evidence of thrombosis, as  determined by transverse CT images.",OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
Anticoagulation in LC with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384two patients (14.3%) showed partial resolution of the main throm - bus in the control group.,Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
388 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384Clin Mol Hepatol Volume _20  Number _4  December 2014Table 3.,Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
"Anticoagulation in LC with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384(n=11, 78.6%) were analyzed with non-responders (n=3) (Table 4).",OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
"390 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.384Clin Mol Hepatol Volume _20  Number _4  December 2014after the detection of thrombosis was the only factor significantly  associated with recanalization, but did not investigate the param - eters related to the spleen.7 The study population was enrolled  within 6 months of thrombosis detection during scheduled imag - ing studies, and both studies suggest the importance of early PVT  detection and initiation of anticoagulation in the context of the ir - reversible progress of PVT with chronicity.",Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
Anticoagulation in LC with PVT http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.38414.,Non-OADS,/arxiv_data1/oa_pdf/94/77/cmh-20-384.PMC4278070.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.392 Clinical and Molecular Hepatology 2014;20:392-397 Case Report Corresponding author :  Sang Young Han Department of Gastroenterology, Dong-A University College of Medicine,  26 Daesingongwon-ro, Seo-gu, Busan 602-715, Korea Tel: +82-51-240-5678, Fax: +82-51-240-5852 E-mail: syhan@dau.ac.krAbbreviations:   CT, computed tomography; FNH, focal nodular hyperplasia; MRI,  magnetic resonance imaging; WHO,  World Health Organization Received :  Aug. 17, 2012 /  Revised :  Nov. 6, 2012 /  Accepted :  Feb. 6, 2013INTRODUCTION  Focal nodular hyperplasia of the liver is the second most com - mon benign tumor, after cavernous hemangioma.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
"(Clin  Mol Hepatol 2014;20:392-397) Keywords:  Focal nodular hyperplasia; Pregnancy; Hepatic adenoma Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
Focal nodular hyperplasia and pregnancy http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.392of this hepatic mass.,Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
"394 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.392Clin Mol Hepatol Volume _20  Number _4  December 2014alpha-fetoprotein level was 2.6 ng/mL, HBsAg negative, HBsAb  negative, and anti-HCV negative.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
"Focal nodular hyperplasia and pregnancy http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.392ture, or necrosis of tumor were not observed.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
"396 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.392Clin Mol Hepatol Volume _20  Number _4  December 2014tion of radiological imaging tests.3,11,12 The usefulness of fine needle aspiration for a definitive diagno - sis of focal nodular hyperplasia may be controversial.13 However,  ultrasonography-guided liver needle biopsy is helpful for its diag - nosis according to Fabre et al., and moderate subcapsular hema - toma occurred in only 1 out of 30 patients, as a complication of  liver needle biopsy.14 Even after careful diagnostic evaluation, patients with focal  nodular hyperplasia undergo surgery due to uncertainty of diagno - sis or risk factors of hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
Focal nodular hyperplasia and pregnancy http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.392REFERENCES   1.,Non-OADS,/arxiv_data1/oa_pdf/b4/4b/cmh-20-392.PMC4278071.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.398 Clinical and Molecular Hepatology 2014;20:398-401 Case Report Corresponding author :  So Young Kwon Department of Internal Medicine, Konkuk University School of Medicine,  Konkuk University Medical Center, 120-1 Neungdong-ro, Gwangjin-gu,  Seoul 143-729, Korea Tel: +82-2-2030-5010, Fax: +82-2-2030-5029  E-mail: sykwonmd@hotmail.comAbbreviations:   EEG, electroencephalography; DWI, diffusion-weighted imaging.",Non-OADS,/arxiv_data1/oa_pdf/2f/46/cmh-20-398.PMC4278072.pdf
"(Clin Mol Hepatol 2014;20:398-401) Keywords:  Acute hepatitis A; Encephalopathy; Magnetic resonance imaging; Corpus callosum Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/46/cmh-20-398.PMC4278072.pdf
Reversible splenial lesion in hepatitis A http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.398CASE REPORT A 30-year-old healthy male was admitted with dysarthria after a  4-day prodromal illness consisting of fever.,Non-OADS,/arxiv_data1/oa_pdf/2f/46/cmh-20-398.PMC4278072.pdf
"400 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.398Clin Mol Hepatol Volume _20  Number _4  December 2014ammonia of 50 µ g/dL, sodium of 138 mmol/L, potassium of 3.8  mmol/L, chloride of 114 mmol/L, and calcium of 8.3 mg/dL.",Non-OADS,/arxiv_data1/oa_pdf/2f/46/cmh-20-398.PMC4278072.pdf
Reversible splenial lesion in hepatitis A http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.398REFERENCES   1.,Non-OADS,/arxiv_data1/oa_pdf/2f/46/cmh-20-398.PMC4278072.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.402 Clinical and Molecular Hepatology 2014;20:402-405 Liver Pathology Corresponding author :  Haeryoung Kim Department of Pathology, Seoul National University Bundang Hospital,  Seoul National University College of Medicine, 82 Gumi-ro 173-beon-gil,  Bundang-gu, Seongnam 463-707 , Korea  Tel.",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/cmh-20-402.PMC4278073.pdf
"Intrahepatic cholangiocarcinoma arising in Caroli’s disease Min Hye Jang1, Yoon Jin Lee2, and Haeryoung Kim1 Department of 1Pathology and 2Radiology, Seoul National University Bundang Hospital, Seoul National University College of Medicine,  Seongnam, Korea Keywords:  Cholangiocarcinoma; Caroli’s disease; Pathology; Liver Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/cmh-20-402.PMC4278073.pdf
"Intrahepatic cholangiocarcinoma arising in Caroli’s disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.402Considering the possibility of a hepatic malignancy, a left lateral  sectionectomy of the liver was performed.",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/cmh-20-402.PMC4278073.pdf
404 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.402Clin Mol Hepatol Volume _20  Number _4  December 2014bile duct structure surrounding venous branches and directly jux - taposed to the limiting plate of the hepatocytic parenchyme.,Non-OADS,/arxiv_data1/oa_pdf/c6/9a/cmh-20-402.PMC4278073.pdf
"Intrahepatic cholangiocarcinoma arising in Caroli’s disease http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.402ly observed, with neutrophilic infiltrates or microabscesses.",Non-OADS,/arxiv_data1/oa_pdf/c6/9a/cmh-20-402.PMC4278073.pdf
"pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2014.20.4.406 Clinical and Molecular Hepatology 2014;20:406-410 Liver Imaging Corresponding author :  Chandana Lall Department of Radiological Sciences, University of California, Irvine,   101 The City Drive South, Suite #1105, Orange, CA 92868, USA Tel: +1-714-456-2216, Fax: +1-714-456-7428 E-mail: clall@uci.eduAbbreviations:   CT, computed tomorgraphy; CC, cholangiocarcinoma; FLHCC,  fibrolamellar variant of HCC; HCC, hepatocellular carcinoma; MRI,  magnetic resonance imagingINTRODUCTION  Composite tumors are typically comprised of two tumors each  of different origin, pathology and phenotype in close proximity - which results in actual histologic intermingling of tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
"(Clin Mol Hepatol  2014;20:406-410) Keywords:  Hepatoceullular carcinoma; Cholangiocarcinoma; Bi-phenotypic tumors; Computed tomography, Magnetic  resonance imaging   Copyright © 2014 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
Composite liver tumors: A radiologic-pathologic correlation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.406pathologic correlation of bi-phenotypic composite liver tumors.,Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
"408 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.406Clin Mol Hepatol Volume _20  Number _4  December 2014The CC component may also not show associated biliary dilata - tion or delayed enhancement; although, mild enhancement during  the portal venous phase with persistent enhancement on the de - layed phase is seen sometimes due to predominant fibrous com - ponent as seen in Figure 2.10 Classification systems of combined HCC-CC tumor CT findings  have been described by Aoki et al.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
"Composite liver tumors: A radiologic-pathologic correlation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.406aging features, biopsy is indicated for confirmation.5 On biopsy,  immuno-histochemical analysis will show both hepatocellular and  bile duct epithelium, as shown in Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
410 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2014.20.4.406Clin Mol Hepatol Volume _20  Number _4  December 20141993;18:1090-1095.,Non-OADS,/arxiv_data1/oa_pdf/a5/38/cmh-20-406.PMC4278074.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/162/145760 Copyright: © 2014 Miller CF .,Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Access this article online Quick Response Code: Website:    www.surgicalneurologyint.com DOI:    10.4103/2152-7806.145760  Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.com",Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Surgical Neurology International 2014,5:162  http://www.surgicalneurologyint.com/content/5/1/162care physicians and patients what most experienced  spine surgeons had known all along, yet were perhaps  selfishly loathe to disclose: Medical management is  often equivalent to surgical management in outcome,  thus surgery is not necessarily mandatory as many had  previously naïvely assumed.",Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Surgical Neurology International 2014,5:162  http://www.surgicalneurologyint.com/content/5/1/162as “The Conversation.” However, I would suggest that  in fact some of the blame falls squarely on the shoulders  of physician choice: Specifically, how a physician chooses  to conduct the difficult educational and decision‑making  process in life‑altering or end‑of‑life situations.",Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Surgical Neurology International 2014,5:162  http://www.surgicalneurologyint.com/content/5/1/162inescapable fact was crystallized for me when I chanced  upon a Memorial Sloan‑Kettering Cancer Center’s  full page advertisement in the Sunday New Y ork Times  magazine.",Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Surgical Neurology International 2014,5:162  http://www.surgicalneurologyint.com/content/5/1/162aerobic exercise promoting endorphin release that she  had found salvation from her lifelong depression and  managed to keep it at bay.",Non-OADS,/arxiv_data1/oa_pdf/71/ef/SNI-5-162.PMC4278083.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Spinal intradural subpial angiolipoma: Case report and review of  literature G. Lakshmi Prasad, Sumit Sinha Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India E‑mail:  G. Lakshmi Prasad ‑ dadu_glp@yahoo.co.in; *Sumit Sinha ‑ sumitneuro@gmail.com   *Corresponding author Received: 13 August 14  Accepted: 16 September 14  Published: 28 November 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.145770  Quick Response Code: Abstract Background:  Spinal angiolipomas are rare tumors consisting of mature adipose  tissue and abnormal vascular elements.",Non-OADS,/arxiv_data1/oa_pdf/d2/6d/SNI-5-164.PMC4278084.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/164/145770 Copyright: © 2014 Prasad GL.,Non-OADS,/arxiv_data1/oa_pdf/d2/6d/SNI-5-164.PMC4278084.pdf
"Surgical Neurology International 2014, 5:164  http://www.surgicalneurologyint.com/content/5/1/164features were compatible with angiolipoma, consisting  of mature fat cells mixed with vascular channels.",Non-OADS,/arxiv_data1/oa_pdf/d2/6d/SNI-5-164.PMC4278084.pdf
"Surgical Neurology International 2014, 5:164  http://www.surgicalneurologyint.com/content/5/1/164in location and differentiation from normal tissue is  often difficult.",Non-OADS,/arxiv_data1/oa_pdf/d2/6d/SNI-5-164.PMC4278084.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Neurosurgery: A  profession or a technical trade?",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/168/145932 Copyright: © 2014 Watts C. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168ORIGINS In lands where most of our Western thought first was  spoken, medicine has had its own defined role in society,  its own history, and its own heritage, separate from that  of business or commerce, or entrepreneurial sophistry.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168entity, revealed its Purposes and Principles were almost  identical to those of the Association.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/1681980s, there has been open competition between the  two surgical specialties for these patients.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168surgical procedures for this condition was stable or had  fallen slightly, the rate of treatment of spinal stenosis  with complex fusions increased from 1.3 per 100,000  Medicare beneficiaries in 2002 to 19.9 per 100,000 in  2007, a 15‑fold increase without a showing of increased  disease complexity.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168should be based upon the best medical science available  to both, along with appropriate consideration for the art of  medicine[13,27] that, for example, helps the surgeon factor  into the treatment plan human characteristics unique to  the individual patient.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168trust, and fully comforted by the imperative primum  nonnocere  (first [do] no harm) may deliberately be set  aside by the physician during the consent process, for the  simplicity of the business plan, without thought of the  plan’s vicissitudinous imperative, cavete emptor  (buyer  beware).",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology International 2014, 5:168  http://www.surgicalneurologyint.com/content/5/1/168“if reasonably available”.",Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
Available  from: http://www.nonprofitlawcenter.com/resDetails.php?item_ref=247.,Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
Available from: http://www.aaos.org/govern/state/organizationaltools/50.,Non-OADS,/arxiv_data1/oa_pdf/23/90/SNI-5-168.PMC4278085.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Endovascular management of external ventricular  drain‑associated cerebrovascular injuries Omar Choudhri, Mihir Gupta, Abdullah H. Feroze, Jeremy J. Heit1, Huy M. Do1 Departments of Neurosurgery and 1Radiology, Stanford University School of Medicine, Stanford, California 94305, USA E‑mail: *Omar Choudhri ‑ ochoudhri@stanford.edu; Mihir Gupta ‑ nose.mihir@gmail.com; Abdullah Feroze ‑ aferoze@stanford.edu;   Jeremy Heit ‑ jheit@stanford.edu; Huy Do ‑ huymdo@stanford.edu   *Corresponding Author Received: 11 July 14   Accepted: 22 September 14  Published: 29 November 14 Abstract Background:  Placement of external ventricular drains (EVDs) is a common,  life‑saving neurosurgical procedure indicated across a variety of settings.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/167/145930 Copyright: © 2014 Choudhri O.,Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Surgical Neurology International 2014, 5:167  http://www.surgicalneurologyint.com/content/5/1/167Common complications of EVD placement include  infection and shunt malfunction.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Surgical Neurology International 2014, 5:167  http://www.surgicalneurologyint.com/content/5/1/167ventricular catheter trajectory.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Surgical Neurology International 2014, 5:167  http://www.surgicalneurologyint.com/content/5/1/167of NBCA: Ethiodized oil (Codman and Shurtleff),  which terminated contrast extravasation from the lesion.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Surgical Neurology International 2014, 5:167  http://www.surgicalneurologyint.com/content/5/1/167approach have been previously described.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Surgical Neurology International 2014, 5:167  http://www.surgicalneurologyint.com/content/5/1/1675.",Non-OADS,/arxiv_data1/oa_pdf/6a/15/SNI-5-167.PMC4278086.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/66/145895Journal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format Address for correspondence:   Dr. Athiyappan Kumaresh,Department of Radiology,Sri Ramachandra University, Porur, Chennai - 600 116, Tamil Nadu, India.",Non-OADS,/arxiv_data1/oa_pdf/ed/1d/JCIS-4-66.PMC4278087.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comErratum Hyperosmolar and methotrexate therapy avoiding surgery in the  acute presentation of primary central nervous system lymphoma:  Erratum In the article that appeared on page 175 of Unique Case Observations Supplement of Surgical Neurology International[1],  authors affiliation were incorrectly displayed.",Non-OADS,/arxiv_data1/oa_pdf/23/a4/SNI-5-165.PMC4278088.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/64/145867Received : 04‑08‑2014 Accepted : 20‑10‑2014 Published : 29‑11‑2014 ORIGINAL ARTICLE at mid-treatment observed with bCT , with an average  tumor volume reduction of 47%.",Non-OADS,/arxiv_data1/oa_pdf/8b/8f/JCIS-4-64.PMC4278089.pdf
"J Clin Imaging Sci 2014;4:67.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/67/145903ORIGINAL ARTICLEJournal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format Address for correspondence: Prof. Wael E Saad,Department of Radiology,Cardiovascular Center, University of Michigan, RM 5588, 1500 East Medical Center Drive, Ann Arbor - 48109, Michigan, United States.E-mail: wsaad@umich.edu Received :  19-05-2014 Accepted :  07-10-2014 Published :  29-11-2014 TIPS and transvenous obliteration.",Non-OADS,/arxiv_data1/oa_pdf/06/71/JCIS-4-67.PMC4278090.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/62/145850CASE REPORT Received :  12-06-2014 Accepted :  24-09-2014 Published :  29-11-2014 Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.145850,Non-OADS,/arxiv_data1/oa_pdf/63/48/JCIS-4-62.PMC4278091.pdf
"J Clin  Imaging Sci 2014;4:63.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/63/145860Journal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format Address for correspondence:   Dr. Jillian Karow,Department of Radiology, University of Illinois at Chicago Medical Center (M/C 931), 1740 West Taylor Street, Room 2483, Chicago, IL 60612, United states.",Non-OADS,/arxiv_data1/oa_pdf/d9/7e/JCIS-4-63.PMC4278092.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial The Death of Spine Surgery, Sequel - 2014 James I. Ausman  Editor-in-Chief, Rancho Mirage, CA, USA E-mail: *James I. Ausman - jia@surgicalneurologyint.com   *Corresponding Author Received: 17 September 14   Accepted: 17 September 14  Published: 29 November 14 Clark Watts has published an outstanding paper on  the shift of the American Association of Neurological  Surgeons (AANS) from an educational association to a  trade association in 2003.",Non-OADS,/arxiv_data1/oa_pdf/6f/b8/SNI-5-169.PMC4278093.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/169/145933 Copyright: © 2014 Ausman JI.,Non-OADS,/arxiv_data1/oa_pdf/6f/b8/SNI-5-169.PMC4278093.pdf
"Surgical Neurology International 2014, 5:169  http://www.surgicalneurologyint.com/content/5/1/169debt backed by the printing of money that is not backed  by gold and thus has no value, governments will be forced  to make decisions to restrict expenses.",Non-OADS,/arxiv_data1/oa_pdf/6f/b8/SNI-5-169.PMC4278093.pdf
"J Clin Imaging Sci 2014;4:68.Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/68/145907Journal of Clinical Imaging Science www.clinicalimagingscience.orgFor entire Editorial Board visit : www.clinicalimagingscience.org/editorialboard.aspEditor-in-Chief: Vikram S. Dogra, MD  Department of Imaging Sciences, University of Rochester Medical Center, Rochester, USAOPEN ACCESS HTML format CASE REPORT Received :  14-09-2014 Accepted :  10-11-2014 Published :  29-11-2014 INTRODUCTION The levoatriocardinal vein (LACV) was first reported by  McIntosh in 1926 and the term was used by Edwards and DuShane in 1950.",Non-OADS,/arxiv_data1/oa_pdf/a0/36/JCIS-4-68.PMC4278095.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/2/5/145898DENTAL ARTICLE Received :  15-09-2014 Accepted :  25-10-2014 Published :  29-11-2014,Non-OADS,/arxiv_data1/oa_pdf/7e/93/JCIS-4-5.PMC4278096.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Surgical strategy for intracranial dermoid and epidermoid tumors:  An experience with 33 Patients Jose Carlos Lynch, Antônio Aversa, Celestino Pereira, Jânio Nogueira, Mariangela Gonçalves,   Hélio Lopes Department of Neurosurgery, Hospital Federal dos Servidores do Estado and National Cancer Institute, Rio de Janeiro, Brazil E-mail: *José Carlos Lynch - jclynch@globo.com; Antonio Aversa - aversadosouto@gmail.com; Celestino Pereira - celestino.pereira@br.inter.net;   Jânio Nogueira - JanioNogueira@inca.gov.br; Mariangela Gonçalves - goncalvesmb@gmail.com; Hélio Ferreira Lopes - Hlopes@inca.gov.br   *Corresponding Author Received: 23 March 14  Accepted: 27 June 14  Published: 28 November 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.145764  Quick Response Code: Abstract Background:  The aim of this paper is to report on our surgical strategy and  technique and to identify the best management for intracranial dermoids and  epidermoids tumors (IDETs).",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/163/145764 Copyright: © 2014 Lynch JC.,Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/163removal (GTR), which can result in unwarranted cranial  nerve (CN) deficit and arterial injury, or should GTR be  avoided and a safer, subtotal tumor removal (STR) be  performed instead?",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/163sterile fashion.",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/163proceeded within the space provided by the progressive  tumor debulking, the IDET was dissected and mobilized  away from the facial, acoustic and trigeminal nerves,  the brainstem, and blood vessels by gentle, meticulous  microsurgical techniques.",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/16337.9 years, ranging between 1 and 78 years.",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/163reported zero or low operative mortality[4,7,15,17,25,26,29,34]  [Table 2].",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology International 2014, 5:163  http://www.surgicalneurologyint.com/content/5/1/163CONCLUSIONS The neurosurgical management of IDET s remains  controversial, but our results and literature data allow  us to conclude that the best surgical strategy is GTR,  using meticulous microsurgery techniques to obtain the  cure of the patient.",Non-OADS,/arxiv_data1/oa_pdf/62/13/SNI-5-163.PMC4278097.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Intradural vertebral endarterectomy with nonautologous patch  angioplasty for refractory vertebrobasilar ischemia: Case report  and literature review Timothy Uschold, Adib A. Abla, David A. Wilson, Cameron G. McDougall, Peter Nakaji Division of Neurological Surgery, Barrow Neurological Institute, St. Joseph’s Hospital and Medical Center, Phoenix, Arizona, USA E‑mail:   *Peter Nakaji ‑ Neuropub@dignityhealth.org   *Corresponding author Received: 18 December 13  Accepted: 17 July 14  Published: 29 November 14 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.145927  Quick Response Code: Abstract Background:  The natural history of patients with symptomatic vertebrobasilar  ischemic symptoms due to chronic bilateral vertebral artery occlusive disease is  progressive, and poses significant challenges when refractory to medical therapy.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2014/5/1/166/145927 Copyright: © 2014 Uschold T.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166or percutaneous transluminal angioplasty (PTA) and  stent placement.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166The right VA origin stenosis was successfully treated  with deployment of a 4.0 × 12 mm balloon‑mounted  coronary stent (Multi‑Link Vision, Abbott Vascular,  Abbot Park, IL).",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166and distally relatively smoothly.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166distal vertebrobasilar stenosis, respectively.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166that it would be useful especially for patients  with (orthostatic) hypoperfusion phenomenon.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/166access to the condylar region.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
"Surgical Neurology International 2014, 5:166  http://www.surgicalneurologyint.com/content/5/1/16626.",Non-OADS,/arxiv_data1/oa_pdf/4d/0c/SNI-5-166.PMC4278098.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2014/4/1/65/145889,Non-OADS,/arxiv_data1/oa_pdf/4c/32/JCIS-4-65.PMC4278099.pdf
Available from: http://www.ash.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/ac/d3/JISPCD-4-110.PMC4278102.pdf
Available from: http://ayurveda.iloveindia.com/herbology/ medicinal-value-of-herbs.html.,Non-OADS,/arxiv_data1/oa_pdf/8a/b6/JISPCD-4-116.PMC4278103.pdf
Available from: http://en.wikipedia.org/wiki/Stevia.,Non-OADS,/arxiv_data1/oa_pdf/8a/b6/JISPCD-4-116.PMC4278103.pdf
Available from:  http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_an.pdf.,OADS,/arxiv_data1/oa_pdf/08/97/JISPCD-4-122.PMC4278104.pdf
Available from:  http://www.unsystem.org/scn/archives/adults/ch06.htm.,Non-OADS,/arxiv_data1/oa_pdf/08/97/JISPCD-4-122.PMC4278104.pdf
Available from: http://www.inotektextiles.com/ technology.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/JISPCD-4-78.PMC4278107.pdf
Available from: http://www.stanford.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/JISPCD-4-78.PMC4278107.pdf
Available  from: http://www.ncrm.org/biomimetics.htm.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/JISPCD-4-78.PMC4278107.pdf
Available from: http://www.eolss.net/Sample-Chapters/C03/E6-59-13-07.pdf  [Last accessed on 2013 Mar 22].,Non-OADS,/arxiv_data1/oa_pdf/93/2e/JISPCD-4-78.PMC4278107.pdf
[Available from: http://www.deorematerials.com/wordpress/wp-content/uploads/2011/11/implant-site-development.pdf.,Non-OADS,/arxiv_data1/oa_pdf/93/2e/JISPCD-4-78.PMC4278107.pdf
Available	 from:	http://www.meditationasheville.blogspot.,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/IJY-8-1.PMC4278129.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/ yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/IJY-8-1.PMC4278129.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free  applications.,Non-OADS,/arxiv_data1/oa_pdf/b6/cd/IJY-8-1.PMC4278129.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/77/4c/IJY-8-22.PMC4278131.pdf
Available	 from:	http://www.who.int/mediacentre/ factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/45/c3/IJY-8-27.PMC4278132.pdf
Available	from:	http:// www.humankinetics.com/products/all‑products/the‑fitnessgramactivitygram‑ test‑administration‑manual‑updated‑4th‑edition		and	http://www.cooperinstitute.,Non-OADS,/arxiv_data1/oa_pdf/45/c3/IJY-8-27.PMC4278132.pdf
Available	from:	https://www.presidentschallenge.org/informed/ digest/docs/200003digest.pdf.,Non-OADS,/arxiv_data1/oa_pdf/45/c3/IJY-8-27.PMC4278132.pdf
"and Sancheti Institute of Orthopaedics and Rehabilitation Shivaji  Nagar, Pune, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/45/c3/IJY-8-27.PMC4278132.pdf
Available	 from:	http://www.life.gaiam.com/article/how‑does‑yoga‑relieve‑ back‑pain.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
Available	 from:	http://www.equator ‑network.org/reporting‑guidelines/ prisma/.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
"Iyengar	 Yoga,	Research	1996‑2012,	 Compiled	by	Ross	A;	2012.,	Available	 on:	http://www.iyengaryoganorthcounty.com/wp‑content/uploads/2013/02/ Iyengar‑Yoga‑Research.pdf.",Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
Available	 from:	http://www.health.india.com/news/iyengar ‑yoga‑effective‑ in‑treating‑chronic‑neck‑pain.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
Available	 from:	http://www.yogauonline.com/yogatherapy/yoga‑for ‑back‑ pain/yoga‑for ‑shoulder‑and‑neck‑pain/1191051013‑study‑iyengar ‑yoga‑ practic.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
Available	 from:	http://www.edition.cnn.com/2011/10/24/health/yoga‑eases‑ back‑pain.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/9b/79/IJY-8-3.PMC4278133.pdf
"Available	 from:	http://www.en.wikipedia.org/w/index.php?title=Yoga_Sutras_of_ Patanjali	and	oldid=563453481.Dear Sir, Yoga is an ancient practice of lifestyle[1] having eight  limbs as described in Patanjali Yoga Suthra.",Non-OADS,/arxiv_data1/oa_pdf/ae/ed/IJY-8-80.PMC4278141.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1017/S0033583500001402 Bai, Y., M. Li, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10 .1085/jgp.201010480 Bai, Y., M. Li, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.201110705 Baukrowitz, T., T.C.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/0896-6273(94) 90206-2 Betto, G., O.L.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp .201411182 Bompadre, S.G., T. Ai, J.H.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/ 10.1085/jgp.200409227 Boyle, M.P., and K. De Boeck.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/S2213-2600 (12)70057-7 Chen, T.-Y.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1152/physrev.00058.2006 Chen, T.Y., and C. Miller.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"108:237– 250. http://dx.doi.org/10.1085/jgp.108.4.237 Contreras, J.E., D. Srikumar, and M. Holmgren.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1073/ pnas.0709809105 Cotten, J.F., and M.J. Welsh.",Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1074/jbc.272.41.25617 Csanády, L. 2000.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/S0006-3495(00)76636-7 Csanády, L., and B. Töröcsik.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.201311089 Csanády, L., K.W.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi .org/10.1085/jgp.116.3.477 Csanády, L., P. Vergani, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1073/ pnas.0911061107 Cui, L., L. Aleksandrov, X.B.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
http://dx.doi.org/10.1016/j.jmb .2006.10.086should exert its effect at the interface between the CFTR  protein and the aqueous phase.,OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
http://dx.doi.org/10.1007/s00424-004-1317-y,Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/j.jcf.2014.04.003 Lin, W.-Y., K.-Y.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.201411247 Linsdell, P. 2001.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1111/j.1469-7793.2001.0051j.x Linsdell, P. 2014.",Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.111.4.601 Linsdell, P ., A. Evagelidis, and J.W.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"78:2973– 2982. http://dx.doi.org/10.1016/S0006-3495(00)76836-6 Liu, J., and S.A. Siegelbaum.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/S0896-6273(00) 00162-8 Liu, Y., M. Holmgren, M.E.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80357-8 Rees, D.C., E. Johnson, and O. Lewinson.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1126/science.2156338 Riordan, J.R., J.M.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.114.6.799 Szollosi, A., D.R.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.201110608 Tabcharani, J.A., J.M.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi .org/10.1038/366079a0 Tsai, M.-F., H. Shimizu, Y. Sohma, M. Li, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.200810186 Tsai, M.-F., M. Li, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp.201010399 Van Goor, F., S. Hadida, P.D.J.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"7:743– 753. http://dx.doi.org/10.1016/0896-6273(91)90277-7 Dutzler, R., E.B.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1126/science.1082708 Eckford, P.D.W., C. Li, M. Ramjeesingh, and C.E.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10 .1074/jbc.M112.393637 Feng, L., E.B.",Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi .org/10.1126/science.1195230 Feng, L., E.B.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/ 10.1073/pnas.1205764109 Gadsby, D.C., P. Vergani, and L. Csanády.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1038/nature04712 Gao, X., Y. Bai, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/ 10.1016/j.bpj.2012.12.048 Gunderson, K.L., and R.R.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/ 0092-8674(95)90310-0 Hille, B.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1113/jphysiol .2009.171595 Hwang, T.C., G. Nagel, A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1073/ pnas.91.11.4698 Jih, K.-Y., and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1085/jgp .201210834 Jih, K.-Y., Y. Sohma, M. Li, and T.-C. Hwang.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
http://dx.doi.org/10.1085/jgp.201210789,Non-OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/j.jcf.2013.06.008 Vergani, P ., C. Basso, M. Mense, A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"33:1003– 1007. http://dx.doi.org/10.1042/BST20051003 Wang, Y., J.A.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/j.biocel.2014.04.001 Wright, A.M., X. Gong, B. Verdon, P. Linsdell, A. Mehta, J.R.  Riordan, B.E.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"279:41658– 41663. http://dx.doi.org/10.1074/jbc.M405517200 Yu, H., B. Burton, C.-J.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi.org/10.1016/ j.jcf.2011.12.005 Zeltwanger, S., F. Wang, G.T.",OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
http://dx.doi.org/10.1085/jgp.113.4.541,OADS,/arxiv_data1/oa_pdf/24/b8/JGP_201411272.PMC4278182.pdf
"http://dx.doi .org/10.1074/jbc.M110.205948 Gianulis, E.C., Q. Liu, and M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp.201310995 Gustina, A.S., and M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp .201010582 Gustina, A.S., and M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp .201210870Haitin, Y., A.E.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1038/nature12487 Herzberg, I.M., M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.003bi.x Trudeau, M.C., and W.N.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)00647-5 Trudeau, M.C., and W.N.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1073/ pnas.122015999 Trudeau, M.C., and W.N.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp.200409101 Trudeau, M.C., J.W.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/ 10.1126/science.7604285 Trudeau, M.C., L.M.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp.201110683 Wang, J., M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp.112.5.637 Zheng, J.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
"http://dx.doi.org/10.1085/jgp.201311090 Zheng, J., M.C.",OADS,/arxiv_data1/oa_pdf/77/df/JGP_201411331.PMC4278183.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
Online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201411194/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/ jgp.63.5.533 Bao, L., and D.H. Cox.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.200509346 Brayden, J.E., and M.T.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1126/science.1373909 Brelidze, T.I., and K.L.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"126:105– 121. http://dx.doi.org/10.1085/jgp.200509286 Brelidze, T.I., X. Niu, and K.L.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(92)81630-2 Carvacho, I., W. Gonzalez, Y.P.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/ jgp.201110632 Chen, X., J. Yan, and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1073/ pnas.1321697111 Contreras, G.F., A. Neely, O. Alvarez, C. Gonzalez, and R. Latorre.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1073/ pnas.79.3.805 Ledwell, J.L., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/ 10.1085/jgp.113.3.389 Li, W., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.200409067 Lippiat, J.D., N.B.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1111/j.1469-7793.2000.00131.x Liu, Y., M. Holmgren, M.E.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1016/S0896-6273(00) 80357-8 Marty, A.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1038/291497a0 Melo, F., and E. Feytmans.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1006/jmbi.1998.1665 Miranda-Rottmann, S., A.S. Kozlov, and A.J.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1128/ MCB.00073-10 Moscoso, C., A. Vergara-Jaque, V. Márquez-Miranda, R.V.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1016/j.bpj.2012.08.015 Orio, P., and R. Latorre.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1038/293471a0 Patel, S., A.D. Mackerell Jr., and C.L.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi .org/10.1002/jcc.20077 Phillips, J.C., R. Braun, W. Wang, J. Gumbart, E. Tajkhorshid,  E. Villa, C. Chipot, R.D.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1002/jcc.20289 Piskorowski, R.A., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.200509482 Posson, D.J., J.G.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/ 10.1038/nsmb.2473 Sali, A., and T.L.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.110.3.257 Cuello, L.G., V. Jogini, D.M.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"466:203– 208. http://dx.doi.org/10.1038/nature09153 Doyle, D.A., J. Morais Cabral, R.A. Pfuetzner, A. Kuo, J.M.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1126/science .280.5360.69 Edgerton, J.R., and P.H.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/ 10.1113/jphysiol.2002.027854 Galvez, A., G. Gimenez-Gallego, J.P. Reuben, L. Roy-Contancin, P.  Feigenbaum, G.J.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/ 10.1007/s00232-005-0830-z Ghatta, S., D. Nimmagadda, X. Xu, and S.T.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1021/bi00144a011 Gola, M., and M. Crest.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1016/0896-6273(93)90170-V Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi .org/10.1085/jgp.114.2.305 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.20028605 Humphrey, W., A. Dalke, and K. Schulten.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi .org/10.1016/0263-7855(96)00018-5 Kaczorowski, G.J., and M.L.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1016/S1367-5931(99) 80066-0 Klauda, J.B., R.M.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1021/jp101759q Lancaster, B., and R.A. Nicoll.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp.201110748 Toro, L., M. Wallner, P. Meera, and Y. Tanaka.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/ jgp.200609596 Wells, D.B., S. Bhattacharya, R. Carr, C. Maffeo, A. Ho, J. Comer,  and A. Aksimentiev.",Non-OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1085/jgp .200609579 Wu, Y., Y. Xiong, S. Wang, H. Yi, H. Li, N. Pan, F.T.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
"http://dx.doi.org/10.1074/ jbc.M109.027789 Yan, J., and R.W.",OADS,/arxiv_data1/oa_pdf/c7/51/JGP_201411194.PMC4278184.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1085/jgp.201311046 Armstrong, C.M.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"69:1– 18. http://dx.doi.org/10.1146/annurev.physiol.69.120205.124448 Armstrong, C.M., and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1038/242459a0 Bagnéris, C., P.G.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
4:2465. http://dx.doi.org/10.1038/ncomms3465(Fig.,Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi .org/10.1073/pnas.0402692101 Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1038/417523a Klose, D.P., B.A.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi .org/10.1093/bioinformatics/btq480 Koishi, R., H. Xu, D. Ren, B. Navarro, B.W.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10 .1074/jbc.M313100200 Kuzmenkin, A., F. Bezanilla, and A.M. Correa.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1085/jgp.200409139 Lehmann-Horn, F., and K. Jurkat-Rott.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi .org/10.1038/nature06265 McCusker, E.C., N. D’Avanzo, C.G.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1074/jbc.C111.228122 McCusker, E.C., C. Bagnéris, C.E.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"3:1102. http://dx.doi.org/10.1038/ ncomms2077 Mio, K., M. Mio, F. Arisaka, M. Sato, and C. Sato.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"103:111– 121. http://dx.doi.org/10.1016/j.pbiomolbio.2010.05.002 Noda, M., S. Shimizu, T. Tanabe, T. Takai, T. Kayano, T. Ikeda, H.  Takahashi, H. Nakayama, Y. Kanaoka, N. Minamino, et al.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/ 10.1038/312121a0 Nurani, G., M. Radford, K. Charalambous, A.O.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1021/ bi800645w O’Reilly, A.O., K. Charalambous, G. Nurani, A.M. Powl, and  B.A.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10 .1080/09687680802508754 Oelstrom, K., M.P.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"5:3420. http://dx.doi .org/10.1038/ncomms4420 Pavlov, E., C. Bladen, R. Winkfein, C. Diao, P. Dhaliwal, and R.J.  French.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1038/nature10238 Payandeh, J., T.M.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1016/j.bbamem.2012.05.002 Catterall, W.A.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1113/jphysiol.2011.224204 Charalambous, K., and B.A.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/ 10.1074/jbc.M208356200 D’Avanzo, N., E.C.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1126/science.280.5360.69 Finol-Urdaneta, R.K., Y. Wang, A. Al-Sabi, C. Zhao, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1085/jgp.201311037 Goldschen-Ohm, M.P., D.L.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"4:1350. http://dx.doi.org/10.1038/ncomms2356 Guy, H.R., and P. Seetharamulu.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"3:793. http://dx.doi.org/ 10.1038/ncomms1797 Ito, M., H. Xu, A.A. Guffanti, Y. Wei, L. Zvi, D.E.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"294:2372– 2375. http://dx.doi.org/10.1126/science.1065635 Shafrir, Y., S.R.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1016/j.jmb.2013.10.010 Sievers, F., A. Wilm, D. Dineen, T.J. Gibson, K. Karplus, W. Li, R.  Lopez, H. McWilliam, M. Remmert, J. Söding, et al.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1038/nature12775 Tsai, C.-J., K. Tani, K. Irie, Y. Hiroaki, T. Shimomura, D.G.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1016/ j.jmb.2013.06.036 Ulmschneider, M.B., C. Bagnéris, E.C.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1016/S0014-5793(03)01084-6 Yarov-Yarovoy, V., J.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1074/jbc.M006992200 Yu, F.H., V. Yarov-Yarovoy, G.A.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi .org/10.1124/pr.57.4.13 Zarrabi, T., R. Cervenka, W. Sandtner, P. Lukacs, X. Koenig, K.  Hilber, M. Mille, G.M.",Non-OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"http://dx.doi.org/10.1074/jbc.M110.132886 Zhang, X., W. Ren, P. DeCaen, C. Yan, X. Tao, L. Tang, J. Wang,  K. Hasegawa, T. Kumasaka, J.",OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
http://dx.doi.org/10.1016/ S0896-6273(04)00116-3,OADS,/arxiv_data1/oa_pdf/4f/aa/JGP_201411242.PMC4278185.pdf
"Jinsei Jung1,2 and Min Goo Lee1,2 1Department of Pharmacology and 2Brain Korea 21 Plus Project for Medical Sciences, Yonsei University College of Medicine,  Seoul 120-752, Korea © 2015 Jung and Lee  This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
"http://dx.doi.org/10.1096/ fj.10-166884 Vocke, K., K. Dauner, A. Hahn, A. Ulbrich, J. Broecker, S. Keller,  S. Frings, and F. Möhrlen.",OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
"http://dx.doi.org/10.1085/ jgp.201311015 Yu, K., J. Zhu, Z. Qu, Y.Y.",OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
"http://dx.doi.org/ 10.1085/jgp.201311047 Yu, Y., A.S. Kuan, and T.Y.",OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
http://dx.doi.org/10.1085/jgp.201411179,OADS,/arxiv_data1/oa_pdf/e9/95/JGP_201411283.PMC4278186.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"Online supplemental material The SCAN, EKDIST, SCSIM, and HJCFIT programs are available  as ZIP files and at http://onemol.org.uk, where they will continue  to be updated.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
The online supplemental material is available at  http://www.jgp.org/cgi/content/full/jgp.201411234/DC1.,Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1038/nature07462 Burzomato, V., M. Beato, P.J.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi .org/10.1098/rspb.1990.0048 Colquhoun, D., and R. Lape.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/ 10.1085/jgp.201210844 Colquhoun, D., A.G. Hawkes, and K. Srodzinski.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1098/rsta.1996.0115 Colquhoun, D., C.J.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1113/jphysiol.2002.034165 Colquhoun, D., K.A.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1529/ biophysj.103.038679 Corradi, J., F. Gumilar, and C. Bouzat.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/ j.bpj.2009.06.018 Dellisanti, C.D., S.M.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1074/jbc.M110.156851 Elenes, S., Y. Ni, G.D. Cymes, and C. Grosman.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1085/jgp.200609570 Gonzalez-Gutierrez, G., and C. Grosman.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/j.jmb.2010.09.026 Gonzalez-Gutierrez, G., T. Lukk, V. Agarwal, D. Papke, S.K.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/S0165-0270(01)00500-3 Grosman, C., M. Zhou, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1038/35001586 Hawkes, A.G., A. Jalali, and D. Colquhoun.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
http://dx.doi.org/10.1098/rsta.1990.0129propylamine molecules with high maximum Popen.,Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.4420-03.2004 Bocquet, N., L. Prado de Carvalho, J. Cartaud, J. Neyton, C. Le  Poupon, A. Taly, T. Grutter, J.-P. Changeux, and P.J.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1038/ nature07923 Pan, J., Q. Chen, D. Willenbring, K. Yoshida, T. Tillman, O.B.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"3:714. http://dx.doi.org/10.1038/ncomms1703 Purohit, P., A. Mitra, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1038/nature05721 Rayes, D., M.J. De Rosa, S.M.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi .org/10.1038/286071a0 Sauguet, L., A. Shahsavar, F. Poitevin, C. Huon, A. Menny, À.  Nemecz, A. Haouz, J.P. Changeux, P.J.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1113/ jphysiol.2009.178525 Song, C., and B. Corry.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/j.bpj.2009.10.032 Spurny, R., J. Ramerstorfer, K. Price, M. Brams, M. Ernst, H. Nury,  M. Verheij, P. Legrand, D. Bertrand, S. Bertrand, et al.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1074/jbc.M112.424507 Velisetty, P., and S. Chakrapani.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"287:18467– 18477. http://dx.doi.org/10.1074/jbc.M112.348045 Velisetty, P., S.V.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1074/ jbc.M111.305839 Wyllie, D.J., P .",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.001bz.x Zimmermann, I., and R. Dutzler.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001101 Zimmermann, I., A. Marabelli, C. Bertozzi, L.G.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001429Hawkes, A.G., A. Jalali, and D. Colquhoun.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1098/rstb.1992.0116 Hibbs, R.E., and E. Gouaux.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"474:54– 60. http://dx.doi.org/10.1038/nature10139 Hilf, R.J., and R. Dutzler.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/j.sbi.2009.07.006 Hilf, R.J., and R. Dutzler.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1038/nature07461 Jadey, S., and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1085/jgp.201210801 Jones, M.V., and G.L.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"15:181– 191. http://dx.doi.org/10.1016/0896-6273(95)90075-6 Krashia, P., R. Lape, F. Lodesani, D. Colquhoun, and L.G.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1085/jgp.201010521 Krishtal, O.A., and V.I.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1371/journal.pone.0080322 Lape, R., D. Colquhoun, and L.G.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1113/jphysiol.2009.176305 Lape, R., A.J.R.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4346-11.2012 Legendre, P., D.W. Ali, and P. Drapeau.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1085/jgp.106.1.113 Maconochie, D.J., and J.H.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi .org/10.1111/j.1469-7793.1998.053bx.x Marabelli, A., M. Moroni, R. Lape, and L.G.",Non-OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"http://dx.doi.org/10.1016/S0022-2836(65)80285-6 Mukhtasimova, N., W.Y.",OADS,/arxiv_data1/oa_pdf/23/2e/JGP_201411234.PMC4278187.pdf
"In contrast, for all of Jung  and Lee’s recordings that show a positive CaM effect on  TMEM16A, the CaM effect disappears in the Ca2+-con- taining washout solution.Purified human brain calmodulin does not alter the bicarbonate  permeability of the ANO1/TMEM16A channel Yawei Yu1,2 and Tsung-Yu Chen1,2 1Center for Neuroscience and 2Department of Neurology, University of California, Davis, Davis, CA 95618 © 2015 Yu and Chen  This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"http://dx.doi.org/10.1096/ fj.10-166884 Tien, J., C.J.",OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"3. http://dx.doi.org/10.7554/eLife.02772 Vocke, K., K. Dauner, A. Hahn, A. Ulbrich, J. Broecker, S. Keller,  S. Frings, and F. Möhrlen.",OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"http://dx.doi.org/10.1085/jgp .201311015 Yu, K., J. Zhu, Z. Qu, Y.Y.",OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"http://dx.doi.org/10 .1085/jgp.201311047 Yu, Y., A.S. Kuan, and T.Y.",OADS,/arxiv_data1/oa_pdf/8a/0b/JGP_201411294.PMC4278188.pdf
"Six additional proteins, 3–8, were subse­ quently found to have similar sequences, thus defining  a family of  subunits (Klugbauer et al., 2000; Burgess  et al., 2001).Accessories assist AMPA receptors to close pockets Gabriela K. Popescu Department of Biochemistry, University at Buffalo, The State University of New York, Buffalo, NY 14214 © 2015 Popescu  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1016/S0896­6273(00)00094­5 Bats, C., D. Soto, D. Studniarczyk, M. Farrant, and S.G. Cull ­Candy.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"15:853– 861. http://dx.doi.org/10.1038/nn.3107 Burgess, D.L., L.A. Gefrides, P.J.",Non-OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1006/ geno.2000.6440 Cais, O., B. Herguedas, K. Krol, S.G. Cull­Candy, M. Farrant, and  I.H.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"7:129– 135. http://dx.doi.org/10.1016/0920­1211(90)90098­G Priel, A., A. Kolleker, G. Ayalon, M. Gillor, P. Osten, and Y. Stern ­Bach.",Non-OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4834­04.2005 Robert, A., N. Armstrong, J.E.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/ 10.1016/S0306­4522(01)00220­2 Sobolevsky, A.I., M.P.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1038/nature08624 Tomita, S., M. Fukata, R.A. Nicoll, and D.S.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1126/ science.1090262 Tomita, S., H. Adesnik, M. Sekiguchi, W. Zhang, K. Wada, J.R.  Howe, R.A. Nicoll, and D.S.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1038/nature03624 Traynelis, S.F., L.P. Wollmuth, C.J.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3309 ­07.2008receptors and TARPs reveals a role for the receptor N­terminal domain in channel gating.,OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi .org/10.1016/j.celrep.2014.09.029 Chen, L., D.M.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1038/35050030 Chetkovich, D.M., L. Chen, T.J. Stocker, R.A. Nicoll, and D.S.",Non-OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/10.1016/S0014­ 5793(00)01306­5 Landes, C.F., A. Rambhadran, J.N.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"http://dx.doi.org/ 10.1085/jgp.201411287 Noebels, J.L., X. Qiao, R.T. Bronson, C. Spencer, and M.T.",OADS,/arxiv_data1/oa_pdf/9b/90/JGP_201411320.PMC4278189.pdf
"Management of hemolytic uremic syndrome David Kavanagh1, Shreya Raman2and Neil S. Sheerin3* Addresses:1Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK;2Department of Histopathology, Newcastle upon Tyne Hospitals NHS Trust, Newcastle upon Tyne, UK;3Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK * Corresponding author: Neil S. Sheerin (neil.sheerin@ncl.ac.uk) F1000Prime Reports 2014, 6:119 (doi:10.12703/P6-119) All F1000Prime Reports articles are distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, and reproduction in any medium , provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/6/119 Abstract Hemolytic uremic syndrome (HUS) is a disease characterized by hemolysis, thrombocytopenia, and acute kidney injury, although other organs may be involved.",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 2 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 3 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 4 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 5 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"As most complement proteins are synthesized in the liver (with the exception of CD46), combined liver and kidney Page 6 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Chaisri U, Nagata M, Kurazono H, Horie H, Tongtawe P, Hayashi H, Watanabe T, Tapchaisri P, Chongsa-nguan M, Chaicumpa W: Locali- zation of Shiga toxins of enterohaemorrhagic Escherichia coli Page 7 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaime F, Dragon- Durey MA, Ngo S, Moulin B, Servais A, Provot F, Rostaing L, Burtey S, Page 8 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Menne J, Nitschke M, Stingele R, Abu-Tair M, Beneke J, Bramstedt J, Bremer JP, Brunkhorst R, Busch V, Dengler R, Deuschl G, Fellermann K, Fickenscher H, Gerigk C, Goettsche A, Greeve J, Hafer C, Hagenmüller F, Haller H, Herget-Rosenthal S, Hertenstein B,Hofmann C, Lang M, Kielstein JT, Klostermeier UC, Knobloch J, Kuehbacher M, Kunzendorf U, Lehnert H, Manns MP: Validation of treatment strategies for enterohaemorrhagic Escherichia Page 9 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 10 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Page 11 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:119 http://f1000.com/prime/reports/m/6/119",Non-OADS,/arxiv_data1/oa_pdf/0a/17/medrep-06-119.PMC4278190.pdf
"Update onhidradenitis suppurativa: connecting thetracts Liza Gill1,Melissa Williams2andIltefat Hamzavi2* Addresses:1College ofHuman Medicine, Michigan State University, 965FeeRoad, Room A110, East Lansing, MI48824, USA;2Department of Dermatology, Henry Ford Hospital, 3031 W.Grand Boulevard, Suite 800, Detroit, MI48202, USA *Corresponding author: Iltefat Hamzavi (ihamzav1@hfhs.org) F1000Prime Reports 2014, 6:112 (doi:10.12703/P6-112) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/m/6/112 Abstract Hidradenitis suppurativa (HS) isadebilitating skindisease characterized byrecurrent abscesses, sinus tract formation, andscarring.",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"These findingsmay be a reflection of an active IL-23/Th17 pathway, Page 2 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 3 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 4 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 5 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"In the other RCT, every-other-week dosing showed a statistically significant decrease in the Sartorius score at 6 weeks but not at Page 6 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 7 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 8of11 (page number notforcitation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Tierney E, Mahmoud BH, Hexsel C, Ozog D, Hamzavi I: Rando- mized control trial for the t reatment of hidradenitis Page 9 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Kimball AB, Kerdel F, Adams D, Mrowietz U, Gelfand JM, Gniadecki R, Prens EP, Schlessinger J, Zouboulis CC, van der Zee, Hessel H, Rosenfeld M, Mulani P, Gu Y, Paulson S, Okun M, Jemec, Gregor BE: Adalimumab for the treatment of moderate to severe Page 10 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
"Page 11 of 11 (page number not for citation purposes)F1000Prime Reports 2014, 6:112 http://f1000.com/prime/reports/m/6/112",Non-OADS,/arxiv_data1/oa_pdf/3f/13/medrep-06-112.PMC4278191.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/41/04/ijbsv11p0001.PMC4278249.pdf
"C-myc directly targets the Bmi1 -mediated  migration and invasion of cancer stem -like  cells in TSCC   As shown in Figure 5 A, a C -myc  recognition site  is present in the promoter of Bmi1 genes  (http://genome.ucsc.edu/), suggesting that the e x- pression of Bmi1 may be regulated by C -myc.",Non-OADS,/arxiv_data1/oa_pdf/41/04/ijbsv11p0001.PMC4278249.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/79/58/ijbsv11p0011.PMC4278250.pdf
Analysis of the origin of the mmuM gene   The plasmid  and chromosome genome s e- quences  used in this study  for extensive ly compar a- tive analysis were downloaded from NCBI  GenBank  database  (http://www.ncbi.nlm.nih.gov).,OADS,/arxiv_data1/oa_pdf/79/58/ijbsv11p0011.PMC4278250.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/87/bf/ijbsv11p0022.PMC4278251.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/db/e7/ijbsv11p0031.PMC4278252.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/06/77/ijbsv11p0038.PMC4278253.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/f6/18/ijbsv11p0048.PMC4278254.pdf
This  is an open -access  article  distributed  under  the terms  of the Creative  Commons  License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/32/38/ijbsv11p0059.PMC4278255.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c7/ce/ijbsv11p0067.PMC4278256.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/53/e4/ijbsv11p0075.PMC4278257.pdf
Alignment and homology modeling    A blast search of the full length  of cloned   SlitOBP1 (accession number EF159978) was conduc t- ed against the current Protein Data Bank (PDB;  http://www.rcsb.org) to find structural template.,OADS,/arxiv_data1/oa_pdf/53/e4/ijbsv11p0075.PMC4278257.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9c/a8/ijbsv11p0088.PMC4278258.pdf
All Affymetrix  HG-U133 Plus 2.0 microarrays were normalized with  MAS 5.0 in BRB array tools Version 4.2.1 (http://linus.nci.nih.gov/BRB -ArrayTools.html ).,OADS,/arxiv_data1/oa_pdf/9c/a8/ijbsv11p0088.PMC4278258.pdf
Class comparison of the gene expression data was  performed in BRB -Array Tools ( http://linus.nci.nih.,OADS,/arxiv_data1/oa_pdf/9c/a8/ijbsv11p0088.PMC4278258.pdf
Organ  site-specific metastasis gene lists resulting from class  comparisons were analyzed by Ingenuity Pathway Analysis (IPA; http://www.ingenuity.com/   products/ipa ).,OADS,/arxiv_data1/oa_pdf/9c/a8/ijbsv11p0088.PMC4278258.pdf
This is an open- acces s article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/3c/ijbsv11p0099.PMC4278259.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5d/5f/ijbsv11p0109.PMC4278260.pdf
"Target  gene s of m iRNA -467a were predicted using the  algorithms TargetScan (http://www.targetscan.org),  miRanda (http://www.cbio.mskcc.org/  mirnavie wer), PicTar  (http://www.pictar.bio.nyu.",OADS,/arxiv_data1/oa_pdf/5d/5f/ijbsv11p0109.PMC4278260.pdf
"edu), miRGen  and miRBase  (http://www.microrna.",OADS,/arxiv_data1/oa_pdf/5d/5f/ijbsv11p0109.PMC4278260.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
Direct link to deposited data Raw and processed data for the studies described here may be found at the following links: Somatic tissue: http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?,OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
acc=GSE49222ES and Neuro2A cells: http://www.ncbi.nlm.nih.gov/geo/query/acc.,OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
http://dx.doi.org/10.1016/j.gdata.2014.11.013 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/66/d5/main.PMC4278373.pdf
E-mail: Helena.Liira@uta.ﬁ   This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0)    (Received   9   April   2014  ; accepted   10   October   2014  ),Non-OADS,/arxiv_data1/oa_pdf/6a/b0/pri-32-156.PMC4278388.pdf
The study was registered at Controlled Trials (http://www.controlled-trials.com).,Non-OADS,/arxiv_data1/oa_pdf/6a/b0/pri-32-156.PMC4278388.pdf
"Availabale at:  http://www.diabetes.ﬁ  /ﬁ les/1108/Pro- gramme_for_the_Prevention_of_Type_2_Diabetes_in_Finland_2003-2010.pdf        Alberti   KG ,  Eckel   RH ,  Grundy   SM ,  Zimmet   PZ , [10]   Cleeman   JI ,  Donato   KA ,  Fruchart   JC ,  James   WP ,  Loria   CM ,   Smith   SC   Jr  .",Non-OADS,/arxiv_data1/oa_pdf/6a/b0/pri-32-156.PMC4278388.pdf
E-mail: cecjoh@gmail.com      This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0)   (Received   15   March   2014  ; accepted   10   October   2014  ),Non-OADS,/arxiv_data1/oa_pdf/b3/92/pri-32-226.PMC4278389.pdf
"We describe the selection, recruitment, and  characteristics of the participants in Supplemen-tary Appendix A (available online at http://informahealthcare.com/doi/abs/10.3109/02813432.2014.984961).",Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
We describe details of the survey in Supplementary Appendix B available online at http://informahealthcare.com/doi/abs/10.3109/02813432.2014.984961.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
"Of 740 healthcare professionals, 131 (17%) responded to the survey after two reminders and 129 were included in the analysis (Supplementary Appendix B available online at http://informahealthcare.com/doi/abs/10.3109/02813432.2014.984961).",Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
We list all of the  sugg ested determinants in Supplementary Appendix  C available online at http://informahealthcare.com/doi/abs/10.3109/02813432.2014.984961.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
   Determinants of practice for managing elderly patients with depression    177  Survey ﬁ  ndings   The results of the survey (Supplementary Appen- dix B available online at http://informahealthcare.com/doi/abs/10.3109/02813432.2014.984961) generally supported the ﬁ  ndings of the interviews.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
Available at:  http://www.crd.york.ac.uk/ PROSPERO/display_record.asp?ID    /H11005    CRD42011001582#.,Non-OADS,/arxiv_data1/oa_pdf/67/f6/pri-32-170.PMC4278390.pdf
E-mail: lone.ﬂ  arup@feap.dk     This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0)  (Received   25   June   2014  ; accepted   30   October   2014  ),Non-OADS,/arxiv_data1/oa_pdf/f0/f1/pri-32-208.PMC4278395.pdf
Available at:   http://www.ssb.no/innvbef  (accessed February 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/7a/pri-32-232.PMC4278396.pdf
Available at:  [16]   http://data.worldbank.org/news/new-country-classiﬁ  cations  (accessed February 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/7a/pri-32-232.PMC4278396.pdf
[17]  Available at:   http://www.ssb.no/metadata/conceptvariable/ vardok/927/en (accessed February 2014).,OADS,/arxiv_data1/oa_pdf/4c/7a/pri-32-232.PMC4278396.pdf
Available at:   http://ec.europa.eu/social/main.jsp?catId    /H11005    1050  & intPageId    /H11005    1894 & langId    /H11005    en (accessed February 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/7a/pri-32-232.PMC4278396.pdf
[20]  Available at:   http://www.whocc.no/atc_ddd_index/  ( accessed  February 2014).,Non-OADS,/arxiv_data1/oa_pdf/4c/7a/pri-32-232.PMC4278396.pdf
Available at:   http://www.statistikbanken.,Non-OADS,/arxiv_data1/oa_pdf/98/c8/pri-32-200.PMC4278398.pdf
Available [13]  at:   http://www.ssi.dk/Sundhedsdataogit/Dataformidling/ Laegemiddelstatistikker.aspx (accessed April 2014).,OADS,/arxiv_data1/oa_pdf/98/c8/pri-32-200.PMC4278398.pdf
E-mail: staffan.g.nilsson@liu.se This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0)    (Received   23   August   2013  ; accepted   7   October   2014  ),Non-OADS,/arxiv_data1/oa_pdf/bb/e4/pri-32-241.PMC4278399.pdf
E-mail: kristian.jansen@uni.no     This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License   (http://creativecommons.org/licenses/by-nc/3.0)  (Received   7   June   2014  ; accepted   23   September   2014  ),Non-OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
Available at:  http://www.ssb.no [1]  (accessed 1 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
Available at:   http://www.helsedirektoratet.no   (accessed 1 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
Available [11]  at:   http://www.who.int/classiﬁ  cations/icd/en/  (accessed 4  September 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
Available at:   http://www.whocc.no/atc_ddd_index   (accessed 1 June 2014).,OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
Available at:   http://hospicecare.com/ resources/publications/manual-of-palliative-care/  (accessed  1 June 2014).,Non-OADS,/arxiv_data1/oa_pdf/ea/da/pri-32-187.PMC4278400.pdf
"Recently, the “Comparison of Age-Related Macular  Degeneration Treatments Trials” (CATT) and the “Alternative Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > Received 4 August 2014 | Accepted 17 December 2014 | Published 19 December 2014© 2014 Molecular Vision 1680Pharmacogenetic associations with long-term response to anti- vascular endothelial growth factor treatment in neovascular AMD  patients Un Chul Park,1,2 Joo Young Shin,1 Linda C. McCarthy,3 Sang Jin Kim,1,4 Jung Hyun Park,1,5 Hum Chung,1  Hyeong Gon Yu1,6 1Department of Ophthalmology, College of Medicine, Seoul National University, Seoul, Korea; 2Department of Ophthalmology,  National Medical Center, Seoul, Korea; 3GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom; 4Department  of Ophthalmology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea; 5Department of  Ophthalmology, Seoul Paik Hospital, Inje University, Seoul, Korea; 6Sensory Organs Institute, Medical Research Center, Seoul  National University, Seoul, Korea Purpose:  To investigate the pharmacogenetic associations between the genetic risk variants of age-related macular  degeneration (AMD) and long-term outcome after intravitreal anti-vascular endothelial growth factor (VEGF) treatment  in Korean neovascular AMD patients.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
"Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1681Treatments to Inhibit VEGF in Patients with Age-Related  Choroidal Neovascularization” (IVAN) study groups reported  that the effects of ranibizumab and bevacizumab on visual  acuity were equivalent [ 5,6].",Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1682had been terminated.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
"Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1683continuous outcome variables (i.e., mean changes in BCVA  and CSMT from baseline).",Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1684Table  3.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1685Table  4. p harma Cogene TiC asso CiaTion wiTh anTi-vas Cular  endo Thelial  grow Th faCTor Trea T- men T ouTCome in neovas Cular  age-rela Ted maCular  degenera Tion paTienTs.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1686Outcome parametersGene Variant Genotype (N)*N (%) or Mean*Genetic  model OR (95% CI)**Uncorrected  P - value†Corrected P  - value††   ARMS2 rs10490924TT(183) /  TG(139) /  GG(44) 10.5 / 10.9 / 9.4 Recessive - 0.0338 0.5408   HTRA1 rs11200638AA(188) /  AG(133) /  GG(45) 10.5 / 10.9 / 9.4 Recessive - 0.0275 0.4403 OR = Odds ratio; CI = Confidence interval; BCV A = Best-corrected visual acuity; OCT = Optical Coherence Tomography; CSMT = Central subfield macular thickness *: Major  allele homozygote / Heterozygote / Minor allele homozygote **: Odds ratio calculated for minor allele homozygote †: Uncorrected P - value from logistic regression model  (categorical outcomes) or linear regression model (continuous outcomes); Polymorphisms with uncorrected P value < 0.05 are listed ††: P - value corrected for multiple testing  with Bonferroni method.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1687Regression coefficients (β) and corresponding 95% CI  and p values for non-genetic covariates are presented in  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1688associations with mean CSMT change under the recessive  model.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1689site for transcription factor AP-4 and is reported to inhibit  the transcription of VEGF [ 39].,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1690candidate polymorphism varies among races.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1691APPENDIX 4.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  169217.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  169335.,Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
"Molecular Vision  2014; 20:1680-1694 <http://www.molvis.org/molvis/v 20/1680 > © 2014 Molecular Vision  1694Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/a2/79/mv-v20-1680.PMC4278401.pdf
"The RNA probes were sequentially revealed with custom-made FLUO (FITC; 1 : 200; http://www.xenbase.org /other/static/methods/FISH.jsp), tetramethylrhodamine (TAMRA; 1 : 250) and cyanine 5 (Cy5; 1 : 100; PerkinElmer) conjugated tyramide in PBST containing 2% (v/v) dextran sulfate (Sigma-Aldrich D8906) and 0.003% (v/v)H 2O2for 35 min at RT.",OADS,/arxiv_data1/oa_pdf/dd/16/ejn0040-3302.PMC4278443.pdf
Available at: http://lme4.r-forge.r-project.org/slides/2011-01-11-Madison/6NLMMH.pdf.Last accessed 17 July 2014.,Non-OADS,/arxiv_data1/oa_pdf/bb/ea/jec0102-1673.PMC4278444.pdf
"June 6,2012. http://jcs.mep.gov.cn/hjzl/zkgb/2011zkgb/201206/t20120606_231040.htm.",OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
"December 17, 2012. http://www.mwr.gov.cn/zwzc/hygb/szygb/qgszygb/201212/t20121217_335297.html).",Non-OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://www.chinadaily.com.cn/hqgj/jryw/2012-05-25/content_6009820_2.html (Accessed 30 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://www.gwp.org/Global/ToolBox/Publications/Technical%20Focus%20Papers/03%20Water%20and%20Food%20Sec- urity%20-%20Experiences%20in%20India%20and%20China%20 (2013).,Non-OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://www.ijc.org/rel/boards/watershed/Determination% 20of%20Flows%20for%20Red%20River %20Apportionment.pdf (Accessed 30 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://gb.cri.cn/27824/2013/01/31/5892s4009291.htm (Accessed 30 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://www.mwr.gov.cn/2013pcgb/ (Accessed 30 July 2013).,OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
http://www.mwr.gov.cn/zwzc/hygb/szygb/ (Accessed 30 July 2013).,OADS,/arxiv_data1/oa_pdf/4a/f6/JPE-51-1159.PMC4278448.pdf
Available electronically from http://hdl.handle.net/1969.1/ETD-TAMU-2011-05-9410.,Non-OADS,/arxiv_data1/oa_pdf/01/44/pce0037-2691.PMC4278449.pdf
30 April 2014. http://host.madison.com/ business/drought-creates-danger-of-toxic-fungi-in-surviving-crops/article_f930679a-e5a6-11e1-bc3d-001a4bcf887a.html.,Non-OADS,/arxiv_data1/oa_pdf/01/44/pce0037-2691.PMC4278449.pdf
"04 April 2014. http://ipcm.wisc.edu/blog/2012/09/drought-2012-moldy-corn-and-crop-insurance/ Solomon S., Qin D., Manning M., Chen Z., Marquis M., Averyt K.B., .",Non-OADS,/arxiv_data1/oa_pdf/01/44/pce0037-2691.PMC4278449.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 100-102 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.858 Journal of Microbiology & Biology Education  Volume 15, Number 12 100 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/88/db/jmbe-15-100.PMC4278455.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/88/db/jmbe-15-100.PMC4278455.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 103-107 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.832 Journal of Microbiology & Biology Education   103 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
http://scholarlyoa.com/2014/03/06/is-the- editor-of-the-springer-journal-scientometrics-indifferent-to-plagiarism/.,Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
http://www.icmje.org/recommendations/browse/ roles-and-responsibilities/defining-the-role-of-authors-and- contributors.html .,Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
http://www.slavstuff.com/2011/04/05/the-anthropology-of- cheating-an-east-european-academic-phenomenon/ .,Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
Available  at http://fas.org/sgp/crs/misc/97-746.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
http://ori.hhs.gov/images/ddblock/plagiarism.pdf .,Non-OADS,/arxiv_data1/oa_pdf/2c/8e/jmbe-15-103.PMC4278456.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 108-116 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.852 Journal of Microbiology & Biology Education  Volume 15, Number 12 108 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
See https://www.citiprogram.org/ (accessed on 5 September  2014).,Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
See http://ori.hhs.gov/ (accessed on 5 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
"A summary of this research and the newest, refined versions of the measures are available online ( http://ethics.publishpath.com/ ).",Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
http://www.the-scientist.com/?articles.view/ articleNo/35543/title/Opinion--Ethics-Training-in-Science/ .,Non-OADS,/arxiv_data1/oa_pdf/db/04/jmbe-15-108.PMC4278457.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 117-119 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.853 Journal of Microbiology & Biology Education   117 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/31/b3/jmbe-15-117.PMC4278458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/31/b3/jmbe-15-117.PMC4278458.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 120-123 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.859 Theme:   Scientific Ethics Journal of Microbiology & Biology Education  Volume 15, Number 12 120 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/19/f5/jmbe-15-120.PMC4278459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/19/f5/jmbe-15-120.PMC4278459.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 124-129 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.872 Journal of Microbiology & Biology Education  Volume 15, Number 12 124Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/50/05/jmbe-15-124.PMC4278460.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/50/05/jmbe-15-124.PMC4278460.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 130-134 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.860 Journal of Microbiology & Biology Education  Volume 15, Number 12 130 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://sciencewatch.com/grr/building-bricks.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.cgsnet.org/modeling-effective-research-ethics-education-graduate-international- collaborations.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.cies.org/programs .,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.iie.org/Research-and-Publications/ Open-Doors/Data/International-Students/Leading-Places- of-Origin/2011-13.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://grants.nih.gov/grants/guide/ notice-files/not94-200.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://grants.nih.gov/ grants/guide/notice-files/NOT-OD-10-019.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.fic.nih.gov/Grants/Pages/Frequently-Asked-Questions.aspx.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://grants.nih.gov/grants/policy.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.nsf.gov/statistics/sed/digest/2012/nsf14305.pdf.,OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.nsf.gov/ bfa/dias/policy/rcr.jsp.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://www.nsf.gov/od/iia/ise/intl- research-integrity.jsp.,OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
http://grants.nih.gov/grants/guide/notice-files/NOT- OD-00-039.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/77/jmbe-15-130.PMC4278461.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 135-138 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.841 Journal of Microbiology & Biology Education   135 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/jmbe-15-135.PMC4278462.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/5e/c8/jmbe-15-135.PMC4278462.pdf
http://www.npr.org/blogs/13.7/2014/06/10/320634230/a-problem-like-no- other-science-and-politics.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/jmbe-15-135.PMC4278462.pdf
https://bioethicsarchive.georgetown.edu/nbac/ pubs.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/jmbe-15-135.PMC4278462.pdf
https://bioethicsarchive.georgetown.edu/pcbe/reports/stemcell/.,Non-OADS,/arxiv_data1/oa_pdf/5e/c8/jmbe-15-135.PMC4278462.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 139-142 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.871 Journal of Microbiology & Biology Education   139 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/08/92/jmbe-15-139.PMC4278463.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/08/92/jmbe-15-139.PMC4278463.pdf
http://www.scholarlyintegrity.org/Blog.aspx?blogmonth= 5&blogyear=2009&blogid=544.,Non-OADS,/arxiv_data1/oa_pdf/08/92/jmbe-15-139.PMC4278463.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 143-145 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.869 Journal of Microbiology & Biology Education   143 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/69/66/jmbe-15-143.PMC4278464.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/69/66/jmbe-15-143.PMC4278464.pdf
http://www.nature.com/ news/2010/100817/full/news.2010.414.html.,Non-OADS,/arxiv_data1/oa_pdf/69/66/jmbe-15-143.PMC4278464.pdf
http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3541569/.,Non-OADS,/arxiv_data1/oa_pdf/69/66/jmbe-15-143.PMC4278464.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 146-150 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.829 Journal of Microbiology & Biology Education  Volume 15, Number 12 146 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/64/34/jmbe-15-146.PMC4278465.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/64/34/jmbe-15-146.PMC4278465.pdf
"Many journals refer to the COPE guidelines on retractions, which also cover corrections and expressions of concern ( http://publicationethics.org/files/retraction_guide   lines.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/64/34/jmbe-15-146.PMC4278465.pdf
"In response to this dilemma, COPE has issued a discussion document (but no formal guidance) on the topic (http://publicationethics.org/files/u661/Forum_discussion_ summary_on_Sharing%20of%20information%20among%20editors_Final.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/64/34/jmbe-15-146.PMC4278465.pdf
"FURTHER READING (resources on publication ethics) • COPE (Committee on Publication Ethics) www.publicationethics.org , in particular, see the flow - charts available at www.publicationethics.org/ resources/flowcharts • CSE (Council of Science Editors) www.council   scienceeditors.org • Elsevier Publishing Ethics Resource Kit (PERK) http://www.elsevier.com/editors/perk • Responsible Research Publication: International Standards for Authors http://publicationethics.org/files/International_standards_authors_for_web   site _11_ Nov_ 2011.pdf • Wiley-Blackwell Best Practice Guidelines on Publication Ethics http://authorservices.wiley.com/bauthor/publicationethics.asp • WAME (World Association of Medical Editors) www.wame.org ACKNOWLEDGMENTS The author declares that there are no conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/64/34/jmbe-15-146.PMC4278465.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 151-154 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.855 Journal of Microbiology & Biology Education   151 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/c3/74/jmbe-15-151.PMC4278466.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/c3/74/jmbe-15-151.PMC4278466.pdf
"The Journal of Biological Chemistry , for example, often publishes  unhelpful one-line notices such as “This article has been withdrawn by the authors,” despite its publisher having taken the admirable step of hiring a manager of publication ethics ( http://retractionwatch.com/2012/11/19/jbc-publisher- asbmb-hiring-manager-of-publication-ethics-and-why-retraction-watch-is-cheering/ ).",Non-OADS,/arxiv_data1/oa_pdf/c3/74/jmbe-15-151.PMC4278466.pdf
Elsevier allows authors to  withdraw articles published online ahead of print without explanation ( http://retractionwatch.com/2013/02/25/ is-an-article-in-press-published-a-word-about-elseviers-withdrawal-policy/).,Non-OADS,/arxiv_data1/oa_pdf/c3/74/jmbe-15-151.PMC4278466.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 155-158 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.867 Journal of Microbiology & Biology Education   155 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.esf.org/index.php?id=4479 .,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.wipo.int/wipolex/en/text.jsp?file_id=125393 .,OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.cnpq.br/web/guest/diretrizes .,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.nytimes.com/2014/07/07/world/asia/academic-scandal-shakes-japan.html?module= Search&mabReward=relbias%3As.,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.mext.go.jp/b_menu/houdou/26/08/__icsFiles/ afieldfile/2014/08/26/1351568_02_1.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.fapesp.br/boaspraticas/ FAPESP-Code_of_Good_Scientific_Practice_2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.sesame.org.jo/ sesame/about-us/what-is-sesame.html .,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
http://www.sesame.,Non-OADS,/arxiv_data1/oa_pdf/aa/c4/jmbe-15-155.PMC4278467.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 159-161 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.792 Journal of Microbiology & Biology Education   159 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a9/09/jmbe-15-159.PMC4278468.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/a9/09/jmbe-15-159.PMC4278468.pdf
http://www.battelle.org/docs/ tpp/2014_global_rd_funding_forecast.pdf?sfvrsn=4.,Non-OADS,/arxiv_data1/oa_pdf/a9/09/jmbe-15-159.PMC4278468.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 162-164 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.851 Journal of Microbiology & Biology Education  Volume 15, Number 12 162 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://grants.nih.gov/grants/guide/notice-files/NOT-OD-10-019.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://acd.od.nih.gov/biomedical_research_wgreport.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://www.nsf.gov/pubs/policydocs/pappguide/ nsf10_1/aag_4.jsp.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://ori.hhs.gov/annual_reports.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://www.researchtrends.com/issue-34-september-2013/a-funding-profile-of-the-nih/.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
http://grants.nih.gov/ grants/guide/notice-files/not95-179.html.,Non-OADS,/arxiv_data1/oa_pdf/4a/db/jmbe-15-162.PMC4278469.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 165-168 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.857 Journal of Microbiology & Biology Education   165 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
http://iom.edu/Reports/2002/Integrity-in-Scientific- Research-Creating-an-Environment-That-Promotes-Responsible-Conduct.aspx.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
http://www.ethicsresearch.com/freeresources/ rrwresearchwrongdoing.html.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
http://grants1.nih.gov/grants/guide/notice-files/ NOT-OD-10-019.html.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
http://www.nsf.gov/bfa/dias/policy/ rcr.jsp.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/jmbe-15-165.PMC4278470.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 169-172 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.870 Journal of Microbiology & Biology Education   169 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
"In organizations and professional societies, on grant review committees for funders, and as peer review - ers for journal articles, scientists can comment on research  b  The NSF proposal instructions and proposal review form ask that the  proposal specifically describe and be evaluated on “the broader im - pacts of the proposed activity” (http://www.nsf.gov/pubs/2002/nsf022/bicexamples.pdf).",Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
https://www.govtrack.us/congress/bills/110/hr2272#summary   (accessed 29 September 2014) (see Sections 7008 and 7009).,Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
http://www.nqai.ie/documents/bolognasummary.,Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
pdf (accessed 29 September 2014) and http://www.ond.,Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
21(4): 311–316 (see also http://www.codex.uu.se/en/texts/ Uppsala%20codex.pdf [accessed 29 September 2014]).,Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
http://www.nspe.org/resources/ethics/code-ethics (accessed 29 September 2014).,Non-OADS,/arxiv_data1/oa_pdf/6c/3e/jmbe-15-169.PMC4278471.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 173-176 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.868 Journal of Microbiology & Biology Education   173 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/73/4a/jmbe-15-173.PMC4278472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/73/4a/jmbe-15-173.PMC4278472.pdf
http://www.huffingtonpost.,Non-OADS,/arxiv_data1/oa_pdf/73/4a/jmbe-15-173.PMC4278472.pdf
http://www.foreignpolicy.,Non-OADS,/arxiv_data1/oa_pdf/73/4a/jmbe-15-173.PMC4278472.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 177-180 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.827 Journal of Microbiology & Biology Education   177 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ea/19/jmbe-15-177.PMC4278473.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ea/19/jmbe-15-177.PMC4278473.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 181-185 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.776 Journal of Microbiology & Biology Education   181 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/67/fe/jmbe-15-181.PMC4278474.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/67/fe/jmbe-15-181.PMC4278474.pdf
http://www.ctteam.org/df/resources/ Module5_Manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/fe/jmbe-15-181.PMC4278474.pdf
http://www.genetics.edu.au/Publications-and- Resources/Genetics-Fact-Sheets/FactSheet23.,Non-OADS,/arxiv_data1/oa_pdf/67/fe/jmbe-15-181.PMC4278474.pdf
http://www.breastcancer.org/symptoms/testing/genetic/pos_results.,Non-OADS,/arxiv_data1/oa_pdf/67/fe/jmbe-15-181.PMC4278474.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 186-190 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.873 Journal of Microbiology & Biology Education  Volume 15, Number 12 186 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
"“Legal  1   On September 1, 2014, The House of Commons debated and then resolved,     That this House takes note of the Human Fertilisation and Embryology  Authority’s most recent scientific review into the safety and efficacy of mitochondrial replacement techniques which highlights concerns for subsequent generations of children born through maternal spindle transfer and pronuclear transfer; welcomes the recent comments of scientists including Professor Lord Winston that, prior to the introduc - tion of such techniques, more research ought to be undertaken and a full assessment conducted of the potential risk to children born as a result; and calls upon the Government, in light of these public safety concerns, to delay bringing forward regulations on mitochondrial replacement (http://www.publications.parliament.uk/pa/cm201415/cmhansrd/cm140901/debtext/140901-0003.htm#14090125000001).",Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
"Informed Consent,  available at http://www.hg.org/informed-consent-law.html  (last visited Nov. 4, 2014).",Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
http://usnews.nbcnews.,Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
http://www.newsrecord.co/the- cost-benefit-equation-of-three-parent-ivf/.,Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
http://www.reuters.com/article/2014/08/21/us-usa-california- lgbt-rights-idUSKBN0GL04J20140821.,Non-OADS,/arxiv_data1/oa_pdf/b2/70/jmbe-15-186.PMC4278475.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 191-196 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.856 Journal of Microbiology & Biology Education   191 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
http://www.forbes.com/sites/techonomy/2012/01/12/dna- sequencing-is-now-improving-faster-than-moores-law/.,Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
http://dna-explained.com/2012/12/18/proving-native-american-ancestry-using-dna/.,Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
http://www.nature.com/news/is-the-1-000-genome-for-real-1.14530.,Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
http://indiancountrytodaymedianetwork.com/2011/10/13/ bitter-fight-determine-who-american-indian-turns-dna-testing-57165 .,Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2013/ucm376296.htm.,Non-OADS,/arxiv_data1/oa_pdf/db/dc/jmbe-15-191.PMC4278476.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 197-201 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.773 Journal of Microbiology & Biology Education   197 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5d/01/jmbe-15-197.PMC4278477.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/5d/01/jmbe-15-197.PMC4278477.pdf
https://peerj.com/preprints/242/.,Non-OADS,/arxiv_data1/oa_pdf/5d/01/jmbe-15-197.PMC4278477.pdf
http://bioethics.gov/ education.,Non-OADS,/arxiv_data1/oa_pdf/5d/01/jmbe-15-197.PMC4278477.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 202-207 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.784 Journal of Microbiology & Biology Education  Volume 15, Number 12 202©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/83/fd/jmbe-15-202.PMC4278478.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/83/fd/jmbe-15-202.PMC4278478.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 208-212 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.761 Journal of Microbiology & Biology Education  Volume 15, Number 12 208 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/91/4e/jmbe-15-208.PMC4278479.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/91/4e/jmbe-15-208.PMC4278479.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 213-217 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.783 Journal of Microbiology & Biology Education   213 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
"Although we are not aware of many programs that do so (outside of pre-health stud - ies, such as nursing) one example is the microbiology un - dergraduate program at Rutgers ( http://dbm.rutgers.edu/ microbio.php ) which requires a professional ethics course.",Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
"Also, reliable but briefer introductions to those principles are widely available (for instance, Thomas McCormick’s at https://depts.washington.edu/bioethx/ tools/princpl.html ).",Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://www.hhs.gov/ohrp/policy/belmont.html.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://www.genome.gov/10001618.,OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://journals.heacademy.ac.uk/doi/pdf/10.3108/beej.13.1.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://bioethics.gov/education.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://www.unesco.org/new/en/social-and-human-sciences/ themes/bioethics/ethics-education-programme/.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
http://unesdoc.unesco.org/ images/0014/001461/146180e.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ff/99/jmbe-15-213.PMC4278480.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 218-223 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.850 Journal of Microbiology & Biology Education  Volume 15, Number 12 218* Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
"One case study, from the National Bioethics Institute at Oregon State University, focused on the issue of extinction caused by humans, but had a bit of a twist as it dealt with the intentional destruc - tion of the smallpox virus ( http://www.biotech.iastate.edu/ wp_single/wp-content/uploads/2012/11/extinction.pdf ).",Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
"The second case study, from The Biotechnology Outreach Center at Iowa State University ( http://www.biotech.iastate.edu/wp_single/wp- content/uploads/2012/11/goldenrice.pdf ), provided readings  both in support of and in opposition to funding golden rice research.",Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
"For the discussion about The Immortal Life of Henrietta  Lacks, a Teacher’s Guide developed for the book and available  online ( http://rebeccaskloot.com/wp-content/uploads /2011/03/ RHSklootTeachersGuideLORES.pdf ) provides excellent  discussion questions for each chapter.",Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
Basic facts of the study are reviewed using resources from the Centers for Disease Control and Prevention ( http://www.cdc.gov/tuskegee/timeline.htm ) and  Tuskegee University ( http://www.tuskegee.edu/about_us/ centers_of_excellence/bioethics_center/about_the_usphs_syphilis_study.aspx ).,OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
These classic case studies are followed by the interactive RCR training tool “The Lab” developed by the Office of Research Integrity in the US Department of Health and Human Services ( http://ori.hhs.gov/thelab ).,Non-OADS,/arxiv_data1/oa_pdf/52/74/jmbe-15-218.PMC4278481.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 224-226 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.821 Journal of Microbiology & Biology Education  Volume 15, Number 12 224Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/18/1f/jmbe-15-224.PMC4278482.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/18/1f/jmbe-15-224.PMC4278482.pdf
http://faculty.mwsu.edu/west/maryann.,Non-OADS,/arxiv_data1/oa_pdf/18/1f/jmbe-15-224.PMC4278482.pdf
http://endangeredink.com/programs/population_ and_sustainability/extinction/pdfs/Eldridge-6th-extinction.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/1f/jmbe-15-224.PMC4278482.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 227-228 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.753 Journal of Microbiology & Biology Education   227 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/a1/c7/jmbe-15-227.PMC4278483.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/a1/c7/jmbe-15-227.PMC4278483.pdf
"The assignment was printed to look like a subpoena from the United States Senate (similar to that found at http://www.senate.gov/artandhistory/his - tory/common/investigations/pdf/Pecora_MitchellSubpoena.pdf), calling the student to “testify” as expert witnesses  before the Senate Committee on Commerce, Science, and Transportation: Science Ethics Subcommittee and present “evidence” (a bibliography) to the subcommittee.",Non-OADS,/arxiv_data1/oa_pdf/a1/c7/jmbe-15-227.PMC4278483.pdf
http://visionandchange.org/files/2013/11/aaas-VISchange-web1113.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/c7/jmbe-15-227.PMC4278483.pdf
http://scottnicholson.com/pubs/ meaningfulstrategies.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/c7/jmbe-15-227.PMC4278483.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 229-231 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.771 Journal of Microbiology & Biology Education   229 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3d/fe/jmbe-15-229.PMC4278484.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/3d/fe/jmbe-15-229.PMC4278484.pdf
http://www.facultyfocus.com/articles/teaching-professor- blog/prompts-that-get-students-to-analyze-reflect-relate-and-question/ .,Non-OADS,/arxiv_data1/oa_pdf/3d/fe/jmbe-15-229.PMC4278484.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 232-234 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.781 Journal of Microbiology & Biology Education  Volume 15, Number 12 232Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/85/66/jmbe-15-232.PMC4278485.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/85/66/jmbe-15-232.PMC4278485.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 235-237 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.740 Journal of Microbiology & Biology Education   235 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b7/ba/jmbe-15-235.PMC4278486.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b7/ba/jmbe-15-235.PMC4278486.pdf
http://www.bu.edu/ceit/teaching-resources/using- case-studies-to-teach/.,Non-OADS,/arxiv_data1/oa_pdf/b7/ba/jmbe-15-235.PMC4278486.pdf
https://www.scu.edu/ethics/practicing/decision/framework.html.,Non-OADS,/arxiv_data1/oa_pdf/b7/ba/jmbe-15-235.PMC4278486.pdf
https://www.nwabr.org/teacher- center/ethics-primer#overview.,Non-OADS,/arxiv_data1/oa_pdf/b7/ba/jmbe-15-235.PMC4278486.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 238-239 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.762 Journal of Microbiology & Biology Education  Volume 15, Number 12 238 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/1f/74/jmbe-15-238.PMC4278487.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/1f/74/jmbe-15-238.PMC4278487.pdf
The British Medical Association has created a helpful flow chart for students encountering ethical problems: http://bma.org.uk/ practical-support-at-work/ethics/medical-students-ethics-tool-kit/approaching-an-ethical-dilemma .,Non-OADS,/arxiv_data1/oa_pdf/1f/74/jmbe-15-238.PMC4278487.pdf
http://virtualmentor.ama-assn.,Non-OADS,/arxiv_data1/oa_pdf/1f/74/jmbe-15-238.PMC4278487.pdf
http://www.nytimes.com/1998/04/22/us/ concern-among-jews-is-heightened-as-scientists-deepen-gene-studies.html.,Non-OADS,/arxiv_data1/oa_pdf/1f/74/jmbe-15-238.PMC4278487.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 240-242 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.767 Journal of Microbiology & Biology Education  Volume 15, Number 12 240Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/48/2f/jmbe-15-240.PMC4278488.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/48/2f/jmbe-15-240.PMC4278488.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 243-245 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.839 Journal of Microbiology & Biology Education   243 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ae/e7/jmbe-15-243.PMC4278489.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ae/e7/jmbe-15-243.PMC4278489.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 246-250 Copyright © 2014 American Society for Microbiology Journal of Microbiology & Biology Education  Volume 15, Number 2 246 Theme:   Scientific EthicsREVIEWS  Introducing Ethics in Your Instruction Using a TED  Talks PlaylistDOI: http://dx.doi.org/10.1128/jmbe.v15i2.769 Review of: Selected TED talks focused on ethics, http:// www.ted.com/ .",Non-OADS,/arxiv_data1/oa_pdf/5a/6d/jmbe-15-246-a.PMC4278490.pdf
"Here is our proposed playlist of talks for your instruc - tional activities on ethics in scientific research, including a range of scientific disciplines: • Optional introduction: The playlist ‘The 7 talks to make  you love science’ ( http://www.ted.com/playlists/163/7_ talks_to_make_you_love_scien ) • Optional introduction: Naomi Oreskes: Why we should trust scientists ( http://www.ted.com/talks/ naomi_oreskes_why_we_should_believe_in_science ) • Ben Goldacre: Battling bad science ( http://www.ted.",Non-OADS,/arxiv_data1/oa_pdf/5a/6d/jmbe-15-246-a.PMC4278490.pdf
com/talks/ben_goldacre_battling_bad_science )  • Lee Smolin: Science and democracy ( http://www.ted.,Non-OADS,/arxiv_data1/oa_pdf/5a/6d/jmbe-15-246-a.PMC4278490.pdf
"Mariagiovanna Fragasso  Consiglio per la Ricerca e la Sperimentazione in Agricoltura, Cereal Research Centre, Foggia, Italy Vittorio Capozzi University of Foggia, Foggia, ItalyE-mail: vittorio.capozzi@gmail.com Introductory Text Answers the Question “Why  Does Scientific Ethics Matter?”DOI: http://dx.doi.org/10.1128/jmbe.v15i2.775 Review of: Ethics and Science: An Introduction ; Adam Briggle  and Carl Mitcham; (2012).",Non-OADS,/arxiv_data1/oa_pdf/5a/6d/jmbe-15-246-a.PMC4278490.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 246-250 Copyright © 2014 American Society for Microbiology Journal of Microbiology & Biology Education  Volume 15, Number 2 246 Theme:   Scientific EthicsREVIEWS  Introducing Ethics in Your Instruction Using a TED  Talks PlaylistDOI: http://dx.doi.org/10.1128/jmbe.v15i2.769 Review of: Selected TED talks focused on ethics, http:// www.ted.com/ .",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jmbe-15-246-b.PMC4278491.pdf
"Here is our proposed playlist of talks for your instruc - tional activities on ethics in scientific research, including a range of scientific disciplines: • Optional introduction: The playlist ‘The 7 talks to make  you love science’ ( http://www.ted.com/playlists/163/7_ talks_to_make_you_love_scien ) • Optional introduction: Naomi Oreskes: Why we should trust scientists ( http://www.ted.com/talks/ naomi_oreskes_why_we_should_believe_in_science ) • Ben Goldacre: Battling bad science ( http://www.ted.",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jmbe-15-246-b.PMC4278491.pdf
com/talks/ben_goldacre_battling_bad_science )  • Lee Smolin: Science and democracy ( http://www.ted.,Non-OADS,/arxiv_data1/oa_pdf/17/e1/jmbe-15-246-b.PMC4278491.pdf
"Mariagiovanna Fragasso  Consiglio per la Ricerca e la Sperimentazione in Agricoltura, Cereal Research Centre, Foggia, Italy Vittorio Capozzi University of Foggia, Foggia, ItalyE-mail: vittorio.capozzi@gmail.com Introductory Text Answers the Question “Why  Does Scientific Ethics Matter?”DOI: http://dx.doi.org/10.1128/jmbe.v15i2.775 Review of: Ethics and Science: An Introduction ; Adam Briggle  and Carl Mitcham; (2012).",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jmbe-15-246-b.PMC4278491.pdf
"Christian T. K.-H. Stadtländer St. Paul, MNE-mail: ctkstadtlander@msn.com Teaching Scientific Ethics Effectively at Any Level DOI: http://dx.doi.org/10.1128/jmbe.v15i2.749 Review of: Scientific Integrity: Text and Cases in Responsible  Conduct of Research , 4 th ed; Francis Macrina; (2014).",Non-OADS,/arxiv_data1/oa_pdf/17/e1/jmbe-15-246-b.PMC4278491.pdf
"Christian T. K.-H. Stadtländer St. Paul, MNE-mail: ctkstadtlander@msn.com Teaching Scientific Ethics Effectively at Any Level DOI: http://dx.doi.org/10.1128/jmbe.v15i2.749 Review of: Scientific Integrity: Text and Cases in Responsible  Conduct of Research , 4 th ed; Francis Macrina; (2014).",Non-OADS,/arxiv_data1/oa_pdf/8c/95/jmbe-15-247.PMC4278492.pdf
"Melissa A. Carroll DeSales University, Center Valley, PAE-mail: melissa.carroll@desales.edu Utilizing the Committee on Publication Ethics  (COPE) Resources to Teach Ethical Writing Skills to Undergraduates in STEM CoursesDOI: http://dx.doi.org/10.1128/jmbe.v15i2.751 Review of: Committee on Publication Ethics (COPE)  resources  http://publicationethics.org/ When assigning a research writing assignment in a STEM  course, you may receive papers that contain plagiarism or  improper citations, or that lack citations entirely.",Non-OADS,/arxiv_data1/oa_pdf/8c/95/jmbe-15-247.PMC4278492.pdf
The Committee on Publication Ethics (COPE) [http://publicationethics.org/ ] provides excellent model  guidelines to aid in teaching STEM students ethical scien - tific writing.,Non-OADS,/arxiv_data1/oa_pdf/8c/95/jmbe-15-247.PMC4278492.pdf
"eLearning: Although only the module “Introduction to  Publication Ethics” ( http://publicationethics.org/resources/ elearning/introduction-publication-ethics-0 ) is available to  non-members, this 20-minute video covers the basic prin - ciples and importance of ethical publishing.",Non-OADS,/arxiv_data1/oa_pdf/8c/95/jmbe-15-247.PMC4278492.pdf
"Guidelines:  COPE’s “Code of Conduct and Best Practice  Guidelines for Journal Editors” and “Code of Conduct for  Journal Publishers” ( http://publicationethics.org/resources/ code-conduct ), as well as other guidelines for best practices,  are available as free PDF downloads from their site.",Non-OADS,/arxiv_data1/oa_pdf/8c/95/jmbe-15-247.PMC4278492.pdf
"Melissa A. Carroll DeSales University, Center Valley, PAE-mail: melissa.carroll@desales.edu Utilizing the Committee on Publication Ethics  (COPE) Resources to Teach Ethical Writing Skills to Undergraduates in STEM CoursesDOI: http://dx.doi.org/10.1128/jmbe.v15i2.751 Review of: Committee on Publication Ethics (COPE)  resources  http://publicationethics.org/ When assigning a research writing assignment in a STEM  course, you may receive papers that contain plagiarism or  improper citations, or that lack citations entirely.",Non-OADS,/arxiv_data1/oa_pdf/b7/20/jmbe-15-248.PMC4278493.pdf
The Committee on Publication Ethics (COPE) [http://publicationethics.org/ ] provides excellent model  guidelines to aid in teaching STEM students ethical scien - tific writing.,Non-OADS,/arxiv_data1/oa_pdf/b7/20/jmbe-15-248.PMC4278493.pdf
"eLearning: Although only the module “Introduction to  Publication Ethics” ( http://publicationethics.org/resources/ elearning/introduction-publication-ethics-0 ) is available to  non-members, this 20-minute video covers the basic prin - ciples and importance of ethical publishing.",Non-OADS,/arxiv_data1/oa_pdf/b7/20/jmbe-15-248.PMC4278493.pdf
"Guidelines:  COPE’s “Code of Conduct and Best Practice  Guidelines for Journal Editors” and “Code of Conduct for  Journal Publishers” ( http://publicationethics.org/resources/ code-conduct ), as well as other guidelines for best practices,  are available as free PDF downloads from their site.",Non-OADS,/arxiv_data1/oa_pdf/b7/20/jmbe-15-248.PMC4278493.pdf
"Andrea Pratt Rediske University of Central Florida, Orlando, FL E-mail: andrea.rediske@ucf.edu Online Resources for Introducing Bioethics through  Case-Studies and Active LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i2.804 Comparative review of: Bioethics 101  https://www.nwabr.org/   sites/default/files/NWABR_Bioethics_101_5.13.pdf  and  Exploring Bioethics https://www.nwabr.org/teacher-center/ bioethics-101#overview .",Non-OADS,/arxiv_data1/oa_pdf/b7/20/jmbe-15-248.PMC4278493.pdf
"Andrea Pratt Rediske University of Central Florida, Orlando, FL E-mail: andrea.rediske@ucf.edu Online Resources for Introducing Bioethics through  Case-Studies and Active LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i2.804 Comparative review of: Bioethics 101  https://www.nwabr.org/   sites/default/files/NWABR_Bioethics_101_5.13.pdf  and  Exploring Bioethics https://www.nwabr.org/teacher-center/ bioethics-101#overview .",Non-OADS,/arxiv_data1/oa_pdf/81/27/jmbe-15-249.PMC4278494.pdf
https://www.nwabr.org/teacher-center/ethics-primer#overview .,Non-OADS,/arxiv_data1/oa_pdf/81/27/jmbe-15-249.PMC4278494.pdf
"Joan K. Kiely Stony Brook University, Stony Brook, NYE-mail: joan.kiely@stonybrook.edu Moral Games Teach Bioethics at Any Level DOI: http://dx.doi.org/10.1128/jmbe.v15i2.807 Review of: Moral Games for Teaching Bioethics ; Darryl R. J.  Macer; (2008).",Non-OADS,/arxiv_data1/oa_pdf/81/27/jmbe-15-249.PMC4278494.pdf
http://www.eubios.info/MacerMoralGames.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/27/jmbe-15-249.PMC4278494.pdf
https://www.nwabr.org/teacher-center/ethics-primer#overview .,Non-OADS,/arxiv_data1/oa_pdf/54/13/jmbe-15-250.PMC4278495.pdf
"Joan K. Kiely Stony Brook University, Stony Brook, NYE-mail: joan.kiely@stonybrook.edu Moral Games Teach Bioethics at Any Level DOI: http://dx.doi.org/10.1128/jmbe.v15i2.807 Review of: Moral Games for Teaching Bioethics ; Darryl R. J.  Macer; (2008).",Non-OADS,/arxiv_data1/oa_pdf/54/13/jmbe-15-250.PMC4278495.pdf
http://www.eubios.info/MacerMoralGames.pdf.,Non-OADS,/arxiv_data1/oa_pdf/54/13/jmbe-15-250.PMC4278495.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 251-258 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.693 Journal of Microbiology & Biology Education   251 Volume 15, Number 2Research ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/da/f6/jmbe-15-251.PMC4278496.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/da/f6/jmbe-15-251.PMC4278496.pdf
Accessed May 2014 at http://www.ucd.ie/t4cms/ucdtla0034.pdf .,Non-OADS,/arxiv_data1/oa_pdf/da/f6/jmbe-15-251.PMC4278496.pdf
Accessed August 2009 at http://ww2.odu.edu/educ/roverbau/Bloom/blooms_taxonomy.htm .,Non-OADS,/arxiv_data1/oa_pdf/da/f6/jmbe-15-251.PMC4278496.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 259-267 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.703 Journal of Microbiology & Biology Education   259 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/6f/bb/jmbe-15-259.PMC4278497.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/6f/bb/jmbe-15-259.PMC4278497.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 268-276 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.724 Research Journal of Microbiology & Biology Education  Volume 15, Number 12 268*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jmbe-15-268.PMC4278498.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jmbe-15-268.PMC4278498.pdf
http://pubtrackonline.com/products/ higher.asp?loc1=education.,Non-OADS,/arxiv_data1/oa_pdf/1c/0d/jmbe-15-268.PMC4278498.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 277-286 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.734 Journal of Microbiology & Biology Education   277 Volume 15, Number 2Curriculum ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4e/61/jmbe-15-277.PMC4278499.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/4e/61/jmbe-15-277.PMC4278499.pdf
http://visionandchange.org/finalreport/.,Non-OADS,/arxiv_data1/oa_pdf/4e/61/jmbe-15-277.PMC4278499.pdf
http://www.ted.com/talks/ bonnie_bassler_on_how_bacteria_communicate.html .,Non-OADS,/arxiv_data1/oa_pdf/4e/61/jmbe-15-277.PMC4278499.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 287-291 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.754 Journal of Microbiology & Biology Education   287 Volume 15, Number 2Curriculum ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b0/56/jmbe-15-287.PMC4278500.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b0/56/jmbe-15-287.PMC4278500.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 292-294 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.638 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 292©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/07/1c/jmbe-15-292.PMC4278501.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/07/1c/jmbe-15-292.PMC4278501.pdf
"ncbi.nlm.nih.gov ), guiding students through finding a gene  by name, obtaining the DNA sequence, and searching for similar sequences with the Basic Local Alignment Search Tool (BLAST) ( http://blast.ncbi.nlm.nih.gov/ ).",Non-OADS,/arxiv_data1/oa_pdf/07/1c/jmbe-15-292.PMC4278501.pdf
Students could later be directed to background information on the diseases at Genetics Home Reference ( http://ghr.nlm.nih.gov/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/1c/jmbe-15-292.PMC4278501.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 295-296 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.651 Journal of Microbiology & Biology Education   295 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/b6/88/jmbe-15-295.PMC4278502.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/b6/88/jmbe-15-295.PMC4278502.pdf
"PROCEDURE  In these kits, atoms are modeled using STYROFOAM  balls that have been coated for durability (see Appendix 1 for detail on building kits, as well as video demonstration of kit usage at http://www.jht.com/icuf/Science-Math%20Master/Science-Math_Master_Molecules.html) .",Non-OADS,/arxiv_data1/oa_pdf/b6/88/jmbe-15-295.PMC4278502.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 297-298 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.695 Journal of Microbiology & Biology Education   297 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/5c/2f/jmbe-15-297.PMC4278503.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/5c/2f/jmbe-15-297.PMC4278503.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 299-300 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.699 Journal of Microbiology & Biology Education   299 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7e/91/jmbe-15-299.PMC4278504.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/7e/91/jmbe-15-299.PMC4278504.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 301-303 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.713 Journal of Microbiology & Biology Education   301 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://pewinternet.org/Reports/2013/Social-media-users.aspx .,Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://www.educatorstechnology.,Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://www.scribd.com/collections/2978508/Facebook-for-Educators .,Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
"Videos Gram Stain Procedure Ernie Godsey, http://www.youtube.com/watch?v=OQ6C-gj_UHM) HIV Lifecycle Howard Hughes Medical Institute, http://www.hhmi.org/biointeractive/   hiv-life-cycle How We’ll Stop Polio   for GoodBruce Aylward, http://www.ted.com/talks/bruce_aylward_how_we_ll_stop_ polio.html  T utorials, Animations The Scale of the Universe Cary and Michael Huang, http://htwins.net/scale2  Cellular Immunity W. H. Freeman Publishers, http://bcs.whfreeman.com/thelifewire/content/ chp18/1802003.html News/Media Reports It’s T urkey Time: Safely   Prepare Y our Holiday MealCDC, http://www.cdc.gov/features/turkeytime/ MERS Virus Found in   Patient’s Pet CamelDonald G. McNeil Jr., http://www.nytimes.com/2013/11/12/world/middleeast/ saudi-arabia-mers-virus-found-in-patients-pet-camel.html?_r=0 Humor Comic Strips Games Sneeze (Flash game on   spreading infections)Oil Productions and Playerthree, http://www.miniclip.com/games/sneeze/en/   Podcasts Meet the Scientist:   “E.",Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
"coli and the human gut” American Society for Microbiology, http://www.microbeworld.org/careers/ audio-interviews/244-mts5-brett-finlay-ecoli-and-the-human-gut).",Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
"This Week in Parasitism,   “Tapeworms, the long   and short of it”Vincent Racaniello and Dickson Despommier, http://www.microbeworld.org/ podcasts/this-week-in-parasitism/archives/615-twip-6-tapeworms-the-long- and-short-of-it",Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://www.nielsen.,Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://www.nielsen.com/content/ dam/corporate/us/en/reports-downloads/2013%20Reports/ Mobile-Consumer-Report-2013.pdf.,OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
http://www.onlinecollege.org/2012/05/21/100-ways-you-should-be-using-facebook-in-your-classroom-updated/.,Non-OADS,/arxiv_data1/oa_pdf/63/e1/jmbe-15-301.PMC4278505.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 304-306 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.714 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 304Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
"Commercial kits are also available, such as organic chemistry building kits students may already own—purchased for a chemistry class for example, such as a MolyMod kit (http://www.molymod.com/sets.html) (see supplemental materials).",Non-OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
"There are also more expensive protein-building kits and 3D models from several companies, such as the Tangle Proteins (https://www.tanglecreations.com/products/Details.aspx?p=854), about $35 per kit, which makes three models (Fig.",Non-OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
http://wuhsag.weebly.com/uploads/1/4/0/9/14095127/pipe_cleaner_ protein_modeling.docx .,OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
http://www.indiana.edu/~oso/lessons/prot/folding1.,Non-OADS,/arxiv_data1/oa_pdf/c9/f9/jmbe-15-304.PMC4278506.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 307-309 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.735 Journal of Microbiology & Biology Education   307 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/11/98/jmbe-15-307.PMC4278507.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/11/98/jmbe-15-307.PMC4278507.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 310-312 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.737 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 310*Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/68/c4/jmbe-15-310.PMC4278508.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/68/c4/jmbe-15-310.PMC4278508.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 313-315 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.741 Journal of Microbiology & Biology Education   313 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/59/2a/jmbe-15-313.PMC4278509.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/59/2a/jmbe-15-313.PMC4278509.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 316-318 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.742 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 316Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/jmbe-15-316.PMC4278510.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/a6/0a/jmbe-15-316.PMC4278510.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 319-320 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.752 Journal of Microbiology & Biology Education   319 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/90/1a/jmbe-15-319.PMC4278511.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/90/1a/jmbe-15-319.PMC4278511.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 321-322 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.763 Journal of Microbiology & Biology Education   321 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/e3/ef/jmbe-15-321.PMC4278512.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/e3/ef/jmbe-15-321.PMC4278512.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 323-324 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.768 Journal of Microbiology & Biology Education   323 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/9c/3c/jmbe-15-323.PMC4278513.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/9c/3c/jmbe-15-323.PMC4278513.pdf
http://visionandchange.org/finalreport.,Non-OADS,/arxiv_data1/oa_pdf/9c/3c/jmbe-15-323.PMC4278513.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 325-327 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.789 Journal of Microbiology & Biology Education   325 Volume 15, Number 2Tips & Tools ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
"Alternative methods for building simple biofilm growth chambers can be utilized (see Chapter 11 in the Biofilm Hy - pertextbook for examples, http://www.hypertextbookshop.com/biofilmbook/v004/r003/ ).",Non-OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
"Qiagen spin columns were used to clean up PCR prior to sequencing, and samples were mailed to a regional facility ( http://www.biotech.cornell.edu/brc/genomics ) for  sequencing.",OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
"Goal Resource 1) Change orientation of reverse data http://www.bioinformatics.org/sms/rev_comp.html 2)  Compare forward and reverse sequence (from Step 1) for differences http://www.ebi.ac.uk/T ools/msa/clustalw2/ 3)  Consult raw chromatogram to resolve differences http://www.geospiza.com/Products/finchtv.shtml 4) Compare consensus sequence to database EzTaxon at http://www.ezbiocloud.net/ 5)  Assemble multiple alignment and phylogenic tree of highest hits on EzTaxon http://www.ebi.ac.uk/T ools/msa/clustalw2/!""#""$!""$#""%!""%#""&!""&#""'!""",Non-OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
http://www.plosone.org/ .,Non-OADS,/arxiv_data1/oa_pdf/69/1b/jmbe-15-325.PMC4278514.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 328-329 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.794 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 328Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/87/b9/jmbe-15-328.PMC4278515.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/87/b9/jmbe-15-328.PMC4278515.pdf
"Indeed, genetic testing is mainstream with some commercial efforts being approved by the FDA ( http://www.fda.gov/medical   devices/productsandmedicalprocedures/invitrodiagnostics/ucm330711.htm ) and tests being documented by the NIH  through the Genetic Testing Registry ( http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/87/b9/jmbe-15-328.PMC4278515.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 330-331 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.796 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 330Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/84/68/jmbe-15-330.PMC4278516.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/84/68/jmbe-15-330.PMC4278516.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 332-334 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.815 Tips & Tools Journal of Microbiology & Biology Education  Volume 15, Number 12 332 Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
"The stories used in the classroom (see http://www.slideshare.net/karobi/story-telling-in-the-classroom-lilly-conference-presentation-2014-1hr-session-copy-3 for syllabus) were broadly based on two books, Tears of the Cheetah by Stephen J. O’Brien (3),  and The Journey of Man by Spencer Wells (5).",Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
(For an example see http://www.slideshare.net/karobi/tears-of-the-cheetah?utm_campaign=ss_search&utm_medium=default&utm_source=9&qid=4f225c94-313b-461b-   8348-dd66a87bd915&v=default&b=&from_search=9.),Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
"In “The Journey of Man,” information on genetic mark - ers and chromosome mapping was integrated into the story (see http://www.slideshare.net/karobi/story-telling-in-the- classroom-lilly-conference-presentation-2014-1hr-session-copy-3 ).",Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
"For visual con - tent, pictures, links to videos ( http://www.youtube.com/ watch?v=nBJDGzzrMyQ&list=PLWZV5kah919pzbtXykm_zFVCJ2NkLFi4v ), and educational resources ( https:// genographic.nationalgeographic.com ) were added.",Non-OADS,/arxiv_data1/oa_pdf/14/fc/jmbe-15-332.PMC4278517.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 335-338 Copyright © 2014 American Society for Microbiology Journal of Microbiology & Biology Education   335 Volume 15, Number 2Reviews JOURNAL WATCH  DOI: http://dx.doi.org/10.1128/jmbe.v15i2.854 In this section, I provide articles on recent develop - ments and new technology used in microbiology and related  fields.",Non-OADS,/arxiv_data1/oa_pdf/b5/79/jmbe-15-335-a.PMC4278518.pdf
"BOOKS  Introducing Undergraduates to Global Health Epidemiology, Emerging Infectious Diseases, and Parasitology: A Small Book with a Big ImpactDOI: http://dx.doi.org/10.1128/jmbe.v15i2.791 Review of: Forgotten People, Forgotten Diseases: The Neglected  Tropical Diseases and their Impact on Global Health and De - velopment , 2 nd Edition; Peter J. Hotez; (2013).",Non-OADS,/arxiv_data1/oa_pdf/b5/79/jmbe-15-335-a.PMC4278518.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 335-338 Copyright © 2014 American Society for Microbiology Journal of Microbiology & Biology Education   335 Volume 15, Number 2Reviews JOURNAL WATCH  DOI: http://dx.doi.org/10.1128/jmbe.v15i2.854 In this section, I provide articles on recent develop - ments and new technology used in microbiology and related  fields.",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/jmbe-15-335-b.PMC4278519.pdf
"BOOKS  Introducing Undergraduates to Global Health Epidemiology, Emerging Infectious Diseases, and Parasitology: A Small Book with a Big ImpactDOI: http://dx.doi.org/10.1128/jmbe.v15i2.791 Review of: Forgotten People, Forgotten Diseases: The Neglected  Tropical Diseases and their Impact on Global Health and De - velopment , 2 nd Edition; Peter J. Hotez; (2013).",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/jmbe-15-335-b.PMC4278519.pdf
"Dara L. Wegman-Geedey Augustana College, Rock Island, ILE-mail: darawegman-geedey@augustana.eduEvidence-Based Strategies to Improve Memory and LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i2.790 Review of: Make It Stick: The Science of Successful Learning;  Peter C. Brown, Henry L. Roediger III, and Mark A. McDaniel; (2014).",Non-OADS,/arxiv_data1/oa_pdf/2a/a1/jmbe-15-335-b.PMC4278519.pdf
"Dara L. Wegman-Geedey Augustana College, Rock Island, ILE-mail: darawegman-geedey@augustana.eduEvidence-Based Strategies to Improve Memory and LearningDOI: http://dx.doi.org/10.1128/jmbe.v15i2.790 Review of: Make It Stick: The Science of Successful Learning;  Peter C. Brown, Henry L. Roediger III, and Mark A. McDaniel; (2014).",Non-OADS,/arxiv_data1/oa_pdf/e0/eb/jmbe-15-336.PMC4278520.pdf
"Heidi M. Sleister Drake University, Des Moines, IAE-mail: heidi.sleister@drake.edu Overuse of Antibiotics: A Voice (with Multiple  Agendas) Crying Out in the Microbial WildernessDOI: http://dx.doi.org/10.1128/jmbe.v15i2.793 Review of: Missing Microbes: How the Overuse of Antibiotics is  Fueling our Modern Plagues ; Martin J. Blaser; (2014).",Non-OADS,/arxiv_data1/oa_pdf/e0/eb/jmbe-15-336.PMC4278520.pdf
"Heidi M. Sleister Drake University, Des Moines, IAE-mail: heidi.sleister@drake.edu Overuse of Antibiotics: A Voice (with Multiple  Agendas) Crying Out in the Microbial WildernessDOI: http://dx.doi.org/10.1128/jmbe.v15i2.793 Review of: Missing Microbes: How the Overuse of Antibiotics is  Fueling our Modern Plagues ; Martin J. Blaser; (2014).",Non-OADS,/arxiv_data1/oa_pdf/92/32/jmbe-15-337.PMC4278521.pdf
"Narveen Jandu Ashland University, Ashland, OHE-mail: njandu@ashland.eduMark O. Martin University of Puget Sound, Tacoma, WAE-mail: mowenmartin@gmail.com Getting to Know Your Microbiota in Health and  DiseaseDOI: http://dx.doi.org/10.1128/jmbe.v15i2.772 Review of:  The Human Microbiota: How Microbial Communities  Affect Health and Disease ; David N. Fredricks (ed.",Non-OADS,/arxiv_data1/oa_pdf/92/32/jmbe-15-337.PMC4278521.pdf
"Narveen Jandu Ashland University, Ashland, OHE-mail: njandu@ashland.eduMark O. Martin University of Puget Sound, Tacoma, WAE-mail: mowenmartin@gmail.com Getting to Know Your Microbiota in Health and  DiseaseDOI: http://dx.doi.org/10.1128/jmbe.v15i2.772 Review of:  The Human Microbiota: How Microbial Communities  Affect Health and Disease ; David N. Fredricks (ed.",Non-OADS,/arxiv_data1/oa_pdf/e3/dc/jmbe-15-338.PMC4278522.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 81 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.883 Journal of Microbiology & Biology Education   81 Volume 15, Number 2Editorial  ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/4f/93/jmbe-15-81.PMC4278523.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/4f/93/jmbe-15-81.PMC4278523.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 82 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.878 Journal of Microbiology & Biology Education  Volume 15, Number 12 82 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/9f/06/jmbe-15-82.PMC4278524.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/9f/06/jmbe-15-82.PMC4278524.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 83-87 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.874 Journal of Microbiology & Biology Education   83 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/7f/43/jmbe-15-83.PMC4278525.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/7f/43/jmbe-15-83.PMC4278525.pdf
http://www.faseb.org/portals/2/ pdfs/opa/ori2000.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7f/43/jmbe-15-83.PMC4278525.pdf
http://www.faseb.org/portals/2/Content/ NSF_RCR_Letter.4.7.09.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7f/43/jmbe-15-83.PMC4278525.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 88-92 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.849 Journal of Microbiology & Biology Education  Volume 15, Number 12 88©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
http://www.asbmb.org/asbmbtoday/asbmbtoday_article.,Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
http://grants.nih.gov/grants/guide/ historical/1989_12_22_Vol_18_No_45.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
http://grants.nih.gov/grants/guide/notice-files/not-od-10-019.html.,Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
http://www.nsf.gov/pubs/policydocs/pappguide/nsf10_1/aag_4.jsp#IVB.,Non-OADS,/arxiv_data1/oa_pdf/3c/9b/jmbe-15-88.PMC4278526.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 93-95 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.866 Journal of Microbiology & Biology Education   93 Volume 15, Number 2 ©2014 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/db/4a/jmbe-15-93.PMC4278527.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/db/4a/jmbe-15-93.PMC4278527.pdf
http://www.nap.edu/catalog.php?record_id=10430 .,Non-OADS,/arxiv_data1/oa_pdf/db/4a/jmbe-15-93.PMC4278527.pdf
http://www.nap.edu/catalog.php?record_ id=12695 .,Non-OADS,/arxiv_data1/oa_pdf/db/4a/jmbe-15-93.PMC4278527.pdf
http://grants.nih.gov/grants/guide/notice-files/not- od-10-019.ht ml.,Non-OADS,/arxiv_data1/oa_pdf/db/4a/jmbe-15-93.PMC4278527.pdf
"JOURNAL OF MICROBIOLOGY & BIOLOGY EDUCATION, December 2014, p. 96-99 DOI: http://dx.doi.org/10.1128/jmbe.v15i2.865 Journal of Microbiology & Biology Education  Volume 15, Number 12 96 *Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/ef/e3/jmbe-15-96.PMC4278528.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-NoDerivatives 4.0 International  license (https://creativecommons.org/licenses/by-nc-nd/4.0/ and https://creativecommons.org/licenses/by-nc-nd/4.0/legalcode), which grants the public the nonexclusive right to copy, distribute, or display the published work.",Non-OADS,/arxiv_data1/oa_pdf/ef/e3/jmbe-15-96.PMC4278528.pdf
"Microarray data preprocessing Microarray data preprocessing and analysis were performed using R (http://cran.r-project.org) and tools from the Biocon-ductor project (http://www.bioconductor.org), adapted to our needs.",OADS,/arxiv_data1/oa_pdf/b6/14/ijc0136-0656.PMC4278533.pdf
Microarray data have been deposited at theEuropean Genome-phenome Archive (EGA; https://www.ebi.,OADS,/arxiv_data1/oa_pdf/b6/14/ijc0136-0656.PMC4278533.pdf
Sequence reads were preprocessed for quality and trimmed using a combination of in-house Ruby scripts andopen-source tools ( http://wiki.bioinformatics.ucdavis.edu/index.php /Trim.pl andhttp://www.mothur.org/ ).,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
"In addition, the small fraction of noncoding mRNA reads(from 0.01 to 7.3% of the total generated reads per library) was furtherBLAST searched against the BSRD database (http://kwanlab.bio.cuhk.edu.hk/BSRD), where sequence matches of /H1102228 nt with /H1102298% sequence homology and an E value of 0.001 were considered.",OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
"Statistical analyses were carried out using both PRIMER (v.6.1.6, PRIMER-E; Plymouth Marine Laboratory) and the freesoftware R package for statistical computing and graphics (http://www.r-project.org).",OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
The RNA sequencing reads have been deposited at the European Nucleotide Archive under the accessionnumber PRJEB6003 (http://www.ebi.ac.uk/ena/data/view/PRJEB6003).,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
Lancet 368: 874 – 885. http://dx.doi.org/10.1016/ S0140-6736(06)68853-3 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1056/NEJM199808203390806 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1128/ jb.184.4.1095-1101.2002 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1371/journal.pone.0041329 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1093/ infdis/jit668 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1016/j.ajpath.2012.07.005 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
189: 4275– 4289. http://dx.doi.org/10.1128/JB.00081-07 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1128/IAI.69.6.3744-3754.2001 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1016/S0300- 9084(01)01250-0 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/ 10.1016/j.ijmm.2013.11.009 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
EMBO J.18:6934 – 6949. http://dx.doi.org/10.1093/emboj/18.24.6934 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1146/annurev.micro.62.081307.162903 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1016/S0065- 2911(06)51004-5 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1016/ j.matbio.2006.01.005 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1038/nrmicro1289 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1038/ni1235 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
Microbiol.2:12. http://dx.doi.org/10.3389/fcimb.2012.00012 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
11:667– 673. http://dx.doi.org/10.1038/ nrmicro3110 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
16: 451– 456. http://dx.doi.org/10.1111/cmi.12233 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/ 10.1016/S0168-6445(03)00055-X .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1007/ s10534-005-4863-7 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1016/j.femsre.2003.09.003 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1371/journal.ppat.1002006 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/ 10.2741/908 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
1:70 – 87. http://dx.doi.org/10.1159/ 000181144 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
56:4131– 4139. http://dx.doi.org/10.1128/AAC.00273-12 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
32:463– 488. http://dx.doi.org/10.1615/ CritRevImmunol.v32.i6.10 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1371/journal.ppat.1000899 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
182:4995– 4997. http://dx.doi.org/10.1128/JB.182.17.4995-4997.2000 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
"http://dx.doi.org/10.1371/ journal.ppat.1000944 .37.Alonzo F III, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ.",OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
83:423– 435. http://dx.doi.org/10.1111/j.1365- 2958.2011.07942.x .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1086/656043 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
69:6902– 6911. http://dx.doi.org/10.1128/ IAI.69.11.6902-6911.2001 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/ 10.1086/592051 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1128/JB.186.4.1175- 1181.2004 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
Cell 43:880 – 891. http://dx.doi.org/ 10.1016/j.molcel.2011.08.022 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
49:4821– 4823. http://dx.doi.org/10.1128/AAC.49.12.4821- 4833.2005 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1111/j.1365-2958.2010.07455.x .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/ 10.1016/j.ijmm.2013.03.004 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1038/nrmicro1384 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1002/emmm.201000115 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
http://dx.doi.org/10.1093/nar/25.17.3389 .,Non-OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
Nat.Methods 5:621– 628. http://dx.doi.org/10.1038/nmeth.1226 .,OADS,/arxiv_data1/oa_pdf/3c/80/mBio.01775-14.PMC4278534.pdf
